# EDGAR Filing Document

**Accession Number:** 0001898601
**File Stem:** 0001898601-25-000013
**Filing Date:** 2025-10
**Character Count:** 630463
**Document Hash:** 5dd5c9f16c36cd393b62d631a1905406
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001898601-25-000013.hdr.sgml**: 20251014

**ACCESSION NUMBER**: 0001898601-25-000013

**CONFORMED SUBMISSION TYPE**: 20-F

**PUBLIC DOCUMENT COUNT**: 127

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20251014

**DATE AS OF CHANGE**: 20251014

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IPERIONX Ltd
- **CENTRAL INDEX KEY:** 0001898601
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS METAL ORES [1090]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 20-F
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41338
- **FILM NUMBER:** 251392260

**BUSINESS ADDRESS:**
- **STREET 1:** 129 W TRADE STREET
- **STREET 2:** SUITE 1405
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28202
- **BUSINESS PHONE:** 9802378900

**MAIL ADDRESS:**
- **STREET 1:** 129 W TRADE STREET
- **STREET 2:** SUITE 1405
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hyperion Metals Ltd
- **DATE OF NAME CHANGE:** 20211210

?xml version='1.0' encoding='ASCII'? ipx-20250630

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

As filed with the Securities and Exchange Commission on October 14, 2025

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, DC 20549

**FORM 20-F**

□ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the fiscal year ended <u>June 30, 2025</u>**

OR

□ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

□ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of event requiring this shell company report

For the transition period from __________ to __________

Commission file number <u>001-41338</u>

**IPERIONX LIMITED**

(Exact name of Registrant as specified in its charter)

---

| | |
|:---|:---|
| **N/A** | **AUSTRALIA** |
| (Translation of Registrant's name into English) | (Jurisdiction of incorporation or organization) |

---

**129 W Trade Street**

**Suite 1405**

**Charlotte, NC 28202**

(Address of principal executive offices)

**Anastasios Arima**

**Chief Executive Officer and Managing Director**

**(980) 237-8900 (telephone)**

**info@iperionx.com (e-mail)**

**129 W Trade Street**

**Suite 1405**

**Charlotte, NC 28202**

*(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)*

Securities registered or to be registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| *<u>Title of each class</u>* | *<u>Trading Symbol(s)</u>* | *<u>Name of each exchange on which registered or to be registered:</u>* |
| American Depositary Shares each representing 10 Ordinary Shares, no par value<sup>(1)</sup> | **IPX** | The Nasdaq Capital Market |

---

______________________________________

<sup>(1)</sup> Evidenced by American Depositary Receipts

Securities registered or to be registered pursuant to Section 12(g) of the Act:

**None**

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

**None**

______________________________________

Number of outstanding shares of each of the issuer's classes of capital or common stock as of June 30, 2025:

**319,927,854 ordinary shares**

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes □ No ⌧

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Yes □ No ⌧

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ⌧ No □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company

Large accelerated filer ⌧ Accelerated filer □ Non-accelerated filer □ Emerging growth company □

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ⌧

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. □

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). □

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

□&nbsp;&nbsp;&nbsp;&nbsp;U.S. GAAP

⌧&nbsp;&nbsp;&nbsp;&nbsp;International Financial Reporting Standards as issued by the International Accounting Standards Board

□&nbsp;&nbsp;&nbsp;&nbsp;Other

If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item 17 □ Item 18 □

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes □ No ⌧

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

Yes □ No □

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**TABLE OF CONTENTS**

---

| | | | |
|:---|:---|:---|:---|
| <u>[Glossary of Terms and Definitions](#i760a975fe85d4d298949348d23ef9dde_1074)</u> | <u>[Glossary of Terms and Definitions](#i760a975fe85d4d298949348d23ef9dde_1074)</u> | <u>[Glossary of Terms and Definitions](#i760a975fe85d4d298949348d23ef9dde_1074)</u> | [3](#i760a975fe85d4d298949348d23ef9dde_1074) |
| <u>[INTRODUCTION](#i760a975fe85d4d298949348d23ef9dde_10)</u> | <u>[INTRODUCTION](#i760a975fe85d4d298949348d23ef9dde_10)</u> | <u>[INTRODUCTION](#i760a975fe85d4d298949348d23ef9dde_10)</u> | [7](#i760a975fe85d4d298949348d23ef9dde_10) |
| <u>[ABOUT THIS ANNUAL REPORT](#i760a975fe85d4d298949348d23ef9dde_13)</u> | <u>[ABOUT THIS ANNUAL REPORT](#i760a975fe85d4d298949348d23ef9dde_13)</u> | <u>[ABOUT THIS ANNUAL REPORT](#i760a975fe85d4d298949348d23ef9dde_13)</u> | [8](#i760a975fe85d4d298949348d23ef9dde_13) |
| <u>[PART I.](#i760a975fe85d4d298949348d23ef9dde_16)</u> | <u>[PART I.](#i760a975fe85d4d298949348d23ef9dde_16)</u> | <u>[PART I.](#i760a975fe85d4d298949348d23ef9dde_16)</u> | [10](#i760a975fe85d4d298949348d23ef9dde_16) |
| | [ITEM 1](#i760a975fe85d4d298949348d23ef9dde_19) | <u>[IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS](#i760a975fe85d4d298949348d23ef9dde_19)</u> | [10](#i760a975fe85d4d298949348d23ef9dde_19) |
| | [ITEM 2](#i760a975fe85d4d298949348d23ef9dde_22) | <u>[OFFER STATISTICS AND EXPECTED TIMETABLE](#i760a975fe85d4d298949348d23ef9dde_22)</u> | [10](#i760a975fe85d4d298949348d23ef9dde_22) |
| | [ITEM 3](#i760a975fe85d4d298949348d23ef9dde_25) | <u>[KEY INFORMATION](#i760a975fe85d4d298949348d23ef9dde_25)</u> | [10](#i760a975fe85d4d298949348d23ef9dde_25) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_28) | <u>[\[Reserved\]](#i760a975fe85d4d298949348d23ef9dde_28)</u> | [10](#i760a975fe85d4d298949348d23ef9dde_28) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_31) | <u>[Capitalization and Indebtedness](#i760a975fe85d4d298949348d23ef9dde_31)</u> | [10](#i760a975fe85d4d298949348d23ef9dde_31) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_34) | <u>[Reasons for the Offer and Use of Proceeds](#i760a975fe85d4d298949348d23ef9dde_34)</u> | [10](#i760a975fe85d4d298949348d23ef9dde_34) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[D.](#i760a975fe85d4d298949348d23ef9dde_37) | <u>[Risk Factors](#i760a975fe85d4d298949348d23ef9dde_37)</u> | [11](#i760a975fe85d4d298949348d23ef9dde_37) |
| | [ITEM 4](#i760a975fe85d4d298949348d23ef9dde_40) | <u>[INFORMATION ON THE COMPANY](#i760a975fe85d4d298949348d23ef9dde_40)</u> | [26](#i760a975fe85d4d298949348d23ef9dde_40) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_43) | <u>[History and Development of the Company](#i760a975fe85d4d298949348d23ef9dde_43)</u> | [26](#i760a975fe85d4d298949348d23ef9dde_43) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_46) | <u>[Business Overview](#i760a975fe85d4d298949348d23ef9dde_46)</u> | [26](#i760a975fe85d4d298949348d23ef9dde_46) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_49) | <u>[Organizational Structure](#i760a975fe85d4d298949348d23ef9dde_49)</u> | [47](#i760a975fe85d4d298949348d23ef9dde_49) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[D.](#i760a975fe85d4d298949348d23ef9dde_52) | <u>[Property, Plant and Equipment](#i760a975fe85d4d298949348d23ef9dde_52)</u> | [48](#i760a975fe85d4d298949348d23ef9dde_52) |
| | [ITEM 4A.](#i760a975fe85d4d298949348d23ef9dde_55) | <u>[UNRESOLVED STAFF COMMENTS](#i760a975fe85d4d298949348d23ef9dde_55)</u> | [56](#i760a975fe85d4d298949348d23ef9dde_55) |
| | [ITEM 5.](#i760a975fe85d4d298949348d23ef9dde_58) | <u>[OPERATING AND FINANCIAL REVIEW AND PROSPECTS](#i760a975fe85d4d298949348d23ef9dde_58)</u> | [56](#i760a975fe85d4d298949348d23ef9dde_58) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_61) | <u>[Operating Results](#i760a975fe85d4d298949348d23ef9dde_61)</u> | [57](#i760a975fe85d4d298949348d23ef9dde_61) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_64) | <u>[Liquidity and Capital Resources](#i760a975fe85d4d298949348d23ef9dde_64)</u> | [58](#i760a975fe85d4d298949348d23ef9dde_64) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_67) | <u>[Research and Development, Patents and Licenses](#i760a975fe85d4d298949348d23ef9dde_67)</u> | [61](#i760a975fe85d4d298949348d23ef9dde_67) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[D.](#i760a975fe85d4d298949348d23ef9dde_70) | <u>[Trend Information](#i760a975fe85d4d298949348d23ef9dde_70)</u> | [61](#i760a975fe85d4d298949348d23ef9dde_70) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[E.](#i760a975fe85d4d298949348d23ef9dde_73) | <u>[Critical Accounting Policies and Estimates](#i760a975fe85d4d298949348d23ef9dde_73)</u> | [61](#i760a975fe85d4d298949348d23ef9dde_73) |
| | [ITEM 6.](#i760a975fe85d4d298949348d23ef9dde_76) | <u>[DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES](#i760a975fe85d4d298949348d23ef9dde_76)</u> | [61](#i760a975fe85d4d298949348d23ef9dde_76) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_79) | <u>[Directors and Senior Management](#i760a975fe85d4d298949348d23ef9dde_79)</u> | [61](#i760a975fe85d4d298949348d23ef9dde_79) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_82) | <u>[Compensation](#i760a975fe85d4d298949348d23ef9dde_82)</u> | [64](#i760a975fe85d4d298949348d23ef9dde_82) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_85) | <u>[Board Practices](#i760a975fe85d4d298949348d23ef9dde_85)</u> | [77](#i760a975fe85d4d298949348d23ef9dde_85) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[D.](#i760a975fe85d4d298949348d23ef9dde_88) | <u>[Employees](#i760a975fe85d4d298949348d23ef9dde_88)</u> | [79](#i760a975fe85d4d298949348d23ef9dde_88) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[E.](#i760a975fe85d4d298949348d23ef9dde_91) | <u>[Share Ownership](#i760a975fe85d4d298949348d23ef9dde_91)</u> | [79](#i760a975fe85d4d298949348d23ef9dde_91) |
| | [ITEM 7.](#i760a975fe85d4d298949348d23ef9dde_97) | <u>[MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS](#i760a975fe85d4d298949348d23ef9dde_97)</u> | [79](#i760a975fe85d4d298949348d23ef9dde_97) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_100) | <u>[Major Shareholders](#i760a975fe85d4d298949348d23ef9dde_100)</u> | [79](#i760a975fe85d4d298949348d23ef9dde_100) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_103) | <u>[Related Party Transactions](#i760a975fe85d4d298949348d23ef9dde_103)</u> | [81](#i760a975fe85d4d298949348d23ef9dde_103) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_106) | <u>[Interests of Experts and Counsel](#i760a975fe85d4d298949348d23ef9dde_106)</u> | [81](#i760a975fe85d4d298949348d23ef9dde_106) |
| | [ITEM 8.](#i760a975fe85d4d298949348d23ef9dde_109) | <u>[FINANCIAL INFORMATION](#i760a975fe85d4d298949348d23ef9dde_109)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_109) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_112) | <u>[Consolidated Statements and Other Financial Information](#i760a975fe85d4d298949348d23ef9dde_112)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_112) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_115) | <u>[Significant Changes](#i760a975fe85d4d298949348d23ef9dde_115)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_115) |
| | [ITEM 9.](#i760a975fe85d4d298949348d23ef9dde_118) | <u>[THE OFFER AND LISTING](#i760a975fe85d4d298949348d23ef9dde_118)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_118) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_121) | <u>[Offer and Listing Details](#i760a975fe85d4d298949348d23ef9dde_121)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_121) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_124) | <u>[Plan of Distribution](#i760a975fe85d4d298949348d23ef9dde_124)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_124) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_127) | <u>[Markets](#i760a975fe85d4d298949348d23ef9dde_127)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_127) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[D.](#i760a975fe85d4d298949348d23ef9dde_130) | <u>[Selling Shareholders](#i760a975fe85d4d298949348d23ef9dde_130)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_130) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[E.](#i760a975fe85d4d298949348d23ef9dde_133) | <u>[Dilution](#i760a975fe85d4d298949348d23ef9dde_133)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_133) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[F.](#i760a975fe85d4d298949348d23ef9dde_136) | <u>[Expenses of the Issue](#i760a975fe85d4d298949348d23ef9dde_136)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_136) |
| | [ITEM 10.](#i760a975fe85d4d298949348d23ef9dde_139) | <u>[ADDITIONAL INFORMATION](#i760a975fe85d4d298949348d23ef9dde_139)</u> | [82](#i760a975fe85d4d298949348d23ef9dde_139) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_142) | <u>[Share Capital](#i760a975fe85d4d298949348d23ef9dde_142)</u> | [83](#i760a975fe85d4d298949348d23ef9dde_142) |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

---

| | | | |
|:---|:---|:---|:---|
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_145) | <u>[Constitutional Documents](#i760a975fe85d4d298949348d23ef9dde_145)</u> | [83](#i760a975fe85d4d298949348d23ef9dde_145) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_148) | <u>[Material Contracts](#i760a975fe85d4d298949348d23ef9dde_148)</u> | [97](#i760a975fe85d4d298949348d23ef9dde_148) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[D.](#i760a975fe85d4d298949348d23ef9dde_151) | <u>[Exchange Controls](#i760a975fe85d4d298949348d23ef9dde_151)</u> | [97](#i760a975fe85d4d298949348d23ef9dde_151) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[E.](#i760a975fe85d4d298949348d23ef9dde_154) | <u>[Taxation](#i760a975fe85d4d298949348d23ef9dde_154)</u> | [97](#i760a975fe85d4d298949348d23ef9dde_154) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[F.](#i760a975fe85d4d298949348d23ef9dde_157) | <u>[Dividends and Paying Agents](#i760a975fe85d4d298949348d23ef9dde_157)</u> | [104](#i760a975fe85d4d298949348d23ef9dde_157) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[G.](#i760a975fe85d4d298949348d23ef9dde_160) | <u>[Statement by Experts](#i760a975fe85d4d298949348d23ef9dde_160)</u> | [104](#i760a975fe85d4d298949348d23ef9dde_160) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[H.](#i760a975fe85d4d298949348d23ef9dde_163) | <u>[Documents on Display](#i760a975fe85d4d298949348d23ef9dde_163)</u> | [104](#i760a975fe85d4d298949348d23ef9dde_163) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[I.](#i760a975fe85d4d298949348d23ef9dde_166) | <u>[Subsidiary Information](#i760a975fe85d4d298949348d23ef9dde_166)</u> | [105](#i760a975fe85d4d298949348d23ef9dde_166) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[J.](#i760a975fe85d4d298949348d23ef9dde_169) | <u>[Annual Report to Security Holders](#i760a975fe85d4d298949348d23ef9dde_169)</u> | [105](#i760a975fe85d4d298949348d23ef9dde_169) |
| | [ITEM 11.](#i760a975fe85d4d298949348d23ef9dde_172) | <u>[QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#i760a975fe85d4d298949348d23ef9dde_172)</u> | [105](#i760a975fe85d4d298949348d23ef9dde_172) |
| | [ITEM 12.](#i760a975fe85d4d298949348d23ef9dde_175) | <u>[DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES](#i760a975fe85d4d298949348d23ef9dde_175)</u> | [106](#i760a975fe85d4d298949348d23ef9dde_175) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[A.](#i760a975fe85d4d298949348d23ef9dde_178) | <u>[Debt Securities](#i760a975fe85d4d298949348d23ef9dde_178)</u> | [106](#i760a975fe85d4d298949348d23ef9dde_178) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[B.](#i760a975fe85d4d298949348d23ef9dde_181) | <u>[Warrants and Rights](#i760a975fe85d4d298949348d23ef9dde_181)</u> | [106](#i760a975fe85d4d298949348d23ef9dde_181) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[C.](#i760a975fe85d4d298949348d23ef9dde_184) | <u>[Other Securities](#i760a975fe85d4d298949348d23ef9dde_184)</u> | [106](#i760a975fe85d4d298949348d23ef9dde_184) |
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[D.](#i760a975fe85d4d298949348d23ef9dde_187) | <u>[American Depositary Shares](#i760a975fe85d4d298949348d23ef9dde_187)</u> | [107](#i760a975fe85d4d298949348d23ef9dde_187) |
| <u>[PART II.](#i760a975fe85d4d298949348d23ef9dde_190)</u> | <u>[PART II.](#i760a975fe85d4d298949348d23ef9dde_190)</u> | <u>[PART II.](#i760a975fe85d4d298949348d23ef9dde_190)</u> | [109](#i760a975fe85d4d298949348d23ef9dde_190) |
| | [ITEM 13.](#i760a975fe85d4d298949348d23ef9dde_193) | <u>[DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES](#i760a975fe85d4d298949348d23ef9dde_193)</u> | [109](#i760a975fe85d4d298949348d23ef9dde_193) |
| | [ITEM 14.](#i760a975fe85d4d298949348d23ef9dde_196) | <u>[MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS](#i760a975fe85d4d298949348d23ef9dde_196)</u> | [109](#i760a975fe85d4d298949348d23ef9dde_196) |
| | [ITEM 15.](#i760a975fe85d4d298949348d23ef9dde_199) | <u>[CONTROLS AND PROCEDURES](#i760a975fe85d4d298949348d23ef9dde_199)</u> | [109](#i760a975fe85d4d298949348d23ef9dde_199) |
| | [ITEM 16.](#i760a975fe85d4d298949348d23ef9dde_202) | <u>[\[RESERVED\]](#i760a975fe85d4d298949348d23ef9dde_202)</u> | [110](#i760a975fe85d4d298949348d23ef9dde_202) |
| | [ITEM 16A.](#i760a975fe85d4d298949348d23ef9dde_205) | <u>[AUDIT COMMITTEE FINANCIAL EXPERT](#i760a975fe85d4d298949348d23ef9dde_205)</u> | [110](#i760a975fe85d4d298949348d23ef9dde_205) |
| | [ITEM 16B.](#i760a975fe85d4d298949348d23ef9dde_208) | <u>[CODE OF ETHICS](#i760a975fe85d4d298949348d23ef9dde_208)</u> | [110](#i760a975fe85d4d298949348d23ef9dde_208) |
| | [ITEM 16C.](#i760a975fe85d4d298949348d23ef9dde_211) | <u>[PRINCIPAL ACCOUNTANT FEES AND SERVICES](#i760a975fe85d4d298949348d23ef9dde_211)</u> | [111](#i760a975fe85d4d298949348d23ef9dde_211) |
| | [ITEM 16D.](#i760a975fe85d4d298949348d23ef9dde_214) | <u>[EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES](#i760a975fe85d4d298949348d23ef9dde_214)</u> | [111](#i760a975fe85d4d298949348d23ef9dde_214) |
| | [ITEM 16E.](#i760a975fe85d4d298949348d23ef9dde_217) | <u>[PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS](#i760a975fe85d4d298949348d23ef9dde_217)</u> | [111](#i760a975fe85d4d298949348d23ef9dde_217) |
| | [ITEM 16F.](#i760a975fe85d4d298949348d23ef9dde_220) | <u>[CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT](#i760a975fe85d4d298949348d23ef9dde_220)</u> | [111](#i760a975fe85d4d298949348d23ef9dde_220) |
| | [ITEM 16G.](#i760a975fe85d4d298949348d23ef9dde_223) | <u>[CORPORATE GOVERNANCE](#i760a975fe85d4d298949348d23ef9dde_223)</u> | [111](#i760a975fe85d4d298949348d23ef9dde_223) |
| | [ITEM 16H.](#i760a975fe85d4d298949348d23ef9dde_226) | <u>[MINE SAFETY DISCLOSURE](#i760a975fe85d4d298949348d23ef9dde_226)</u> | [112](#i760a975fe85d4d298949348d23ef9dde_226) |
| | [ITEM 16J.](#i760a975fe85d4d298949348d23ef9dde_229) | <u>[INSIDER TRADING POLICIES](#i760a975fe85d4d298949348d23ef9dde_229)</u> | [112](#i760a975fe85d4d298949348d23ef9dde_229) |
| | [ITEM 16K.](#i760a975fe85d4d298949348d23ef9dde_232) | <u>[CYBERSECURITY](#i760a975fe85d4d298949348d23ef9dde_232)</u> | [112](#i760a975fe85d4d298949348d23ef9dde_232) |
| <u>[PART III.](#i760a975fe85d4d298949348d23ef9dde_235)</u> | <u>[PART III.](#i760a975fe85d4d298949348d23ef9dde_235)</u> | <u>[PART III.](#i760a975fe85d4d298949348d23ef9dde_235)</u> | [112](#i760a975fe85d4d298949348d23ef9dde_235) |
| | [ITEM 17.](#i760a975fe85d4d298949348d23ef9dde_238) | <u>[FINANCIAL STATEMENTS](#i760a975fe85d4d298949348d23ef9dde_238)</u> | [112](#i760a975fe85d4d298949348d23ef9dde_238) |
| | [ITEM 18.](#i760a975fe85d4d298949348d23ef9dde_241) | <u>[FINANCIAL STATEMENTS](#i760a975fe85d4d298949348d23ef9dde_241)</u> | [112](#i760a975fe85d4d298949348d23ef9dde_241) |
| | [ITEM 19.](#i760a975fe85d4d298949348d23ef9dde_244) | <u>[EXHIBITS](#i760a975fe85d4d298949348d23ef9dde_244)</u> | [113](#i760a975fe85d4d298949348d23ef9dde_244) |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**GLOSSARY OF TERMS AND DEFINITIONS**

When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:

---

| | |
|:---|:---|
| ADSs | American Depository Shares |
| ALC | Australian land corporation |
| AMC | Advanced Manufacturing Center |
| Apollo Group | Apollo Group Pty Ltd |
| ARPA-E | Advanced Research Projects Agency-Energy |
| ARH<sup>TM</sup> | IperionX proprietary technology for alkaline roasting and hydrolysis |
| ASIC | Australian Securities and Investments Commission |
| ASTM | American Society of Testing and Materials |
| ASX | Australian Securities Exchange |
| Blacksand | Blacksand Technology LLC |
| CAA | Clean Air Act |
| CAP | Compensation Advisory Partners |
| CCO | Chief Commercial Officer |
| CEO | Chief Executive Officer |
| CERCLA | Comprehensive Environmental Response, Compensation, and Liability Act |
| CFI | Conduit foreign income |
| CFO | Chief Financial Officer |
| CO2e | Carbon dioxide equivalents |
| COO | Chief Operating Officer |
| CSO | Chief Strategy Officer |
| CWA | Clean Water Act |
| DoW | Department of War |
| DRS | Direct Registration System |
| DTC | Depository Trust Company |
| DPA Title III | a provision of the Defense Production Act of 1950 that allows the President to expand the production and supply of critical materials necessary for national defense. |
| ECL | Expected credit loss |
| EPA | United States Environmental Protection Agency |
| EPS | Earnings per share |
| ESA | Endangered Species Act |
| Exchange Act | U.S. Securities Exchange Act of 1934, as amended |
| FATA | Foreign Acquisition and Takeovers Act |
| FIP | Foreign Investment Policy |
| FIRB | Foreign Investment Review Board |
| GHGs | Greenhouse gases |
| Green Rutile<sup>TM</sup> | IperionX proprietary technology for low carbon titanium mineral enrichment |
| GSD<sup>TM</sup> | IperionX proprietary technology for the granulation sintering deoxygenation process |
| HAMR<sup>TM</sup> | IperionX patented technology for hydrogen assisted metallothermic reduction |
| HMAPL | Hyperion Metals (Australia) Pty Ltd |
| HSPT<sup>TM</sup> | IperionX patented technology for hydrogen sintering and phase transformation process |
| HfO₂ | Hafnium Dioxide |
| IAS | International Accounting Standards |
| IASB | International Accounting Standards Board |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

---

| | |
|:---|:---|
| IBAS | U.S. DoW Industrial Base Analysis and Sustainment grant program |
| IFRS | International Financial Reporting Standards |
| IperionX Limited | "Company" or "IperionX", "Consolidated Entity" or "Group" |
| IP | Intellectual property |
| IPF | Industrial Pilot Facility in Salt Lake City, Utah |
| IRS Code | Internal Revenue Code of 1986, as amended |
| JORC Code | Joint Ore Reserves Committee of The Australasian Institute of Mining and Metallurgy, Australian Institute of Geoscientists and Minerals Council of Australia |
| kg | kilogram |
| KMP | Key Management Personnel |
| KPI's | Key performance indicators |
| LCA | Life Cycle Assessment |
| LTI's | Long term incentives |
| LTIP | Long-term incentive plan |
| Mt | Metric ton |
| N/A | Not applicable |
| Nasdaq | Nasdaq Capital Market |
| NEDs | Non-Executive Directors |
| NEPA | National Environmental Policy Act |
| Ordinary Shares | Common shares, equity instruments that give shareholders voting rights and potential dividends |
| PCAOB | Public Company Accounting Oversight Board |
| Performance Rights | Unquoted performance rights |
| Performance Shares | Contingent stock awards that are vesting based on performance metrics |
| PFIC | Passive foreign investment company |
| QEF | Qualified Electing Fund |
| QP | Qualified Person |
| R&D | Research and development |
| RCRA | Resource Conservation and Recovery Act |
| REE | Rare earth elements |
| RSUs | Restricted stock units |
| Regulation FD | Regulation Fair Disclosure |
| SBIR | Small Business Innovation Research |
| SDWA | Safe Drinking Water Act |
| SEC | Securities and Exchange Commission |
| Securities Act | U.S. Securities Act of 1933 |
| S-K 1300 | Regulation S-K, Subpart 1300, under the Securities Act of 1933, as amended |
| SPCC plans | Spill prevention, control and countermeasure plans |
| STI | Short term incentives |
| Technologies | IperionX's collection of patents to certain titanium and metal alloy production technologies |
| THM | Metric tons of total heavy metal |
| TiCl4 | Titanium tetrachloride |
| TiO2 | Titanium dioxide |
| TiH2 | Titanium hydride |
| Ti-6Al-4V | Grade 5 titanium alloy |
| Titan Project | Titan Critical Minerals Project in Tennessee |
| tpa | Tons per annum |
| TPF | Titanium Production Facility |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

---

| | |
|:---|:---|
| TREO | Total rare earth oxides |
| Treaty | the Convention between the Government of the United States of America and the Government of Australia for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income, as amended |
| U.S. | United States of America |
| USACE | U.S. Army Corps of Engineers |
| U.S. GAAP | U.S. generally accepted accounting principles |
| UIC | Underground Injection Control |
| Unlisted Options | Unquoted incentive options |
| VWAP | Volume-weighted average price |
| WA | Weighted average |
| WCP | Wet Concentrator Plant |
| ZrO2 | Zirconium Dioxide |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

![Image_1.jpg](ipx-20250630_g1.jpg)

**INTRODUCTION**

IperionX is set to be a leading American titanium metal and critical materials company – using patented titanium technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions.

IperionX's award-winning patented technology portfolio enables high strength forged titanium alloy products at low cost, with class-leading sustainability and superior process energy efficiencies when compared to current industry methods such as the Kroll process.

Using its technologies, IperionX has now transitioned to be a growing commercial producer of titanium metal products in the United States.

IperionX produces low-cost and high-quality angular and spherical titanium powder, which is used to produce near-net-shape and final titanium parts through powder metallurgy or additive manufacturing. These technologies provide IperionX with a sustainable competitive advantage and significant value uplift from upgrading raw titanium materials through to finished high-performance titanium products when compared to traditional titanium industry supply chains.

*Operations are underway to re-shore a low cost, sustainable, U.S. titanium supply chain*

Titanium has superior material properties that are prized across advanced industries, including high strength, light weight and corrosion resistance.

However, the U.S. no longer produces any primary titanium metal (i.e. titanium sponge), including for defense, with China and Russia controlling around 75% of global supply.

IperionX is now actively re-shoring a low-cost, sustainable U.S. titanium supply chain, through the commercialization of its titanium technologies and its commercial operations in Virginia.

*Commissioning of initial commercial operations is complete; an order of magnitude scale up is now underway* 

IperionX has demonstrated commercial-scale titanium production, with the commissioning and commencement of commercial operations at the Titanium Manufacturing Campus in Virginia, United States, at a rate of 125 metric tons per year, and has detailed its plans to scale up to 1,400 metric tons per year in 2027.

*Global leadership in advanced manufacturing of high-performance titanium components* 

IperionX is aiming for global leadership in advanced manufacturing of high-performance titanium components of over 10,000 tpa by 2030, and has developed a plan to scale titanium capacity in high-performance titanium components, targeting cost competitiveness with stainless steel and aluminum.

The aggregate market value of the registrant's voting and non-voting shares held by non-affiliates of the registrant on December 31, 2024, the last business day of the registrant's most recently completed second fiscal quarter was approximately $1.08 billion (assuming that the registrant's only affiliates are its officers, directors and non-institutional 10% shareholders) based upon the closing market price on that date of A$5.50 per share as reported on the Nasdaq Capital Market.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**ABOUT THIS ANNUAL REPORT**

Unless otherwise indicated or the context implies otherwise, any reference in this annual report on Form 20-F to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "IperionX" refers to IperionX Limited, an Australian corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "the Company," "the Group", "we," "us," or "our" refer to IperionX and its consolidated subsidiaries, through which it conducts its business, unless otherwise indicated;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "shares" or "ordinary shares" refers to ordinary shares of IperionX;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "ADS" refers to the American Depositary Shares; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "ASX" refers to the Australian Securities Exchange.

Unless otherwise indicated, all references to "A$" are to Australian dollars, and all references to "US$" and "$" are to United States dollars. Our financial statements are presented in U.S. dollars which is the Company's presentation currency. This annual report on Form 20-F contains references to U.S. dollars where the underlying transaction or event was denominated in U.S. dollars. This annual report on Form 20-F contains forward-looking statements that involve risks and uncertainties. See "*Cautionary Note Regarding Forward-Looking Statements.*"

**CAUTIONARY NOTE TO UNITED STATES INVESTORS**

We are subject to the reporting requirements of the applicable U.S. and Australian securities laws, and as a result we will report any mineral reserves and mineral resources as required by both of these standards. As an Australian listed public company, we are required to report in Australia any estimates of mineral resources and ore reserves in terms of "Measured, Indicated and Inferred" Mineral Resources and "Proved and Probable" Ore Reserves in compliance with the JORC 2012, Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves. The JORC Code was prepared by the Joint Ore Reserves Committee of The Australasian Institute of Mining and Metallurgy, Australian Institute of Geoscientists and Minerals Council of Australia. These defined terms contained within the JORC Code differ in some respects from the definitions under the U.S. Securities Act of 1933, as amended, including in Regulation S-K 1300.

Information about mineral reserves and resources, if any, contained in our filings with the SEC also will be presented in compliance with S-K 1300. While guidelines for reporting mineral resources, including subcategories of measured, indicated and inferred resources, are largely similar between JORC Code and S-K 1300 standards, information contained in our future SEC filings that describes mineral deposits may not be directly comparable to similar information made public by other U.S. companies under the SEC's old reporting standard, Industry Guide 7, or to similar information published by other ASX-listed companies. Investors are cautioned that any public disclosure we make in Australia as to mineral reserves or resources in accordance with ASX Listing Rules will not form a part of our SEC filings except to the extent stated therein.

**INDUSTRY AND MARKET DATA**

This annual report includes information with respect to market and industry conditions and market share from third-party sources or that is based upon estimates using such sources when available. We believe that such information and estimates are reasonable and reliable. We also believe the information extracted from publications of third-party sources has been accurately reproduced. However, we have not independently verified any of the data from third-party sources. Similarly, our internal research is based upon the understanding of industry conditions, and such information has not been verified by any independent sources.

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

Certain information included in this annual report on Form 20-F may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Such forward-looking statements concern our anticipated results and progress of our operations in future periods, planned exploration and, if warranted, development of our properties, plans related to our business and other matters that may occur in the future. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. All statements contained herein that are not clearly historical in nature are forward-looking, and the words "anticipate", "believe", "expect", "estimate", "may", "will", "could", "leading", "intend", "contemplate", "aim", "shall" and similar expressions are generally intended to identify forward-looking

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

statements. Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements. Forward-looking statements in this annual report on Form 20-F include, but are not limited to, statements with respect to: risks related to our limited operating history in the titanium metal manufacturing industry; risks related to our ability to commercialize our titanium technologies; risks related to our ability to produce titanium metal powders and products to customers' exact specification; risks related to our ability to identify and contract long-term offtake customers for our titanium metal products; risks related to our limited operating history in the minerals extraction industry; risks related to our status as an exploration stage company; risks related to our ability to identify mineralization and achieve commercial minerals extraction; risks related to minerals extraction, exploration and extraction site construction, if warranted, on our properties; risks related to our ability to fully achieve and maintain profitability and to develop positive cash flow from any minerals extraction activities; risks related to investment risk and operational costs associated with our exploration activities; risks related to our ability to access capital and the financial markets; risks related to compliance with government regulations; risks related to our ability to acquire necessary minerals extraction licenses, permits or access rights; risks related to environmental liabilities and reclamation costs; risks related to volatility in minerals and metals prices or demand for minerals and metals; risks related to stock price and trading volume volatility; risks relating to the development of an active trading market for the ADSs; risks related to ADS holders not having certain shareholder rights; risks related to ADS holders not receiving certain distributions; risks related to our status as a foreign private issuer; and risks related to the other matters described in the section titled "Risk Factors."

All forward-looking statements reflect our beliefs and assumptions based on information available at the time the assumption was made. These forward-looking statements are not based on historical facts but rather on management's expectations regarding future activities, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. By its nature, forward-looking information involves numerous assumptions, inherent risks and uncertainties, both general and specific, known and unknown, that contribute to the possibility that the predictions, forecasts, projections or other forward-looking statements will not occur. Although we have attempted to identify important factors that could cause actual results to differ materially from those described in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the securities laws of the United States and Australia, we disclaim any obligation to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events. We qualify all the forward-looking statements contained in this annual report on Form 20-F by the foregoing cautionary statements.

**PRESENTATION OF FINANCIAL INFORMATION**

Our fiscal year ends on June 30. We designate our fiscal year by the year in which that fiscal year ends; for example, fiscal 2025 refers to our fiscal year ended June 30, 2025.

Unless otherwise indicated, the consolidated financial statements and related notes included in this annual report are presented in U.S. dollars and have been prepared in accordance with IFRS as issued by the IASB which differ in certain significant respects from generally accepted accounting principles in the United States, or U.S. GAAP. As a result, our financial statements may not be comparable to the financial statements of U.S. companies. Because the U.S. SEC has adopted rules to accept financial statements prepared in accordance with IFRS as issued by the IASB without reconciliation to U.S. GAAP from foreign private issuers such as us, we will not be providing a description of the principal differences between U.S. GAAP and IFRS.

Our financial statements are presented in U.S. dollars, which is the Company's presentation currency. This annual report contains translations of some Australian dollar amounts into U.S. dollars. Except as otherwise stated in this annual report, all translations from Australian dollars to U.S. dollars are based on the rates published by the Reserve Bank of Australia. No representation is made that the Australian dollar amounts referred to in this annual report could have been or could be converted into U.S. dollars at such rate.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**QUALIFIED PERSON**

Unless otherwise indicated, the disclosure of exploration results and mineral resources included in this annual report is based on, and accurately reflects, information and supporting documentation prepared, reviewed and approved by Karst Geo Solutions, LLC, who is a qualified person within the meaning of S-K 1300 and is not affiliated with the Company.

**COMPETENT PERSONS STATEMENT**

As required by Australian securities laws and the ASX Listing Rules, we hereby notify Australian investors that the information in this annual report that relates to Exploration Results and Mineral Resources was extracted from our ASX announcement dated October 6, 2021 which is available to view on the Company's website at www.iperionx.com. We confirm to Australian investors that (a) we are not aware of any new information or data that materially affect the information included in the original ASX announcement; (b) all material assumptions and technical parameters underpinning the Mineral Resource estimate included in the original ASX announcement continue to apply and have not materially changed; and (c) the form and context in which the relevant Competent Persons' findings are presented in this annual report have not been materially changed from the original ASX announcement. "Competent Person" under the Australian rules is a minerals industry professional who is a Member or Fellow of The Australasian Institute of Mining and Metallurgy, or of the Australian Institute of Geoscientists, or of a "Recognized Professional Organization", as included in a list available on the JORC and ASX websites.

**PART I.**

**ITEM 1&nbsp;&nbsp;&nbsp;&nbsp;IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS**

Not applicable.

**ITEM 2&nbsp;&nbsp;&nbsp;&nbsp;OFFER STATISTICS AND EXPECTED TIMETABLE**

Not applicable.

**ITEM 3&nbsp;&nbsp;&nbsp;&nbsp;KEY INFORMATION**

A.**[Reserved]**

B.**Capitalization and Indebtedness**

Not applicable.

C.**Reasons for the Offer and Use of Proceeds**

Not applicable.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

D.**Risk Factors**

*You should carefully consider the risks described below, together with all of the other information in this annual report on Form 20-F. If any of the following risks occur, our business, financial condition and results of operations could be seriously harmed, and you could lose all or part of your investment. Further, if we fail to meet the expectations of the public market in any given period, the market price of the ADSs could decline. We operate in a competitive environment that involves significant risks and uncertainties, some of which are outside of our control. If any of these risks actually occurs, our business and financial condition could suffer and the price of the ADSs could decline.*

**Risks Related to Our Business**

***We have a history of financial losses and expect to incur continuing losses in the near future.***

We incurred net losses of $35.3 million and $21.8 million for fiscal 2025 and fiscal 2024, respectively. We incurred net cash outflows from operating and investing activities of $46.1 million and $25.1 million for fiscal 2025 and fiscal 2024, respectively. We believe that we will continue to incur net losses until the recently commenced commercial scale production of titanium metals ramps up. At June 30, 2025, we had cash reserves of $54.8 million and net assets of $92.4 million.

In the longer term, the successful scale-up of the Company's titanium metal production capacity and/or the development of economically recoverable mineral deposits on the Company's mineral properties depends on the ability of the Company to obtain financing through equity financing, debt financing or other means. If the Company's exploration programs are ultimately successful, additional funds will be required to expand the Company's titanium metal production capacity and/or develop the Company's mineral properties and to place them into commercial production. The ability to arrange such funding in the future will depend in part upon the prevailing capital market conditions as well as the business performance of the Company. There can be no assurance that the Company will be successful in its efforts to raise additional funding on terms satisfactory to the Company. If adequate funding is not available, the Company may be required to delay, reduce the scope of, or eliminate its future business activities or relinquish rights to certain of its interests.

Although the Company's financial statements for the year ended June 30, 2025 were prepared based on the assumption of going concern, failure to obtain additional funding on a timely basis could materially and adversely affect our plans for expansion, results of operations, cash flows, and financial condition or prospects.

***Our continued growth depends on our ability to fully scale-up our commercial titanium metal production capacity and failure to commercially scale our closed-loop titanium production processes may result in material adverse impacts to, or failure to achieve, our growth projections.***

Sustained growth of our company relies on our ability to fully scale up our titanium metal production capacity. Examples of things that could jeopardize that production progress include: an adverse event at a production facility; a delay in procuring necessary equipment for processing our titanium; and/or difficulty hiring and training qualified employees. If we are unsuccessful in reaching and maintaining expected production rates, including by failing to reach anticipated throughput, recoveries, uptimes, yields, or any combination thereof, within expected time frames or at all, we may not be able to build a sustainable or profitable metals technology business as currently expected or at all.

We announced in August 2024, that we had successfully commissioned our HAMR furnace, marking the first titanium de-oxygenation product run at our Virginia facility. Despite this success, it remains possible that we may have difficulty commercially scaling up our production processes at new or existing facilities at a sufficient level to generate meaningful revenue. Failure to do so may result in material adverse impacts to, or failure to achieve, our growth projections. This could be due to a variety of factors, including hiring and training new personnel, implementing new production processes, recalibrating and re-qualifying existing processes, the inability to achieve repeatable processes, impurities, defects with respect to the equipment or facilities, and the inability to achieve required yield levels. In the future, we may face construction delays or interruptions, infrastructure failure, or delays in upgrading or expanding existing facilities or changing our process technologies, which may adversely affect our ability to scale up production in accordance with our plans. Our failure to scale up our production on a timely basis could cause delays in product deliveries, which may result in the loss of customers and sales. For products that cannot meet the quality standards of our customers, we may suffer indemnification losses in addition to the production cost. It could also prevent us from recouping our investments in a timely manner or at all, and otherwise adversely affect our business and operating results.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***Unanticipated costs or delays associated with our ongoing titanium metal commercialization may materially and adversely affect our financial condition or results of operations.***

The full commercialization and scale-up of the Technologies will require the commitment of substantial resources and capital expenditures. Our future expenditures may increase as consultants, personnel and equipment associated with our efforts are added. The success of the full commercialization and scale-up of the Technologies and the amounts and timing of expenditures to fully commercialize and scale-up the Technologies will depend in part on the following: our ability to timely procure equipment or repair existing equipment, certain of which may involve long lead-times; maintaining, and procuring, as required, applicable federal, state and local permits; the results of consultants' analysis and recommendations; negotiating contracts for equipment, earthwork, construction, equipment installation, labor and completing infrastructure and construction work; effects of planned and unplanned shut-downs and delays in our production; effects of stoppages or delays on construction projects; disputes with contractors or other third parties; negotiating sales and offtake contracts for our planned production; the execution of any joint venture agreements or similar arrangements with strategic partners; the impact of pandemics on our business, our strategic partners' or suppliers' businesses, logistics or the global economy; the impact of the wars on the global economy; the effects of inflation; and other factors, many of which are beyond our control. Most of these activities require significant lead times and must be advanced concurrently. Unanticipated costs or delays associated with a full commercialization and scale-up of the Technologies could materially and adversely affect our financial condition or results of operations and could require us to seek additional capital.

***If our titanium metal products fail to perform as expected in our customers' desired applications, our ability to develop, market and sell our products could be adversely affected.***

Our products may contain defects in design and manufacture that may cause them to not perform as expected or that may require repairs, recalls, and design changes. Our products incorporate technology and components that may have not been used for other applications and that may contain defects and errors, particularly when first introduced. We have a limited frame of reference from which to evaluate the long-term performance of our planned products. We cannot assure you that we will be able to detect and fix any defects in our products prior to sale. If our products fail to perform as expected, we may lose customers or customers may delay or terminate orders, each of which could adversely affect our business, prospects and results of operations.

***We may be unable to adequately control the costs associated with continued expansion of our titanium metal production capacity.***

We require significant capital to develop and grow our business, and we expect to incur significant expenses, including those relating to research and development, raw material procurement, leases, sales and distribution, as we grow our titanium metal production capacity. Our ability to become profitable will depend on successfully marketing our titanium metal products while controlling our costs. If we are unable to cost effectively design, manufacture, market, sell and distribute our titanium metal products, our margins, profitability and prospects would be materially and adversely affected.

***Titanium mineral extraction and processing and the production of titanium products involves complex safety and operational risks.***

The extraction and processing of titanium minerals and the production of titanium metal products involve serious safety and operational risks. Operational problems or errors with the machinery could result in personal injury to or death of workers, the loss of production equipment, damage to manufacturing facilities, monetary losses, delays and unanticipated fluctuations in production. In addition, operational problems may result in environmental damage, administrative fines, increased insurance costs and potential legal liabilities. All of these safety and operational problems could materially and adversely affect our business, results of operations, cash flows, financial condition or prospects.

***If we fail to accurately predict our manufacturing requirements and timelines, we could incur additional costs or experience delays.***

We are in the early stages of commercializing our products, and we have limited historical information to accurately assess demand for our ability to extract and process titanium and to develop, manufacture and deliver titanium metal products. As a result, it is difficult to predict our future revenues and expenses or trends in such revenues or expenses.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***We may be adversely affected by fluctuations in demand for, and prices of, titanium metal and products.***

We expect to generate revenue from the sale of titanium products. As a result, our profitability could be adversely affected by changes in demand for, and the market price of, titanium products.

***The success of our business will depend on the growth of existing and emerging uses for titanium.***

The success of our business will depend on the growth of existing and emerging uses for titanium. Our business strategy principally relies on commercializing the Technologies to produce titanium products for markets including consumer electronics, aerospace, space, defense, medical, additive manufacturing and automotive. Our long-term success depends on the continued growth of these markets and successfully commercializing titanium metal products in such markets. Our estimates of market opportunity and market growth, whether derived from third-party sources or developed internally, are subject to significant uncertainty and are based on assumptions and estimates that may prove to be inaccurate. If these markets do not grow as we expect or if the demand for our intended products decreases, then our business, prospects, financial condition and operating results could be adversely affected.

***If we are unable to protect our right to the Technologies, our business and competitive position could be adversely affected.***

We rely heavily on our right to use our licensed Technologies to grow our business. We may not be able to prevent unauthorized use of such Technology, which could harm our business and competitive position. We rely upon a combination of license agreements, patents, trademarks and trade secret laws in the United States, as well as other contractual protections, to establish, maintain and enforce our rights. Despite our efforts to protect our rights to the Technologies, third parties may attempt to copy or otherwise obtain and use such Technology. Monitoring unauthorized use of such Technologies is difficult and costly, and any steps take to prevent misappropriation may not be sufficient, could be time-consuming and expensive and could divert management's attention, which could harm our business, results of operations and financial condition.

In addition, companies holding patents or other intellectual property rights relating to titanium technologies may bring suits alleging infringement of such rights by us or otherwise asserting rights in or licenses to the Technologies. If we are determined to have infringed upon a third party's intellectual property rights, we may be required to cease using the challenged intellectual property, to pay substantial damages or to obtain a license from the holder of the infringed rights. In the event of a successful claim of infringement against us, our business, prospects, operating results and financial condition could be materially adversely affected. In addition, any litigation or claims, whether or not valid, could result in substantial costs and diversion of resources and management's attention.

Patent, trademark and trade secret laws vary significantly throughout the world. A number of foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States. Therefore, our intellectual property rights may not be as strong or as easily enforced outside of the United States and efforts to protect against the unauthorized use of our intellectual property rights, Technology and other proprietary rights may be more expensive and difficult outside of the United States. Failure to adequately protect our intellectual property rights could result in our competitors using our intellectual property to offer products, potentially resulting in the loss of some of our competitive advantage and a decrease in its revenue which would adversely affect our business, prospects, financial condition and operating results.

***Changes in the U.S. political environment and federal policies, including changes in research grant funding policy or the potential critical materials designation of titanium metal may adversely affect our financial condition and results of operations.***

Our business may be adversely affected by the current and future political environment in the United States and the policies of the U.S. federal government, including changes in research grant funding policy or the potential critical materials designation of titanium metal. IperionX is currently undertaking a definitive feasibility study on the Titan Project, funded by the U.S. Department of Defense. A material reduction or termination of such funding would adversely affect our business, prospects, financial condition and operating results.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***Some of our assets used in the TPF are acquired with federal government funds. The U.S. government holds the title with respect to such assets.***

Our operations, particularly the TPF, rely on federal funds for the acquisition of certain assets, including equipment and real property. See "Item 5. *Operating and Financial Review and Prospectus – Liquidity and Capital Resources- Funding Requirements and Capital Expenditures.*" Under the terms of this funding arrangement, title to all equipment and real property acquired with federal funds vests with the U.S. government. The U.S. government can elect to, but is not obliged to, transfer such title to all or a portion of the equipment or real property to the Company at the end of the agreement, which is scheduled to terminate on January 30, 2027, if the Company's performance is satisfactory and subject to other conditions. This arrangement presents several risks to our business:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Loss of Use of Certain Assets: Because the title to these assets is held by the U.S. government, we do not have full control over them. Any changes in government policy or a decision by the U.S. government not to transfer title of some or all of these assets to the Company at the end of the agreement could adversely affect our operations. If the U.S. government were to exercise its rights to reclaim these assets, we might be unable to continue operating the TPF effectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Operational Disruptions: Some of the assets acquired with federal funds are integral to the operation of the TPF. If we are required to relinquish these assets to the U.S. government, it could jeopardize our ability to operate the facility. This could lead to operational disruptions, increased costs, and potential loss of revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Dependency on Federal Funding: Our reliance on federal funds for acquiring certain assets makes us dependent on continued government support. Any reduction in federal funding or changes in the terms of funding could impact our ability to acquire or operate certain assets in the future, thereby affecting our operational capabilities and financial performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Regulatory and Compliance Risks: The use of federal funds subjects us to additional regulatory and compliance requirements. Any failure to comply with these requirements could result in penalties, loss of funding, or other adverse consequences that could negatively impact our business operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financial Implications: Any decision by the U.S. government not to transfer title of some or all of these assets to the Company at the end of the agreement may necessitate additional expenditures to replace or replicate these assets, thereby increasing our capital expenditures and affecting our financial condition.

Accordingly, our dependence on federal funds and the resulting government ownership of certain assets poses risks to our operations, financial performance, and overall business continuity.

***There is no guarantee that our properties contain mineral deposits that are economically extractable.***

We currently have no reserves, and we cannot assure you about the existence of economically extractable mineralization at this time, nor about the quantity or grade of any mineralization we may have found. In our upstream operations, we are engaged in the business of exploring and developing mineral properties with the intention of locating economic deposits of titanium metal. We cannot assure you that, to the extent economic deposits of minerals are located, such minerals can be commercially extracted. The exploration and development of mineral deposits involves a high degree of financial risk over a significant period of time which a combination of careful evaluation, experience and knowledge of management may not eliminate. While discovery of additional ore-bearing deposits may result in substantial rewards, few properties which are explored are ultimately developed into producing extraction sites. Major expenses may be required to construct extraction and processing facilities. Exploration project items, such as any future estimates of reserves, metal recoveries or cash operating costs will to a large extent be based upon the interpretation of geologic data, obtained from a limited number of drill holes and other sampling techniques, and our ongoing feasibility studies. Because the probability of an individual prospect ever having reserves is uncertain, our properties may not contain any reserves and any funds spent on evaluation and exploration may be lost. Even if we confirm reserves on our properties, any quantity or grade of reserves we indicate must be considered as estimates only until such reserves are actually extracted. We do not know with certainty that economically recoverable metals exist on our properties.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***We face operational risks related to minerals extraction, exploration and site construction.***

We are subject to the operational risks normally encountered in the minerals extraction industry, such as: the discovery of unusual or unexpected geological formations; accidental fires, floods, earthquakes or other natural disasters; unplanned power outages and water shortages; controlling water and other similar extraction hazards; operating labor disruptions and labor disputes; the ability to obtain suitable or adequate machinery, equipment, or labor; our liability for pollution or other hazards; and other known and unknown risks involved in the conduct of exploration and operation of minerals extraction sites. The nature of these risks is such that liabilities could exceed any applicable insurance policy limits or could be excluded from coverage. There are also risks against which we cannot insure or against which we may elect not to insure. The potential costs which could be associated with any liabilities not covered by insurance, or in excess of insurance coverage, or compliance with applicable laws and regulations may cause substantial delays and require significant capital outlays, adversely affecting our results of operations and financial viability.

***We depend on our ability to successfully access the capital and financial markets. Any inability to access the capital or financial markets may limit our ability to fund future operations, execute our business plan or pursue investments that we may rely on for future profit and growth.***

Until we achieve commercial production of critical minerals or scale commercialization of titanium products, we will continue to incur operating and investing net cash outflows. As a result, we rely on access to capital markets as a significant source of funding four our capital and operating requirements. We will require substantial additional capital to fund future expansions. We cannot assure you that such additional funding will be available to us on satisfactory terms, or at all. If we are unable to obtain additional financing, as needed and at competitive rates, our ability to implement our business plan and strategy will be adversely affected. Certain market disruptions may increase our cost of borrowing or affect our ability to access financial markets. Such market disruptions could result from: rising inflation; bank failures and the potential adverse effect on the credit market; adverse economic conditions; adverse general capital market conditions; poor performance and health of the minerals and metals industry or minerals extraction in general; bankruptcy or financial distress of other metals companies; significant decrease in the demand for metals; or adverse regulatory actions that affect our business plans.

***Climate change may adversely affect our business operations.***

We are subject to risks associated with climate change which could harm our results of operations and increase our costs and expenses. The occurrence of severe adverse weather conditions, including increased temperatures, hail, droughts, fires or floods, may have a potentially devastating impact on our operations. Adverse weather may result in physical damage to our operations, instability of our infrastructure and equipment, washed-out roads to our projects, and alter the supply of water and electricity to our mining sites. Increased temperatures may also decrease worker productivity at our projects and raise cooling costs. Should the impacts of climate change be material in nature or occur for lengthy periods of time, our financial condition or results of operations would be adversely affected.

***Cybersecurity risks and cyber incidents may adversely affect our business.***

Attempts to gain unauthorized access to our information technology systems become more sophisticated over time. These attempts, which might be related to industrial or other espionage, include covertly introducing malware to our computers and networks and impersonating authorized users, among others. We seek to detect and investigate all security incidents and to prevent their recurrence, but in some cases, we might be unaware of an incident or its magnitude and effects. The theft, unauthorized use, or publication of our intellectual property and/or confidential business information could harm our competitive position, reduce the value of our investment in research and development and other strategic initiatives or otherwise adversely affect our business. In addition, the devotion of additional resources to the security of our information technology systems in the future could significantly increase the cost of doing business or otherwise adversely impact our financial results.

***We depend on key management employees.***

The responsibility of overseeing the day-to-day operations and strategic management of our business depends substantially on our senior management and key personnel. Loss of such personnel may have an adverse effect on our performance. The success of our operations will depend upon numerous factors, many of which are beyond our control, including our ability to attract and retain key employees and hire qualified management, technical, engineering and sales personnel. We currently depend upon a relatively small number of key persons to seek out and form strategic alliances and find and retain

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

additional employees. We may not be successful in attracting and retaining the personnel required to grow and operate our business profitably.

***Our success will depend in part on developing and maintaining relationships with local communities and other stakeholders.***

Our success may depend in part on developing and maintaining productive relationships with the communities surrounding our operations and other stakeholders in our operating locations. Notwithstanding our ongoing efforts, local communities and stakeholders can become dissatisfied with our activities, which may result in legal or administrative proceedings or campaigns against us, which could materially adversely affect our financial condition, results of operations and cash flows.

***Our business could be adversely affected if our reputation is harmed.***

Our reputation is important to the success of our business. If our reputation is damaged as a result of our actions or by events outside of our control, our business and results of operations could be adversely affected. If we fail to address, or appear to fail to address, successfully and promptly, the underlying causes of any reputational harm, we may be unsuccessful in repairing any damage to our reputation and our future business prospects would likely be adversely affected.

***Our mineral properties may be subject to defects in title.***

The ownership and validity or title of unpatented minerals extraction claims and concessions are often uncertain and may be contested. We also may not have, or may not be able to obtain, all necessary surface rights to develop a property. Although we have taken reasonable measures to ensure proper title to our properties, there is no guarantee that title to any of our properties will not be challenged or impugned. Title insurance is generally not available for mineral properties and our ability to ensure that we have obtained a secure claim to individual mineral properties or extraction concessions may be severely constrained. Our mineral properties may be subject to prior unregistered agreements, transfers or claims, and title may be affected by, among other things, undetected defects. We may incur significant costs related to defending the title to our properties. A successful claim contesting our title to a property may cause us to compensate other persons or perhaps reduce our interest in the affected property or lose our rights to explore and, if warranted, develop that property. This could result in us not being compensated for our prior expenditures relating to the property.

***Our directors and officers may be in a position of conflict of interest.***

Some of our directors and officers currently also serve as directors and officers of other companies involved in similar industries and any of our directors may in the future serve in such positions. There exists the possibility that they may in the future be in a position of conflict of interest. Any decision made by such persons involving us will be made in accordance with their duties and obligations to deal fairly and in good faith with us and such other companies. In addition, any such directors will declare, and refrain from voting on, any matter in which such directors may have a material interest.

***Lawsuits may be filed against us and an adverse ruling in any such lawsuit may adversely affect our business, financial condition or liquidity or the market price of the ADSs.***

The products we intend to supply may be used in potentially hazardous or critical applications that could result in death, personal injury, property damage, loss of production, punitive damages and consequential damages. Actual or claimed defects in the products we supply could result in our being named as a defendant in lawsuits asserting potentially large claims. The outcome of outstanding, pending or future proceedings cannot be predicted with certainty and may be determined adversely to us and as a result, could have a material adverse effect on our assets, liabilities, business, financial condition or results of operations. Even if we prevail in any such legal proceeding, the proceedings could be costly and time-consuming and may divert the attention of management and key personnel from our business operations, which could adversely affect our financial condition.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**The government holds the title to some of our assets.**

Some of our assets used in the Titanium Production Facility are acquired with federal government funds. The government holds the title with respect to such assets. Our operations, particularly the TPF rely on federal funds for the acquisition of certain assets, including equipment and real property.

See "Item 4. *Information on the Company – B. Business Overview*." Under the terms of this funding arrangement, title to all equipment and real property acquired with federal funds vests with the government. The government can elect to, but is not obliged to, transfer such title to all or a portion of the equipment or real property to the Company at the end of the agreement, which is scheduled to terminate on January 30, 2027, if the Company's performance is satisfactory and subject to other conditions. This arrangement presents several risks to our business:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Loss of Use of Certain Assets*: Because the title to these assets is held by the government, we do not have full control over them. Any changes in government policy or a decision by the government not to transfer title of some or all of these assets to the Company at the end of the agreement could adversely affect our operations. If the government were to exercise its rights to reclaim these assets, we might be unable to continue operating the TPF effectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Operational Disruptions*: Some of the assets acquired with federal funds are integral to the operation of the TPF. If we are required to relinquish these assets to the government, it could jeopardize our ability to operate the facility. This could lead to operational disruptions, increased costs, and potential loss of revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Dependency on Federal Funding*: Our reliance on federal funds for acquiring certain assets might make us dependent on continued government support. Any reduction in federal funding or changes in the terms of funding could impact our ability to acquire or operate certain assets in the future, thereby affecting our operational capabilities and financial performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Regulatory and Compliance Risks*: The use of federal funds subjects us to additional regulatory and compliance requirements. Any failure to comply with these requirements could result in penalties, loss of funding, or other adverse consequences that could negatively impact our business operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Financial Implications*: Any decision by the government not to transfer title of some or all of these assets to the Company at the end of the agreement may necessitate additional expenditures to replace or replicate these assets, thereby increasing our capital expenditures and affecting our financial condition.

In summary, our dependence on federal funds and the resulting government ownership of certain assets poses risks to our operations, financial performance, and overall business continuity.

**Risks Related to Regulatory and Industry Matters**

***We have incurred increased costs and become subject to additional regulations and requirements as a result of being a large accelerated filer, which could have a material adverse effect on our business, financial condition, and results of operations, and make it more difficult to run our business or divert management's attention from our business.***

As a public company, we are required to commit significant resources and management time and attention to the requirements of being a public company, which have caused us to incur significant accounting and other expenses, associated with the Sarbanes-Oxley Act and related rules implemented by the SEC and Nasdaq, and compliance with these requirements place significant demands on our legal, accounting and finance staff and on our accounting, financial and information systems.

We intend to hire additional accounting and finance personnel with system implementation experience and expertise regarding compliance with the Sarbanes-Oxley Act. We may be unable to locate and hire qualified professionals with requisite technical and public company experience when and as needed. In addition, new employees will require time and training to learn our business and operating processes and procedures. If we are unable to recruit and retain additional finance personnel or if our finance and accounting team is unable for any reason to respond adequately to the increased demands that will result from being a public company, the quality and timeliness of our financial reporting may suffer, which could result in the identification of material weaknesses in our internal controls. Any consequences resulting from inaccuracies or delays in our reported financial statements could cause our stock price to decline and could harm our business, financial condition, and results of operations

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***We will be subject to significant governmental regulations, including the U.S. Federal Mine Safety and Health Act.***

Minerals extraction activities in the United States are subject to extensive federal, state, local and foreign laws and regulations governing environmental protection, natural resources, prospecting, development, production, post-closure reclamation, taxes, labor standards and occupational health and safety laws and regulations, including mine safety, toxic substances and other matters. The costs associated with compliance with such laws and regulations are substantial. In addition, changes in such laws and regulations, or more restrictive interpretations of current laws and regulations by governmental authorities, could result in unanticipated capital expenditures, expenses or restrictions on or suspensions of our operations and delays in the development of our properties.

***We will be required to obtain and renew governmental permits in order to achieve our business plans, a process that is often costly and time-consuming.***

Obtaining and renewing governmental permits is a complex and time-consuming process. The timeliness and success of permitting efforts are contingent upon many variables not within our control, including the interpretation of permit approval requirements administered by the applicable permitting authority. We may not be able to obtain or renew permits that are necessary to our planned operations or we may find that the cost and time required to obtain or renew such permits exceeds our expectations, which in turn could materially adversely affect our business plans or our prospective or actual revenues and profitability. In addition, private parties, such as environmental activists, frequently attempt to intervene in the permitting process and to persuade regulators to deny necessary permits or seek to overturn permits that have been issued. These third-party actions can materially increase the costs and cause delays in the permitting process and could cause us to not proceed with the development or operation of a property.

***Compliance with environmental regulations and litigation based on environmental regulations could require significant expenditures.***

Environmental regulations mandate, among other things, the maintenance of air and water quality standards, land development and land reclamation, and set forth limitations on the generation, transportation, storage and disposal of solid and hazardous waste. In connection with our current business activities operations, we may incur environmental costs that could have a material adverse effect on financial condition and results of operations. Any failure to remedy an environmental problem could require us to suspend operations or enter into interim compliance measures pending completion of the required remedy. Moreover, governmental authorities and private parties may bring lawsuits based upon damage to property and injury to persons resulting from the environmental, health and safety impacts of prior and current operations, including operations conducted by other extraction companies many years ago at sites located on properties that we currently own or formerly owned. We cannot assure you that any such law, regulation, enforcement or private claim would not have a material adverse effect on our financial condition, results of operations or cash flows. If we violate or fail to comply with applicable environmental laws and regulations, we could be subject to penalties, restrictions on operations or other sanctions. Such liability could materially adversely affect our reputation, business, results of operations and financial condition.

***Mineral and metal prices are subject to unpredictable fluctuations.***

We expect our future revenues, if any, to be derived from the production and sale of titanium and titanium products and also in part from the extraction and sale of critical minerals including titanium, rare earth element, and zircon containing minerals. The price of such minerals and metals may fluctuate widely and is affected by numerous factors beyond our control, including international, economic and political trends, expectations of inflation, currency exchange fluctuations, interest rates, global or regional consumptive patterns, speculative activities, increased production due to new extraction developments and improved extraction and production methods and technological changes in the markets for the end products. The effect of these factors on metals prices, and therefore the economic viability of any of our exploration properties, cannot accurately be predicted. Additionally, new production of critical minerals including titanium, rare earth elements, and zircon from current or new competitors in the critical minerals markets could adversely affect prices. In recent years, new and existing competitors have increased the supply of certain critical minerals including titanium, rare earth elements, and zircon, which may have negatively affected its price. Further production increases could negatively affect prices. We cannot make accurate projections regarding the capacities of possible new entrants into the market and the dates on which they could become operational.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***We are subject to risks associated with currency fluctuations, and changes in foreign currency exchange rates could impact our results of operations.***

Our operating expenses are denominated in U.S. dollars and Australian dollars. Our cash and cash equivalents are denominated in U.S. dollars and Australian dollars. Because we have multiple functional currencies across different jurisdictions, changes in the exchange rate between these currencies and the foreign currencies of the transactions recorded in our accounts could materially impact our reported results of operations and distort period-to-period comparisons. More specifically, as a result of our cash and cash equivalents that are denominated in Australian dollars, any appreciation of the U.S. dollar against the Australian dollar would have a negative effect on the U.S. dollar amount available to us. Appreciation or depreciation in the value of the Australian dollar relative to the U.S. dollar would affect our financial results reported in U.S. dollar terms without giving effect to any underlying change in our business or results of operations. As a result of such foreign currency fluctuations, it could be more difficult to detect underlying trends in our business and results of operations.

***We in the past have had, and in the future may have, a material weakness in our internal control over our financial reporting process. If we are unable to remediate an identified material weakness, we may not be able to accurately or timely report our financial condition or results of operations.***

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis. In connection with the audits of our 2023 and 2024 consolidated financial statements, we identified control deficiencies in the design and operation of our internal control over financial reporting that constituted material weaknesses. Management assessed and our independent registered public accounting firm audited our internal control over financial reporting for the year ended June 30, 2025. As of June 30, 2025, these material weaknesses were remediated, see "Part II - Item 15-*Controls and Procedures*". Although we were able to remediate this past material weakness, there is no guarantee that we will not identify additional material weaknesses in the future or that we will be able to remediate any such material weakness in a timely manner or at all.

If we identify future material weaknesses in our internal control over financial reporting, we may be unable to accurately report our financial results or report them within the timeframes required by law or stock exchange regulations. Failure to comply with Section 404 of the Sarbanes-Oxley Act could also potentially subject us to sanctions or investigations by the SEC or other regulatory authorities. If additional material weaknesses exist or are discovered in the future, and we are unable to remediate any such material weakness, our reputation, results of operations and financial condition could suffer.

**Risks Related to Our ADSs**

***An active trading market for the ADSs may not be developed or sustained, and the trading price for the ADSs may be volatile and affected by economic conditions beyond our control.***

We listed the ADSs on Nasdaq in June 2022. However, a liquid public market in the United States for your ADSs may not develop or be sustained, which means you may experience a decrease in the value of the ADSs regardless of our operating performance. In addition, the market price of the ADSs may be highly volatile and subject to wide fluctuations. For instance, during fiscal 2025, the closing price of our ADSs ranged from $12.98 to $38.02. We cannot assure you that the market price of the ADSs will not fluctuate or decline significantly in the future. Some specific factors that could adversely affect the price of the ADSs or trading volumes include actual or expected changes in our prospects or operating results; changes in actual or anticipated demand for our products; general economic conditions; and the liquidity of U.S. and Australian trading markets. In the past, following periods of volatility in the market price of a company's securities, shareholders often instituted securities class action litigation against that company. If we were involved in a class action suit, it could divert the attention of senior management and, if adversely determined, could have a material adverse effect on our results of operations and financial condition.

***ADS holders are not shareholders and do not have shareholder rights.***

The Bank of New York Mellon, as depositary, issues and delivers ADSs. ADS holders will not be treated as shareholders and will not have shareholders rights. The depositary will be the holder of our ordinary shares represented by the ADSs. Holders of ADSs will have ADS holder rights. A deposit agreement among us, the depositary, and the beneficial owners and holders of ADSs, sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs. We and the depositary may amend or terminate the deposit agreement

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

without the ADS holders' consent in a manner that could prejudice ADS holders. For a description of ADS holder rights, see "Item 12. *Description of Securities Other Than Equity Securities-D. American Depositary Shares.*" Our shareholders have shareholder rights. Australian law and our Constitution govern shareholder rights. For a description of ADS holder rights and the rights of our ordinary shares, see "Item 10. *Additional Information-A. Share Capital*."

ADS holders do not have the same voting rights as our shareholders. Shareholders are entitled to receive our notices of general meetings and to attend and vote at our general meetings of shareholders. At a general meeting, every shareholder present (in person or by proxy, attorney or representative) and entitled to vote has one vote on a show of hands. Every shareholder present (in person or by proxy, attorney or representative) and entitled to vote has one vote per fully paid ordinary share on a poll. This is subject to any other rights or restrictions which may be attached to any shares. ADS holders may instruct the depositary to vote the ordinary shares underlying their ADSs, but only if we ask the depositary to ask for their instructions. If we do not ask the depositary to ask for the instructions, our ADS holders are not entitled to receive our notices of general meeting. ADS holders will not be entitled to attend and vote at a general meeting unless they surrender their ADSs and withdraw the ordinary shares. However, our ADS holders may not have sufficient advance notice about the meeting to surrender their ADSs and withdraw the shares. If we ask for ADS holders' instructions, the depositary will notify ADS holders of the upcoming vote and arrange to deliver our voting materials and form of notice to them. The depositary will try, as far as practical, subject to Australian law and the provisions of the deposit agreement, to vote the shares as ADS holders instruct. The depositary will not vote or attempt to exercise the right to vote other than in accordance with the instructions of the ADS holders. We cannot assure ADS holders that they will receive the voting materials in time to ensure that they can instruct the depositary to vote their shares. In addition, there may be other circumstances in which ADS holders may not be able to exercise voting rights.

ADS holders do not have the same rights to receive dividends or other distributions as our shareholders. Subject to any special rights or restrictions attached to any shares, the directors may determine that a dividend will be payable on our ordinary shares and fix the amount, the time for payment and the method for payment (although we have never declared or paid any cash dividends on our ordinary shares, and we do not anticipate paying any cash dividends in the foreseeable future). Dividends may be paid on our ordinary shares of one class but not another and at different rates for different classes. Dividends and other distributions payable to our shareholders with respect to our ordinary shares generally will be payable directly to them. Any dividends or distributions payable with respect to ordinary shares will be paid to the depositary, which has agreed to pay to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, after deducting its fees and expenses and subject to the provisions of the deposit agreement. Before the depositary makes a distribution to you on behalf of your ADSs, any withholding taxes that must be paid will be deducted. Additionally, if the exchange rate fluctuates during a time when the ADS depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution. ADS holders will receive these distributions in proportion to the number of ordinary shares their ADSs represent. In addition, there may be certain circumstances in which the depositary may not pay to ADS holders amounts distributed by us as a dividend or distribution.

***There are circumstances where it may be unlawful or impractical to make distributions to the holders of ADSs.***

The deposit agreement allows the depositary to distribute the foreign currency only to those ADS holders to whom it is possible to do so. If a distribution is payable by us in Australian dollars, the depositary will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest. If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, ADS holders may lose some of the value of the distribution. The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. This means that ADS holders may not receive the distributions we make on our ordinary shares or any value for them if it is illegal or impractical for us to make them available to them.

***Holders of the ADSs may have difficulty in effecting service of process in the United States or enforcing judgments obtained in the United States.***

We are a public company incorporated under the laws of Australia. Therefore, the rights of holders of our ordinary shares are governed by Australian law and our Constitution. These rights differ from the typical rights of shareholders in U.S. corporations. The rights of holders of ADSs are affected by Australian law and our Constitution but are governed by U.S. law. Circumstances that under U.S. law may entitle a shareholder in a U.S. company to claim damages may also give rise to a cause of action under Australian law entitling a shareholder in an Australian company to claim damages. However, this will not always be the case.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Holders of the ADSs may have difficulties enforcing, in actions brought in courts in jurisdictions located outside the United States, liabilities under U.S. securities laws. In particular, if such a holder sought to bring proceedings in Australia based on U.S. securities laws, the Australian court might consider whether:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• it did not have jurisdiction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• it was not an appropriate forum for such proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• applying Australian conflict of laws rule, U.S. law (including U.S. securities laws) did not apply to the relationship between holders of our ordinary shares or ADSs and us or our directors and officers; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the U.S. securities laws were of a public or penal nature and should not be enforced by the Australian court.

Certain of our directors and executive officers are residents of countries other than the United States. Furthermore, a portion of our and their assets are located outside the United States. As a result, it may not be possible for a holder of our ordinary shares or ADSs to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• effect service of process within the United States upon certain directors and executive officers or on us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• enforce in U.S. courts judgments obtained against any of our directors and executive officers or us in the U.S. courts in any action, including actions under the civil liability provisions of U.S. securities laws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• enforce in U.S. courts judgments obtained against any of our directors and senior management or us in courts of jurisdictions outside the United States in any action, including actions under the civil liability provisions of U.S. securities laws; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• bring an action in an Australian court to enforce liabilities against any of our directors and executive officers or us based upon U.S. securities laws.

Holders of our ordinary shares and ADSs may also have difficulties enforcing in courts outside the U.S. judgments obtained in the U.S. courts against any of our directors and executive officers or us, including actions under the civil liability provisions of the U.S. securities laws.

***ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action.***

The deposit agreement governing the ADSs provides that, to the fullest extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our ordinary shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. The waiver of jury trial provision applies to all holders of ADSs, including purchasers who acquire the ADSs on the open market. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable state and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally adjudicated by the United States Supreme Court. However, we believe that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the laws of the State of New York, which govern the deposit agreement, by a federal or state court in the City of New York, which has non-exclusive jurisdiction over matters arising under the deposit agreement. In determining whether to enforce a contractual pre-dispute jury trial waiver provision, courts will generally consider whether a party knowingly, intelligently and voluntarily waived the right to a jury trial. We believe that this is the case with respect to the deposit agreement and the ADSs. In addition, New York courts will not enforce a jury trial waiver provision in order to bar a viable setoff or counterclaim sounding in fraud or one which is based upon a creditor's negligence in failing to liquidate collateral upon a guarantor's demand, or in the case of an intentional tort claim (as opposed to a contract dispute), none of which we believe are applicable in the case of the deposit agreement or the ADSs. It is advisable that you consult legal counsel regarding the jury waiver provision before entering into the deposit agreement.

If you or any other owner or holder of ADSs bring a claim against us or the depositary in connection with matters arising under the deposit agreement or the ADSs, including claims under federal securities laws, you or such other owner or holder may not be entitled to a jury trial with respect to such claims, which may have the effect of limiting and discouraging lawsuits against us and/or the depositary. If a lawsuit is brought against us and/or the depositary under the deposit agreement, it may be heard only by a judge or justice of the applicable trial court, which would be conducted according to different civil procedures and may result in different outcomes than a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in any such action. Nevertheless, if this jury trial waiver provision is not permitted

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

by applicable law, an action could proceed under the terms of the deposit agreement with a jury trial. No condition, stipulation or provision of the deposit agreement or ADSs serves as a waiver by any owner or holder of ADSs or by us or the depositary of compliance with any substantive provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder. By agreeing to the jury trial waiver provision in the deposit agreement, investors will not be deemed to have waived our compliance with or the depositary's compliance with the federal securities laws and the rules and regulations promulgated thereunder.

***The dual listing of our ordinary shares and the ADSs may adversely affect the liquidity and value of the ADSs.***

Our ordinary shares are listed on the ASX and the ADSs are listed on Nasdaq. We cannot predict the effect of this dual listing on the value of our ordinary shares and ADSs. However, the dual listing of our ordinary shares and ADSs may dilute the liquidity of these securities in one or both markets and may adversely affect the development of an active trading market for the ADSs in the United States. The price of the ADSs could also be adversely affected by trading in our ordinary shares on the ASX.

***Certain of outstanding securities may dilute the value of our ordinary shares.***

As of June 30, 2025, we had 319,927,854 ordinary shares outstanding and 19,800,000 ordinary shares reserved for issuance upon conversion of Performance Shares upon the satisfaction of certain performance conditions. To the extent that the conditions to the vesting of such securities are satisfied, the value of our ordinary shares may be diluted.

***Currency fluctuations may adversely affect the price of the ADSs relative to the price of our ordinary shares.***

The price of our ordinary shares is quoted in Australian dollars, and the price of the ADSs is quoted in U.S. dollars. Movements in the Australian dollar/U.S. dollar exchange rate may adversely affect the U.S. dollar price of the ADSs and the U.S. dollar equivalent of the price of our ordinary shares. If the Australian dollar weakens against the U.S. dollar, the U.S. dollar price of the ADSs could decline, even if the price of our ordinary shares in Australian dollars increases or remains unchanged. If we pay dividends, we will likely calculate and pay any cash dividends in Australian dollars and, as a result, exchange rate movements will affect the U.S. dollar amount of any dividends holders of the ADSs will receive from the depositary.

***As a foreign private issuer, we are permitted and expect to follow certain home country corporate governance practices in lieu of certain Nasdaq requirements applicable to domestic issuers.***

As a foreign private issuer listed on Nasdaq, we are permitted to follow certain home country corporate governance practices in lieu of certain Nasdaq practices. Following our home country corporate governance practices, as opposed to the requirements that would otherwise apply to a U.S. company listed on Nasdaq, may provide less protection than is afforded to investors under the Nasdaq rules applicable to domestic issuers.

In particular, we follow home country law instead of Nasdaq practice regarding:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that our independent directors meet regularly in executive sessions. The ASX Listing Rules and the Corporations Act do not require the independent directors of an Australian company to have such executive sessions and, accordingly, we have claimed this exemption.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that an issuer provide for a quorum as specified in its by laws for any meeting of the holders of ordinary shares, which quorum may not be less than 33 1/3% of the outstanding shares of an issuer's voting ordinary shares. In compliance with Australian law, our Constitution provides that two shareholders present shall constitute a quorum for a general meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that issuers obtain shareholder approval prior to the issuance of securities in connection with certain acquisitions, changes of control or private placements of securities, or the establishment or amendment of certain stock option, purchase or other compensation plans. Applicable Australian law and rules differ from Nasdaq requirements, with the ASX Listing Rules providing generally for prior shareholder approval in numerous circumstances, including (i) issuance of equity securities exceeding 15% (or an additional 10% capacity to issue equity securities for the proceeding 12-month period if shareholder approval by special resolution is sought at the Company's annual general meeting) of our issued share capital in any 12-month period (but, in determining the available issue limit, securities issued under an exception to the rule or with

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

shareholder approval are not counted), (ii) issuance of equity securities to related parties (as defined in the ASX Listing Rules) and (iii) directors or their associates acquiring securities under an employee incentive plan.

***As a foreign private issuer, we are permitted to file less information with the SEC than a domestic issuer.***

As a foreign private issuer, we are exempt from certain rules under the Exchange Act, that impose requirements for proxy solicitations under Section 14 of the Exchange Act. In addition, our officers, directors and principal shareholders are exempt from the reporting and "short-swing" profit recovery provisions of Section 16 of the Exchange Act. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as a domestic issuer, nor are we generally required to comply with the SEC's Regulation FD, which restricts the selective disclosure of material non-public information.

Under Australian law, we prepare financial statements on an annual and semi-annual basis, we are not required to prepare or file quarterly financial information other than quarterly updates. Our quarterly updates have consisted of a brief review of operations for the quarter together with a statement of cash expenditure during the quarter and the cash and cash equivalents balance as at the end of the quarter.

For as long as we are a "foreign private issuer," we intend to file our annual financial statements on Form 20-F and furnish our semi-annual financial statements and quarterly updates on Form 6-K to the SEC as long as we are subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act. However, the information we file or furnish is not the same as the information that is required in annual and quarterly reports on Form 10-K or Form 10-Q for U.S. domestic issuers. Accordingly, there may be less information publicly available concerning us than there is for a company that files as a domestic issuer.

***We may lose our foreign private issuer status, which would then require us to comply with the Exchange Act's domestic reporting regime and cause us to incur additional legal, accounting and other expenses.***

We are required to determine our status as a foreign private issuer on an annual basis at the end of our second fiscal quarter. In order to maintain our current status as a foreign private issuer, either (1) a majority of our ordinary shares must be either directly or indirectly owned of record by non-residents of the United States or (2) (a) a majority of our executive officers or directors must not be U.S. citizens or residents, (b) more than 50 percent of our assets cannot be located in the United States; and (c) our business must be administered principally outside the United States. If we lost this status, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required to make changes in our corporate governance practices and to comply with U.S.GAAP, as opposed to IFRS. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs.

***We will incur significant costs as a result of operating as a company whose ADSs are publicly traded in the United States, and our management is required to devote substantial time to compliance initiatives.***

We originally listed the ADSs in the United States in June 2022 and, as a result, we expect to incur significant legal, accounting, insurance and other expenses in the future periods that we did not incur prior to listing in the United States. In addition, the Sarbanes-Oxley Act, Dodd-Frank Wall Street Reform and Consumer Protection Act and related rules implemented by the SEC, have imposed various requirements on public companies including requiring establishment and maintenance of effective disclosure and internal controls. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time consuming and costly. These laws and regulations could also make it more difficult and expensive for us to attract and retain qualified persons to serve on our board of directors, our board committees or as our senior management. Furthermore, if we are unable to satisfy our obligations as a public company in the United States, we could be subject to delisting of the ADSs, fines, sanctions and other regulatory action and potentially civil litigation.

***We do not anticipate paying dividends in the foreseeable future.***

We have not declared any dividends during the last three fiscal years and do not anticipate that we will do so in the foreseeable future. We currently intend to retain future earnings, if any, to finance the development of our business. Dividends, if any, on our outstanding ordinary shares will be declared by and subject to the discretion of the Board on the

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

basis of our earnings, financial requirements and other relevant factors, and subject to Australian law. As a result, a return on your investment will only occur if the ADS price appreciates. We cannot assure you that the ADSs will appreciate in value or even maintain the price at which you purchase the ADSs. You may not realize a return on your investment in the ADSs and you may even lose your entire investment in the ADSs.

***If U.S. securities or industry analysts do not publish research reports about our business, or if they issue an adverse opinion about our business, the market price and trading volume of our ordinary shares or ADSs could decline.***

The trading market for our ordinary shares and ADSs will be influenced by the research and reports that U.S. securities or industry analysts publish about us or our business. Securities and industry analysts may discontinue research on us, to the extent such coverage currently exists, or in other cases, may never publish research on us. If no or too few U.S. securities or industry analysts commence coverage of our Company, the trading price for the ADSs would likely be negatively affected. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade the ADSs or publish inaccurate or unfavorable research about our business, the market price of the ADSs would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for the ADSs could decrease, which might cause our price and trading volume to decline. In addition, research and reports that Australian securities or industry analysts publish about us, our business or our ordinary shares may impact the market price of the ADSs.

***You may be subject to limitations on transfers of your ADSs.***

Your ADSs are transferable on the books of the depositary. However, the depositary may close its transfer books at any time or from time to time when it deems expedient in connection with the performance of its duties. In addition, the depositary may refuse to deliver, transfer or register transfers of ADSs generally when our books or the books of the depositary are closed, or at any time if we or the depositary deems it advisable to do so because of any requirement of law or of any government or governmental body, or under any provision of the deposit agreement, or for any other reason.

***We and the depositary are entitled to amend the deposit agreement and to change the rights of ADS holders under the terms of such agreement, and we may terminate the deposit agreement, without the prior consent of the ADS holders.***

We and the depositary are entitled to amend the deposit agreement and to change the rights of the ADS holders under the terms of such agreement, without the prior consent of the ADS holders. In the event that the terms of an amendment are materially prejudicial to ADS holders' substantial rights, ADS holders will only receive 30 days' advance notice of the amendment, and no prior consent of the ADS holders is required under the deposit agreement. Furthermore, we may decide to terminate the ADS facility at any time for any reason, or the depositary agent may on its own initiative terminate the deposit agreement. If the ADS facility is terminated, ADS holders will receive at least 90 days' prior notice, but no prior consent is required from them. Under the circumstances that we decide to make an amendment to the deposit agreement that is materially prejudicial to the substantial rights of the ADS holders or terminate the deposit agreement, the ADS holders may choose to sell their ADSs or surrender their ADSs and become direct holders of the underlying ordinary shares but will have no right to any compensation whatsoever.

***ADS holders have limited recourse if we or the depositary fail to meet our respective obligations under the deposit agreement.***

The deposit agreement expressly limits our obligations and liability and those of the depositary. We and the depositary are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith, and the depositary will not be a fiduciary or have any fiduciary duty to holders of ADSs; are not liable if we are or it is prevented or delayed by law or by events or circumstances beyond our or its ability to prevent or counteract with reasonable care or effort from performing our or its obligations under the deposit agreement; are not liable if we or it exercises discretion permitted under the deposit agreement; are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement; have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person; and are not liable for the acts or omissions of any securities depository, clearing agency or settlement system.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***Our Constitution and Australian laws and regulations applicable to us may adversely affect our ability to take actions that could be beneficial to our shareholders.***

As an Australian company we are subject to different corporate requirements than a corporation organized under the laws of the United States. Our Constitution, as well as the Australian Corporations Act, set forth various rights and obligations that are unique to us as an Australian company and which may not apply to a U.S. corporation. These requirements may operate differently than those of many U.S. companies.

***If we fail to maintain proper internal controls, our ability to produce accurate financial statements or comply with applicable regulations could be impaired.***

We are subject to the reporting obligations under the U.S. securities laws. The SEC, as required under Section 404 of the Sarbanes-Oxley Act, has adopted rules requiring a public company to include a report of management on the effectiveness of such company's internal control over financial reporting in its annual report on Form 20-F. In addition, an independent registered public accounting firm for a public company must issue an attestation report on the effectiveness of our internal control over financial reporting. If in the future, we are unable to conclude that we have effective internal controls over financial reporting or our independent auditors are unwilling or unable to provide us with an unqualified report on the effectiveness of our internal controls over financial reporting as required by the Sarbanes-Oxley Act, investors may lose confidence in our operating results, the price of the ADSs could decline and we may be subject to litigation or regulatory enforcement actions. In addition, if we are unable to meet the requirements of the Sarbanes-Oxley Act, we may not be able to remain listed on Nasdaq.

***We may be, or may become, a passive foreign investment company, or PFIC, which could result in adverse U.S. federal income tax consequence to U.S. investors.***

There is a risk that we will be a PFIC for any taxable year, which could result in adverse U.S. federal income tax consequences to U.S. Holders (as defined in "Item 10. Additional Information-E. Taxation-Material U.S. Federal Income Tax Considerations"). Under the IRS Code, in general, a non-U.S. corporation is a PFIC for any taxable year in which, after the application of certain "look-through" rules with respect to its subsidiaries, either (i) 75% or more of its gross income consists of "passive income," or (ii) 50% or more of the average quarterly value of its assets consist of assets that produce, or are held for the production of, "passive income." Passive income generally includes interest, dividends, rents, certain non-active royalties and capital gains.

Based on the composition of our income and assets and the value of our assets, including goodwill, we do not believe that we were a PFIC for the taxable year ended June 30, 2025. Our status in future years will depend on our income, assets, and activities in those years, and there can be no assurance that we will not be classified as a PFIC for future taxable years. However, the proper application of the PFIC rules to a company with a business such as ours is not entirely clear. Because the proper characterization of certain components of our income and assets is not entirely clear and because our PFIC status for any taxable year will depend on the composition of our income and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our shares, which could be volatile), there can be no assurance that we were not a PFIC for the taxable year ended June 30, 2025.

Additionally, even if we are not a PFIC for a particular taxable year, we could become a PFIC for future years based on changes in our assets or the value thereof, including the value of our goodwill as indicated by our market capitalization, and based on changes in our activities and income, particularly given the fact that it is not entirely clear how the asset and income tests should apply to us. For these reasons, and since a non-U.S. corporation's annual PFIC status can be determined only after the end of each taxable year, we cannot express a view as to whether we will be a PFIC for the current or any future taxable year.

If we are characterized as a PFIC for any taxable year during which a U.S. Holder holds ADSs, we generally would continue to be treated as a PFIC with respect to that U.S. Holder for all succeeding years during which the U.S. Holder holds ADSs or ordinary shares, even if we ceased to meet the threshold requirements for PFIC status.

U.S. Holders should consult their own tax advisors regarding all aspects of the possible application of the PFIC rules to our ADSs and ordinary shares. For a more detailed explanation of the tax consequences of PFIC classification to U.S. Holders, see "Item 10. *Additional Information-E. Taxation-Material U.S. Federal Income Tax Considerations-Passive Foreign Investment Company*."

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**ITEM 4.&nbsp;&nbsp;&nbsp;&nbsp;INFORMATION ON THE COMPANY**

A.**History and Development of the Company**

Our head office is located at 129 West Trade Street, Suite 1405, Charlotte, North Carolina 28202, United States. Our registered office is located at 28 The Esplanade, Level 9, Perth WA 6000, Australia. The telephone number of our registered office is +(61) 8-9322-6322.

IperionX was originally incorporated in Western Australia on May 5, 2017. We are an Australian public company subject to the provisions of the Australian Corporations Act.

Our ordinary shares have been listed on the Australian Securities Exchange since 2018, previously under the symbols "TAO" and "HYM" and currently under the symbol "IPX." Our ADSs, each representing 10 of our ordinary shares, are listed on the Nasdaq under the symbol "IPX." The Bank of New York Mellon acts as depositary for the ADSs.

The SEC maintains an internet site at http://www.sec.gov that contains reports, information statements, and other information regarding issuers that file electronically with the SEC. We also maintain a web site at www.iperionx.com. The information contained on our website or available through our website is not incorporated by reference into and should not be considered a part of this annual report on Form 20-F, and the reference to our website in this annual report on Form 20-F is an inactive textual reference only.

**IperionX Timeline**

![Picture3.jpg](ipx-20250630_g2.jpg)

B.**Business Overview**

**Our mission**

IperionX has transitioned to become a leading sustainable producer of titanium products for a wide range of industries.

Titanium is prized for its high strength-to-weight ratio and its resistance to high temperatures and corrosion. Titanium is used in numerous advanced industries, including consumer electronics, aerospace, defense, industrial, medical, bicycles and automotive. IperionX has developed commercial relationships with a range of customers across these sectors that desire high-performance titanium products via a more sustainable supply chain.

IperionX aims to sell titanium products directly to these customers. Our future products may include manufactured titanium components, titanium powders for additive manufacturing and powder metallurgy and traditional mill products. We offer a range of titanium alloys, including aerospace grade titanium alloys and other high performance titanium alloys.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Since the 1940's, titanium has been commercially produced using the Kroll Process, which is a relatively energy and cost-intensive method that produces high levels of greenhouse gas emissions. In contrast, IperionX controls the intellectual property rights to certain patented titanium and metal alloy production technologies which use less energy to produce high-performance titanium products, at lower costs, with zero Scope 1 and 2 emissions, driven by the expected use of 100% renewable energy at our facilities (as reported in our recent life cycle assessment published in June 2024).

Today the United States has minimal commercial domestic primary titanium metal (titanium sponge) production capacity and the U.S. currently imports almost all of the titanium sponge required for its advanced industries. We are re-shoring titanium metal production, thereby reducing America's acute reliance on primary titanium imports and strengthening the domestic titanium supply chain. To achieve our goals, IperionX has two key value drivers:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Titanium Metals: IperionX has successfully scaled and commissioned its first commercial operations using the Technologies to produce high performance titanium alloys and products at lower costs, with zero Scope 1 and 2 emissions, from either scrap titanium or titanium minerals. IperionX is currently ramping up production at its large-scale titanium production facility, in Virginia; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Critical Minerals: IperionX owns the Titan Project in Tennessee, an exploration stage project, which is currently one of the largest titanium, zircon and rare earth mineral resources, reported in accordance with the JORC Code, in the U.S. At full production, we anticipate that the Titan Project could produce approximately 100,000 tons per annum of titanium minerals that could potentially be used as a feedstock to produce 100% American-made titanium alloys. IperionX is currently undertaking a definitive feasibility study on the Titan Project, funded by the U.S. DoW, and expected to be complete in Q2 2026.

To meet the growing demand for sustainable and lower cost titanium products, IperionX is ramping up production at its titanium manufacturing facility in Virginia, with first production of deoxygenated titanium achieved in August 2024, and full system commissioning completed in 2025.

Technology and process improvements at the titanium manufacturing facility have already lifted nameplate titanium powder capacity from 125 tpa to 200 tpa, as well as laid the groundwork for our planned seven-fold scale-up in titanium production to reach 1,400 tpa in 2027.

IperionX is aiming for global leadership in advanced manufacturing of high-performance titanium components of over 10,000 tpa by 2030, and has developed a plan to scale titanium capacity in high-performance titanium components, targeting cost competitiveness with stainless steel and aluminum.

To support the potential future growth in titanium production, we also plan to develop the Titan Project in Tennessee to provide low-cost titanium mineral feedstock. In addition, we believe the Titan Project has the potential to be a sustainable, low-cost and globally significant producer of titanium, rare earths and zircon minerals. These minerals are important for advanced U.S. industries including consumer electronics, aerospace, defense, medical, bicycles, additive manufacturing and automotive.

**Why Titanium?**

Titanium is a strong, lightweight metal with important material properties for applications in consumer electronics, aerospace, defense, medical, bicycles, additive manufacturing and automotive. A range of titanium alloys are recognized for high strength-to-weight ratio and excellent corrosion resistance that exceed many alloys of stainless steel and aluminum. However, titanium's high production and manufacturing cost has historically been a key factor in hindering its widespread application versus other structural metals such as stainless steel and aluminum.

Currently, primary titanium metal is largely produced by the Kroll Process, invented in the 1940s. The Kroll Process works by reducing titanium from titanium tetrachloride with magnesium in a capital and energy-intensive batch process.

After primary titanium is produced with the Kroll Process, it must be melted, alloyed and remelted into ingots. The ingots are then processed in a series of manufacturing steps to produce mill products, including consecutive rolling steps, extruding and forging. Mill products can be machined into parts using subtractive methods where large portions of the titanium metal are machined away into scrap. Some mill products are drawn into wire and used in a gas atomization process to produce spherical titanium powders.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The United States depends on imported titanium to support its defense and critical infrastructure needs. In 2018, Russian and Chinese titanium sponge producers controlled 61% of the world's titanium sponge production. In 2024, Russia and China's control of global titanium sponge production had increased to approximately 75%.

IperionX is currently re-shoring an end-to-end titanium supply chain to the United States by vertically integrating the Technologies, and ultimately the Titan Project, to make sustainable, lower cost high-performance titanium.

**Titanium Products**

IperionX intends to target high-value, high 'buy-to-fly' ratio titanium components, in the form of near-net-shape and manufactured products. By leveraging cost advantages from patented HAMR™ and HSPT™ technologies, IperionX expects a material cost reduction across a range of titanium product categories, including fasteners, enclosures & controls, consumer electronics, gears & actuator housings, and titanium brackets.

Other titanium product categories include mill replacement products, and high-value additive manufactured parts.

![TITANIUM METAL PRODUCT MAP JPG.jpg](ipx-20250630_g3.jpg)

IperionX titanium metal product map and current market price range estimates

*Titanium fasteners*

Fasteners — bolts, screws, nuts, washers, rivets — are ubiquitous across major U.S. markets in automotive, construction, aerospace, marine, and industrial machinery. Titanium fasteners represent a large addressable market for IperionX. Leveraging our integrated patented technologies and near-net-shape manufacturing, IperionX modeling indicates scope for product cost reductions of over 80%, and in some cases more than 90%, versus current market levels.

Based on third party market research, we believe the global titanium fastener market is approximately $4.3 billion annually, with the global stainless steel fastener market approximately $15.2 billion annually. Lower-cost titanium fasteners, priced competitively with stainless steel, could unlock accelerated substitution, volume growth and a larger addressable market.

*Enclosures & controls (consumer electronics)*

The premium consumer electronics market is adopting titanium at scale, with leading global brands adding titanium to flagship devices. Based on third party market research, we believe over 1.2 billion mobile phones and 180 million smartwatches are sold every year.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

IperionX offers a fully circular titanium supply chain that can convert consumer-electronics titanium scrap into high-quality titanium powder and titanium near-net-shape components, at lower energy, cost and environmental footprint. Our first commercial project is already in progress to deliver into this market.

*Gears & actuators (humanoid robotics)*

The humanoid robotics market is forecasted to expand from under $3 billion today to more than $38 billion by 2035. Core to these systems are lightweight, strong, corrosion-resistant gears and actuators — ideal for titanium and perfectly suited to our uniaxial press-and-sinter manufacturing route, which mirrors traditional steel powder metallurgy gear production.

*Titanium brackets*

Titanium brackets are the natural complement to titanium fasteners across aerospace, marine, and construction—combining high strength, low weight, and exceptional corrosion resistance.

*Mill products*

Although not central to our market product plan, IperionX's powder metallurgy process can produce near-final-gauge titanium plate, sheet, and bar after sintering - bypassing large portions of the titanium melt–forge–roll chain. Multiple industry partners are collaborating to quantify the cost and efficiency gains.

*High-value additive manufactured parts* 

For strategic programs and customers, we will manufacture high-value complex titanium parts via Laser Powder Bed Fusion and E-Beam Powder Bed Fusion, smaller in output but with high-value margins. As the expected lowest cost U.S. titanium-powder producer, IperionX will strengthen the additive manufacturing supply chain and deliver lower-cost advanced manufactured titanium parts.

**Titanium Markets**

Titanium and its alloys are used in high-performance applications across a wide range of advanced industries. Titanium alloys are prized for their strength, lightweight, and high resistance to corrosion.

IperionX's technologies produce lower-cost and high-quality titanium metal powder that can be used to produce titanium semi-finished stock products, near-net forged titanium alloy shapes and high-performance final titanium parts. A significant reduction in the end-to-end cost of manufacturing titanium parts has the potential to increase the application of titanium to a wider range of markets.

![BOX WITH IMAGE TI MARKETS.jpg](ipx-20250630_g4.jpg)

**IperionX's Titanium Technologies**

IperionX's world-leading portfolio of patented titanium technologies has been developed, enhanced and protected over a decade of research and development. The technology portfolio consists of over 40 global patents related to the innovative titanium technologies owned by IperionX. The Company is developing a range of innovative new technologies that are related to the core technologies and titanium manufacturing.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

IperionX is uniquely positioned to re-shore a fully integrated mineral-to-metal titanium supply chain to the U.S. IperionX has developed an innovative 'end-to-end' American titanium supply chain solution, that spans from the production of domestically sourced titanium minerals, the technology to upgrade these minerals to more than 99% TiO2, as well as the ability to utilize the largest range of recycled scrap titanium as feedstocks for low-cost titanium metal production.

Titanium is a superior metal in many applications to both steel and aluminum, but its high production and manufacturing cost often limits its use to high performance applications.

The incumbent industry titanium production method is the Kroll Process which is an energy and capital-intensive batch process that has limited titanium's market penetration to advanced applications. The Kroll Process is also complex, requiring toxic reagents and repeated high temperature melting processes. Over the years, the search for a more efficient lower-cost production method for titanium has failed to meet quality requirements, cost reduction needs or commercial scalability.

In contrast, IperionX's patented titanium technologies feature lower energy consumption, lower capex, faster cycle times and higher product yields – produced from either titanium minerals or scrap – to produce low-cost and high-quality angular and spherical titanium powder to produce titanium semi-finished stock products for advanced applications. IperionX can also use these titanium powders to produce near-net forged titanium alloy shapes and high-value final titanium parts and components using additive manufacturing. The interlocking series of patented titanium technologies span the full supply chain and offers a vertical integration platform.

These technologies provide IperionX with the capacity to re-shore a fully integrated mineral-to-metal titanium supply chain to the U.S. IperionX's innovative "end-to-end" American titanium supply chain solution spans from the production of domestically sourced titanium minerals, the technology to upgrade those minerals, as well as the ability to utilize recycled scrap titanium as key feedstocks for low-cost titanium production and manufacturing.

IperionX has proven the capability of the patented titanium technologies to upgrade titanium minerals from the Titan Project in Tennessee to produce high grade (more than 99%) TiO2, and then successfully use this enriched feedstock to manufacture high-quality spherical titanium alloy (Ti-6Al-4V) powder. Quality testing of this spherical titanium powder surpassed industry standard Grade 5 specifications for oxygen content.

![Picture1.jpg](ipx-20250630_g5.jpg)

Refer to ASX release dated 15 August 2024 for further information

*HAMR Titanium Technologies*

The HAMR<sup>TM</sup> titanium production process is a patented breakthrough technology originally developed at the University of Utah with funding from the U.S. Department of Energy's ARPA-E program.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

HAMR<sup>TM</sup>, which stands for Hydrogen Assisted Metallothermic Reduction, is a patented powder metallurgy process technology to produce titanium and other metal powders. This process can take almost any form of titanium minerals or scrap titanium feedstock and produce titanium powders at low energy intensity, enabling the potential for low-cost, low-carbon emission titanium production in a sustainable closed loop. The majority of the energy and emissions savings are realized by eliminating the need to chlorinate TiO2 to make TiCl4 and removing the need for vacuum distillation after the reduction of TiCl4.

The HAMR<sup>TM</sup> process uses powder metallurgy processing steps to control the size of the particles, add alloying elements, to produce high-quality titanium powder. The HAMR<sup>TM</sup> process destabilizes TiO2 using hydrogen, making it possible to turn the reduction of TiO2 with magnesium from being thermodynamically impossible to thermodynamically favored. This allows TiO2 to be reduced and deoxygenated directly by magnesium to form TiH2 with low oxygen levels to meet industry quality standards. TiH2 is then processed into titanium metal alloys for advanced market applications.

*HSPT™ Titanium Forging Technologies*

The Granulation-Sintering-Deoxygenation process is a patented thermochemical technology designed to produce spherical titanium powders for 3D printing and additive manufacturing. This innovative process significantly enhances production efficiency, increasing powder yield by up to 50%, while delivering spherical titanium powders with low oxygen content, precise particle size control, and excellent flowability.

In contrast, existing methods for producing spherical metal powders - such as gas atomization, plasma atomization, and the plasma rotating electrode process - face significant limitations. While gas and plasma atomization can generate fine powders, their final product yield is low after size classification. A common challenge across all these methods is the low production yield of fine powders, which is a key driver of the high cost of titanium powder in additive manufacturing. GSD™ technology addresses these limitations, offering a more efficient and cost-effective solution for high-quality titanium powder production.

The HAMR™ technologies offer the capability to directly manufacture advanced alloys from the oxides of alloying elements. These technologies enable the use of alloying elements like iron, niobium, zirconium, and molybdenum etc. to create titanium alloys with enhanced strength, ductility, and fatigue performance. The HAMR™ technology offers advantages to manufacture advanced metal alloys that are difficult to produce at scale using traditional methods, such as melt processes.

*GSD™ Technologies*

The Granulation-Sintering-Deoxygenation process is a patented thermochemical technology designed to produce spherical titanium powders for 3D printing and additive manufacturing. This innovative process significantly enhances production efficiency, increasing powder yield by up to 50%, while delivering spherical titanium powders with low oxygen content, precise particle size control, and excellent flowability.

In contrast, existing methods for producing spherical metal powders - such as gas atomization, plasma atomization, and the plasma rotating electrode process - face significant limitations. While gas and plasma atomization can generate fine powders, their final product yield is low after size classification. A common challenge across all these methods is the low production yield of fine powders, which is a key driver of the high cost of titanium powder in additive manufacturing. GSD™ technology addresses these limitations, offering a more efficient and cost-effective solution for high-quality titanium powder production.

The HAMR™ technologies offer the capability to directly manufacture advanced alloys from the oxides of alloying elements. These technologies enable the use of alloying elements like iron, niobium, zirconium, and molybdenum etc. to create titanium alloys with enhanced strength, ductility, and fatigue performance. The HAMR™ technology offers advantages to manufacture advanced metal alloys that are difficult to produce at scale using traditional methods, such as melt processes.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

![Picture2.jpg](ipx-20250630_g6.jpg)

*Green Rutile™ & ARH™ Technologies*

IperionX's proprietary mineral upgrading technologies, Green Rutile<sup>TM</sup> and ARH<sup>TM</sup>, can add value to titanium minerals to produce low-cost and high-purity titanium feedstock for use at HAMR<sup>TM</sup> titanium production facilities.

The proprietary Green Rutile™ process upgrades lower grade titanium minerals into higher-grade synthetic rutile titanium product plus a co-product of purified iron oxide powder that could be used for metal alloying or produced as a pre-cursor for Lithium Iron Phosphate batteries.

Most of global synthetic rutile production is based upon the incumbent Becher Process, which consists of roasting lower-grade ilmenite titanium minerals using coal as a reductant in a rotary kiln at temperatures of more than 1,100°C to convert the iron oxide in the ilmenite to metallic iron, and then 'rusting' the kiln product in an aerated salt solution to remove most of the metallic iron.

The Scope 1 and 2 emissions from the current production of synthetic rutile and titanium slag are significant, estimated at approximately 3.3 tons and 2 tons of CO2 equivalent per ton of product. In contrast, IperionX's Green Rutile™ process does not use coal as a reductant, and when combined with renewable or low-carbon sourced electricity, has the potential to result in high-quality titanium product with low carbon emissions.

IperionX is advancing plans to scale-up the Green Rutile™ enrichment technology to upgrade lower grade ilmenite titanium minerals from the Titan Project into a high-quality synthetic rutile titanium product and iron oxide powder co-product.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

IperionX's proprietary Alkaline Roasting and Hydrolysis (ARH<sup>TM</sup>) technology can further upgrade rutile titanium minerals, including Green Rutile™, to +99% TiO2 feedstock so that it can be used as a high-purity feedstock for the HAMR<sup>TM</sup> titanium production process.

![Img.jpg](ipx-20250630_g7.jpg)

**Sustainability**

IperionX believes that a sustainable economy and technologies of the future will assist to drive increased demand for critical minerals and metals, including titanium. IperionX's technologies bypass the high-cost, high-carbon Kroll Process and the energy intensive titanium melt processes and forging. IperionX's core patented technologies can provide a more sustainable and circular titanium metal supply chain compared to the current titanium supply chain.

*Sustainability Governance and Disclosures*

IperionX was founded with the mission to build an end-to-end, low cost, and sustainable titanium supply chain in the United States. Sustainability is governed from the highest levels of IperionX's management, with the Sustainability Sub-Committee overseeing all related initiatives, including the Annual Sustainability Report and annual sustainability goals. IperionX reports annually on its sustainability progress following Global Reporting Initiative, the Sustainability Accounting Standards Board, and the Task Force on Climate-related Financial Disclosures guidance.

*Social Responsibility*

IperionX values its employees and local communities in Virginia, Utah, Tennessee and North Carolina. Protecting the health and safety of all our stakeholders, including our employees, contractors, visitors, and communities, is a core value of IperionX and fundamental to our future success. IperionX takes the responsibility of creating a safe workplace for employees seriously, ensuring compliance with applicable occupational and environmental health and safety laws and regulations governing our operations.

*Sustainable Titanium Technologies*

We believe that IperionX can revolutionize the titanium industry by enabling a truly circular titanium supply chain. Our patented technologies can utilize 100% titanium scrap, including low-quality (and high-oxygen) titanium scrap that other processes can't recycle economically. Our resulting 100% recycled, high-quality (and low-oxygen) titanium powder and parts can be used for a wide variety of applications and industries. Once those products have come to the end of their useful life, the technologies can be used to recycle the post-consumer titanium again, enabling a true "closed-loop" and low-carbon titanium supply chain at scale.

By diverting valuable titanium from downcycling – or from yesterday's waste stream – and upcycling it for new titanium products, we help meet today's needs for sustainable, domestically sourced critical minerals and help our customers achieve their product circularity and sustainability goals.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*Low Carbon Footprint*

IperionX's sustainable and low-carbon titanium powders are produced using 100% renewable energy, with zero associated Scope 1 and 2 carbon emissions. The low Scope 3 emissions associated with the titanium production process are being actively managed and have the potential to be reduced via the procurement of low-carbon process inputs.

IperionX completed a comparative life cycle assessment (LCA) to demonstrate the low-carbon offerings of its spherical titanium powders compared to other conventionally produced metal powders for additive manufacturing. Results of the comparative LCA for climate change impacts indicate that 100% recycled spherical titanium powder to be produced at IperionX's Titanium Production Facility in Virginia has the potential for a life cycle carbon footprint as low as 7.8 kg of CO2e per kg of powder. This finding represents over a 90% decrease in carbon footprint when compared to conventional titanium powders produced using the plasma atomization process (estimated to be 88.8 kg CO2e per kg powder).

*UL validated 100% Recycled Content Titanium Metal Powder*

IperionX achieved re-validation by UL Solutions (UL) according to Environmental Claim Validation Procedure 2809-2 for its 100% recycled content titanium metal powder made in the U.S. in late fiscal year 2023 and this was valid through fiscal year 2025. UL is one of the world's most trusted names in third-party product safety and standards. IperionX recognizes that third-party certifications provide important independent validation of our unique titanium product offerings.

*Sustainable Mineral Development*

IperionX is committed to resource efficiency, sustainable land management, and biodiversity at its Titan Project in Tennessee. The Titan Project aims to serve as a global model of sustainability and land stewardship throughout its lifecycle. Once operational, mineral extraction activities at the Titan Project are expected to be low impact, requiring no drilling or blasting. Completing the project in a phased approach with progressive reclamation will minimize our active operations to a small footprint at any given time. We are working with the University of Tennessee Institute of Agriculture to research methods of restoring the land in ways that will improve soil fertility and benefit a biodiverse ecosystem. We are committed to having a net positive impact on the land in all our operations.

*Environmental Regulation*

Our operations are subject to various environmental laws and regulations under the relevant government's legislation.

Full compliance with these laws and regulations is regarded as a minimum standard for all operations to achieve. Instances of environmental non-compliance by an operation are identified either by external compliance audits or inspections by relevant government authorities. There were no known breaches by IperionX during the fiscal year ended June 30, 2025.

**Our Production Facilities**

*Titanium Manufacturing Campus – Virginia*

IperionX's Titanium Manufacturing Campus (TMC) in Virginia comprises the Titanium Production Facility (TPF) and the Advanced Manufacturing Center (AMC). Commissioning of the TPF is complete, which has started producing high-quality and low-cost angular and spherical titanium powders. These titanium metal powders will be marketed to a wide range of customers for use in additive manufacturing and powder metallurgy.

The high-quality titanium powders are an important low-cost internal feedstock for the AMC, where they are utilized to manufacture a wide range of higher value titanium products such as semi-finished traditional mill products, near-net-shape forged titanium components and high-value titanium products using additive manufacturing.

*Titanium Production Facility – First Titanium Deoxygenation Production Run Complete*

In August 2024, IperionX's HAMR™ furnace successfully completed the first titanium deoxygenation production run at the TPF. The successful titanium deoxygenation production cycle was a significant milestone in the development of HAMR™ technology that has the potential to revolutionize the titanium industry and demonstrates the commercial-scale capabilities of IperionX's breakthrough titanium deoxygenation technologies.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Produced entirely from 100% scrap titanium (Ti-6Al-4V alloy, Grade 5 titanium), quality assessments confirmed a large reduction in oxygen levels from 3.42% to below 0.07%, far exceeding the ASTM standard requirement of 0.2% for Grade 5 titanium.

In December 2024, IperionX completed the inaugural "end-to-end" commercial HAMR™ production cycle, efficiently deoxygenating high-oxygen titanium scrap and producing high-quality, low-oxygen titanium metal powder, and in September 2025, IperionX fully commissioned all critical systems at its titanium production facility, demonstrating steady-state production of high-quality, low-cost titanium metal products directly from recycled titanium scrap, using IperionX's patented HAMR™ & HSPT™ technologies.

Technology and process improvements at the titanium manufacturing facility have already lifted nameplate titanium powder capacity from 125 tpa to 200 tpa - and laid the groundwork for a seven-fold scale-up in titanium production to 1,400 tpa in 2027.

IperionX is aiming for global leadership in advanced manufacturing of high-performance titanium components of over 10,000 tpa by 2030, and has developed a plan to scale titanium capacity in high-performance titanium components, targeting cost competitiveness with stainless steel and aluminum.

*Advanced Manufacturing Center – High-performance Titanium Product Manufacturing*

IperionX leverages its patented HAMR™ and HSPT™ technologies with powder metallurgy to manufacture high-performance forged titanium products at its AMC, also located at the Titanium Manufacturing Campus in Virginia.

The use of powder metallurgy has historically been limited in the titanium industry for two key reasons:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Titanium powder manufactured from high-cost titanium billets generates high yield losses for on-spec (low oxygen) titanium metal angular powders. This results in high-cost angular titanium powders, limiting their application for traditional powder metallurgy production processes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Standard argon-vacuum sintering processes used to consolidate titanium powder can produce inferior microstructure, strength and fatigue properties compared to traditional forged titanium products.

IperionX's patented HAMR™ titanium production technology can produce low-cost and high-quality titanium metal angular powders. Importantly, the patented HSPT™ 'forging' technology yields a wrought-like ultrafine grain microstructure to produce titanium products with superior fatigue properties versus traditional titanium powder metallurgy methods.

Capacity at the AMC will also be scaled in order to meet the scaled up titanium powder targeted production of 1,400 tpa in 2027.

*Industrial Pilot Facility – Utah*

The IPF, located in Salt Lake City, Utah, has been producing titanium metal powder with the Technologies since 2019. IperionX has been producing angular and spherical titanium metal powders in approximately 50 kilogram batches at the IPF for customers and advanced prototyping. Scrap titanium metal is the key titanium feedstock, with renewable power utilized to produce high-quality titanium powder.

Production at the IPF has demonstrated that the Technologies can reduce high oxygen content material to very low levels in titanium metal. With the commissioning of the large-scale manufacturing plant, this facility has been re-purposed as an R&D facility.

**Re-shoring U.S. Critical Mineral Production with the Titan Critical Mineral Project**

IperionX plans to initially use 100% recycled titanium metal scrap as feedstock for the titanium powder and products produced at the Titanium Manufacturing Campus. However, with high levels of forecast demand growth, IperionX intends to backwards integrate using upgraded titanium mineral feedstock from the Titan Project in Tennessee.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The Titan Project has the potential to be a long-term, low-cost and globally significant producer of titanium, rare earth and zircon critical minerals. These critical minerals are required for advanced U.S. industries, including consumer electronics, aerospace, defense, medical, additive manufacturing and automotive.

Future development of the Titan Project could provide a long-term source for low-cost upgraded titanium feedstocks that, combined with the Technologies, could help establish a fully integrated U.S. titanium supply chain. Vertical integration of the Technologies along with a U.S. supply of critical minerals, including titanium, offers potential long-term competitive and strategic advantages.

In February 2025, the DoW obligated $5 million through the Industrial Base Analysis and Sustainment program (IBAS) to expedite the Titan Critical Minerals Project in Tennessee to "shovel-ready" status through the completion of a definitive feasibility study, due to be completed in the second quarter of 2026.

The Titan Project's Mineral Resources are as follows:

**Titan Project - Mineral Resources**

**at the End of the Fiscal Year Ended June 30, 2025**

**Based on Prices Set Forth in Footnote 3 Below**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Resource<br>Category** | **Metric tons<br>(in<br>millions)** | **Grade<br>(THM%)** | **THM<br>(million<br>metric tons)** | **Cut-off<br>grade<br>(THM%)** | **THM assemblage** | **THM assemblage** | **THM assemblage** | **THM assemblage** |
| **Resource<br>Category** | **Metric tons<br>(in<br>millions)** | **Grade<br>(THM%)** | **THM<br>(million<br>metric tons)** | **Cut-off<br>grade<br>(THM%)** | **Zircon<br>(% of<br>THM)** | **Rutile<br>(% of<br>THM)** | **Ilmenite<br>(% of<br>THM)** | **REE<br>(% of<br>THM)** |
| Measured | - | - | - | - | - | - | - | - |
| Indicated | 241 | 2.2 | 5.3 | 0.4 | 11.3 | 9.3 | 39.7 | 2.1 |
| Measured and Indicated | 241 | 2.2 | 5.3 | 0.4 | 11.3 | 9.3 | 39.7 | 2.1 |
| Inferred | 190 | 2.2 | 4.2 | 0.4 | 11.7 | 9.7 | 41.2 | 2.2 |
| **Total** | **431** | **2.2** | **9.5** | **0.4** | **11.5** | **9.5** | **40.3** | **2.1** |

---

1. Mineral resources are reported using the definitions set out in Regulation S-K 1300 and are current as at June 30, 2025. Mineral resources are reported exclusive of the mineral reserves.

2. The third-party firm responsible for the estimate is Karst Geo Solutions LLC.

3. Mineral resources are reported within a conceptual pit shell that uses the following key assumptions: rutile prices of $1,440/t; ilmenite prices of $280/t; rare earth mineral concentrate prices of $11,630/t; zircon prices of $1,680/t; metallurgical recoveries: rutile of 66.9%, ilmenite of 79.7%, rare earth mineral concentrate of 82.6%, zircon of 77.6%; mining costs of $2.66/t run-of-mine; processing costs of $2.91/t run-of-mine, transport cost of $0.22/t run-of-mine, general and administrative costs of $0.71/t run-of-mine, reclaim/rehandle cost of $2.66/t run-of-mine (only used for selective mining comparison) and incremental in pit management cost of 1.00$/t run-of-mine (only used for selective mining comparison) and royalty of 5%.

4. Mineral resources are reported above a cut-off grade of 0.4% THM.

5. Estimates have been rounded.

**Our Strategies**

The objective of the Group is to create long-term shareholder value by combining its patented titanium technologies to continue to scale a low-cost titanium supply chain business in the U.S. and, in time, globally.

After completing industrial pilot scale production of titanium metal using 100% recycled titanium feedstocks in Utah IperionX has now transitioned to be a commercial producer of titanium metal products in the United States, based on the Virginia Titanium Manufacturing Campus. IperionX produces low-cost and high-quality angular and spherical titanium powder, which is used to produce near-net-shape and final titanium parts through powder metallurgy or additive manufacturing. These technologies provide IperionX with a sustainable competitive advantage and significant value uplift from upgrading raw titanium materials through to finished high-performance titanium products when compared to traditional titanium industry supply chains.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

To achieve its objective, the Group currently has the following business strategies and prospects over the medium-to-long term:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• commercialize the Technologies to produce titanium metal and metal powders for key markets, including consumer electronics, aerospace, defense, medical, bicycles, additive manufacturing and automotive;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• complete techno-economic evaluations, including working with current and potential customers to provide titanium metal powder samples and prototype titanium components produced with our titanium metal powder using the Technologies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• continue to investigate alternative applications of the Technologies to additional value-added metal closed-loop production capabilities, including zircon and synthetic rutile, and the potential production of rare earth elements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• continue discussions with current and potential customers and strategic partners for future production and sale of titanium metal products, titanium minerals and other critical minerals, including, but not limited to, rare earth elements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• continue to expand IperionX's critical mineral land position in the United States, explore for additional critical minerals and secure final permit and zoning approvals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• complete the Feasibility Study on the Titan Project to assess the economic potential of the Project and define an initial Ore Reserve; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• vertically integrate the Technologies with titanium material feedstocks from the Titan Project to develop an end-to-end U.S.-based titanium and critical mineral supply chain.

**Strategic Advantages**

We believe that we are well-positioned to execute our business strategies because of the following competitive strengths:

*Fully integrated, lower-cost and sustainable solution via patented titanium technologies*

IperionX's HAMR™ titanium production technology provides a lower-energy, faster and lower temperature process to produce titanium, with energy consumption <50% vs. current industry, and zero direct carbon emissions.

The HSPT™ "forging" technology, is a non-melt, advanced sintering technology that delivers forged quality titanium products.

HAMR™ and HSPT™ can lower the cost, energy, and yield loss of producing titanium products, and can produce titanium near-net-shape products at significantly higher yields and lower cost, unlocking a circular and zero direct carbon emission titanium supply chain.

IperionX's proprietary mineral upgrading technologies, Green Rutile<sup>TM</sup> and ARH<sup>TM</sup>, can add value to titanium minerals to produce low-cost and high-purity titanium feedstock for our HAMR<sup>TM</sup> titanium production facilities.

*The largest commercial producer of primary titanium metal in the U.S.*

IperionX's advanced HAMR<sup>TM</sup> furnace was successfully commissioned at the Titanium Manufacturing Campus in August 2024, marking the first titanium deoxygenation production run. IperionX successfully increased production by approximately 60 times from pilot scale to 125 metric tons per year, producing high performance titanium that exceeds industry quality standards, and has subsequently further increased capacity to 200 metric tons per year through operational improvements.

*Rapid expansion of operations, supported by the U.S. Government* 

The U.S. government is investing significant resources to re-shore a secure domestic titanium supply chain that is currently dominated globally by China and Russia. IperionX is well positioned to benefit from these resources to scale titanium production and manufacturing capacity.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The $47.1 million award in February of 2025 through the IBAS program builds upon the $12.7 million in funding previously awarded under the DoW's DPA Title III Program, as well as up to $99 million in contract awards under the SBIR Phase III program.

The awards have allowed IperionX to commence scale up plans to 1,400 metric tons per year in 2027. IperionX is aiming to be a leading U.S. titanium producer of over 10,000 metric tons per annum by 2030.

*Future integration using upgraded minerals from Titan Projects' titanium mineral resources*

The fully permitted Titan Project in Tennessee is one of the largest titanium mineral resources in North America, as well as a leading U.S. resource of zircon and rare earth critical minerals.

The Titan Project, combined with our patented titanium mineral upgrading technologies, has the potential to deliver an innovative end-to-end solution for a U.S. titanium supply chain, providing significant strategic value for defense and advanced manufacturing.

IperionX is currently undertaking a definitive feasibility study on the Titan Project, funded by the DoW, and expected to be complete in Q2 2026.

*U.S. Government support to accelerate our growth plans*

The U.S. government continues to support IperionX's efforts to re-shore a secure domestic titanium supply chain, building upon the initial $12.7 million contract awarded to IperionX in 2023. As of June 30, 2025, the Company has been awarded approximately $60 million in funding and grants through the U.S. DoW DPA Title III and IBAS programs.

<u>DPA Title III funding of Equipment for Virginia Titanium Manufacturing Facilities</u>

In October 2023, IperionX executed a $12.7 million contract in funding under the U.S. DoW DPA Title III authorities to address the U.S. titanium supply chain vulnerabilities. The government share will be matched with $13.4 million in funding from IperionX, for a total funding amount of $26.1 million. This funding is being applied towards the Group's Titanium Production Facility in Virginia. The agreement has an initial term of 39 months, scheduled to terminate on January 30, 2027, and provides that it may be extended by mutual agreement. Under the agreement, the Company and the U.S. government have agreed to use best efforts to achieve the goals of the agreement, which include the Company conducting a research and development program with respect to titanium technology.

Pursuant to the terms of the agreement, the cost principles applicable to the agreement are contained in 2 CFR 200, *Subpart E, Cost Principles*. Costs must meet the following criteria to be allowable under federal awards: (i) be necessary and reasonable for the performance of the awards; (ii) conform to any applicable limitations or exclusion as to types and amounts; (iii) be consistent with policies and procedures that apply uniformly to both federally financed and other activities of the recipient; (iv) be accorded consistent treatment; (v) be determined in accordance with generally accepted accounting principles; (vi) not be included as a cost or used to meet cost sharing requirements of any federally-financed program in the current or prior period; (vii) be adequately documented; and (viii) in relation to administrative close out costs, be incurred until the due date of the final report. Additionally, the Company uses the Federal Acquisition Regulation Part 31 and its internal regulations entitled "unallowable Cost Policy" to determine which costs are reimbursable. To the extent designated as the government's share, the Company is entitled to request reimbursement from time to time of the cost to purchase.

For accounting purposes, the Company's role with respect to the equipment is to acquire it on behalf of the government in an agency capacity. Upon procurement of the asset for the government, only a receivable is recognized reflecting the reimbursement due from the government. No amounts are capitalized or expensed by the Company.

As of June 30, 2025, the Company has procured assets on behalf of the government that cost approximately $10.3 million, (2025: $4.0 million), (2024: $6.3 million) for which the Company has sought reimbursement under the agreement. (2025: $4.0 million), (2024: $6.3 million). We received cash reimbursements from the U.S. DoW of $5.6 million during the twelve months ended June 30, 2025 (2024: $4.7 million). We expect to utilize the full $12.7 million of available funding by the end of fiscal year 2026.

Title to all equipment and real property acquired with federal funds vests with the government throughout the agreement. The government can elect to, but is not obliged to, transfer such title to all or a portion of the equipment or real property to

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

the Company at the end of the agreement, which is scheduled to terminate on January 30, 2027, if the Company's performance is satisfactory and provided that (a) the Company has used the equipment or real property for the authorized purposes of the project funding until funding for the project ceases, (b) the Company has not encumbered the equipment or real property without approval of the government, and (c) the Company has otherwise complied with the terms of the agreement. All equipment acquired with federal funds is tagged and segregated from equipment acquired with Company funds using a Property Control List that tracks all equipment purchased under the agreement. The Property Control List is submitted quarterly to the government and includes a description of the equipment, an asset number, manufacturer's serial number, ordered date, received date, installed date, location of the asset, and disposition date (if applicable). When the equipment arrives at our Virginia facility, it is tagged with an identification tag marked "Property of the Government of the United States" and which also included the serial number, asset number, and date received.

Through June 30, 2025, the Company used government funds primarily to acquire equipment used to produce titanium powder from recycled sources of scrap at the construction site. The assets acquired are designed to establish, outfit and operationalize the TPF in accordance with the Statement of Work included in the DPA agreement. Although theses assets are integral to the operation of the TPF, if the U.S. government does not relinquish these assets to the Company at the end of the agreement, the Company would seek to acquire or lease such equipment from the government, replace such equipment with new equipment using the Company's existing cash reserves, or consider other options. See "Item 3. *Key Information - D. Risk Factors*."

<u>IBAS Funding for the Advance Titan Critical Mineral Project</u>

In February 2025, the Company was awarded up to $47.1 million by the U.S. DoW to strengthen the U.S. Defense Industrial Base by accelerating the scale-up of a resilient, low-cost, and fully-integrated U.S. mineral-to-metal titanium supply chain. The grant will be matched with $23.6 million in funding by IperionX, for a total funding amount of $70.7 million. This funding aims to bolster the U.S. defense Industrial base by developing a fully integrated, low-cost titanium supply chain sourced domestically. The project scope under the IBAS program had been revised to prioritize accelerated expansion of IperionX's titanium metal and manufacturing production capacity at IperionX's Virginia Titanium Manufacturing Campus.

As part of the initial phase, the DoW has obligated $5.0 million, and IperionX will contribute $1.0 million, to expedite the Titan Critical Minerals Project in Tennessee to 'shovel-ready' status, an important milestone in securing a new domestic source of titanium, rare earths and zircon critical minerals. Subsequent to year end, the DoW obligated an additional $12.5 million in August of 2025, and another $25.0 million in September of 2025, through the IBAS program to purchase orders for long-lead, major capital equipment required for the next stage of capacity scale-up to over 1,400 metric tons per year at the Virginia Titanium Manufacturing Campus. Total obligations now stand at $42.5 million, with the remaining $4.6 million expected to be obligated by the DoW over the contract term. The matching funding by IperionX increased to $48.1 million for a total funding amount of $95.2 million as of the date of this filing. Government reimbursements provided as grants are subject to conditional funding provisions. Grants for the initial phase are recognized as "Other income and expenses" in the consolidated statements of profit and loss and other comprehensive income, once all conditions for reimbursement are met.

The criteria that defines permissible expenditures are the same as of the DPA Title II program mentioned above (the cost principles contained in 2 CFR 200, *Subpart E, Cost Principles*, and the cost principles or standards in accordance with 32 CFR 37.625).

Through June 30, 2025, the company has expensed $1.3 million in costs under the phases 1 and 2 of the program (2024 and 2023: Nil), dedicated to expedite the definite feasibility study of the Titan Critical Minerals Project, and has sought reimbursement of $0.9 million of which $0.1 million was received as of June 30, 2025, in accordance with the agreement. The Company has used government funds primarily to fully fund the Phase 1, the Definite Feasibility Study, the Production and Process Control Plan (PCP) and Operational Qualification Protocol of Phase 2.

A range of other U.S. Government funding opportunities is also available as potential funding sources for further scale-up and these are currently being actively progressed.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Customers Engagements**

*Partnership with Aperam to advance a circular titanium supply chain* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In July 2024, IperionX and Aperam signed an agreement to apply IperionX's fully circular and sustainable titanium supply chain solution to the consumer electronics sector, with IperionX to use its patented titanium technologies to upcycle up to 12 metric tons of titanium scrap from the consumer electronics sector to manufacture a range of high-performance titanium products.

*IperionX executes sourcing contract with global automaker* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In September 2024, IperionX executed a sourcing contract for the supply of manufactured metal components for Ford Motor Company. The term of the Contract runs for 45 months commencing in 2025, with IperionX contracted to supply titanium metal powder and manufacture components. Total revenues from the contract are expected to be approximately $11 million.

*IperionX secures first U.S. army task order under $99 million SBIR Phase III contract*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In June 2025, IperionX received the first task order, valued at $1.3 million, from the U.S. Army under a SBIR Phase III Indefinite Delivery Indefinite Quantity contract with the U.S. DoW. The task order facilitates the production and delivery of titanium parts for U.S. Army ground vehicle programs. The project was the first of further task orders expected under the $99 million SBIR Phase III contract, which enables any DoW and U.S. Government agency to support production capabilities to procure titanium parts and materials directly from IperionX.

*Other ongoing customer engagements and developments*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Product development and qualification continues to build momentum across key customer sectors - defense, automotive and consumer electronics.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• There has been very strong customer engagement for high-performance titanium components that suffer from historically low material yields (high scrap rates) - such as titanium fasteners, housings, and precision components.

**Competition**

IperionX's principal competition is the high-carbon, high-cost incumbent titanium and critical mineral producers outside of the U.S., including from China and Russia. Many of our competitors have been in business longer than we have and have established more strategic partnerships and relationships and have greater financial accessibility than we have.

While we compete with other companies in the metals and natural resource space, we believe that there may be interested customers for our critical materials, including titanium metal, titanium minerals and rare earth minerals, if we can successfully develop the Titan Project. The price of metals and minerals can be affected by factors beyond our control, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fluctuations in the market prices for critical materials, titanium metal, titanium minerals and rare earth minerals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fluctuating supplies of critical materials, titanium metal, titanium minerals and rare earth minerals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fluctuating demand for critical materials, titanium metal, titanium minerals and rare earth minerals; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Metals and extraction activities of others.

**EXPLORATION RESULTS**

Since securing the initial Titan Project land position in late-2020, we have focused on proving the project's potential. We have conducted multiple drilling programs at the Titan Project, comprising more than 360 drill holes totaling more than 11,000 meters drilled during the fiscal periods ended June 30, 2023, 2024, and 2025. On June 30, 2023, we reported the results of the Initial Assessment on the Titan Project, which demonstrate the Titan Project's potential to be a low cost and globally significant North American producer of titanium, rare earths and other critical minerals needed for advanced U.S.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

industries such as consumer electronics, aerospace, space, defense, medical, bicycles, additive manufacturing and automotive. We also believe that there is a significant potential to increase production capacity at the Titan Project. The Initial Assessment, which adhered to the guidelines in S-K 1300, considered mining, processing, metallurgical, infrastructure, economic, marketing, legal, environment, social and government factors.

However, we remain an exploration stage minerals extraction company, and we have declared no reserves as defined under S-K 1300 standards. See "Item 4. *Information on the Company – D. Property, Plant and Equipment*" for additional information relating to the Titan Project, including the relevant exploration results, which information is incorporated by reference.

**EXPLORATION AND DEVELOPMENT PLANS**

We are required by ASX Listing Rules to report ore reserves and mineral resources in Australia in compliance with the Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves (the JORC Code 2012 Edition) prepared by JORC. In contrast, the SEC generally requires disclosure of extraction reserves in accordance with S-K 1300. We are an exploration stage minerals extraction company, and we have no reserves as defined under S-K 1300 standards. See "*Cautionary Note to United States Investors.*"

We are incorporating by reference a Technical Report Summary on the Titan Project, dated June 30, 2024 (incorporated by reference to Exhibit 15.1 to the Company's Annual Report on Form 20-F for the year ended June 30, 2024), which includes an Initial Assessment to support our Mineral Resource estimate and address reasonable prospects of eventual economic extraction.

IperionX is currently undertaking a definitive feasibility study on the Titan Project, funded by the DoW, and expected to be complete in the second quarter of 2026. These additional studies will also adhere to the guidelines in S-K 1300. If we complete all technical studies (and all necessary permitting activities), we may then undertake minerals extraction and processing activities. However, we currently do not have detailed plans for any component of the exploration and development plans.

Subject to market conditions and the ability to define an economically viable critical minerals deposit, our separate business plan for the Titan Project is to become a strategic, U.S. domestic source of high-quality and sustainable titanium and other critical mineral feedstocks, including rare earths, to the United States. The titanium minerals could form an important sustainable feedstock for the Technologies and assist in the scale up of the Technologies to meet potential future market demand. We believe that vertical integration with U.S.-based resource operations is a major competitive advantage for IperionX, providing a potential source of critical mineral feedstock.

We plan to effect our business plan for the Titan Project by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• completing our exploration drilling program on initial land position and continuing to secure additional land leases to undertake additional exploration;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• undertaking necessary technical studies to assess the economic potential of the Titan Project and defining a critical minerals reserve base;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• completing required permitting and zoning activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• undertaking discussions with potential customers for future sale of titanium and other critical minerals, including rare earths;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• completing required financing activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• completing construction of the Titan Project's minerals extraction and processing facilities; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• commencing minerals extraction and processing activities to supply the United States demand for clean, low-cost domestic sources of titanium and other critical minerals, including rare earths.

**Extraction Permits and Approvals**

In August 2023, we received what we believe are the requisite development permits required to start construction and operations of our planned wet concentrator plant at the Titan Project, including the National Pollutant Discharge

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Elimination System Permit and Surface Mining Permit, which were issued by the Tennessee Department of Environment & Conservation.

We will require additional governmental permits to construct our planned dry mineral separation plant. We also will be required to renew our permits from time to time. Obtaining and renewing governmental permits is a complex and time-consuming process. The timeliness and success of permitting efforts are contingent upon many variables not within our control, including the interpretation of permit approval requirements administered by the applicable permitting authority. We may not be able to obtain or renew permits that are necessary to our planned operations or we may find that the cost and time required to obtain or renew such permits exceeds our expectations, which in turn could materially adversely affect our business plans or our prospective or actual revenues and profitability. In addition, private parties, such as environmental activists, frequently attempt to intervene in the permitting process and to persuade regulators to deny necessary permits or seek to overturn permits that have been issued. These third-party actions can materially increase the costs and cause delays in the permitting process and could cause us to not proceed with the development or operation of a property.

Our exploration operations are subject to extensive laws and regulations, which are overseen and enforced by multiple U.S. federal, state and local authorities. These laws govern exploration, development, production, exports, various taxes, labor standards, occupational health and safety, waste disposal, protection and remediation of the environment, protection of endangered and protected species and other matters. Mineral exploration operations are also subject to U.S. federal and state laws and regulations that seek to maintain health and safety standards by regulating the design and use of drilling methods and equipment. Various permits from government bodies are required for drilling operations to be conducted, and we cannot assure you such permits will be received. Environmental laws and regulations may also, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Require notice to stakeholders of proposed and ongoing operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Require the installation of pollution control equipment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Restrict the types, quantities and concentration of various substances that can be released into the environment in connection with minerals extraction or drilling activities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Limit or prohibit extraction or drilling activities on lands located within wetlands, areas inhabited by endangered species and other protected areas, or otherwise restrict or prohibit activities that could impact the environment, including water resources.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Impose substantial liabilities for pollution resulting from current or former operations on or for any preexisting environmental impacts at the Titan Project site.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Require preparation of an Environmental Assessment or an Environmental Impact Statement.

**Environmental Regulation**

IperionX's operations are subject to various environmental laws and regulations under the relevant government's legislation. Full compliance with these laws and regulations is regarded as a minimum standard for all operations to achieve. Instances of environmental non-compliance by an operation are identified either by external compliance audits or inspections by relevant government authorities. There have been no known breaches by the Group during the fiscal year ended June 30, 2025. For more information, see "*Government Regulations*" below.

As of the date hereof, other than with respect to the acquisition of the Titan Project and related permitting activities, we have not been required to spend material amounts on compliance with environmental regulations. However, compliance with these laws and regulations may impose substantial costs on us, subject us to significant potential liabilities, and have an adverse effect upon our capital expenditures, results of operations or competitive position. Violations and liabilities with respect to these laws and regulations could result in significant administrative, civil, or criminal penalties, remedial clean-ups, natural resource damages, permit modifications or revocations, operational interruptions or shutdowns and other liabilities. The costs of remedying such conditions may be significant, and remediation obligations could adversely affect our business, results of operations and financial condition. Additionally, Congress and federal and state agencies frequently revise environmental laws and regulations, and any changes in these regulations or the interpretations thereof could require us to expend significant resources to comply with new laws or regulations or changes to current requirements and could have a material adverse effect on our business operations.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**GOVERNMENTAL REGULATIONS**

***U.S. Securities Regulations***

On December 31, 2024, the market value of our ordinary shares held by non-affiliates exceeded $700,000,000. As a result, as of June 30, 2025, IperionX no longer qualified as an emerging growth company and is now a large accelerated filer.

*Foreign Private Issuer Status*

We are also considered a "foreign private issuer" pursuant to Rule 405 under the Securities Act. As a foreign private issuer, we are exempt from certain rules under the Exchange Act that impose certain disclosure obligations and procedural requirements for proxy solicitations under Section 14 of the Exchange Act. In addition, our officers, directors and principal shareholders are exempt from the reporting and "short-swing" profit recovery provisions of Section 16 of the Exchange Act and the rules under the Exchange Act with respect to their purchases and sales of our ordinary shares or ADSs. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as United States companies whose securities are registered under the Exchange Act. In addition, we are not required to comply with Regulation FD, which restricts the selective disclosure of material information.

Nasdaq also allows us as a foreign private issuer to elect to follow certain home country laws instead of Nasdaq practices applicable to U.S. companies. In particular, we follow home country law instead of Nasdaq practice regarding:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that our independent directors meet regularly in executive sessions. The ASX Listing Rules and the Corporations Act do not require the independent directors of an Australian company to have such executive sessions and, accordingly, we have claimed this exemption.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that an issuer provide for a quorum as specified in its bylaws for any meeting of the holders of ordinary shares, which quorum may not be less than 33 1/3% of the outstanding shares of an issuer's voting ordinary shares. In compliance with Australian law, our Constitution provides that two shareholders present shall constitute a quorum for a general meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that issuers obtain shareholder approval prior to the issuance of securities in connection with certain acquisitions, changes of control or private placements of securities, or the establishment or amendment of certain stock option, purchase or other compensation plans. Applicable Australian law and rules differ from Nasdaq requirements, with the ASX Listing Rules providing generally for prior shareholder approval in numerous circumstances, including (i) issuance of equity securities exceeding 15% (or an additional 10% capacity to issue equity securities for the proceeding 12-month period if shareholder approval by special resolution is sought at the Company's annual general meeting) of our issued share capital in any 12-month period (but, in determining the available issue limit, securities issued under an exception to the rule or with shareholder approval are not counted), (ii) issuance of equity securities to related parties (as defined in the ASX Listing Rules) and (iii) directors or their associates acquiring securities under an employee incentive plan.

For as long as we are a "foreign private issuer" we intend to file our annual financial statements on Form 20-F and furnish our semi-annual financial statements and quarterly updates on Form 6-K to the SEC for so long as we are subject to the reporting requirements of Section 13(g) or 15(d) of the Exchange Act. However, the information we file or furnish is not the same as the information that is required in annual and quarterly reports on Form 10-K or Form 10-Q for U.S. domestic issuers. Accordingly, there may be less information publicly available concerning us than there is for a company that files as a domestic issuer.

We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We are required to determine our status as a foreign private issuer on an annual basis at the end of our second fiscal quarter. We would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (1) the majority of our executive officers or directors are U.S. citizens or residents; (2) more than 50% of our assets are located in the United States; or (3) our business is administered principally in the United States. Since more than 50% of our assets are located in the United States, we will lose our status as a foreign private issuer if more than 50% of our outstanding voting securities are held by U.S. residents as of the last day of our second fiscal quarter in any year.

For information on the risks that accompany our status as a foreign private issuer, see "Item 3. *Key Information – D. Risk Factors – Risks Related to Our ADSs – As a foreign private issuer, we are permitted to file less information with the SEC* 

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*than a domestic issuer*" and "Item 3. *Key Information-D. Risk Factors – Risks Related to Our ADSs – We may lose our foreign private issuer status, which would then require us to comply with the Exchange Act's domestic reporting regime and cause us to incur additional legal, accounting and other expenses.*"

***U.S. Environmental, Health and Safety Laws***

IperionX's business operations, including the Technologies and the Titan Project, will be required to comply with applicable environmental protection laws and regulations and licensing and permitting requirements. The material environmental, health and safety laws and regulations that we must comply with include, among others, the following United States federal laws and regulations:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• National Environmental Policy Act, which requires careful evaluation of the environmental impacts of major federal actions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Clean Air Act and its amendments, which governs air emissions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Clean Water Act, which governs discharges to and excavations within the waters of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Safe Drinking Water Act, which governs the underground injection and disposal of wastewater;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Resource Conservation and Recovery Act, which governs the management of both hazardous and non-hazardous solid waste;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Comprehensive Environmental Response, Compensation, and Liability Act, which imposes liability where hazardous substances have been released into the environment (commonly known as Superfund);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Department of Transportation Hazardous Materials Regulations, which govern the handling and transportation of hazardous materials to ensure safety and security across all modes of transportation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Endangered Species Act, which establishes protections for fish, wildlife, and plants that are listed as threatened or endangered;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Occupational Safety and Health Act, which governs the safe and healthful working conditions for private sector workers; and the

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Federal Mine Safety and Health Act, which established the primary safety and health standards regarding working conditions of employees engaged in extraction, related operations, and preparation and milling of the minerals extracted.

Our operations may also be subject to state and local environmental law and regulations, including but not limited to laws and regulations related to the air emissions, wastewater discharges, and reclamation of mined lands, which may require reclamation permits to be acquired prior to the commencement of minerals extraction operations and may require substantial financial guarantees to cover the cost of future reclamation activities.

***Solid and Hazardous Waste***

The Resource Conservation and Recovery Act (RCRA), and comparable state statutes, affect our operations by imposing regulations on the generation, transportation, treatment, storage, disposal and cleanup of hazardous wastes and on the disposal of non-hazardous wastes. Under the auspices of the EPA, the individual states administer some or all of the provisions of RCRA, sometimes in conjunction with their own, more stringent requirements.

In addition, the federal Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) - Superfund law - can impose joint and several liability without regard to fault or legality of conduct on classes of persons who are statutorily responsible for the release of a hazardous substance into the environment. These persons can include the current and former owners, lessees or operators of a site where a release occurs, and anyone who disposes or arranges for the disposal of a hazardous substance. Under CERCLA, such persons may be subject to strict, joint and several liability for the entire cost of cleaning up hazardous substances that have been released into the environment and for other costs, including response costs, alternative water supplies, damage to natural resources and for the costs of certain health studies. Moreover, it is not uncommon for neighboring landowners, workers and other third parties to file claims for personal injury and property damage allegedly caused by hazardous substances released into the indoor or outdoor environment. Each state also has environmental cleanup laws analogous to CERCLA. Hazardous wastes may have been previously handled, disposed of, or released on or under properties currently or formerly owned or leased by us or on or under other locations to which we sent waste for disposal. These properties and any materials disposed or released on them may subject us to

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

liability under CERCLA, RCRA and analogous state laws. Under such laws, we could be required to remove or remediate disposed wastes or property contamination, to contribute to remediation costs, or to perform remedial activities to prevent future environmental harm.

***Air Emissions***

The federal Clean Air Act (CAA) and comparable state and local laws restrict the emission of air pollutants from numerous sources through the issuance of permits and the imposition of other requirements. Major sources of air pollutants are subject to more stringent, federally imposed permitting requirements. Air pollution regulations may require us to obtain pre-approval for the construction or modification of certain projects or facilities expected to produce or significantly increase air emissions, obtain air permits and comply with stringent permit requirements or utilize specific equipment or technologies to control emissions of certain pollutants. The need to obtain permits has the potential to delay our operations, and we may be required to incur capital expenditures for air pollution control equipment or other air emissions related obligations. Administrative enforcement actions for failure to comply strictly with air pollution regulations or permits are generally resolved by payment of monetary fines and correction of any identified deficiencies. Alternatively, regulatory agencies could require us to forego construction, modification or operation of certain air emission sources.

***Climate Change***

Numerous regulatory initiatives have been enacted, and are likely to continue to be developed, at the international, national, regional and state levels of government to monitor and limit existing emissions of Greenhouse gas (GHG) as well as to restrict or eliminate such future emissions. At the federal level, in December 2009, the EPA determined that emissions of carbon dioxide, methane and other GHGs endanger public health and the environment because emissions of such gases are, according to the EPA, contributing to warming of the earth's atmosphere and other climatic changes. Based on these findings, the EPA began adopting and implementing regulations to restrict emissions of GHGs under existing provisions of the CAA.

Congress has from time to time considered adopting legislation to reduce emissions of GHGs, and a number of state and regional efforts have emerged that are aimed at tracking and/or reducing GHG emissions by means of cap-and-trade programs. Cap and trade programs typically require major sources of GHG emissions to acquire and surrender emission allowances in return for emitting those GHGs. The adoption of legislation or regulatory programs or other government action to reduce emissions of GHGs could require us to incur increased operating costs.

***Clean Water Act***

The CWA imposes restrictions and strict controls regarding the discharge of wastes, including mineral processing wastes, into waters of the United States, a term broadly defined to include, among other things, certain wetlands. Permits must be obtained to discharge pollutants into federal waters. The CWA provides for civil, criminal and administrative penalties for unauthorized discharges, both routine and accidental, of pollutants. It imposes substantial potential liability for the costs of removal or remediation associated with discharges of oil or hazardous substances. State laws governing discharges to water also provide varying civil, criminal and administrative penalties, and impose liabilities in the case of a discharge of petroleum or its derivatives, or other hazardous substances, into state waters. In addition, the EPA has promulgated regulations that require permits to discharge storm water runoff, including discharges associated with construction activities. In the event of an unauthorized discharge of industrial wastes, we may be liable for penalties and costs.

Pursuant to these laws and regulations, we may also be required to develop and implement spill prevention, control and countermeasure plans, also referred to as "SPCC plans," in connection with on-site storage of significant quantities of oil. Some states also maintain groundwater protection programs that require permits for discharges or operations that may impact groundwater conditions. The CWA also prohibits the discharge of fill materials to regulated waters including wetlands without a permit from the USACE.

In May 2015, the EPA issued a final rule that attempted to clarify the federal jurisdictional reach over waters of the United States, but the agency repealed this rule in September 2019 and replaced it with the Navigable Water Protection Rule in April 2020, which narrowed federal jurisdictional reach relative to the 2015 rule. The repeal and replacement of the 2015 rule is currently subject to litigation and the scope of the jurisdictional reach of the Clean Water Act may therefore remain uncertain for several years, with a patchwork of legal guidelines applicable to various states potentially developing. We could face increased costs and delays with respect to obtaining permits for dredge and fill activities in wetland areas to the extent they are required.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***Underground Injection Control Permits***

The federal Safe Drinking Water Act (SDWA) creates a nationwide regulatory program protecting groundwater. This act is administered by the EPA. However, to avoid the burden of dual federal and state (or Indian tribal) regulation, the SDWA allows for the UIC permits issued by states (and Indian tribes determined eligible for treatment as states) to satisfy the UIC permit required under the SDWA under two conditions. First, the state's program must have been granted primacy. Second, the EPA must have granted, upon request by the state, an aquifer exemption. The EPA may delay or decline to process the state's application if the EPA questions the state's jurisdiction over the mine site. Permits must be obtained before developing and using deep injection wells for the disposal or storage of produced fluids, and well casing integrity monitoring must be conducted periodically to ensure the well casing is not leaking produced fluids to groundwater. Contamination of groundwater by natural gas and oil drilling, production and related operations may result in fines, penalties, remediation costs and natural resource damages, among other sanctions and liabilities under the SDWA and other federal and state laws. In addition, third-party claims may be filed by landowners and other parties claiming damages for groundwater contamination, alternative water supplies, property impacts and bodily injury.

*NEPA*

The National Environmental Policy Act (NEPA) requires federal agencies to evaluate major agency actions having the potential to significantly impact the environment. The NEPA process may involve public input through comments which can alter the nature of a proposed project either by limiting the scope of the project or requiring resource-specific mitigation. NEPA decisions can be appealed through the court system by process participants. The NEPA process may result in delaying the funding, permitting, or development of projects or increase the costs of permitting and developing some facilities.

*Endangered Species Act*

The federal ESA restricts activities that may affect endangered and threatened species or their habitats. Some of our operations may be located in areas that are designated as habitats for endangered or threatened species. A critical habitat designation could result in further material restrictions to federal and private land use and could delay or prohibit land access or development. The United States Fish and Wildlife Service continues its effort to make listing decisions and critical habitat designations where necessary. The ESA has not previously had a significant impact on our operations. However, the designation of previously unprotected species as being endangered or threatened could cause us to incur additional costs or become subject to operating restrictions in areas where the species are known to exist.

***Extraction Permits and Approvals***

We currently have permits authorizing the exploration drilling activities with respect to the Titan Project. We are required to obtain governmental permits for some of our exploration activities and may be required to renew the permits we already have. Prior to developing or extracting any mineralization that we discover, we will be required to obtain new governmental permits authorizing, among other things, further site development activities and site operating activities. Obtaining and renewing governmental permits is a complex and time-consuming process and involves numerous jurisdictions, public hearings and possibly costly undertakings. The timeliness and success of permitting efforts are contingent upon many variables not within our control, including the interpretation of permit approval requirements administered by the applicable permitting authority. We may not be able to obtain or renew permits that are necessary to our planned operations or the cost and time required to obtain or renew such permits may exceed our expectations. Any unexpected delays or costs associated with the permitting process could delay the exploration, development or operation of our properties.

See "Item 3. Key Information – D. Risk Factors – *Risks Related to Regulatory and Industry Matters* – *We will be required to obtain governmental permits in order to conduct development and minerals extraction operations, a process which is often costly and time-consuming*."

Our exploration operations are subject to extensive laws and regulations, which are overseen and enforced by multiple U.S. federal, state and local authorities. These laws govern exploration, development, production, exports, various taxes, labor standards, occupational health and safety, waste disposal, protection and remediation of the environment, protection of endangered and protected species and other matters. Mineral exploration operations are also subject to U.S. federal and state laws and regulations that seek to maintain health and safety standards by regulating the design and use of drilling

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

methods and equipment. Various permits from government bodies are required for drilling operations to be conducted, and we cannot assure you such permits will be received. Environmental laws and regulations may also, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Require notice to stakeholders of proposed and ongoing operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Require the installation of pollution control equipment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Restrict the types, quantities and concentration of various substances that can be released into the environment in connection with minerals extraction or drilling activities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Limit or prohibit extraction or drilling activities on lands located within wetlands, areas inhabited by endangered species and other protected areas, or otherwise restrict or prohibit activities that could impact the environment, including water resources.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Impose substantial liabilities for pollution resulting from current or former operations on or for any preexisting environmental impacts at the Titan Project site.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Require preparation of an Environmental Assessment or an Environmental Impact Statement.

As of the date hereof, other than with respect to the acquisition of the Titan Project and related permitting activities, we have not been required to spend material amounts on compliance with environmental regulations. However, compliance with these laws and regulations may impose substantial costs on us, subject us to significant potential liabilities, and have an adverse effect upon our capital expenditures, results of operations or competitive position. Violations and liabilities with respect to these laws and regulations could result in significant administrative, civil, or criminal penalties, remedial clean-ups, natural resource damages, permit modifications or revocations, operational interruptions or shutdowns and other liabilities. The costs of remedying such conditions may be significant, and remediation obligations could adversely affect our business, results of operations and financial condition. Additionally, Congress and federal and state agencies frequently revise environmental laws and regulations, and any changes in these regulations or the interpretations thereof could require us to expend significant resources to comply with new laws or regulations or changes to current requirements and could have a material adverse effect on our business operations.

C.**Organizational Structure**

The following reflects our organizational structure. All our subsidiaries are wholly-owned.

![Image_7.jpg](ipx-20250630_g8.jpg)

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

D.**Property, Plant and Equipment**

Our executive offices are located at 129 West Trade Street, Suite 1450, Charlotte, North Carolina, We have a lease for 3,326 square feet of office space, which expires August 31, 2026. We also lease three facilities in the South Boston, Virginia Manufacturing Campus: (1) a 50,000 square foot building at 1080 Confroy Drive, which is used as the Company's titanium production hub (lease expires July 31, 2034); (2) a 15,000 square foot building at 1092 Confroy Drive, which is used as the Company's Advanced Manufacturing Center (expires October 31, 2033); and (3) 2,500 square feet of office space located in Suite 6 of a commercial building at 1100 Confroy Drive, South Boston, Virginia, (expires June 15, 2026, with two renewal options). We also hold the exclusive right to occupy and use the premises and equipment located at 1782 W 2300 South, West Valley City, UT 84119 (expires January 1, 2026, with renewal options).

**Titan Project**

***Overview***

IperionX holds a 100% interest in the Titan Project, covering more than 10,000 acres of mineral properties in Tennessee, United States, which we consider prospective for critical minerals including titanium, rare earth elements, silica sand and zircon.

The Titan Project is located in west Tennessee, and we believe the Titan Project has access to strategic infrastructure, with nearby access to roads, rail, river, power and skilled labor.

At June 30, 2025, the book carrying value of the Titan Project was $6.5 million. See Note 10 to our audited consolidated financial statements for the fiscal period ended June 30, 2025 included in this annual report for further details.

The Titan Project is located in an area which saw past exploration from the 1950's to the 1990's by companies including DuPont, Kerr-McGee Corp., BHP Group, RGC Ltd and Altair International Corp. The Titan Project is also strategically located in the southeast of the United States, close to significant manufacturing capacity, including the Chemours facility in New Johnsonville, one of the world's largest producers of titanium dioxide.

***Geology and geological interpretation***

The Titan Project's location in western Tennessee represents the eastern flank of the Mississippi embayment, a large, southward plunging syncline within the Gulf Coastal Plain. This feature extends from southern Illinois to the north and to Mississippi and Alabama to the south. The embayment is filled with sediments and sedimentary rocks of Cretaceous to Quaternary age.

Mineralization at the Titan Project resides primarily in two zones within the primary McNairy Sand Formation. The main mineralized zone at the 'Benton' deposit is hosted stratigraphically in the lower member of the McNairy Formation.

The 'Camden' deposit represents the up-dip extension of the lower portion of the McNairy Sand formation encountered at the Company's Benton deposit. The McNairy Sand dips gently to the west and the Camden deposit represents the most easterly outcrop of this formation.

***Drilling and exploration***

Since securing the initial Titan Project land position in late-2020, we have focused on delineating the Titan Project's potential. We have conducted multiple drilling programs at the Titan Project, comprising more than 360 drill holes totaling more than 11,000 meters drilled during fiscal 2023, 2024 and 2025.

To date we have drilled 162 holes on the Project's mineral resource area, comprising 16 reverse circulation holes (for a total of 837 meters) and 146 roto-sonic drill holes (for a total of 7,338 meters). We also drilled an additional 11 roto-sonic drill holes for the purposes of a hydrogeological study, which have not been used for mineral resource definition purposes.

The drilling results at the Benton deposit highlight a consistent grade and thickness of mineralization averaging 31 meters thickness, and to-date has been traced for approximately 6 kilometers along strike. The mineralization appears to occur as a single, large, and coherent near-surface deposit.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

In addition to the Benton deposit, exploration drilling at other properties within the Titan Project, located approximately 4 kilometers southeast of the Benton deposit, has indicated potential additional near surface, high-grade mineralization. We have designated this new discovery as the 'Camden' deposit. The Camden deposit represents the up-dip extension of the lower portion of the McNairy Sand formation encountered at the Benton deposit.

We received updated results from metallurgical test work conducted in 2023 designed to confirm process design and critical mineral product recoveries at the Titan Project, including excellent simulated recoveries of the high value natural rutile, zircon and rare earth mineral products, as set out in the table below.

*Titan Project Metallurgical Test Work Results*

---

| | |
|:---|:---|
| **Product** | **2023 Metallurgical Test Work Simulated Recoveries (+45 µm material)** |
| Rare Earths | 83% |
| Rutile – Titanium | 67% |
| Ilmenite – Titanium | 80% |
| Premium Zircon | 78% |

---

***Mineral resources***

The mineral resource figures presented herein are estimates based on information available at the time of calculation. A "mineral resource" is a concentration or occurrence of solid material of economic interest in or on the earth's crust in such form, grade, or quality and quantity that there are reasonable prospects for eventual economic extraction. The location, quantity, grade or quality, continuity and other geological characteristics of a mineral resource are known, estimated or interpreted from specific geological evidence and knowledge, including sampling. The reference point for mineral resources is exclusive of the mineral reserves. Mineral resources are subdivided in order of increasing geological confidence into inferred, indicated and measured categories. Metric tons of mineral resources containing total heavy minerals, included in the indicated, and inferred resources, are those contained prior to losses during metallurgical treatment. The terms "measured resource", "indicated resource", and "inferred resource" mean the part of a mineral resource for which quantity and grade or quality are estimated on the basis of geological evidence and sampling that is considered to be comprehensive, adequate, or limited, respectively.

Market fluctuations in the price of the underlying minerals which make up THM, as well as increased production costs or reduced metallurgical recovery rates, could change future estimates of resources.

We have reported mineral resources, prepared in accordance with S-K 1300 requirements of the SEC as part of our exploration and evaluation activities. Our Technical Report Summary on the Titan Project, dated as of June 30, 2024 is incorporated by reference in this Annual Report on Form 20-F. As stated below, as a result of the annual review of the Company's mineral resources, there has been no change to the mineral resources reported for the Titan Project. As of June 30, 2025, we have reported 431 million metric tons of mineral resources at a grade of 2.2% THM, containing 9.5 million metric tons of THM at a 0.4% cut-off. Slimes and oversize material accounts for approximately 20% and 2.5% of the THM fraction respectively. Mineralization occurs as a single, large, and coherent near-surface deposit. In addition, preliminary analysis of valuable heavy minerals (which form a proportion of the THM) indicates a valuable mineral assemblage consisting of zircon, rutile, ilmenite, and REE.

Mineral resources are reported above a cut-off grade of 0.4% THM. All material at or above the bottom cut-off grade of 0.4% used in a constraining pit shell is expected to be processed, on the basis that the incremental cost of selectively extracting this material, hauling it to a long- term stockpile, and subsequently reclaiming and re-placing the material into the a mine void for progressive rehabilitation would be higher than the net cost (operating cost less revenue) of the central case method, being the processing of this material, extracting the contained valuable critical minerals for sale and immediately returning the remaining material, mostly silica sand, back to the deposit void.

The mineral resources were constrained within a conceptual pit shell that used the assumptions listed in the table below. An assumed vertical slope was applied to the pit shells. The vertical slopes are attainable due to low depths of mineralization, unconsolidated material and the active reclamation process.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***<u>Assumptions used in defining prospects of economic extraction</u>***

---

| | | |
|:---|:---|:---|
| **Parameter** | **Units** | **Value** |
| Commodity price |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rutile | $/t | 1440 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Ilmenite | $/t | 280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rare earth mineral concentrate | $/t | 11630 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Zircon | $/t | 1680 |
| Metallurgical recovery |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rutile | % | 66.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Ilmenite | % | 79.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rare earth mineral concentrate | % | 82.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Zircon | % | 77.6 |
| Operating costs |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Mining cost | $/ROM t | 2.66 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Processing cost | $/ROM t | 2.91 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Transport cost | $/ROM t | 0.22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reclaim/rehandle | $/ROM t | 2.66 (only used for selective mining comparison) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Incremental in pit management | $/ROM t | 1.00 (only used for selective mining comparison) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• General and administrative cost | $/ROM t | 0.71 |
| Royalty | % | 5 |

---

Material considered to meet reasonable prospects for economic extraction was reported using a cut-off grade of 0.4% THM.

***Historic and forecast product prices ($/t, 2025 real terms, rounded).***

---

| | | | |
|:---|:---|:---|:---|
| **Product** | **Historic<br>2019 – 2023\*<br>(annual average,<br>US$/t)** | **Historic<br>2019 – 2023\*<br>(annual average,<br>US$/t)** | **Forecast<br>2026 – 2050\*<br>(annual average,<br>US$/t)** |
| Rare earth concentrate | 6150 | \*\* | 11630 |
| Rutile | 1700 |  | 1440 |
| Chloride Ilmenite | 280 |  | 280 |
| Zircon (premium) | 1820 |  | 1680 |

---

*\*Source: Argus Media, TZMI, and Adamas Intelligence. Inflationary/CPI data from U.S. Government's Fiscal Year 2025 Budget assumptions.*

*\*\*Please refer to table below for individual prices for REE's that contribute to the REE concentrate price and table below for the percentage of each REE in our REE concentrate.*

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***Historic and forecast individual REE prices ($/kg, 2025 real terms, rounded).***

---

| | | |
|:---|:---|:---|
| **Rare Earth Oxide** | **Historic<br>2019 – 2023\*<br>(annual average<br>US$/kg)** | **Forecast<br>2026 – 2050\*<br>(annual average<br>US$/kg)** |
| Lanthanum | 1.3 | 1.4 |
| Cerium | 1.3 | 1.5 |
| Praseodymium | 78.9 | 157.9 |
| Neodymium | 80.0 | 166.1 |
| Samarium | 2.3 | 4.0 |
| Europium | 30.0 | 39.5 |
| Gadolinium | 40.0 | 86.4 |
| Terbium | 1157.3 | 1764.9 |
| Dysprosium | 322.0 | 555.0 |
| Holmium | 102.4 | 199.3 |
| Erbium | 33.6 | 57.2 |
| Ytterbium | 14.6 | 18.3 |
| Lutetium | 743.5 | 954.2 |
| Yttrium | 5.9 | 8.0 |

---

*\*Source: Argus Media and Adamas Intelligence.*

Pricing has been based upon the following standard product specification requirements:

***Initial Assessment product specification requirements.***

---

| | |
|:---|:---|
| **Product** | **Product specification requirements** |
| Rare earth <br>concentrate | Mineral rare earth concentrate with 59.08 weight % total rare earth oxides (TREO) - as set out in the table below. Value of rare earth concentrate calculated as 31% value of contained TREO plus 10% premium for Titan Project's heavy rare earth enrichment. |
| Rutile | Bulk rutile with titanium dioxide content (TiO2) of 94% - 96% |
| Chloride<br>Ilmenite | Chloride ilmenite with titanium dioxide content (TiO2) of 58% - 65% |
| Zircon <br>(premium) | Premium bulk zircon with ZrO₂ + HfO₂ >66% |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***Key product specifications of Titan-derived rare earth mineral concentrate from 2023 test work.***

---

| | |
|:---|:---|
| **Rare Earth Oxide** | **Concentration (weight %)** |
| La | 11.28 |
| Ce | 24.20 |
| Pr | 2.96 |
| Nd | 10.87 |
| Sm | 1.97 |
| Eu | 0.15 |
| Gd | 1.43 |
| Tb | 0.19 |
| Dy | 0.87 |
| Ho | 0.15 |
| Er | 0.38 |
| Tm | 0.05 |
| Yb | 0.31 |
| Lu | 0.04 |
| Y | 4.23 |
| **Total rare earth oxides** | **59.08** |

---

Key assumptions and parameters relating to the THM mineral resources are discussed in the Technical Report Summary for our Titan Project incorporated by reference in this annual report.

**Titan Project - Mineral Resources as of June 30, 2025 (see pricing assumptions used in assumptions table above)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Resource<br>Category** | **Metric tons<br>(in<br>millions)** | **Grade<br>(THM%)** | **THM<br>(million<br>metric tons)** | **Cut-off<br>grade<br>(THM%)** | **THM assemblage** | **THM assemblage** | **THM assemblage** | **THM assemblage** |
| **Resource<br>Category** | **Metric tons<br>(in<br>millions)** | **Grade<br>(THM%)** | **THM<br>(million<br>metric tons)** | **Cut-off<br>grade<br>(THM%)** | **Zircon<br>(% of<br>THM)** | **Rutile<br>(% of<br>THM)** | **Ilmenite<br>(% of<br>THM)** | **REE<br>(% of<br>THM)** |
| Measured | - | - | - | - | - | - | - | - |
| Indicated | 241 | 2.2 | 5.3 | 0.4 | 11.3 | 9.3 | 39.7 | 2.1 |
| Inferred | 190 | 2.2 | 4.2 | 0.4 | 11.7 | 9.7 | 41.2 | 2.2 |
| **Total** | **431** | **2.2** | **9.5** | **0.4** | **11.5** | **9.5** | **40.3** | **2.1** |

---

*Comparison of mineral resources as of June 30, 2025 and June 30, 2024*

As a result of the annual review of the Company's mineral resources, there has been no change to the mineral resources reported for the Titan Project. For information about the assumptions and criteria used in preparing our mineral resources, please see our technical report summary, including Section 11 (*Mineral Resource Estimate*), which is incorporated by reference in an exhibit to this annual report.

*Mineral resource internal controls*

We have internal controls for reviewing and documenting the information supporting the mineral resource estimates, describing the methods used, and ensuring the validity of the estimates. Information that is utilized to compile mineral resources is reviewed by appropriate QPs and is subject to our internal review process, which includes an internal peer-review. The QP reviews and validates the reasonableness of the criteria used for the purposes of estimating resources and reserves. We recognize the risks inherent in mineral resource and reserve estimates, such as the geological complexity, interpretation and extrapolation of data, changes in operating approach, macroeconomic conditions and new data, among others. Overestimated resources and reserves resulting from these risks could have a material effect on future profitability.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

***Initial Assessment***

We have filed a Technical Report Summary on the Titan Project as an exhibit to our Annual Report on Form 20-F for the year ended June 30, 2024, which includes an Initial Assessment to support our Mineral Resource estimate and address reasonable prospects of eventual economic extraction. We completed internal studies that reviewed potential mining methods, infrastructure locations, and process methods. Our Qualified Person reviewed these studies when determining appropriate assumptions in support of reasonable prospects for economic extraction. Material considered to meet reasonable prospects for economic extraction was reported using a cut-off grade of 0.4% THM.

***Land tenure status***

At June 30, 2025, the Titan Project comprised approximately 10,083 acres of surface and associated mineral rights in Tennessee, of which approximately 1,488 acres are owned by IperionX, approximately 417 acres are subject to long-term lease by IperionX, and approximately 8,178 acres are subject to exclusive option to lease agreements with IperionX. These exclusive option agreements, upon exercise, allow IperionX to lease the surface property and associated mineral rights. Other than the option agreements described above, there currently are no material liens or encumbrances on the property comprising the Titan Project. However, in order to develop the project, we will need to obtain permits and approvals as described under "Item 4. Information on the Company-B. Business Overview-Governmental Regulations-Extraction Permits and Approvals."

Our option to lease agreements, upon exercise, allow us to lease the surface property and associated mineral rights from the local landowners, and generally have expiry dates between mid-2026 to late-2027. During the option period, our option to lease agreements provide us with exclusive right to access, enter, occupy and use the surface property for all purposes related to exploring for and evaluating all minerals in return for making annual option payments and bonus payments during periods when we conduct drilling. Our annual option payments are generally $75.00 per acre and our drilling bonuses generally average approximately $1.00 per drill foot. Our obligation to make annual option payments and drilling bonus payments cease if we exercise our option to lease. Upon exercise, in the case of an option to lease, we will pay an annual minimum royalty, generally $75.00 per acre, and an extraction royalty, generally 5% of net revenues from products sold.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

![Titan Updated Parcels 09_10_25-Basic.jpg](ipx-20250630_g9.jpg)

*Figure 1: Titan Project location of properties*

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

![Titan Zoomed Parcels (002).jpg](ipx-20250630_g10.jpg)

*Figure 2: Titan Project location of properties containing mineral resources (the coordinate system and datum used for modeling is UTMZ16N, NAD83)*

***Exploration and development plans***

During the next twelve months, we may undertake further drilling to expand and increase confidence in Titan Project deposit, as well as further metallurgical test work, hydrology and geotechnical studies, and economic studies to assess the economic potential of the Titan Project and define a critical minerals reserve base.

Incorporated by reference in this Annual Report on Form 20-F is an updated Technical Report Summary for our Titan Project, dated June 30, 2024, which includes an Initial Assessment to support our Mineral Resource estimate and address reasonable prospects of eventual economic extraction. The Initial Assessment demonstrates the Titan Project's potential to

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

be a North American producer of titanium, rare earths and other critical minerals needed for advanced U.S. industries such as consumer electronics, space, defense, medical, bicycles, additive manufacturing, and automotive.

Following the completion of this Initial Assessment, we may undertake additional technical studies, including pre-feasibility and/or feasibility studies. These additional studies will also adhere to the guidelines in S-K 1300. If we complete all technical studies (and all necessary permitting activities), we may then undertake minerals extraction and processing activities. However, we currently do not have detailed plans for any component of the exploration and development plans.

Subject to market conditions and the ability to define an economically viable critical minerals deposit, our separate business plan for the Titan Project is to become a strategic, U.S. domestic source of high-quality and sustainable titanium and other critical mineral feedstocks, including rare earths, to the United States.

We plan to effect our business plan as described in "Item 4. Information on the Company-A. History and Development of the Company-Exploration and Development Plans."

**ITEM 4A.&nbsp;&nbsp;&nbsp;&nbsp;UNRESOLVED STAFF COMMENTS**

Not applicable.

**ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp;OPERATING AND FINANCIAL REVIEW AND PROSPECTS**

The following discussion and analysis should be read in conjunction with our financial statements and related notes included elsewhere in this annual report on Form 20-F. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this annual report on Form 20-F, particularly those in the section of this annual report on Form 20-F entitled "Risk Factors." The consolidated general purpose financial statements of the consolidated Company have been prepared in accordance with IFRS as issued by the IASB.

Critical accounting policies adopted in the preparation of this financial report are presented below and have been consistently applied unless otherwise stated.

Our financial statements for fiscal 2025 are presented in U.S. dollars and have been prepared in accordance with IFRS.

This annual report includes consolidated financial statements for the years ended June 30, 2025, 2024, and 2023. However, as permitted by Instruction 6 to Item 5 of Form 20-F, a discussion of the year ended June 30, 2024 and 2023 has been omitted because such discussion was already included in Item 5 of IperionX's annual report on Form 20-F for the year ended June 30, 2024.

**Business Strategy**

IperionX is set to be a leading American titanium metal and critical materials company – using patented titanium technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions.

IperionX's award-winning patented technology portfolio enables high strength forged titanium alloy products at low cost, with class-leading sustainability and superior process energy efficiencies when compared to current industry methods such as the Kroll process.

Using its technologies, IperionX has now transitioned to be a commercial producer of titanium metal products in the United States.

IperionX produces low-cost and high-quality angular and spherical titanium powder, which is used to produce near-net-shape and final titanium parts through powder metallurgy or additive manufacturing. These technologies provide IperionX with a sustainable competitive advantage and significant value uplift from upgrading raw titanium materials through to finished high-performance titanium products when compared to traditional titanium industry supply chains.We plan to effect our business plan as described in "Item 4B. *Information on the Company – Strategies.*"

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

A.**Operating Results**

**Financial Overview of IperionX**

The following discussion relates to our consolidated results of operations, financial condition and capital resources. You should read this discussion in conjunction with our consolidated financial statements and the notes thereto incorporated by reference in this annual report.

---

| | | |
|:---|:---|:---|
| | **Year ended<br>June 30,<br>2025**<br>**US$** | **Year ended<br>June 30,<br>2024**<br>**US$** |
| **Continuing operations** | | |
| &nbsp;&nbsp;Research and development costs | **(12748973)** | (8712610) |
| &nbsp;&nbsp;Exploration and evaluation expenses | **(2894369)** | (1950583) |
| &nbsp;&nbsp;Corporate and administrative expenses | **(10686376)** | (4516393) |
| &nbsp;&nbsp;Business development expenses | **(3373992)** | (3646141) |
| &nbsp;&nbsp;Share-based payment expenses | **(9568191)** | (3791541) |
| &nbsp;&nbsp;Finance income | **3550633** | 546029 |
| &nbsp;&nbsp;Finance costs | **(306250)** | (187119) |
| &nbsp;&nbsp;Other income and expenses | **678843** | 414712 |
| Loss before income tax | **(35348675)** | (21843646) |

---

***Year Ended June 30, 2025 Compared to Year Ended June 30, 2024***

*Research and development expenses*

Research and development, or R&D expenses encompass expenditures incurred by the Company in connection with the research and development of the Company's titanium processing technologies, including salaries and related personnel expenses, subcontractor expenses, patent registration expenses, materials, and other related research and development expenses associated with processing operations.

Research and development expenses increased by $4.0 million from $8.7 million for fiscal 2024 to $12.7 million for fiscal 2025 principally due to (i) increased staff costs and overheads to support our increased processing operations at our IPF in Utah and our new TPF and AMC in Virginia.

*Exploration and evaluation expenses*

Exploration and evaluation expenses encompasses expenditures incurred by the Company in connection with the exploration for and evaluation of mineral resources before the technical feasibility and commercial viability of extracting a mineral resource are demonstrable (other than costs associated with acquiring our exploration properties, which are capitalized), including drilling and sampling costs, technical and engineering studies, permitting costs and overhead costs associated with maintaining our exploration headquarters.

Exploration and evaluation expenses increased by $0.9 million from $2.0 million for fiscal 2024 to $2.9 million for fiscal 2025 principally due to an increase in technical and engineering work associated with the Titan Project.

*Corporate and administrative expenses*

Corporate and administrative expenses encompass overhead costs, such as maintaining our corporate headquarters, public company costs, audit and other fees for professional services, IT licenses and legal compliance.

Corporate and administrative expenses increased by $6.2 million from $4.5 million for fiscal 2024 to $10.7 million for fiscal 2025, principally due to increased staff costs and overheads to support our continued growth, system implementation and compliance requirements.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*Business development expenses*

Business development expenses encompass costs of our customer engagement expenses, our secondary listing on Nasdaq, our investor relations expenses, including costs for press releases, maintenance of the Company's website and our other investor marketing and information initiatives, and other fees for corporate advisory services.

Business development expenses decreased by $0.3 million from $3.6 million for fiscal 2024 to $3.4 million for fiscal 2025. The nature and level of business development expenses remained largely consistent between both financial periods.

*Share-based payment expense*

Share-based payment expense encompasses expenses incurred by the Company in connection with ordinary shares, Restricted Stock Units, Unlisted Options and Performance Rights granted by the Company to officers, employees, consultants and other key advisors as part of remuneration and incentive arrangements.

Share-based payment expenses from such remuneration arrangements increased by $5.8 million from $3.8 million for fiscal 2024 to $9.6 million for fiscal 2025, principally due to the ongoing expensing of existing equity awards over their vesting period and the decision to grant approximately 10.2 million additional equity awards during fiscal 2025 to secure the services of directors, employees and consultants to support our continued growth.

*Finance income*

Finance income encompasses interest income and foreign exchange gains.

Finance income increased by $3.0 million from $0.5 million for fiscal 2024 to $3.6 million for fiscal 2025, principally due to an increased of interest income of $1.7 million due to our increased cash balances and investing strategies as well as an increase of $1.3 million in foreign exchange gain related to transactions denominated in currencies other than the functional currency for each of our subsidiaries. We expect our foreign currency exchange gains and losses to continue to fluctuate in the future as foreign currency exchange rates change.

*Finance costs*

Finance costs encompass interest expenses and foreign exchange losses.

Finance costs increased by $0.1 million from $0.2 million for fiscal 2024 to $0.3 million for fiscal 2025, principally due to the result of increasing lease liabilities held by the Company.

*Other income and expenses*

For fiscal 2025, we had $0.9 million in grant income from the U.S. DoW for reimbursements for expenditures related to the Titan Project definitive feasibility study in conjunction with the IBAS agreement. See Note 1(aa) to our audited consolidated financial statements for fiscal 2025, included in this annual report. The grant income was offset by a loss of $0.3 million relating to certain property, plant and equipment. For fiscal 2024, we had other income of $0.6 million principally from a research contract which was offset by an impairment loss of $0.2 million relating to certain plant and equipment.

**B.Liquidity and Capital Resources**

The liquidity and capital resources discussion that follows contains certain estimates as of the date of this annual report of our estimated future sources and uses of liquidity (including estimated future capital resources and capital expenditures) and future financial and operating results. These estimates reflect numerous assumptions made by us with respect to general business, economic, regulatory, market and financial conditions, industry conditions and other future events, and matters specific to our businesses, all of which are difficult or impossible to predict and many of which are beyond our control. Please carefully read the risks discussed in "Risk Factors" contained in this annual report which describe significant risks and uncertainties that may affect us and our financial conditions.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Sources and Uses of Liquidity**

We have not yet commenced significant commercial production at any of our facilities or properties and expect to continue to incur losses during the research and development of our metals technologies, the commissioning and scale-up of our metals production facilities, and the exploration and evaluation of our mineral properties. Our operations have been financed by proceeds from issuances of ordinary shares and government funding.

At June 30, 2025, we had cash reserves of $54.8 million and net assets of $92.4 million. Our primary use of cash currently comprises the research and development of our metals technologies, the commissioning and scale-up of our metals production facilities, the exploration and evaluation expenditures relating to our mineral properties in the United States and administrative and corporate costs.

On July 29, 2025, the Company completed the first tranche of a placement of 14,000,000 new fully paid ordinary shares at A$5.00 per share, to raise gross proceeds of $46 million (approximately A$70 million) before costs.

We incurred net losses of $35.3 million and $21.8 million for fiscal 2025 and fiscal 2024, respectively. We incurred net cash outflows from operating and investing activities of $46.1 million and $25.1 million for fiscal 2025 and fiscal 2024, respectively. We believe that we will continue to incur net losses until such time as we commence commercial scale production of titanium metals and/or critical minerals.

If we decide to expand the capacity of our Titanium manufacturing Campus, this might require significant additional funds, which would require future debt or equity financings. Similarly, if we ultimately make a decision to develop the Titan Project, this will require significant additional funds, which might require future debt or equity financings.

We may decide to pursue additional financing activities to facilitate development activities at the Titan Project and to fund working capital and expansion projects. We expect that such financing would result in additional sales or issuances of our ordinary shares or ADSs, but we also may engage in debt financing.

If we decide to raise capital by issuing equity securities, the issuance of additional ordinary shares or ADSs would result in dilution to our existing shareholders. We cannot assure you that we will be successful in completing any financings or that any such equity or debt financing will be available to us if and when required or on satisfactory terms.

**Funding Requirements and Capital Expenditures**

The Company's capital expenditures amounted to $17.6 million for fiscal 2025 and $8.1 million for fiscal 2024 which represents the purchase of property, plant, and equipment and exploration and evaluation properties.

Using its technologies, IperionX has now transitioned to be a commercial producer of titanium metal products in the United States. Titanium powder production commenced in 2024 and, by 2025, nameplate capacity has increased by 60% from 125 metric tons per year (tpa) to 200 tpa, driven by operational and technology process improvements with no additional capex.

During fiscal 2024, the U.S. DoW contracted to award the Company $12.7 million in funding under the DPA Title III authorities. This funding has been or will be applied towards the Titanium manufacturing Campus to reach its initial Phase I production capacity of 125 tpa. Title to all assets purchased by IperionX with funds from the U.S. government vests with the U.S. government during the term of the technology investment agreement. At the end of the agreement, title may be transferred back to the Company subject to certain conditions.

The Company can acquire equipment or real property and designate the related purchase price as reflecting the U.S. government's share of funding or the Company's share of funding. To the extent designated as the U.S. government's share, the Company is entitled to request reimbursement from time to time of the cost to purchase. Title to all equipment and real property acquired with federal funds vests with the U.S. government throughout the agreement. The U.S. government can elect to, but is not obliged to, transfer such title to all or a portion of the equipment or real property to the Company at the end of the agreement, which is scheduled to terminate on January 30, 2027, if the Company's performance is satisfactory and provided that (a) the Company has used the equipment or real property for the authorized purposes of the project funding until funding for the project ceases, (b) the Company has not encumbered the equipment or real property without approval of the U.S. government, and (c) the Company has otherwise complied with the terms of the agreement. All equipment acquired with federal funds is tagged and segregated from equipment acquired with Company funds using a Property Control List that tracks all equipment purchased under the agreement. The Property Control List is

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

submitted quarterly to the U.S. government and includes a description of the equipment, an asset number, manufacturer's serial number, ordered date, received date, installed date, location of the asset, and disposition date (if applicable). When the equipment arrives at our Virginia facility, it is tagged with an identification tag marked "Property of the Government of the United States" and which also included the serial number, asset number, and date received.

Through June 30, 2025, the Company has used government funds primarily to acquire equipment used to produce titanium powder from recycled sources of scrap at the construction site. The assets acquired are designed to establish, outfit and operationalize the TPF in accordance with the Statement of Work included in the DPA agreement. Although these assets are integral to the operation of the TPF, in the scenario in which the U.S. government does not relinquish these assets to the Company at the end of the agreement, the Company would seek to acquire or lease such equipment from the U.S. government, replace such equipment with new equipment using the Company's existing cash reserves, or consider other options. See "*Item 3. Key Information – D. Risk Factors - Risks Related to Our Business - Some of our assets used in the TPF are acquired with federal government funds. The U.S. government holds the title with respect to such assets.*"

In February 2025, the Company was awarded up to $47.1 million by the U.S. DoW to strengthen the U.S. Defense Industrial Base by accelerating the scale-up of a resilient, low-cost, and fully-integrated U.S. mineral-to-metal titanium supply chain. The grant will be matched with $23.6 million in funding by IperionX, for a total funding amount of $70.7 million. As part of the initial phase, the DoW has obligated $5.0 million, and IperionX will contribute $1.0 million, to expedite the Titan Critical Minerals Project in Tennessee to 'shovel-ready' status, an important milestone in securing a new domestic source of titanium, rare earths and zircon critical minerals. Subsequent to year end, the DoW obligated an additional $12.5 million in August of 2025, and another $25.0 million in September of 2025, through the IBAS program to purchase orders for long-lead, major capital equipment required for the next stage of capacity scale-up to over 1,400 metric tons per year at the Virginia Titanium Manufacturing Campus. Total obligations now stand at $42.5 million, with the remaining $4.6 million expected to be obligated by the DoW over the contract term. The matching funding by IperionX increased to $48.1 million for a total funding amount of $95.2 million as of the date of this filing. Government reimbursements provided as grants are subject to conditional funding provisions. Grants for the initial phase are recognized as "Other income and expenses" in the consolidated statements of profit and loss and other comprehensive income, once all conditions for reimbursement are met.

We retain optionality to expand the capacity of the TPF to above 1,400 tpa of angular titanium powder. Comprehensive engineering, commercial, and financial studies are underway to review potential product mix, production scale, and associated capital and operational expenditures at higher production levels. If we ultimately decide to expand the capacity of the TPF to above 1,400 tpa, this will require additional funds, which may require future debt, government or equity financings.

If we make a Final Investment Decision to develop the Titan Project, this will require substantial additional funding, which may require future debt or equity financings or joint venture partnership.

**Cash Flows**

The following table summarizes our sources and uses of cash for the years ended June 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Year ended<br>June 30, 2025**<br>**US$** | **Year ended<br>June 30, 2024**<br>**US$** |
| **Net cash provided by (used in):** | | |
| &nbsp;&nbsp;Operating activities | **(21797685)** | (18607063) |
| &nbsp;&nbsp;Investing activities | **(24277010)** | (6529569) |
| &nbsp;&nbsp;Financing activities | **67991632** | 46592163 |
| Net increase in cash and cash equivalents | **21916937** | 21455531 |

---

*Operating Activities*

For fiscal 2025, net cash used in operating activities was $21.8 million ($18.6 million for 2024). Net cash used in operating activities represents payments to suppliers and employees and interest paid and received.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*Investing Activities*

For fiscal 2025, net cash used in investing activities was $24.3 million ($6.5 million for 2024). Net cash used in investing activities represents the purchase of exploration and evaluation properties, the purchase of property, plant and equipment, and payments related to the IP acquisition.

*Financing Activities*

For fiscal 2025, net cash provided by financing activities was $68.0 million ($46.6 million for 2024). Net cash provided by financing activities primarily represents proceeds and costs from the issuance of ordinary shares, and payment of the principal portion of lease liabilities.

**Off-balance sheet arrangements**

During fiscal 2025 and 2024, we did not have any off-balance sheet arrangements.

**C.Research and Development, Patents and Licenses**

IperionX's R&D policies are focused on optimizing its R&D resources relating to human talent, infrastructure, and working with select partners including leading academic institutions to bring specific, high-level skills to its core R&D projects. These projects include the commercialization of patented technologies to produce low-cost, low-carbon titanium products and powders, as well as recycled scrap. The core technologies behind IperionX's products were discovered by researchers at the University of Utah. IperionX acquired and holds the exclusive rights to commercialize these technologies. IperionX's R&D activities may also extend to its Titan Project in Tennessee, which will incorporate surface mining activities and mineral processing activities at a nearby Wet Concentrator Plant and dry Mineral Separation Plant.

**D.Trend Information**

Not applicable, as the Company is commencing its activities in Virginia and still in the exploration stage in Tennessee, and therefore has no material trends in production, sales or inventory.

**E.Critical Accounting Policies and Estimates**

See Note 1 to our audited consolidated financial statements for fiscal 2025, included in this annual report.

**ITEM 6.&nbsp;&nbsp;&nbsp;&nbsp;DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES**

**A.Directors and Senior Management**

The following discussion sets forth information regarding our directors and executive officers as of the date of this annual report on Form 20-F. In accordance with the ASX Listing Rules, a Director (other than the Managing Director) must not hold office, without re-election, past the third annual general meeting following the Director's appointment or three years, whichever is longer. The following table lists the names of our directors and executive officers. The business address for each director and member of senior management is c/o Level 9, 28 The Esplanade, Perth WA 6000, Australia.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Name** | **Age** | **Position** |
| &nbsp;&nbsp;Todd W. Hannigan | 51 | Executive Chairman |
| &nbsp;&nbsp;Anastasios (Taso) Arima | 41 | Chief Executive Officer and Managing Director |
| &nbsp;&nbsp;Lorraine M. Martin | 63 | Lead Independent Non-Executive Director |
| &nbsp;&nbsp;Vaughn W. Taylor | 40 | Independent Non-Executive Director |
| &nbsp;&nbsp;Tony Tripeny | 66 | Independent Non-Executive Director |
| &nbsp;&nbsp;Melissa G. Waller | 55 | Independent Non-Executive Director |
| &nbsp;&nbsp;Beverly M. Wyse | 62 | Independent Non-Executive Director |
| &nbsp;&nbsp;Toby E. Symonds | 56 | President and Chief Strategy Officer |
| &nbsp;&nbsp;W. Scott Sparks | 63 | Chief Operating Officer |
| &nbsp;&nbsp;Dominic P. Allen | 41 | Chief Commercial Officer |
| &nbsp;&nbsp;Marcela R. Castro | 53 | Chief Financial Officer |

---

**Todd Hannigan (51 years of age) – Executive Chairman**

*Mr. Hannigan was appointed as Non-Executive Chairman of IperionX on February 1, 2021, and as Executive Chairman on May 24, 2021.* 

Todd Hannigan has over 28 years of global experience in natural resources as company founder, chief executive officer, private capital investor and non-executive director. Mr. Hannigan has worked internationally in the natural resources sector including for Piedmont Lithium Inc., Aston Resources, Hanson PLC and BHP Billiton. Mr. Hannigan holds a Bachelor of Engineering (Mining) from The University of Queensland and an MBA from INSEAD. Other Public Directorships: Executive Chairman Brazilian Rare Earths (January 2023 – present)

**Anastasios (Taso) Arima (41 years of age) – Chief Executive Officer and Managing Director**

*IperionX Director since September 13, 2021*

Anastasios (Taso) Arima has over 15 years of experience in founding and developing critical material companies in North America. Mr. Arima was a founder and director of Piedmont Lithium and was instrumental in the development of the company. Mr. Arima attended the University of Western Australia and earned a Bachelor of Commerce whilst studying for a Bachelor of Engineering. Other Public Directorships: InVert Graphite Limited (formerly Dominion Minerals Limited) (November 2021 – present)

**Lorraine M. Martin (63 years of age) – Lead Independent Non-Executive Director**

*CEO of the National Safety Council*

*IperionX Director since September 13, 2021*

Lorraine M. Martin is a director and CEO of the National Safety Council, serving in this position since June 2019. She is also co-founder and President of Pegasus Springs Foundation, a non-profit organization focused on education and mentoring. Ms. Martin is the retired Executive Vice President and Deputy of Rotary and Mission Systems ("RMS") for Lockheed Martin Corporation, a global aerospace, defense, security and advance technologies company. Prior to RMS, Ms. Martin was Executive Vice President and General Manager for the F-35 Lightning II Program for Lockheed Martin Aeronautics Company. Her leadership of the F-35 program earned Pentagon recognition for reducing program costs while increasing production and fielding more aircraft worldwide. She joined Lockheed Martin in 1988 and during her tenure, held a variety of high visibility leadership positions across the corporation. Prior to joining Lockheed Martin, she served as an officer in the U.S. Air Force, holding various leadership positions for software intensive technology and development programs. She has a Master of Science degree in Computer Science from Boston University and a Bachelor of Arts degree in Computational Mathematics from DePauw University. Other Public Directorships: Kennametal Inc. (July 2018 – present)

**Vaughn Taylor (40 years of age) – Independent Non-Executive Director**

*Former Executive Director and Chief Investment Officer of AMB Capital Partners*

*IperionX Director since March 3, 2021*

Vaughn Taylor previously served as Executive Director and Chief Investment Officer of AMB Capital Partners, ("AMB") the global investment platform of the Bennett Family. Mr. Taylor was responsible for executing on the investment strategy,

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

expanding the investment portfolio into international markets and sourcing new investment opportunities. Mr. Taylor is an active global investor and is a board member of a number of listed and private market organizations both in Australia and the U.S. across a range of sectors. Mr. Taylor holds a Bachelor of Business (Accounting) and a Master of Business (Real Estate) from RMIT University. Mr. Taylor also holds a Graduate Diploma in Applied Finance and Investment from Financial Services Professional Body, ("FINSIA"). Other Public Directorships: Alta Global Group Ltd (August 2021 – present)

**Tony Tripeny (67 years of age) – Independent Non-Executive Director**

*Former Executive Vice President and Chief Financial Officer of Corning Incorporated*

*IperionX Director since March 17, 2025*

Tony Tripeny brings over 40 years of financial and operational leadership in advanced manufacturing, technology and materials science. Mr. Tripeny's successful 36-year career at Corning Incorporated, a global innovator and leader in advanced materials science, included senior roles of Executive Vice President and Chief Financial Officer, as well as Senior Vice President and Corporate Controller, until his retirement in 2022. Mr. Tripeny currently serves as a Director at Mesa Laboratories and Origin Materials. He holds an economics degree from the Wharton School of Business at the University of Pennsylvania and is a member of both the Financial Executives Institute and the Institute of Management Accounting. Other Public Directorships: Mesa Laboratories, Inc. (NASDAQ: MLAB) (2022 – present)**,** Origin Materials, Inc. (NASDAQ: ORGN) (May 2023 - present)

**Melissa G. Waller (55 years of age) – Independent Non-Executive Director**

*Former Deputy Treasurer and Chief of Staff for the North Carolina Department of State Treasury*

*IperionX Director since September 13, 2021*

Melissa G. Waller has over 30 years' experience as a senior finance executive and is President for the AIF Institute, providing essential education, research and resources to investors and investment firms globally with over $50 trillion assets under management. Ms. Waller is the former Deputy Treasurer and Chief of Staff for the North Carolina Department of State Treasury, where she successfully oversaw Department strategic planning, operations, and public-policy implementation, along with a staff of more than 400 employees, including the North Carolina Retirement Systems, the pension fund for the state and the tenth largest public pension fund in the United States, with assets in excess of $90 billion. Ms. Waller has served as Chair of the Department's Corporate Governance Committee, as well as on the Council of Institutional Investors Board of Directors and the Governor's Board of Innovation for the North Carolina University System. She currently serves as Executive Program Director for the National Institute of Public Finance, as well as Director of Public and Private Partnerships for the Kenan Institute. Ms. Waller has a bachelor's degree in journalism and mass communications from the University of North Carolina.

**Beverly M. Wyse (62 years of age) – Independent Non-Executive Director**

*Former President of Shared Services, Boeing*

*IperionX Director since September 13, 2021*

Beverly M. Wyse worked for over 30 years at Boeing, most recently as President of Shared Services, a multi-billion dollar operating group. In that role, she refocused and restructured the organization and also delivered improved efficiency and performance. Previously, she was Vice-President & General Manager of Boeing South Carolina, a major manufacturing, assembly and delivery site for Boeing where she led the team through successful production rate increases, major improvements in workforce relations and significant reductions in operating costs. Throughout her extensive career at Boeing, Ms. Wyse also successfully led the 737, 767 and 787 Charleston programs. Ms. Wyse holds an MBA and a B.Sc. in Mechanical Engineering from the University of Washington. Other Public Directorships: Héroux-Devtek Inc. (February 2019 – February 2025)

**Toby E. Symonds (56 years of age) – President and Chief Strategy Officer**

Toby E. Symonds has over 30 years of experience in finance and asset management. This includes advisory board roles across private equity and real estate investment firms and executive leadership positions within global hedge fund firms and investment banking firms based in London, New York and San Francisco. Mr. Symonds has core competencies in capital markets, corporate strategy, product development, business development, management information systems and project and team management. Mr. Symonds graduated from North Carolina State University. Mr. Symonds was appointed President and Chief Strategy officer effective November 1, 2022.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Scott Sparks (63 years of age) – Chief Operating Officer**

Scott Sparks brings more than 30 years of experience as an engineer and senior executive to the design, construction, and operations of industrial plant facilities in the critical resources industry. He has been a founder and senior management team member at several companies, most recently at Performance Industries, a construction and contract operations firm in West Virginia and at DRA Taggart, a Pennsylvania-based provider of construction and engineering services to the resources industry. Mr. Sparks earned a B.S. degree in Mining Engineering from West Virginia Institute of Technology. Mr. Sparks was appointed as an executive officer effective September 1, 2022.

**Dominic Allen (41 years of age) – Chief Commercial Officer**

Dominic Allen has over 15 years' commercial experience, including senior roles with Sovereign Metals Limited, Rio Tinto Limited and Oyu Tolgoi LLC. Mr. Allen previously worked for Ernst & Young Transaction Advisory Services, completing resource and industrial transactions both in Australia and internationally. Mr. Allen holds a Bachelor of Commerce and a Bachelor of Science (Hons) from the University of Western Australia and is a Member of the Chartered Accountants Australia and New Zealand. Mr. Allen was appointed as Chief Commercial Officer of the Company effective December 1, 2020.

**Marcela Castro (53 years of age) – Chief Financial Officer**

Marcela Castro is an experienced finance professional with over 25 years' experience in global finance leadership for companies across multiple industries, including green technology, manufacturing, mining and industrial and consumer products. Ms. Castro has expertise in U.S. public company accounting, financial analysis and strategic planning. Ms. Castro started her career at Arthur Andersen and progressed across international finance roles with Colgate-Palmolive, Jaguar Mining, the Rev Group and Proterra Inc. Ms. Castro holds a Bachelor of Business Administration with Pontificia Universidade Catolica and an Executive MBA with IBMEC. Ms. Castro was appointed Chief Financial Officer effective from December 21, 2023.

**Family Relationships**

There are no family relationships between any members of our executive management and our directors.

**Arrangements for Election of Directors and Members of Management**

There are no contracts or other arrangements pursuant to which directors have been or must be selected.

**B.Compensation**

**Overview**

IperionX is a U.S.–based titanium technology and manufacturing company listed on both the ASX and Nasdaq. Our executives, employees, customers, and operating assets are overwhelmingly in the United States, and our strategy is anchored in building a low-cost and resilient U.S. titanium supply chain.

The Remuneration Framework for KMP is developed by the Board and its Compensation Committee, with independent advice from U.S-based consultants, benchmarking IperionX against comparable U.S. businesses, reflecting IperionX's position as a U.S.-based technology and metals manufacturing company rather than a ASX resource company. It is designed to:

&nbsp;&nbsp;&nbsp;&nbsp;• Compete for U.S. leadership talent in advanced manufacturing and hard-tech;

&nbsp;&nbsp;&nbsp;&nbsp;• Align rewards to long-term shareholder value, strategic execution, and long term success;

&nbsp;&nbsp;&nbsp;&nbsp;• Reinforce multi-year commitment to scaling operations safely, reliably and profitably; and

&nbsp;&nbsp;&nbsp;&nbsp;• Drive performance while managing risk, particularly during rapid commercial scale-up.

Our structure combines fixed remuneration with a meaningful "at-risk" component across short- and long-term incentives. Deliberately lower fixed pay and a higher proportion of performance-based long-term equity ensure executive outcomes closely mirror shareholder outcomes. A significant share of total compensation is contingent on achieving clearly defined milestones tied to value creation. The table below provides an overview of the remuneration elements for fiscal year 2025.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*Remuneration Benchmarking Review*

From late 2024 to April 2025, the Compensation Committee engaged a U.S.-based independent remuneration consultant, to review IperionX's remuneration structure, policy, and strategy for executives and employees. This review was prompted by the Company's significant growth since the last benchmarking exercise and by stakeholder feedback on previous Remuneration Reports. Looking ahead, the Company intends to review its peer group annually.

**Executive Remuneration**

The Group's executive remuneration policy is to provide a fixed remuneration component and a performance-based component (STI's and LTI's). The Board believes that this remuneration policy is appropriate given the considerations discussed in the section above and is appropriate in aligning executives' objectives with shareholder and business objectives.

In a significant year for IperionX, executive KMP demonstrated strong performance, and their remuneration outcomes reflect their performance and significant contributions in fiscal 2025.

*Fixed Remuneration*

Fixed remuneration consists of base salaries, as well as employer 401(k) contributions or contributions to superannuation funds and other non-cash benefits. Non-cash benefits may include provision of motor vehicles, rental allowance, health care benefits, health insurance, and life insurance.

Fixed remuneration is reviewed annually by the Board. The process consists of a review of company and individual performance, relevant comparative remuneration externally and internally and, where appropriate, external advice on policies and practices.

As outlined above, as part of the implementation of the Remuneration Benchmarking Review completed by the U.S.-based independent consultants, during the fiscal year, the fixed remuneration of Executive KMP was benchmarked to peer comparator groups and adjusted to the 25th percentile, with the following adjustments made for executive KMP fixed remuneration during the fiscal year.

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Executive KMP** | **Previous (US$)** | **Current (US$)** | **Increase (US$)** | **Increase (%)** |
| &nbsp;&nbsp;Todd Hannigan (Executive Chairman) | 250000 | 317500 | 67500 | 27% |
| &nbsp;&nbsp;Anastasios Arima (CEO) | 400000 | 475000 | 75000 | 19% |
| &nbsp;&nbsp;Toby Symonds (President) | 380000 | 451500 | 71500 | 19% |
| &nbsp;&nbsp;W. Scott Sparks (COO) | 250000 | 282500 | 32500 | 13% |
| &nbsp;&nbsp;Dominic Allen (CCO) | 250000 | 282500 | 32500 | 13% |
| &nbsp;&nbsp;Marcela Castro (CFO) | 250000 | 270000 | 20000 | 8% |

---

*Performance Based Remuneration – Short-Term Incentive*

Some executive KMP are entitled to an annual cash bonus upon achieving various KPI's, as set by the Board. Having regard to the current size, nature and opportunities of the Group, the Board has determined that these KPI's will include measures related to successful completion of activities as outlined in the below table. Prior to the end of each financial year, the Board assesses performance against these criteria.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The following table sets out the key criteria which were set by the Board and used to determine executive STI outcomes for fiscal 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Feature** | **Description** | **Description** | **Description** | **Description** |
| Eligibility | Limited to select employees, as determined by the Board. | Limited to select employees, as determined by the Board. | Limited to select employees, as determined by the Board. | Limited to select employees, as determined by the Board. |
| Opportunity | The target opportunity as a percentage of fixed remuneration is set out below: | The target opportunity as a percentage of fixed remuneration is set out below: | The target opportunity as a percentage of fixed remuneration is set out below: | The target opportunity as a percentage of fixed remuneration is set out below: |
|  |  | **Executive KMP** | **Executive KMP** | **Target STI (% of FR)** |
|  |  | Todd Hannigan (Executive Chairman) | Todd Hannigan (Executive Chairman) | 50% |
|  |  | Anastasios Arima (CEO) | Anastasios Arima (CEO) | 60% |
|  |  | Toby Symonds (President) | Toby Symonds (President) | 60% |
|  |  | W. Scott Sparks (COO) | W. Scott Sparks (COO) | 50% |
|  |  | Dominic Allen (CCO) | Dominic Allen (CCO) | 50% |
|  |  | Marcela Castro (CFO) | Marcela Castro (CFO) | 50% |
|  | Payout Methodology |  | The total payout is calculated based on incremental objectives completed. To receive a payout, the total completion percentage must exceed 50% and is capped at 200% of target. The relationship between weighted score card achievement and payout is reflected in the chart below.. | The total payout is calculated based on incremental objectives completed. To receive a payout, the total completion percentage must exceed 50% and is capped at 200% of target. The relationship between weighted score card achievement and payout is reflected in the chart below.. |
|  |  |  | **Weighted Scorecard<br>Achievement** | **Payout % of<br>Target STIP** |
|  |  | Threshold | 0% - 50% | –% |
|  |  | Target | 75% | 100% |
|  |  | Maximum | 100% | 200% |
| Performance Assessment | IperionX utilizes a weighted scorecard methodology to award annual cash bonuses to executive KMP, which enhances transparency on the determination of annual cash bonuses. This approach links short-term incentives for executive KMP to clearly defined Company objectives to create a performance-based compensation opportunity that furthers stockholders' interests while motivating and challenging our executive talent to achieve strategic priorities.<br>The cash bonus scorecard for the STIP paid in fiscal year 2025 comprises of six primary strategic goals, each weighted between 15-25%. Each of these goals contained a number of defined objectives. As part of the methodology, scorecard completion determines the total payout. | IperionX utilizes a weighted scorecard methodology to award annual cash bonuses to executive KMP, which enhances transparency on the determination of annual cash bonuses. This approach links short-term incentives for executive KMP to clearly defined Company objectives to create a performance-based compensation opportunity that furthers stockholders' interests while motivating and challenging our executive talent to achieve strategic priorities.<br>The cash bonus scorecard for the STIP paid in fiscal year 2025 comprises of six primary strategic goals, each weighted between 15-25%. Each of these goals contained a number of defined objectives. As part of the methodology, scorecard completion determines the total payout. | IperionX utilizes a weighted scorecard methodology to award annual cash bonuses to executive KMP, which enhances transparency on the determination of annual cash bonuses. This approach links short-term incentives for executive KMP to clearly defined Company objectives to create a performance-based compensation opportunity that furthers stockholders' interests while motivating and challenging our executive talent to achieve strategic priorities.<br>The cash bonus scorecard for the STIP paid in fiscal year 2025 comprises of six primary strategic goals, each weighted between 15-25%. Each of these goals contained a number of defined objectives. As part of the methodology, scorecard completion determines the total payout. | IperionX utilizes a weighted scorecard methodology to award annual cash bonuses to executive KMP, which enhances transparency on the determination of annual cash bonuses. This approach links short-term incentives for executive KMP to clearly defined Company objectives to create a performance-based compensation opportunity that furthers stockholders' interests while motivating and challenging our executive talent to achieve strategic priorities.<br>The cash bonus scorecard for the STIP paid in fiscal year 2025 comprises of six primary strategic goals, each weighted between 15-25%. Each of these goals contained a number of defined objectives. As part of the methodology, scorecard completion determines the total payout. |
| Performance Assessment |  | **Measure** | **Measure** | **Weighting** |
| Performance Assessment |  | Safety | Managing the health and safety matters as a critical business activity | 15% |
| Performance Assessment |  | People & Sustainability | Recruitment and retention of key talent across the business, managing environmental compliance and promoting sustainable development | 15% |
| Performance Assessment |  | Product Innovation / R&D / IP | Ongoing innovation and protection of existing IP | 15% |
| Performance Assessment |  | Commercial and Government Engagements | Focus on delivering numerous commercial and government contracts | 15% |
| Performance Assessment |  | Operations | Focus on delivery of key scale-up targets | 15% |
| Performance Assessment |  | Funding, Corporate, Financial and Investor Relations | Focus on delivery and commercialization of our assets and balance sheet strength | 25% |
| Payment |  | The STI awards were paid in cash after the completion of reviews at December 31, 2024. | The STI awards were paid in cash after the completion of reviews at December 31, 2024. | The STI awards were paid in cash after the completion of reviews at December 31, 2024. |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The following table outlines the fiscal 2025 performance against the above short-term incentive criteria:

---

| | | |
|:---|:---|:---|
| **Measure** | **Measure** | **Weighting** |
| Safety | Managing the health and safety matters as a critical business activity | 15% |
| People & Sustainability | Recruitment and retention of key talent across the business, managing environmental compliance and promoting sustainable development | 15% |
| Product Innovation / R&D / IP | Ongoing innovation and protection of existing IP | 15% |
| Commercial and Government Engagements | Focus on delivering numerous commercial and government contracts | 15% |
| Operations | Focus on delivery of key scale-up targets | 15% |
| Funding, Corporate, Financial and Investor Relations | Focus on delivery and commercialization of our assets and balance sheet strength | 25% |

---

Based on these performance outcomes, the table below outlines the STI awarded to executive KMP with respect to performance in fiscal 2025. During fiscal 2025, bonuses of $1,486,000 were paid to executive KMP. (2024: $734,560)

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Executive KMP** | **Target STI (%<br> of FR)** | **Target STI<br> (US$)** | **STI Awarded<br> for 2025 (US$)** | **% of Target<br> STI Awarded** |
| &nbsp;&nbsp;Todd Hannigan (Executive Chairman)<sup>(1)</sup> | 200% | 125000 | - | -% |
| &nbsp;&nbsp;Anastasios Arima (CEO) | 200% | 240000 | 480000 | 200% |
| &nbsp;&nbsp;Toby Symonds (President and CSO) | 200% | 228000 | 456000 | 200% |
| &nbsp;&nbsp;W. Scott Sparks (COO) | 200% | 125000 | 250000 | 200% |
| &nbsp;&nbsp;Dominic Allen (CCO) | 120% | 120000 | 150000 | 125% |
| &nbsp;&nbsp;Marcela Castro (CFO) | 120% | 125000 | 150000 | 120% |

---

**Notes:**

<sup>(1)</sup> Mr. Hannigan's share-based payments includes 141,844 shares issued in lieu of his cash bonus of $250,000, as approved by shareholders on June 27, 2025.

*Performance Based Remuneration – Long-Term Incentive*

The Group has a LTIP to reward executive KMP and other key employees and contractors for long-term performance. This plan is based on best practice for companies operating in the United States. This LTIP was designed in consultation with our U.S. based remuneration consultant.

The Plan provides for the issuance of Performance Rights, RSU's, and Unlisted Options to eligible employees and contractors as part of their remuneration and incentive arrangements in order to attract and retain their services and to provide an incentive linked to the performance of the Group. The allocation to Performance Rights, RSU's and/or Options is determined by the Board based on the assessment of the contribution by the executive KMP to all aspects of the company's growth.

To achieve its corporate objectives, the Group needs to attract, incentivize, and retain its executive KMP and other key employees and contractors. The Board believes that grants made to eligible participants under the Plan will provide a useful tool to underpin the Group's employment and engagement strategy, and enables the Group to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• recruit, incentivize and retain KMP and other key employees and contractors needed to achieve the Company's business objectives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• link the reward of key staff with the achievement of strategic goals and the long-term performance of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• align the financial interest of participants of the Plan with those of Shareholders; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• provide incentives to participants of the Plan to focus on superior performance that creates Shareholder value.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The issuance of Performance Rights and RSUs for fiscal 2025 is considered in-line with U.S. based peer group comparators and aligned with linking sustained Company performance, retention and long-term shareholder value.

The table below summarizes RSU's, Performance Rights and Unlisted Options that were granted, vested or lapsed relating to executive KMP remuneration during fiscal 2025.

---

| | | | |
|:---|:---|:---|:---|
| | **Granted during<br>2025** | **Vested/exercised during<br>2025** | **Lapsed or expired<br> during 2025** |
| RSU's | 1555640 | (1019668) | - |
| Performance Rights | 3473409 | (17066667) | - |
| Options | 1158074 | (625000) | - |

---

As at June 30, 2025, the Company had a total of 25,206,752 outstanding Performance Rights, RSU's and Unlisted Options on issue that had been granted to employees and contractors of the Company as part of their remuneration arrangements, representing 7.3% of the Company's total shares on issue (on an undiluted basis). The Board considers this reasonable and in-line with peer group comparators.

<u>Restricted Stock Units</u>

In fiscal 2025, the Board chose to grant RSUs to attract and retain executives. The use of RSUs aligns with the long-term incentive vehicles used by peer group comparators.

The RSUs vest and convert into an equivalent number of Ordinary Shares over a three-year period with a 3-year vesting cliff. If the relevant service-based vesting condition is not met by the applicable expiry date, the RSUs will automatically lapse.

During fiscal 2025, 1,555,640 RSUs were granted to executive KMP as outlined in the table below.

---

| | |
|:---|:---|
| **Executive KMP** | **No. RSU's Awarded 2025** |
| Todd Hannigan (Executive Chairman) | 295130 |
| Anastasios Arima (CEO) | 419910 |
| Toby Symonds (President and CSO) | 400533 |
| W. Scott Sparks (COO) | 178866 |
| Dominic Allen (CCO) | 178866 |
| Marcela Castro (CFO) | 82335 |

---

<u>Performance Rights</u>

The LTIP provides for the issuance of Performance Rights to eligible participants which, upon satisfaction of the relevant performance conditions attached to the Performance Rights, will result in the issue of an Ordinary Share for each Performance Right. Performance Rights are issued for no consideration and no amount is payable upon conversion thereof.

Performance Rights granted under the Plan to eligible participants will be linked to the achievement by the Group of certain performance conditions as determined by the Board from time to time. These performance conditions must be satisfied in order for the Performance Rights to vest. Upon Performance Rights vesting, Ordinary Shares are automatically issued for no consideration. If a performance condition of a Performance Right is not achieved by the expiry date, then the Performance Right will lapse.

During fiscal 2025, 3,473,409 Performance Rights were granted to executive KMP as outlined in the table below. These Performance Rights were granted to selected executive KMP as one-off grants as either retention awards or sign-on awards. These awards are linked to the creation of shareholder value growth through the utilization of "out of the money" share price hurdles and continuous service periods acting as a retention tool for our executives.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

In addition to performance criteria, these Performance Rights also had a 4-year continuous service period requirement, as well as an additional 1-year lock-up period, meaning even if the vesting condition was achieved, the KMP is required to be in continuous service until April 10, 2030.

---

| | | | |
|:---|:---|:---|:---|
| **KMP** | **No.<br>Performance<br>Rights<br>awarded 2025** | **Rationale** | **Vesting Conditions** |
| Todd Hannigan (Executive Chairman) | 918906 | Tied to performance and shareholder value creation. The share price hurdles were between 100-200% above the 30-day VWAP at the time of board approval (April 10, 2025).<br>Represents 70% of LTIP award for 2025 | Three different performance right awards of 306,302. All three award vest upon four years of continuous service and the Company achieving a 30-day VWAP of at least A$6.00 per share for one award, A$7.00 for one award, A$8.00 for one award, expiring April 10, 2031 |
| Anastasios Arima (CEO) | 1307418 | Tied to performance and shareholder value creation. The share price hurdles were between 100-200% above the 30-day VWAP at the time of board approval (April 10, 2025).<br>Represents 70% of LTIP award for 2025 | Three different performance right awards of 435,806. All three award vest upon four years of continuous service and the Company achieving a 30-day VWAP of at least A$6.00 per share for one award, A$7.00 for one award, A$8.00 for one award, expiring April 10, 2031 |
| Toby Symonds (President and CSO) | 1247085 | Tied to performance and shareholder value creation. The share price hurdles were between 100-200% above the 30-day VWAP at the time of board approval (April 10, 2025).<br>Represents 70% of LTIP award for 2025 | Three different performance right awards of 415,695. All three award vest upon four years of continuous service and the Company achieving a 30-day VWAP of at least A$6.00 per share for one award, A$7.00 for one award, A$8.00 for one award, expiring April 10, 2031 |

---

<u>Unlisted Options</u>

The LTIP provides for the issuance of Unlisted Options to eligible participants. The Board's policy is to grant Unlisted Options to KMP with exercise prices at or above market share price (at the time of agreement). As such, the Unlisted Options granted to KMP are generally only of benefit if the KMP performs to the level whereby the value of the Group increases sufficiently to warrant exercising the Unlisted Options granted.

Other than service-based vesting conditions (if any) and the exercise price required to exercise the Unlisted Options, there are no additional performance criteria on the Unlisted Options granted to KMP. The Group prohibits executive KMP from entering into arrangements to limit their exposure to Unlisted Options granted as part of their remuneration package.

In determining the size of grant, the Board engaged a third party consultant to value the Unlisted Options utilizing a Black Scholes model, with a start date of April 10, 2025 (date of board approval). This resulted in a fair value of the options of A$1.07. The fair value of these unlisted options were updated when the unlisted options were actually issued. For accounting purposes, the share price at the date of issuance was utilized in the financial statements.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

During fiscal 2025, Unlisted Options were granted to executive KMP as outlined in the table below:

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**KMP** | **No. Unlisted Options awarded 2025** | **Rationale** | **Vesting Conditions** |
| &nbsp;&nbsp;W. Scott Sparks (COO) | 470701 | Tied to performance and shareholder value creation. The option exercise price was ~75% above the 30-day VWAP at the time of board approval.<br>Represents 50% of LTIP award for 2025 | Vest upon three years of continuous service and the Company and are exercisable a A$5.00 each, expiring April 10, 2029 |
| &nbsp;&nbsp;Dominic Allen (COO) | 470701 | Tied to performance and shareholder value creation. The option exercise price was ~75% above the 30-day VWAP at the time of board approval.<br>Represents 50% of LTIP award for 2025 | Vest upon three years of continuous service and the Company and are exercisable a A$5.00 each, expiring April 10, 2029 |
| &nbsp;&nbsp;Marcela Castro (CFO) | 216672 | Tied to performance and shareholder value creation. The option exercise price was ~75% above the 30-day VWAP at the time of board approval.<br>Represents 50% of LTIP award for 2025 | Vest upon three years of continuous service and the Company and are exercisable a A$5.00 each, expiring April 10, 2029 |

---

**Non-Executive Director Remuneration**

The Board's policy is to remunerate Non-Executive Directors at market rates for comparable companies for time, commitment and responsibilities. Given the current size, nature and risks of the Group, RSUs, Unlisted Options, and Performance Rights have been used to attract and retain Non-Executive Directors, where deemed appropriate. The Board determines payments to the Non-Executive Directors and reviews their remuneration annually, based on market practice, duties and accountability. Independent external advice is sought when required.

The maximum aggregate amount of fees that can be paid to Non-Executive Directors is subject to approval by shareholders at a General Meeting. Director's fees paid to Non-Executive Directors accrue on a daily basis. Fees for Non-Executive Directors are not linked to the performance of the economic entity. However, to align Directors' interests with shareholder interests, the Directors are encouraged to hold shares in the Company and, subject to shareholder approval, on an annual basis, the Company grants each Non-Executive Director such number of RSUs calculated by dividing $125,000 by the VWAP of a share on ASX over the five trading days immediately prior to the date of the notice of AGM of shareholders. The Lead Director receives an additional $30,000 in annual equity grants. The Company prohibits Non-Executive Directors from entering into arrangements to limit their exposure to options granted as part of their remuneration package. The issuance of RSUs is in-line with U.S. based peer group comparators and aligned with linking sustained Company performance, retention and long-term Shareholder value.

Fees for Non-Executive Directors are presently set at $50,000 (2024: $50,000) per annum. The Lead Non-Executive Independent Director receives an additional $30,000 per annum. These fees cover main board activities only. NEDs may receive additional remuneration for other services provided to the Company, including but not limited to, membership of committees.

Committee fees are $15,000 for the Chair of each committee ($30,000 for the Audit Committee Chair) and $10,000 for committee members. The Company reimburses NEDs for reasonable expenses incurred in performing their duties (including in relation to any authorized independent professional advice sought by the NEDs to assist them in carrying out their duties as Directors). These fees are in line with the median against the benchmarked peer comparator groups.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

During fiscal 2025, 212,430 RSUs were granted to Non-Executive Directors as set out below.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Non-Executive Director** | **Committee** | **Director Fees 2025<br>(US$)** | **No. RSU's Awarded<br>2025** |
| &nbsp;&nbsp;Lorraine Martin | Lead Independent Non-Executive Director, Nominating and Governance Committee, | 75000 | 42486 |
| &nbsp;&nbsp;Vaughn Taylor | Audit Committee, Compensation Committee (Chair) | 80333 | 42486 |
| &nbsp;&nbsp;Tony Tripeny | Audit Committee (Chair), Nominating and Governance Committee | 19167 | 42486 |
| &nbsp;&nbsp;Beverly Wyse | Audit Committee, Nominating and Governance Committee, Compensation Committee | 80000 | 42486 |
| &nbsp;&nbsp;Melissa Waller | Nominating and Governance Committee (Chair), Compensation Committee | 75000 | 42486 |

---

During fiscal 2025, 476,494 RSUs and 300,000 Performance Rights held by Non-Executive Directors vested and converted into Ordinary Shares. No Unlisted Options were exercised by Non-Executive Directors during fiscal 2025. No RSUs, Unlisted Options or Performance Rights held by Non-Executive Directors lapsed during fiscal 2025.

**Relationship between Remuneration of KMP and Shareholder Wealth**

During the Group's commercialization phase of the business, the Board anticipates that the Group will retain earnings (if any) and other cash resources for the commercialization of its metal technologies and the exploration and evaluation of its mineral properties. Accordingly, the Group does not currently have a policy with respect to the payment of dividends and returns of capital. Therefore, there was no relationship between the Board's policy for determining, or in relation to, the nature and amount of remuneration of KMP and dividends paid and returns of capital by the Group during the current and previous four financial years.

Discretionary annual cash bonuses are based upon achieving various non-financial KPI's that are not based on share price or earnings, such as the successful commercialization of the Company's metal technologies, the successful exploration and development of its mineral properties, sustainability measures, corporate activities, safety measures, and business development activities. However, as noted above, certain KMP are granted Performance Rights, RSUs, and/or Unlisted Options which generally will be of greater value to KMP if the value of the Group's shares increases (subject to vesting conditions being met).

**Relationship between Remuneration of KMP and Earnings**

As discussed above, the Group is currently commercializing its metal technologies and does not currently undertake profitable operations until sometime after the successful commercialization, production and sales of its metals. Accordingly, the Board does not consider earnings during the current and previous four financial years when determining, and in relation to, the nature and amount of remuneration of KMP.

**Remuneration Governance**

The Board has overall accountability for the oversight of the Company's remuneration approach for Executive KMP and NEDs, having regard to the recommendations made by the Compensation Committee. The Compensation Committee reviews and makes recommendations to the Board on remuneration and at-risk remuneration policies, taking into account the Company's strategic objectives, corporate governance principles, market practice and stakeholder interests.

The diagram below shows the Company's remuneration governance framework, the key responsibilities of the Board, Compensation Committee and management.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The diagram below shows the Company's remuneration governance framework, the key responsibilities of the Board, RNC and management.

![Rem Report Graphic.jpg](ipx-20250630_g11.jpg)

**Remuneration Advisors**

During fiscal 2025, the Compensation Committee approved the engagement of a U.S.-based independent consultant to provide remuneration recommendations regarding the remuneration quantum for KMP and advise on LTIP and STIP structures. The Compensation Committee considered the recommendations, along with other factors, in making its remuneration decisions. Both the Compensation Committee and the consultants are satisfied the advice received from CAP is free from undue influence from the KMP to whom the remuneration recommendations apply. $114,400 was paid to remuneration advisors during the 2025 fiscal year.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Emoluments of KMP**

Details of the nature and amount of each element of the emoluments of each KMP of the Company for the year ended June 30, 2025 are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Short-term benefits** | **Short-term benefits** | **Short-term benefits** | | | | |
| **2025** | **Salary & fees<br>US$** | **Cash bonus<br>US$** | **Other<br>US$** |<br>**Post-<br>employment <br>benefits<br>US$** |<br>**Share-based <br>payment<br>expense<br>US$** |<br>**Total<br>US$** |<br>**Performance<br> related%** |
| **Directors** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Todd Hannigan<sup>(1)</sup> | 317500 | - | - | 19411 | 834131 | 1171042 | 71 |
| &nbsp;&nbsp;Anastasios Arima | 475000 | 480000 | 7857 | - | 1047347 | 2010204 | 52 |
| &nbsp;&nbsp;Lorraine Martin | 75000 | - | - | - | 111052 | 186052 | 60 |
| &nbsp;&nbsp;Vaughn Taylor | 80833 | - | - | 9296 | 93217 | 183346 | 51 |
| &nbsp;&nbsp;Tony Tripeny | 19167 | - | - | - | 19887 | 39054 | - |
| &nbsp;&nbsp;Melissa Waller | 75000 | - | - | - | 111052 | 186052 | 60 |
| &nbsp;&nbsp;Beverly Wyse | 80000 | - | - | - | 111052 | 191052 | 58 |
| **Other KMP** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Toby Symonds | 451500 | 456000 | 23010 | 9075 | 2040207 | 2979792 | 68 |
| &nbsp;&nbsp;W. Scott Sparks | 282500 | 250000 | 14674 | 8800 | 465379 | 1021353 | 46 |
| &nbsp;&nbsp;Dominic Allen | 282500 | 150000 | 49425 | - | 278638 | 760563 | 37 |
| &nbsp;&nbsp;Marcela Castro | 270000 | 150000 | 23010 | 16050 | 384108 | 843168 | 46 |
| **Total** | **2409000** | **1486000** | **117976** | **62632** | **5496070** | **9571678** |  |

---

**Notes:**

<sup>(1)</sup> Mr. Hannigan's share-based payments includes 141,844 shares issued in lieu of his cash bonus of $250,000, as approved by shareholders on June 27, 2025.

**Loans with Key Management Personnel**

No loans were provided to or received from KMP during the year ended June 30, 2025 (2024: Nil).

**Other Transactions with Key Management Personnel**

Performance Industries, Inc., a company associated with Mr. W. Scott Sparks, Chief Operating Officer of the Company, was paid or is payable $0 during fiscal 2025 (2024: $53,138) for the provision of engineering and construction services to the Company. The Company considers that the services provided by Performance Industries, Inc. were provided on an arm's length or better basis.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Options, Rights and RSU's Granted to Key Management Personnel**

Details of Unlisted Options, Performance Rights and Restricted Stock Units granted, exercised or lapsed for each KMP of the Company during the 2025 financial year are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025** | **No. of<br>options, rights <br>and RSU's<br> granted <br>during year

#** | **No. of<br>options, rights <br>and RSU's <br>vested during <br>year

#** | **Value of options,** <br>**rights and** <br>**RSU's granted**<br>**during year**<sup>(1)</sup><br>**US$** | **Value of**<br>**options, rights** <br>**and RSU's** <br>**exercised**<br>**during year**<sup>(2)</sup><br>**US$** | **Value of<br> options, rights <br>and RSU's<br> included in <br>remuneration <br>for year<br>US$** |
| **Directors** |  |  |  |  |  |
| &nbsp;&nbsp;Todd Hannigan | 1214036 | (3659333) | 3559737 | 10208258 | 584131 |
| &nbsp;&nbsp;Anastasios Arima | 1727328 | (4943667) | 5064786 | 10692507 | 1047347 |
| &nbsp;&nbsp;Lorraine Martin | 42486 | (135790) | 122557 | 339254 | 111052 |
| &nbsp;&nbsp;Vaughn Taylor | 42486 | (369124) | 122557 | 996310 | 93217 |
| &nbsp;&nbsp;Tony Tripeny | 42486 | - | 93867 | - | 19887 |
| &nbsp;&nbsp;Melissa Waller | 42486 | (135790) | 122557 | 339254 | 111052 |
| &nbsp;&nbsp;Beverly Wyse | 42486 | (135790) | 122557 | 339254 | 111052 |
| **Other KMP** |  |  |  |  |  |
| &nbsp;&nbsp;Toby Symonds | 1647618 | (4969334) | 3007791 | 13379556 | 2040207 |
| &nbsp;&nbsp;W. Scott Sparks | 649567 | (479667) | 1178202 | 1228406 | 465379 |
| &nbsp;&nbsp;Dominic Allen | 649567 | (4079667) | 1178202 | 11460405 | 278638 |
| &nbsp;&nbsp;Marcela Castro | 299007 | (579667) | 455838 | 1510907 | 384108 |
| **Total** | **6399553** | **(19487829)** | **15028650** | **50494111** | **5246070** |

---

**Notes:**

<sup>(1)</sup> Determined at the time of grant per IFRS 2 - Share-based Payment, using an exchange rate of US$0.6556=A$1.00, being the average exchange rate for 2025.

<sup>(2)</sup> Determined at the time of exercise or conversion at the intrinsic value using the exchange rate on the date of exercise.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Details of Unlisted Options, Performance Rights and RSUs granted by the Company to each KMP of the Company during the financial year are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **2025** | **Security <br>class** | **Grant<br>date** | **Expiry<br>date** | **Service <br>vesting<br>date** | **Exercise price<br>A$** | **Vesting <br>hurdle (30-<br>day VWAP)** | **Grant date** <br>**fair value**<sup>(1)</sup><br>**A$** | **Number<br> granted** |
| Todd Hannigan | RSUs | 27-Jun-25 | 10-Apr-29 | 10-Apr-28 | - | - | A$4.750 | 295130 |
|  | Rights | 27-Jun-25 | 10-Apr-31 | 10-Apr-29 | - | A$6.00 | A$4.480 | 306302 |
|  | Rights | 27-Jun-25 | 10-Apr-31 | 10-Apr-29 | - | A$7.00 | A$4.380 | 306302 |
|  | Rights | 27-Jun-25 | 10-Apr-31 | 10-Apr-29 |  | A$8.00 | A$4.290 | 306302 |
| Anastasios Arima | RSUs | 27-Jun-25 | 10-Apr-29 | 10-Apr-28 | - | - | A$4.750 | 419910 |
|  | Rights | 27-Jun-25 | 10-Apr-31 | 10-Apr-29 | - | A$6.00 | A$4.480 | 435806 |
|  | Rights | 27-Jun-25 | 10-Apr-31 | 10-Apr-29 | - | A$7.00 | A$4.380 | 435806 |
|  | Rights | 27-Jun-25 | 10-Apr-31 | 10-Apr-29 |  | A$8.00 | A$4.290 | 435806 |
| Lorraine Martin | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-25 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-26 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-27 | - | - | A$4.400 | 14162 |
| Vaughn Taylor | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-25 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-26 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-27 | - | - | A$4.400 | 14162 |
| Melissa Waller | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-25 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-26 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-27 | - | - | A$4.400 | 14162 |
| Beverly Wyse | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-25 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-26 | - | - | A$4.400 | 14162 |
|  | RSUs | 22-Nov-24 | 16-Dec-28 | 16-Dec-27 | - | - | A$4.400 | 14162 |
| Tony Tripeny | RSUs | 9-Mar-25 | 16-Dec-28 | 16-Dec-25 | - | - | A$3.370 | 14162 |
|  | RSUs | 9-Mar-25 | 16-Dec-28 | 16-Dec-26 | - | - | A$3.370 | 14162 |
|  | RSUs | 9-Mar-25 | 16-Dec-28 | 16-Dec-27 | - | - | A$3.370 | 14162 |
| Toby Symonds | RSUs | 15-May-25 | 10-Apr-29 | 10-Apr-28 | - | - | A$3.110 | 400533 |
|  | Rights | 15-May-25 | 10-Apr-31 | 10-Apr-29 | - | A$6.00 | A$2.760 | 415695 |
|  | Rights | 15-May-25 | 10-Apr-31 | 10-Apr-29 | - | A$7.00 | A$2.680 | 415695 |
|  | Rights | 15-May-25 | 10-Apr-31 | 10-Apr-29 |  | A$8.00 | A$2.600 | 415695 |
| W. Scott Sparks | Options | 12-Jun-25 | 10-Apr-29 | 10-Apr-28 | A$5.00 | - | A$2.260 | 470701 |
|  | RSUs | 12-Jun-25 | 10-Apr-29 | 10-Apr-28 | - | - | A$4.100 | 178866 |
| Dominic Allen | Options | 12-Jun-25 | 10-Apr-29 | 10-Apr-28 | A$5.00 | - | A$2.260 | 470701 |
|  | RSUs | 12-Jun-25 | 10-Apr-29 | 10-Apr-28 | - | - | A$4.100 | 178866 |
| Marcela Castro | Options | 23-May-25 | 10-Apr-29 | 10-Apr-28 | A$5.00 | - | A$1.860 | 216672 |
|  | RSUs | 23-May-25 | 10-Apr-29 | 10-Apr-28 | - | - | A$3.550 | 82335 |

---

**Notes:**

<sup>(1)</sup> For details on the valuation of Unlisted Options, RSUs, and Performance Rights, including models and assumptions used, please refer to Note 19 of the financial statements.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Option, Right, and RSU holdings of Key Management Personnel**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **2025** | **Held at<br>July 1, 2024** | **Granted as <br>remuneration** | **Exercise of <br>options, rights <br>and RSUs** | **Held at<br>June 30, 2025** | **Vested and <br>exercisable at <br>June 30, 2025** |
| **Directors** |  |  |  |  |  |
| &nbsp;&nbsp;Todd Hannigan | 4538000 | 1214036 | (3659333) | 2092703 | - |
| &nbsp;&nbsp;Anastasios Arima | 6581000 | 1727328 | (4943667) | 3364661 | - |
| &nbsp;&nbsp;Lorraine Martin | 544768 | 42486 | (135790) | 451464 | 270729 |
| &nbsp;&nbsp;Vaughn Taylor | 578102 | 42486 | (369124) | 251464 | 70729 |
| &nbsp;&nbsp;Tony Tripeny | - | 42486 | - | 42486 | - |
| &nbsp;&nbsp;Melissa Waller | 544768 | 42486 | (135790) | 451464 | 270729 |
| &nbsp;&nbsp;Beverly Wyse | 544768 | 42486 | (135790) | 451464 | 270729 |
| **Other KMP** |  |  |  |  | - |
| &nbsp;&nbsp;Toby Symonds | 6684667 | 1647618 | (4969334) | 3362951 | - |
| &nbsp;&nbsp;W. Scott Sparks | 2049000 | 649567 | (479667) | 2218900 | 200000 |
| &nbsp;&nbsp;Dominic Allen | 5344000 | 649567 | (4079667) | 1913900 | 425000 |
| &nbsp;&nbsp;Marcela Castro | 739000 | 299007 | (579667) | 458340 | - |
| **Total** | **28148073** | **6399553** | **(19487829)** | **15059797** | **1507916** |

---

**Shareholdings of Key Management Personnel**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **2025** | **Held at<br>July 1, 2024** | **Held at<br>July 1, 2024** | **Granted as <br>remuneration** | **Granted as <br>remuneration** | **Exercise of<br>options and rights** | **Exercise of<br>options and rights** | **Net change<br>other** | **Net change<br>other** | **Held at<br>June 30, 2025** | **Held at<br>June 30, 2025** |
| **2025** | **Ord** <sup>(1)</sup> | **Perf** <sup>(2)</sup> | **Ord** <sup>(1)</sup> | **Perf** <sup>(2)</sup> | **Ord** <sup>(1)</sup> | **Perf** <sup>(2)</sup> | **Ord** <sup>(1)</sup> | **Perf** <sup>(2)</sup> | **Ord** <sup>(1)</sup> | **Perf** <sup>(2)</sup> |
| **Directors** |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Todd Hannigan | 17565255 | 2520000 | 141844 | - | 3659333 | - | 4077343 | (1260000) | 25443775 | 1260000 |
| &nbsp;&nbsp;Anastasios Arima | 6461446 | 4500000 | - | - | 4943667 | - | - | (2250000) | 11405113 | 2250000 |
| &nbsp;&nbsp;Lorraine Martin | 468699 | - | - | - | 135790 | - | 158655 | - | 763144 | - |
| &nbsp;&nbsp;Vaughn Taylor | 562194 | - | - | - | 369124 | - | - | - | 931318 | - |
| &nbsp;&nbsp;Tony Tripeny | - | - | - | - | - | - | - | - | - | - |
| &nbsp;&nbsp;Melissa Waller | 168699 | - | - | - | 135790 | - | - | - | 304489 | - |
| &nbsp;&nbsp;Beverly Wyse | 168699 | - | - | - | 135790 | - | - | - | 304489 | - |
| **Other KMP** |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Toby Symonds | 523504 | - | - | - | 4969334 | - | (2304692) | - | 3188146 | - |
| &nbsp;&nbsp;W. Scott Sparks | 1060000 | 1440000 | - | - | 479667 | - | (145696) | (720000) | 1393971 | 720000 |
| &nbsp;&nbsp;Dominic Allen | 2927500 | 3060000 | - | - | 4079667 | - | (2499999) | (1530000) | 4507168 | 1530000 |
| &nbsp;&nbsp;Marcela Castro | - | - | - | - | 579667 | - | (238872) | - | 340795 | - |
| **Total** | **29905996** | **11520000** | **141844** | **-** | **19487829** | **-** | **(953261)** | **(5760000)** | **48582408** | **5760000** |

---

**Notes:**

<sup>(1)</sup> 'Ord' means Ordinary Shares.

<sup>(2)</sup> 'Perf' means Performance Shares issued to the original vendors of HMAPL as consideration for the Company's acquisition of HMAPL in fiscal 2021. For the avoidance of doubt, these Performance Shares do not form part of remuneration.

**Employment Contracts with Key Management Personnel**

Mr. Arima, CEO and Managing Director, has an employment agreement with the Group which may be terminated upon six months' advance written notice, unless mutually agreed upon with the Company. Mr. Arima receives a fixed remuneration component of $550,000 (2024: $400,000) per annum and a discretionary annual bonus of up to $385,000 (2024: $240,000) to be paid upon the successful completion of KPIs as determined by the Board and is entitled to participate in the LTIP on terms to be determined by the Board.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Mr. Symonds, President and CSO, has an employment agreement with the Group which may be terminated upon six months' advance written notice, unless mutually agreed upon with the Company. Mr. Symonds receives a fixed remuneration component of $523,000 (2024: $380,000) per annum and a discretionary annual bonus of up to $366,000 (2024: $228,000) to be paid upon the successful completion of KPIs as determined by the Board and is entitled to participate in the LTIP on terms to be determined by the Board.

Mr. Hannigan, Executive Chairman, has a director appointment letter with the Group. Mr. Hannigan receives a fixed remuneration component of $385,000 (2024: $250,000) per annum and a discretionary annual bonus of up to $270,000 (2024: $125,000) to be paid upon the successful completion of KPIs as determined by the Board and is entitled to participate in the LTIP on terms to be determined by the Board.

Mr. Allen, CCO, has an service agreement with the Group which may be terminated upon three months' advance written notice, unless mutually agreed upon with the Company. Mr. Allen receives a fixed remuneration component of $315,000 (2024: $250,200) per annum and a discretionary annual bonus of up to $158,000 (2024: $125,000) to be paid upon the successful completion of KPIs as determined by the Board and is entitled to participate in the LTIP on terms to be determined by the Board.

Mr. Sparks, COO, has an employment agreement with the Group which may be terminated upon six months' advance written notice, unless mutually agreed upon with the Company. Mr. Sparks receives a fixed remuneration component of $315,000 (2024: $250,000) per annum and a discretionary annual bonus of up to $158,000 (2024: $125,000) to be paid upon the successful completion of KPIs as determined by the Board and is entitled to participate in the LTIP on terms to be determined by the Board.

Ms. Castro, CFO, has an employment agreement with the Group which may be terminated upon four weeks' advance written notice, unless mutually agreed upon with the Company. Ms. Castro receives a fixed remuneration component of $290,000 (2024: $250,000) per annum, a discretionary annual bonus of up to $145,000 (2024: $125,000) to be paid upon the successful completion of KPIs as determined by the Board and is entitled to participate in the LTIP on terms to be determined by the Board.

All Non-Executive Directors have a letter of appointment confirming the terms and conditions of their appointment as Director of the Company.

**C.Board Practices**

The Board is responsible for guiding all matters relating to the strategic direction, policies, practices, establishing goals for management and the operation of the Company. The functions and responsibilities reserved for the Board and those delegated to the Managing Director and executive management are set out in our Board Charter.

Nasdaq listing standards require that a majority of the Board be independent. An "independent director" is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the Board, would interfere with the director's exercise of independent judgment in carrying out the responsibilities of a director. The Board has determined that Mses. Martin, Waller and Wyse and Mrs. Taylor and Tripeny are "independent directors" as defined in the Nasdaq listing standards and applicable SEC rules.

In addition to being set out in the Board Charter, the roles and responsibilities of our directors are also formalized in the letter of appointment which each director receives and commits to on their appointment. The letters of appointment specify the term of appointment, time commitment envisaged, expectations in relations to committee work or any other special duties attaching to the position, reporting lines, remuneration arrangements, disclosure obligations in relation to personal interests, confidentiality obligations, insurance and indemnity entitlements and details of the Company's key governance policies. Each KMP enters into a service contract which sets out the material terms of employment, including a description of position and duties, reporting lines, remuneration arrangement and termination rights and entitlement.

The Constitution of the Company requires the Company, to the extent permitted by law, to indemnify any person who is or has been a director or officer of the Company for any liability caused by such a director or officer and any legal costs incurred by a director or officer in defending an action for any liability caused by such a director or officer. During or since the end of fiscal 2025, no amounts have been paid by the Company in relation to the above indemnities. During fiscal 2025, an insurance premium of $229,238 was paid by the Company to insure against a liability incurred by a person who is or has been a director or officer of the Company or Company.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Board Committees**

The Board has three standing committees, being an audit committee, a remuneration and nomination committee, and an environmental, social and governance committee.

***Audit Committee***

The Board has established an Audit Committee. Assignments to, and chairs of, audit committee will be selected by the Board. The audit committee operates under a charter approved by the Board and reports on its activities to the Board. The audit committee monitors the integrity of our financial statements, the independence and qualifications of our independent auditors, the performance of our accounting staff and independent auditors, our compliance with legal and regulatory requirements and the effectiveness of our internal controls. The audit committee is responsible for selecting, retaining (subject to shareholder approval), evaluating, setting the remuneration of, and, if appropriate, recommending the termination of our independent auditors. The audit committee is established in accordance with Section 10A(m) of the Exchange Act. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of whom must be independent. The audit committee currently consists of Mr. Tony Tripeny (chairperson), Mr. Vaughn Taylor and Ms. Beverly Wyse, all of whom are considered independent under the listing standards of the Nasdaq Capital Market for audit committee members and the heightened independence requirement for audit committee members required by Rule 10A-3 under the Exchange Act. Mr. Tony Tripeny is also an audit committee financial expert.

***Compensation Committee***

The Board has established a separate Compensation Committee. The compensation committee operates under a charter approved by the Board and reports on its activities to the Board. The compensation committee charter sets out the processes the Board employs for setting the level and composition of compensation for directors and senior executives and ensuring that such compensation is appropriate and not excessive. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least two members of the Compensation Committee, all of whom must be independent. The remuneration and nomination committee currently consists of Mr. Vaughn Taylor (chairperson), Mrs. Beverly Wyse and Ms. Melissa Waller, all of whom are considered independent under the Nasdaq listing standards and applicable SEC rules.

***Nominating and Governance Committee***

The Board has established a separate Nominating and Governance Committee. The Nominating and Governance Committee operates under a charter approved by the Board and reports on its activities to the Board. The Nominating and Governance Committee charter sets out the processes the Board employs to oversee and to assist the Board in fulfilling its responsibilities relating to Board member recruitment, succession planning and overseeing and improving the Company's governance policies and practices.. The Nominating and Governance Committee currently consists of Ms. Melissa Waller (chairperson), Ms. Beverly Wyse, Ms. Lorraine Martin, and Mr. Tony Tripeny.

**Code of Conduct**

The Company has adopted a Code of Conduct which provides a framework for decisions and actions in relation to ethical conduct in employment. It aims to encourage the appropriate standards of conduct and behavior of the directors, officers, employees and contractors of the Company. The document sets out the principles covering appropriate conduct in a variety of contexts and outlines the minimum standard of behavior expected from employees, including to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• act honestly, in good faith and in the best interests of the Company as a whole;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• exercise their duty to use due care and diligence in fulfilling the functions of their position;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• recognize that their primary responsibility is to the Company's shareholders as a whole;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• not take advantage of their position for personal gain, or the gain of their associates; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• preserve the confidentiality of sensitive information of the Company.

The directors and executives also have a fiduciary relationship with shareholders of the Company, making it unlawful to improperly use their position to gain advantage for themselves. At all times, directors and officers must act in the best interest of the Company and eliminate or abstain from participating in any discussion or decision-making process in

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

relation to matters which they have a conflict of interest, not engage in insider trading and comply with all applicable anti-bribery laws.

**D.Employees**

As of June 30, 2025, we had 70 employees and 5 employee contractors based in 3 different countries, as shown in the chart below.

---

| | | | |
|:---|:---|:---|:---|
| | **United <br>States** | **Australia** | **Canada** |
| Employees | 70 | - | - |
| Employee Contractors | - | 3 | 2 |

---

The workforce is non-unionized.

E.**Share Ownership**

The following table lists as of June 30, 2025, the number of our shares beneficially owned by each of our directors, our chief executive officer and other members of our senior management as a group. Beneficial ownership is calculated based on 319,927,854 ordinary shares outstanding as of June 30, 2025.

---

| | | |
|:---|:---|:---|
| | **Ordinary Shares**<br>**Beneficially Owned**<sup>(1)</sup> | **Ordinary Shares**<br>**Beneficially Owned**<sup>(1)</sup> |
|<br>**Shareholder** | **Number** | **Percent** |
| Officers and Directors |  |  |
| Todd Hannigan | 25443775 | 8.0% |
| Anastasios Arima | 11405113 | 3.6% |
| Lorraine Martin | 1033873 | \* |
| Vaughn Taylor | 1002047 | \* |
| Tony Tripeny | - | \* |
| Melissa Waller | 575218 | \* |
| Beverly Wyse | 575218 | \* |
| Toby Symonds | 3188146 | \* |
| W. Scott Sparks | 1593971 | \* |
| Dominic Allen | 4932168 | 1.5% |
| Marcela Castro | 340795 | \* |
| Officers and directors as a group (11 persons) | 50090324 | 15.7% |

---

**Notes:**

\*Represents beneficial ownership of less than 1% of the outstanding ordinary shares of IperionX.

<sup>(1)</sup> Beneficial ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power of that security, including options, RSUs, and performance rights that are currently exercisable or exercisable within 60 days of June 30, 2025.

**F.Disclosure of a registrant's action to recover erroneously awarded compensation**

Not applicable.

**ITEM 7.&nbsp;&nbsp;&nbsp;&nbsp;MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS**

**A.Major Shareholders**

The following table and accompanying footnotes set forth, as of June 30, 2025, information regarding beneficial ownership of our ordinary shares by each person known by us to be the beneficial owner of more than 5% of our ordinary shares. In

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

preparing the disclosure below, we have relied to the extent we believe appropriate on substantial shareholder notices provided to us by our substantial shareholders and released to ASX.

Beneficial ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power of that security, including options and performance rights that are currently exercisable or exercisable within 60 days of June 30, 2025. Ordinary shares subject to options and performance rights currently exercisable or exercisable within 60 days of June 30, 2025 are deemed to be outstanding for computing the percentage ownership of the person holding these options and/or performance rights and the percentage ownership of any group of which the holder is a member, but are not deemed outstanding for computing the percentage of any other person.

Our calculation of the percentage of beneficial ownership is based on 319,927,854 ordinary shares issued and outstanding as at June 30, 2025. A large number of our ordinary shares are held by nominee companies so we cannot be certain of the identity of those beneficial owners.

Unless otherwise indicated, to our knowledge each shareholder possesses sole voting and investment power over the ordinary shares listed subject to community property laws, where applicable. None of our shareholders has different voting rights from other shareholders.

---

| | | |
|:---|:---|:---|
| | **Ordinary Shares<br>Beneficially Owned** | **Ordinary Shares<br>Beneficially Owned** |
| **Shareholder** | **Number** | **Percent** |
| FMR LLC (1 St. Martin's Le Grand, London, EC1A 4AS, United Kingdom) | 26097578 | 8.2% |
| DITM Holdings Pty Ltd (15 Lennox Street, Mosman, NSW, 2088, Australia)(1) | 25443775 | 8.0% |
| Regal Funds Management Pty Limited (Level 46, Gateway, 1 Macquarie Place, Sydney NSW 2000 | 18953963 | 5.9% |

---

**Notes:**

<sup>(1)</sup> DITM Holdings Pty Limited is an Australian corporation controlled by Mr. Todd Hannigan.

To our knowledge, there have not been any significant changes in the ownership of our ordinary shares by major shareholders over the past three years, except as follows (which is based upon substantial shareholder notices filed with the ASX and beneficial ownership reports on Schedule 13G filed with the SEC):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• FMR LLC became a substantial shareholder on August 31, 2021, when it acquired 13,499,999 ordinary shares, or 9.7% of the total voting power, pursuant to a private placement by the Company. On February 9, 2023, FMR LLC reported it beneficially owned 16,789,000 ordinary shares, or 9.8% of the total voting power, as of December 31, 2022. On February 9, 2024, FMR LLC reported it beneficially owned 21,131,763 ordinary shares, or 9.4% of the total voting power, as of December 29, 2023. On November 21, 2024, FMR LLC reported that it had a change in substantial holding and reported it held 26,097,578 ordinary shares, or 8.7% of the total voting power, as of that date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• DITM Holdings Pty Ltd became a substantial shareholder on December 1, 2020, when it reported that it held 4,618,357 ordinary shares, or 5.3% of the total voting power, as of that date. On January 27, 2021, DITM Holdings Pty Ltd had a change in substantial holding (due to additional purchases) and reported it held 7,951,691 ordinary shares, or 8.1% of the total voting power, as of that date. On August 31, 2021, DITM Holdings Pty Ltd had a change in substantial holding (due to additional purchases) and reported it held 9,069,086 ordinary shares, or 6.5% of the total voting power, as of that date. On December 13, 2021, DITM Holdings Pty Ltd had a change in holding (due to additional purchases) and reported it held 9,415,927 ordinary shares, or 6.8% of the total voting power, as of that date. On May 5, 2022, DITM Holdings Pty Ltd had a change in holding (due to additional purchases) and reported it held 10,412,842 ordinary shares, or 7.4% of the total voting power, as of that date. On February 14, 2023, DITM Holdings Pty Ltd reported it beneficially owned 15,031,747 ordinary shares, or 8.6% of the total voting power, as of December 31, 2022 (consisting of 12,931,747 ordinary shares and 2,100,000 ordinary shares underlying options that are exercisable within 60 days of December 31, 2022). On May 8, 2023, DITM Holdings Pty Ltd reported it had purchased an additional 847,970 ordinary shares. On June 26, 2023, DITM Holdings Pty Ltd reported it had purchased an additional 700,000 ordinary shares, and beneficially owned 16,579,717 ordinary shares, or 8.5% of the total voting power, as of that date (consisting of 14,479,717 ordinary shares and 2,100,000 ordinary shares underlying options that

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

are exercisable within 60 days). On November 13, 2023, DITM Holdings Pty Ltd reported it had purchased an additional 520,096 ordinary shares, and beneficially owned 17,099,813 ordinary shares, or 8.5% of the total voting power, as of that date (consisting of 14,999,813 ordinary shares and 2,100,000 ordinary shares underlying options that are exercisable within 60 days). On December 21, 2023, DITM Holdings Pty Ltd reported it had exercised 2,100,000 share options, and beneficially owned 17,099,813 ordinary shares as of that date. On January 4, 2024, DITM Holdings Pty Ltd reported it had purchased an additional 465,442 ordinary shares, and beneficially owned 17,565,255 ordinary shares as of that date. On July 9, 2024, DITM Holdings Pty Ltd reported it had purchased an additional 3,173,092 ordinary shares, and beneficially owned 20,738,347 ordinary shares as of that date. On December 9, 2024, DITM Holdings Pty Ltd reported it had received 1 ordinary share upon the conversion of its performance shares, and beneficially owned 20,738,348 ordinary shares as of that date. On December 16, 2024, DITM Holdings Pty Ltd reported it had exercised 3,500,000 performance rights, and beneficially owned 24,238,348 ordinary shares as of that date. On December 18, 2024, DITM Holdings Pty Ltd reported it had purchased an additional 593,750 ordinary shares, and beneficially owned 24,832,098 ordinary shares as of that date. On March 14, 2025, DITM Holdings Pty Ltd reported it had exercised 159,333 RSUs, and beneficially owned 24,991,431 ordinary shares as of that date. On April 16, 2025, DITM Holdings Pty Ltd reported it had purchased an additional 310,500 ordinary shares, and beneficially owned 25,301,931 ordinary shares as of that date. On June 27, 2025, DITM Holdings Pty Ltd reported it had been issued an additional 141,844 ordinary shares, and beneficially owned 25,443,775 ordinary shares as of that date. DITM Holdings Pty Ltd is an entity associated with Mr. Todd Hannigan, Director of the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Regal Funds Management Pty Limited ("Regal Funds") became a substantial shareholder on October 25, 2024 when it reported that it held 17,963,212 ordinary shares, or 6.14% of the total voting power, as of that date. On December 16, 2024, Regal Funds reported that it had a change in substantial holding and reported it held 23,265,521 ordinary shares, or 7.38% of the total voting power, as of that date. On July 23, 2025, Regal Funds reported that it had a change in substantial holding (due to sales) and reported it held 18,953,963 ordinary shares, or 5.9% of the total voting power, as of June 30, 2025.

***Record Holders***

As of June 30, 2025, we had 319,927,854 ordinary shares issued and outstanding. Based on information known to us, as of June 30, 2025, 7,151,833 of our ordinary shares were being held in the United States by 41 shareholders of record. A number of our ordinary shares are held by nominee companies so we cannot be certain of the identity of those beneficial owners. In addition, based on information known to us, as of June 30, 2025, approximately 45,615,920 of our outstanding ordinary shares are held in the form of ADSs.

We are not controlled by another corporation, by any foreign government or by any natural or legal persons except as set forth herein, and there are no arrangements known to us which would result in a change in control of us at a subsequent date.

B.**Related Party Transactions**

Other than as disclosed below, since July 1, 2024, other than employment and remuneration matters described in "Item 6. Directors, Senior Management and Employees – Compensation" we did not enter into any transactions or loans with any: (i) enterprises that directly or indirectly, through one or more intermediaries, control, are controlled by or are under common control with us; (ii) associates; (iii) individuals owning, directly or indirectly, an interest in our voting power that gives them significant influence over us, and close members of any such individual's family; (iv) key management personnel and close members of such individuals' families; or (v) enterprises in which a substantial shareholder interest in our voting power is owned, directly or indirectly, by any person described in (iii) or (iv) or over which such person is able to exercise significant influence.

Performance Industries, Inc., a company associated with Mr. W. Scott Sparks, Chief Operating Officer of the Company, was paid or is payable $0 during fiscal 2025 (2024: $53,138) for the provision of engineering and construction services to the Company. The Company considers that the services provided by Performance Industries, Inc. were provided on an arm's length or better basis.

C.**Interests of Experts and Counsel**

Not applicable.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**ITEM 8.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL INFORMATION.**

A.**Consolidated Statements and Other Financial Information.**

See "Item 18. Financial Statements."

**Legal Proceedings**

We are not a party to any material legal proceedings.

**Dividends**

We have not declared any dividends during fiscal 2025, 2024 or 2023 and do not anticipate that we will do so in the foreseeable future. We currently intend to retain future earnings, if any, to finance the development of our business. Dividends, if any, on our outstanding ordinary shares will be declared by and subject to the discretion of our Board of Directors on the basis of our earnings, financial requirements and other relevant factors, and subject to Australian law.

Any dividend we declare will be paid to the holders of ADSs, subject to the terms of the deposit agreement, to the same extent as holders of our ordinary shares, to the extent permitted by applicable law and regulations, less the fees and expenses payable under the deposit agreement. Any dividend we declare will be distributed by the depositary bank to the holders of the ADSs, subject to the terms of the deposit agreement. See "Item 12. *Description of Securities Other Than Equity Securities-D. American Depositary Shares.*"

**B.Significant Changes**

No significant change, other than as otherwise described in this annual report on Form 20-F, has occurred in our operations since the date of our consolidated financial statements included in this annual report on Form 20-F.

**ITEM 9.&nbsp;&nbsp;&nbsp;&nbsp;THE OFFER AND LISTING**

A.**Offer and Listing Details**

The principal trading market for our ordinary shares is the ASX in Australia. Our ordinary shares trade under the symbol "IPX." Our ADSs are publicly traded in the United States on the Nasdaq Capital Market under the symbol "IPX."

**B.Plan of Distribution**

Not applicable.

**C.Markets**

Our ordinary shares are publicly traded on the ASX under the symbol "IPX." Our ADSs are publicly traded on the Nasdaq Capital Market under the symbol "IPX."

**D.Selling Shareholders**

Not applicable.

**E.Dilution**

Not applicable.

**F.Expenses of the Issue**

Not applicable.

**ITEM 10.&nbsp;&nbsp;&nbsp;&nbsp;ADDITIONAL INFORMATION**

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**A.Share Capital**

Not applicable.

**B.Constitutional Documents**

The following description of our ordinary shares is only a summary. We encourage you to read our Constitution, which is included as an exhibit to our Annual Report on Form 20-F. All references to the "Company," "we," "us," "our" and "ours" refer to IperionX Limited and its consolidated subsidiaries.

**General**

We are a public company limited by shares registered under the Corporations Act by the ASIC. Our corporate affairs are principally governed by our Constitution, the Corporations Act and the ASX Listing Rules. Our ordinary shares trade on the ASX. Our ADSs, each representing 10 of our ordinary shares, are listed on the Nasdaq, under the symbol "IPX." The Bank of New York Mellon, acting as depositary, registers and delivers the ADSs.

The Australian law applicable to our Constitution is not significantly different than a U.S. company's charter documents except we do not have a limit on our authorized share capital and the concept of par value is not recognized under Australian law.

Subject to restrictions on the issue of securities in our Constitution, the Corporations Act and the ASX Listing Rules and any other applicable law, we may at any time issue shares and grant options or warrants on any terms, with the rights and restrictions and for the consideration that the Board determine.

The rights and restrictions attaching to ordinary shares are derived through a combination of our Constitution, the common law applicable to Australia, the ASX Listing Rules, the Corporations Act and other applicable law. A general summary of some of the rights and restrictions attaching to our ordinary shares are summarized below. Each ordinary shareholder is entitled to receive notice of, and to be present, vote and speak at, general meetings.

**Our Constitution**

Our constituent document is our Constitution. Our Constitution is subject to the terms of the ASX Listing Rules and the Corporations Act. It does not provide for or prescribe any specific objectives or purposes of IperionX. It may be amended or repealed and replaced by special resolution of shareholders, which is a resolution passed by at least 75% of the votes cast by shareholders entitled to vote on the resolution. Where there is an inconsistency between the provisions of the Constitution and the Corporations Act, the provisions of the Australian Corporation Act will prevail over any inconsistent provisions of the Constitution.

Under Australian law, a company has the legal capacity and powers of an individual both within and outside Australia. The material provisions of our Constitution are summarized below. This summary is not intended to be complete nor to constitute a definitive statement of the rights and liabilities of our shareholders.

*Interested Directors*

Except where permitted by the Corporations Act, a director may not vote in respect of any contract or arrangement in which the director has, directly or indirectly, any material interest. Such director must not be counted in a quorum, must not vote on the matter and must not be present at the meeting while the matter is being considered.

Unless a relevant exception applies, the Corporations Act requires our directors to provide disclosure of certain interests and prohibits directors of companies listed on the ASX from voting on matters in which they have a material personal interest and from being present at the meeting while the matter is being considered. In addition, the Corporations Act and the ASX Listing Rules require shareholder approval of any provision of related party benefits to our directors.

*Directors' Compensation*

The fixed sum remuneration for non-executive directors may not be increased except at a general meeting of shareholders and the particulars of the proposed increase are required to have been provided to shareholders in the notice convening the

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

meeting. The aggregate, fixed sum for non-executive directors' remuneration is to be divided among the non-executive directors in such proportion as the Board of Directors agree and in accordance with our Constitution. Remuneration payable to executive directors, such as the Managing Director, does not form part of the aggregate remuneration pool through which non-executive directors are paid. Executive directors may be paid remuneration as employees of IperionX.

Pursuant to our Constitution, any director who performs extra or special services that in the opinion of the Board, are outside the scope of the ordinary duties of a director may be paid additional remuneration or provide benefits to that director, which is determined by the Board.

The Company must also pay all reasonable travel, accommodation and other expenses properly incurred by the directors in attending general meetings, Board meetings, committee meetings or otherwise in connection with our business.

In addition, in accordance with our Constitution, a director may be paid a retirement benefit as determined by the Board, subject to the limits set out in the Corporations Act and the ASX Listing Rules.

*Borrowing Powers Exercisable by Directors*

Pursuant to our Constitution, the management and control of our business affairs are vested in the Board. Subject to the Corporations Act and the ASX Listing Rules, the Board has the power to raise or borrow money, and charge any of our property or business or any uncalled capital, and may issue debentures or give any other security for any of our debts, liabilities or obligations or of any other person, in each case, in the manner and on terms it deems fit.

*Retirement of Directors*

Pursuant to our Constitution, one-third of our directors, other than the managing director, must retire from office at every annual general meeting. If the number of directors is not a multiple of three, then the number nearest to, but not exceeding, one-third must retire from office. The directors who retire in this manner are required to be the directors or director longest in office since last being elected. A director, other than the director who is the managing director, must retire from office at the conclusion of the third annual general meeting after which the director was elected. Retired directors are eligible for re-election to the Board of Directors.

*Rights and Restrictions on Classes of Shares*

Subject to the Corporations Act and the ASX Listing Rules, the rights attaching to our Ordinary Shares are detailed in our Constitution. Subject to the Corporations Act, ASX Listing Rules and any rights or restrictions attached to a class of shares, the Company may issue further shares or grant options over shares on any terms, at any time and for any consideration as the Board resolve. Currently, our outstanding share capital consists of only one class of Ordinary Shares.

*Voting Rights*

Subject to our Constitution and any rights or restrictions attached to a class of shares, at a meeting of shareholders each shareholder has one vote determined by a show of hands. On a poll vote, each shareholder shall have one vote for each fully paid share and a fractional vote for each share that is not fully paid, such fraction being equivalent to the proportion of the amount that has been paid to such date on that share. Shareholders may vote by proxy, attorney or representative.

*Right to Share in Our Profits*

Subject to the Corporations Act, the ASX Listing Rules and the rights of the holders of any shares created or raised under any special arrangements as to dividends, the directors may from time to time declare a dividend to shareholders entitled to the dividend. Under the Corporations Act, we must not pay a dividend unless: (a) our assets exceed our liabilities immediately before the dividend is declared and the excess is sufficient for the payment of the dividend; (b) the payment of the dividend is fair and reasonable to our shareholders as a whole; and (c) the payment of the dividend does not materially prejudice our ability to pay our creditors. Unless any share is issued on terms providing to the contrary, the dividends declared will be payable on all shares according to the proportion that the amount paid (not credited) is of the total amounts paid and payable (excluding amounts credited) in respect of such shares.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*Rights to Share in the Surplus in the Event of Liquidation*

Our Constitution provides for the right of shareholders to participate in a surplus in the event of our liquidation.

*No Redemption Provision for Ordinary Shares*

There are no redemption provisions in our Constitution in relation to Ordinary Shares. Under our Constitution and subject to the Corporations Act, any preference shares may be issued on the terms that they are, or may at our option be, liable to be redeemed.

*Variation or Cancellation of Share Rights*

The rights attached to shares in a particular class of shares may only be varied or cancelled by a special resolution of IperionX, together with either:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a special resolution passed by members holding shares in that class; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the written consent of members who are entitled to at least 75% of the votes that may be cast in respect of shares in that class.

*Liability for Further Capital Calls*

According to our Constitution, the Board of Directors may make any calls from time to time upon shareholders in respect of all monies unpaid or partly-paid shares (if any), subject to the terms upon which any of the partly-paid shares have been issued. Each shareholder is liable to pay the amount of each call in the manner, at the time, and at the place specified by the Board of Directors. Calls may be made payable by installment. Failure to pay a call will result in interest becoming payable on the unpaid amount and ultimately, forfeiture of those shares. As of the date of this annual report, all of our issued shares are fully paid.

**Annual General Meetings**

Under the Corporations Act, our directors must convene an annual meeting of shareholders at least once every calendar year and within five months after the end of our last financial year. Notice of the proposed meeting of our shareholders is required at least 28 days prior to such meeting under the Corporations Act.

**General Meetings of Shareholders**

General meetings of shareholders may be called by the Board. Notice of the proposed meeting of our shareholders is required at least 28 days prior to such meeting under the Corporations Act. Except as permitted under the Corporations Act, shareholders may not convene a meeting. Under the Corporations Act, any director or one or more shareholders holding in aggregate at least 5% of the votes that may be cast at a general meeting may call and arrange to hold a general meeting. The meeting must be called in the same way in which general meetings of the company may be called, including the dispatch of a notice of meeting including the matters to be voted upon. The shareholders calling the meeting must pay the expenses of calling and holding the meeting.

The Corporations Act requires the directors to call and arrange to hold a general meeting on the request of shareholders with at least 5% of the votes that may be cast at a general meeting. The request must be made in writing, state any resolution to be proposed at the meeting, be signed by the shareholders making the request and be given to the company. The Board of Directors must call the meeting not more than 21 days after the request is made. The meeting must be held not later than two months after the request is given.

The quorum required for a general meeting of shareholders consists of at least two shareholders present in person, or by proxy, attorney or representative. A meeting (excluding a meeting convened on the requisition of shareholders) which is adjourned for lack of a quorum will be adjourned to the date, time and place as the Directors may by notice to shareholders appoint, or failing any appointment, to the same day in the following week at the same time and place. At the reconvened meeting, the required quorum consists of any two members present in person, or by proxy, attorney or representative appointed pursuant to our Constitution. The meeting is dissolved if a quorum is not present within 30 minutes from the time appointed for the reconvened meeting.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

A meeting of shareholders may be held virtually using any technology that gives shareholders as a whole a reasonable opportunity to participate in the meeting.

An ordinary resolution requires approval by the shareholders by a simple majority of votes cast (namely, a resolution passed by more than 50% of the votes cast by shareholders entitled to vote on the resolution). A special resolution (such as in relation to amending our Constitution, approving any variation of rights attached to any class of shares or our voluntary winding-up), requires approval of a special majority (namely, a resolution that has been passed by at least 75% of the votes cast by shareholders entitled to vote on the resolution).

**The Foreign Acquisitions and Takeovers Act 1975**

*Overview*

Australia's foreign investment regime is set out in the FATA and Australia's Foreign Investment Policy. The Australian Treasurer administers the FATA and the FIP with the advice and assistance of the FIRB.

In the circumstances set out below in the section entitled 'Mandatory Notification Requirements', foreign persons are required to notify and receive a prior statement of no objection, or FIRB clearance, from the Australian Treasurer. In the circumstances set out below in the section entitled 'Other circumstances in which FIRB may be sought', it is generally recommended that foreign persons obtain FIRB clearance.

The Australian Treasurer has powers under the FATA to make adverse orders, including prohibition of a proposal, ordering disposal of an interest acquired or imposing conditions on a proposed transaction, in respect of a relevant acquisition if he or she considers it to be contrary to Australia's national interest.

The obligation to notify and obtain FIRB clearance is upon the acquirer of the interest, and not the Company. The failure to obtain FIRB clearance may be an offense under Australian law.

*Investor's Responsibility*

It is the responsibility of any persons who wish to acquire shares of the Company to satisfy themselves as to their compliance with the FATA, regulations made under the FATA, the FIP, guidelines issued by the FIRB and with any other necessary approval and registration requirement or formality, before acquiring an interest in the Company.

*Mandatory Notification Requirements*

Broadly, FIRB clearance is required for the following transactions involving the acquisition of shares in an Australian corporation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the acquisition of a substantial interest if the Australian corporation is valued in excess of the applicable monetary threshold (see below);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any direct investment by a foreign government investor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any acquisition of shares in an Australian land corporation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any proposed direct investment in a national security business (including starting such a business) or proposed investment in national security land.

Currently, the prescribed threshold is A$289 million though a higher threshold of A$1.250 billion applies for private foreign investors from the United States, New Zealand, China, Japan, Hong Kong, Peru, South Korea, Singapore and Chile unless the transaction involves certain prescribed sensitive sectors.

*Application of these Requirements to the Company*

As at June 30, 2021, the Company did not have any interests in Australian land and hence is not an Australian land corporation, and the Company's gross assets were valued below A$289 million. Accordingly, the only circumstance in which an investor in the Company would currently be subject to the mandatory notification regime is if they are a foreign government investor making a direct investment in the Company. Applications for FIRB clearance may be made by prospective investors in accordance with the information on FIRB's website.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*Other Situations Where FIRB Clearance Might be Sought*

In addition to those circumstances where it is mandatory under the FATA for a foreign person to notify FIRB and seek FIRB clearance for a particular transaction (see above), there are other instances where, despite there being no mandatory notification obligation, the Australian Treasurer may make adverse orders under the FATA (e.g., if he or she considers a particular transaction to have national security concerns).

*National Security Related Transactions*

Under Australia's foreign investment regime, the Australian Treasurer may 'call in' certain transactions for screening on national security grounds and allow investors to voluntarily notify these transactions to obtain certainty about the investment. Where national security concerns are identified, the Australian Treasurer has the power to impose conditions, vary existing conditions, or, as a last resort, force the divestment of any realized investment which was subject to the FATA from January 1, 2021.

Transactions falling within the scope of the national security test are subject to a $0 monetary threshold.

*The Company as a Foreign Person*

If foreign persons have a substantial interest in the Company, it would be considered to be a foreign person under the FATA. In such event, we would be required to obtain the approval of the Australian Treasurer for our own transactions involving the acquisitions of interests in Australian land and some acquisitions of interests in Australian corporations. FIRB clearance may be required for such acquisitions (which may or may not be given or may be given subject to conditions). If FIRB clearance is required and not given in relation to a proposed investment, we may not be able to proceed with that investment. There can be no assurance that we will be able to obtain any required FIRB clearances in the future.

*Defined Terms Used in this Section*

*Foreign Persons*

Under Australia's foreign investment regime, it is the responsibility of any person (including, without limitation, nominees and trustees) who is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a natural person not ordinarily resident in Australia;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a corporation in which a natural person not ordinarily resident in Australia, or a corporation incorporated outside of Australia, holds direct or indirect, actual or potential, voting power of 20% or more;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a corporation in which two or more persons, each of whom is either a non-Australian resident or a non-Australian corporation, hold direct or indirect, actual or potential, voting power in aggregate of 40% or more;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a trustee of a trust estate in which a non-Australian resident or non-Australian corporation holds 20% or more of the corpus or income of the trust estate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a trustee of a trust estate in which two or more persons, each of whom is either a non-Australian resident or a non-Australian corporation, hold in aggregate 40% or more of the corpus or income of the trust estate; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a foreign government investor,

to ascertain if they may be required to notify the Australian Treasurer of their investment.

*Associates*

Associate is broadly defined to include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the person's spouse or de facto partner, lineal ancestors and descendants, and siblings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any partner of the person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any corporation of which the person is an officer, any officer of a corporation (where the person is a corporation), employers and employees, any employee of a natural person of whom the person is an employee;

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any corporation whose directors are accustomed or under an obligation, whether formal or informal, to act in accordance with the directions, instructions or wishes of the person or, where the person is a corporation, of the directors of the person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any corporation in accordance with the directions, instructions or wishes of which, or of the directors of which, the person is accustomed or under an obligation, whether formal or informal, to act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any corporation in which the person holds a substantial interest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• where the person is a corporation-a person who holds a substantial interest in the corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the trustee of a trust estate in which the person holds a substantial interest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• where the person is the trustee of a trust estate-a person who holds a substantial interest in the trust estate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any person who is an associate of any other person who is an associate of the person.

*Australian Land Corporation*

An ALC, is a corporation where the value of its total assets comprising interests in Australian land exceeds 50% of the value of its total gross assets. An ALC is not necessarily a company registered in Australia. It may be registered anywhere. It is the composition of the assets of the corporation that will make it an ALC for the purposes of the Australian foreign investment regime.

*Substantial Interest*

A substantial interest is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• control of 20% or more of the actual or potential voting power or issued shares in a target by a single foreign person (together with associates); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• control of 40% or more of the actual or potential voting power or issued shares in a target by multiple foreign persons (together with associates).

*Direct Investment*

Any investment of an interest of 10% or more is considered to be a direct investment. Investments that involve interests below 10% may also be considered direct investments if the acquiring foreign government investor is building a strategic stake in the target, or can use that investment to influence or control the target. In particular, it includes investments of less than 10% which include any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• preferential, special or veto voting rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability to appoint directors or asset managers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• contractual agreements including, but not restricted to, agreements for loans, provision of services and off take agreements; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• building or maintaining a strategic or long-term relationship with a target entity.

*Foreign Government Issuer*

A Foreign Government Investor is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a body politic of a foreign country;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• entities in which governments, their agencies or related entities from a single foreign country have an aggregate interest (direct or indirect) of 20% or more;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• entities in which governments, their agencies or related entities from more than one foreign country have an aggregate interest (direct or indirect) of 40% or more; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• entities that are otherwise controlled by foreign governments, their agencies or related entities, and any associates, or could be controlled by them including as part of a controlling Company.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

At this time, our total assets do not exceed any of the above thresholds and therefore no approval would be required from the Australian Treasurer. Nonetheless, should our total assets exceed the threshold in the future, we will need to be mindful of the number of ordinary shares that can be made available, and monitor the 40% aggregate shareholding threshold for foreign persons (together with their associates) to ensure that it will not be exceeded without an application to the Australian Treasurer's for approval having been contemplated and submitted if considered necessary. Our Constitution does not contain any additional limitations on a nonresident's right to hold or vote our securities.

*National Security Business*

A business is a national security business if it:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• is a responsible entity (within the meaning of the Security of Critical Infrastructure Act 2018 as enacted) for an asset;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• is an entity that is a direct interest holder in relation to a critical infrastructure asset (within the meaning of those terms in the Security of Critical Infrastructure Act 2018 as enacted);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• is a carrier or nominated carriage service provider to which the Telecommunications Act 1997 applies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• develops, manufacturers or supplies critical goods or critical technology that are, or are intended to be, for a military use, or an intelligence use, by defense and intelligence personnel, the defense force of another country, or a foreign intelligence agency;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• provides, or intends to provide, critical services to defense and intelligence personnel, the defense force of another country, or a foreign intelligence agency;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• stores or has access to information that has a security classification;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• stores or maintains personal information of defense and intelligence personnel collected by the Australian Defence Force, the Defence Department or an agency in the national intelligence community which, if accessed, could compromise Australia's national security;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• collects, as part of an arrangement with the Australian Defence Force, the Defence Department or an agency in the national intelligence community, personal information on defence and intelligence personnel which, if disclosed, could compromise Australia's national security; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• stores, maintains or has access to personal information on defense and intelligence personnel which, if disclosed, could compromise Australia's national security.

*National Security Land*

Land is national security land if it is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Defence" premises within the meaning of section 71A of the Defence Act 1903. This includes all land owned or occupied by Defence, including buildings, structures and Defence prohibited areas. The definition excludes subparagraph (a)(iii) of the definition which relates to vehicles, vessels or aircraft; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• land in which an agency in the national intelligence community has an interest, if the existence of the interest is publicly known or could be known upon the making of reasonable inquiries.

**Ownership Threshold**

There are no provisions in our Constitution that require a shareholder to disclose ownership above a certain threshold. Under the Corporations Act, in relation to a company, a person has a "substantial holding" if (i) the total votes attached to voting shares in the company in which they (or their associates) have a relevant interest in is 5 percent or more of the total number of votes attached to voting shares in the company or (ii) the person has made a takeover bid for voting shares in the company and the bid period has started but not yet ended.

A person who:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• begins to have, or ceases to have, a substantial holding in a listed company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• has a substantial holding in a listed company and there is movement by at least 1 percent in their holding; or

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• makes a takeover bid for securities of the listed company, must give notice to the company and to the ASX.

Upon becoming a U.S. public company, our shareholders will also be subject to disclosure requirements under U.S. securities laws.

**Issues of Shares and Change in Capital**

Subject to the Corporations Act, ASX Listing Rules and any rights or restrictions attached to a class of shares, the Company may issue further shares or grant options over shares on any terms, at any time and for any consideration as the Board resolve. Pursuant to the ASX Listing Rules, we may in our discretion issue securities without the approval of shareholders, if such issue of securities, when aggregated with securities issued by us during the previous 12 month period would be an amount that would not exceed 15% of our issued capital at the commencement of the 12 month period. The Company may seek shareholder approval by special resolution at its annual general meeting to increase its capacity to issue equity securities by an additional 10% for the proceeding 12 month period. Issues of securities in excess of this limit or the issue of securities to our related parties require approval of shareholders (unless otherwise permitted under the ASX Listing Rules or unless we have obtained a waiver from the ASX in relation to the 15% limit).

Subject to the requirements of our Constitution, the Corporations Act, the ASX Listing Rules and any other applicable law, including relevant shareholder approvals, we may consolidate or divide our share capital into a larger or smaller number by resolution, reduce our share capital (provided that the reduction is fair and reasonable to our shareholders as a whole and does not materially prejudice our ability to pay creditors) or buy back our Ordinary Shares whether under an equal access buy-back or on a selective basis.

**Member Approval to Significant Changes**

We must not make a significant change (either directly or indirectly) to the nature and scale of our activities except after having disclosed full details to the ASX in accordance with the requirements of the ASX Listing Rules (and, if required by ASX, subject to us obtaining the approval of shareholders in a general meeting). We must not sell or otherwise dispose of the main undertaking of our company without the approval of shareholders in a general meeting. We need not comply with the above obligations if the ASX grants us an applicable waiver to be relieved of our obligations.

**Change of Control**

Takeovers of listed Australian public companies, such as IperionX, are regulated by the Corporations Act, which prohibits the acquisition of a "relevant interest" in issued voting shares in a listed company if the acquisition will lead to that person's or someone else's voting power in IperionX increasing from 20% or below to more than 20% or increasing from a starting point that is above 20% and below 90%, subject to a range of exceptions.

Generally, a person will have a relevant interest in securities if the person:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• is the holder of the securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• has power to exercise, or control the exercise of, a right to vote attached to the securities; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• has the power to dispose of, or control the exercise of a power to dispose of, the securities (including any indirect or direct power or control).

If, at a particular time, a person has a relevant interest in issued securities and the person:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• has entered or enters into an agreement with another person with respect to the securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• has given or gives another person an enforceable right, or has been or is given an enforceable right by another person, in relation to the securities; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• has granted or grants an option to, or has been or is granted an option by, another person with respect to the securities, and the other person would have a relevant interest in the securities if the agreement were performed, the right enforced or the option exercised, the other person is taken to already have a relevant interest in the securities.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

There are a number of exceptions to the above prohibition on acquiring a relevant interest in issued voting shares above 20%. In general terms, some of the more significant exceptions include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when the acquisition results from the acceptance of an offer under a formal takeover bid;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when the acquisition is conducted on market by or on behalf of the bidder under a takeover bid and the acquisition occurs during the bid period;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when shareholders of IperionX approve the takeover by resolution passed at general meeting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an acquisition by a person if, throughout the six months before the acquisition, that person or any other person has had voting power in IperionX of at least 19% and, as a result of the acquisition, none of the relevant persons would have voting power in IperionX more than three percentage points higher than they had six months before the acquisition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• as a result of a rights issue;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• as a result of dividend reinvestment schemes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• as a result of underwriting arrangements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• through operation of law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an acquisition that arises through the acquisition of a relevant interest in another listed company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• arising from an auction of forfeited shares conducted on market; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• arising through a compromise, arrangement, liquidation or buy-back.

Breaches of the takeovers provisions of the Corporations Act are criminal offenses. ASIC and the Australian Takeover Panel have a wide range of powers relating to breaches of takeover provisions, including the ability to make orders cancelling contracts, freezing transfers of, and rights attached to, securities, and forcing a party to dispose of securities. There are certain defenses to breaches of the takeover provisions provided in the Corporations Act.

**Access to and Inspection of Documents**

Inspection of our records is governed by the Corporations Act. Any member of the public has the right to inspect or obtain copies of our registers on the payment of a prescribed fee. Shareholders are not required to pay a fee for inspection of our registers or minute books of the meetings of shareholders. Other corporate records, including minutes of directors' meetings, financial records and other documents, are not open for inspection by shareholders. Where a shareholder is acting in good faith and an inspection is deemed to be made for a proper purpose, a shareholder may apply to the court to make an order for inspection of our books.

**American Depositary Shares**

The Bank of New York Mellon, as depositary, registers and delivers American Depositary Shares, also referred to as ADSs. Each ADS represents 10 shares (or a right to receive 10 shares) deposited with The Hongkong and Shanghai Banking Corporation Limited, as custodian for the depositary in Sydney, Australia. Each ADS also represents any other securities, cash or other property that may be held by the depositary. The deposited shares together with any other securities, cash or other property held by the depositary are referred to as the deposited securities. The depositary's office at which the ADSs are administered and its principal executive office are located at 240 Greenwich Street, New York, New York 10286.

You may hold ADSs either (A) directly (i) by having an American Depositary Receipt, also referred to as an ADR, which is a certificate evidencing a specific number of ADSs, registered in your name, or (ii) by having uncertificated ADSs registered in your name, or (B) indirectly by holding a security entitlement in ADSs through your broker or other financial institution that is a direct or indirect participant in The Depository Trust Company, also called DTC. If you hold ADSs directly, you are a registered ADS holder, also referred to as an ADS holder. This description assumes you are an ADS holder. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are.

Registered holders of uncertificated ADSs receive statements from the depositary confirming their holdings.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

As an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. Australian law governs shareholder rights. The depositary will be the holder of the shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or beneficially holding ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs.

The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of ADR.

**Dividends and Other Distributions**

*How will you receive dividends and other distributions on the shares?*

The depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of shares your ADSs represent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Cash.*** The depositary will convert any cash dividend or other cash distribution we pay on the shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.

Before making a distribution, any withholding taxes, or other governmental charges that must be paid will be deducted. The depositary will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. *If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some of the value of the distribution.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Shares.*** The depositary may distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will sell shares which would require it to deliver a fraction of an ADS (or ADSs representing those shares) and distribute the net proceeds in the same way as it does with cash. If the depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new shares. The depositary may sell a portion of the distributed shares (or ADSs representing those shares) sufficient to pay its fees and expenses in connection with that distribution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Rights to purchase additional shares.*** If we offer holders of our securities any rights to subscribe for additional shares or any other rights, the depositary may (i) exercise those rights on behalf of ADS holders, (ii) distribute those rights to ADS holders or (iii) sell those rights and distribute the net proceeds to ADS holders, in each case after deduction or upon payment of its fees and expenses. To the extent the depositary does not do any of those things, it will allow the rights to lapse. In that case, you will receive no value for them. The depositary will exercise or distribute rights only if we ask it to and provide satisfactory assurances to the depositary that it is legal to do so. If the depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities or, in the case of shares, new ADSs representing the new shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the depositary. U.S. securities laws may restrict the ability of the depositary to distribute rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Other Distributions.*** The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is legal, fair and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Or, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that distribution. The depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution. U.S. securities laws may restrict the ability of the depositary to distribute securities to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. *This means that you may not receive the distributions we make on our shares or any value for them if it is illegal or impractical for us to make them available to you.*

**Deposit, Withdrawal and Cancellation**

*How are ADSs issued?*

The depositary will deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons that made the deposit.

*How can ADS holders withdraw the deposited securities?*

You may surrender your ADSs to the depositary for the purpose of withdrawal. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the shares and any other deposited securities underlying the ADSs to the ADS holder or a person the ADS holder designates at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible. However, the depositary is not required to accept surrender of ADSs to the extent it would require delivery of a fraction of a deposited share or other security. The depositary may charge you a fee and its expenses for instructing the custodian regarding delivery of deposited securities.

*How do ADS holders interchange between certificated ADSs and uncertificated ADSs?*

You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Upon receipt by the depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs.

**Voting Rights**

*How do you vote?*

ADS holders may instruct the depositary how to vote the number of deposited shares their ADSs represent. If we request the depositary to solicit your voting instructions (and we are not required to do so), the depositary will notify you of a shareholders' meeting and send or make voting materials available to you. Those materials will describe the matters to be voted on and explain how ADS holders may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the depositary. The depositary will try, as far as practical, subject to the laws of Australia and the provisions of our constitution or similar documents, to vote or to have its agents vote the shares or other deposited securities as instructed by ADS holders. If we do not request the depositary to solicit your voting instructions, you can still send voting instructions, and, in that case, the depositary may try to vote as you instruct, but it is not required to do so.

*Except by instructing the depositary as described above, you won't be able to exercise voting rights unless you surrender your ADSs and withdraw the shares. However, you may not know about the meeting enough in advance to withdraw the shares.* In any event, the depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt to vote as instructed.

We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote the shares represented by your ADSs. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. *This means that you may not be able to exercise voting rights and there may be nothing you can do if the shares represented by your ADSs are not voted as you requested.*

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to Deposited Securities, if we request the Depositary to act, we agree to give the depositary notice of any such meeting and details concerning the matters to be voted upon at least 30 days in advance of the meeting date.

**Payment of Taxes**

You will be responsible for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of your ADSs. The depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by your ADSs until those taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property, remaining after it has paid the taxes.

**Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities**

The depositary will not tender deposited securities in any voluntary tender or exchange offer unless instructed to do so by an ADS holder surrendering ADSs and subject to any conditions or procedures the depositary may establish.

If deposited securities are redeemed for cash in a transaction that is mandatory for the depositary as a holder of deposited securities, the depositary will call for surrender of a corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs.

If there is any change in the deposited securities such as a sub-division, combination or other reclassification, or any merger, consolidation, recapitalization or reorganization affecting the issuer of deposited securities in which the depositary receives new securities in exchange for or in lieu of the old deposited securities, the depositary will hold those replacement securities as deposited securities under the deposit agreement. However, if the depositary decides it would not be lawful and practical to hold the replacement securities because those securities could not be distributed to ADS holders or for any other reason, the depositary may instead sell the replacement securities and distribute the net proceeds upon surrender of the ADSs.

If there is a replacement of the deposited securities and the depositary will continue to hold the replacement securities, the depositary may distribute new ADSs representing the new deposited securities or ask you to surrender your outstanding ADSs in exchange for new ADSs identifying the new deposited securities.

If there are no deposited securities underlying ADSs, including if the deposited securities are cancelled, or if the deposited securities underlying ADSs have become apparently worthless, the depositary may call for surrender of those ADSs or cancel those ADSs upon notice to the ADS holders.

**Amendment and Termination**

*How may the deposit agreement be amended?*

We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding ADSs until 30 days after the depositary notifies ADS holders of the amendment. *At the time an amendment becomes effective, you are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended.*

*How may the deposit agreement be terminated?*

The depositary will initiate termination of the deposit agreement if we instruct it to do so. The depositary may initiate termination of the deposit agreement if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 60 days have passed since the depositary told us it wants to resign but a successor depositary has not been appointed and accepted its appointment;

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we delist the ADSs from an exchange in the United States on which they were listed and do not list the ADSs on another exchange in the United States or make arrangements for trading of ADSs on the U.S. over-the-counter market;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we delist our shares from an exchange outside the United States on which they were listed and do not list the shares on another exchange outside the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the depositary has reason to believe the ADSs have become, or will become, ineligible for registration on Form F-6 under the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we appear to be insolvent or enter insolvency proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• all or substantially all the value of the deposited securities has been distributed either in cash or in the form of securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• there are no deposited securities underlying the ADSs or the underlying deposited securities have become apparently worthless; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• there has been a replacement of deposited securities.

If the deposit agreement will terminate, the depositary will notify ADS holders at least 90 days before the termination date. At any time after the termination date, the depositary may sell the deposited securities. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, unsegregated and without liability for interest, for the <u>pro</u> <u>rata</u> benefit of the ADS holders that have not surrendered their ADSs. Normally, the depositary will sell as soon as practicable after the termination date.

After the termination date and before the depositary sells, ADS holders can still surrender their ADSs and receive delivery of deposited securities, except that the depositary may refuse to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind that have not settled if it would interfere with the selling process. The depositary may refuse to accept a surrender for the purpose of withdrawing sale proceeds until all the deposited securities have been sold. The depositary will continue to collect distributions on deposited securities, <u>but</u>, after the termination date, the depositary is not required to register any transfer of ADSs or distribute any dividends or other distributions on deposited securities to the ADSs holder (until they surrender their ADSs) or give any notices or perform any other duties under the deposit agreement except as described in this paragraph.

**Limitations on Obligations and Liability**

*Limits on our Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs*

The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the depositary:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith, and the depositary will not be a fiduciary or have any fiduciary duty to holders of ADSs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• are not liable if we are or it is prevented or delayed by law or by events or circumstances beyond our or its ability to prevent or counteract with reasonable care or effort from performing our or its obligations under the deposit agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• are not liable if we or it exercises discretion permitted under the deposit agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• are not liable for the acts or omissions of any securities depository, clearing agency or settlement system; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the depositary has no duty to make any determination or provide any information as to our tax status, or any liability for any tax consequences that may be incurred by ADS holders as a result of owning or holding ADSs

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

or be liable for the inability or failure of an ADS holder to obtain the benefit of a foreign tax credit, reduced rate of withholding or refund of amounts withheld in respect of tax or any other tax benefit.

In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances.

**Requirements for Depositary Actions**

Before the depositary will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of shares, the depositary may require:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.

The depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so.

**Your Right to Receive the Shares Underlying your ADSs**

ADS holders have the right to cancel their ADSs and withdraw the underlying shares at any time except:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when temporary delays arise because: (i) the depositary has closed its transfer books, or we have closed our transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders' meeting; or (iii) we are paying a dividend on our ordinary shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when you owe money to pay fees, taxes and similar charges; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of ordinary shares or other deposited securities.

This right of withdrawal may not be limited by any other provision of the deposit agreement.

**Direct Registration System**

In the deposit agreement, all parties to the deposit agreement acknowledge that the Direct Registration System, also referred to as DRS, and Profile Modification System, also referred to as Profile, will apply to the ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and holding of security entitlements in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of uncertificated ADSs, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register that transfer.

In connection with and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand that the depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery as described in the paragraph above has the actual authority to act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree that the depositary's reliance on and compliance with instructions received by the depositary through the DRS/Profile system and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary.

**Shareholder Communications; Inspection of Register of Holders of ADSs**

The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications or otherwise make those communications available to you if we ask it to. You have a right

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs.

**C.Material Contracts**

There are no contracts, other than those disclosed in this annual report on Form 20-F and those entered into in the ordinary course of our business, that are material to us, and which were entered into in the last two completed fiscal years or which were entered into before the two most recently completed fiscal years but are still in effect as of the date of this annual report on Form 20-F.

**D.Exchange Controls**

Australia has largely abolished exchange controls on investment transactions. The Australian dollar is freely convertible into U.S. dollars or other currencies. In addition, there are currently no specific rules or limitations regarding the export from Australia of profits, dividends, capital or similar funds belonging to foreign investors, except that certain payments to non-residents must be reported to the Australian Cash Transaction Reports Agency, which monitors such transaction, and amounts on account of potential Australian tax liabilities may be required to be withheld unless a relevant taxation treaty can be shown to apply and under such there are either exemptions or limitations on the level of tax to be withheld.

**E.Taxation**

The following is a summary of material U.S. federal and Australian income tax considerations to U.S. Holders, as defined below, of the ownership and disposition of ADSs and ordinary shares. This discussion is based on the laws as of the date of this annual report, and is subject to changes in the relevant income tax law, including changes that could have retroactive effect. The following summary does not take into account or discuss the tax laws of any country or other taxing jurisdiction other than the United States and Australia. Holders are advised to consult their tax advisors concerning the overall tax consequences of the ownership and disposition of ADSs and ordinary shares in their particular circumstances. This discussion is not intended, and should not be construed, as legal or professional tax advice.

This summary does not address the 3.8% U.S. federal Medicare Tax on net investment income, the effects of U.S. federal estate and gift tax laws, the alternative minimum tax, or any state and local tax considerations within the United States, and is not a comprehensive description of all U.S. federal or Australian income tax considerations that may be relevant to a decision to own or dispose of ADSs or ordinary shares. Furthermore, this summary does not address U.S. federal or Australian income tax considerations relevant to holders subject to taxing jurisdictions other than, or in addition to, the United States and Australia, and does not address all possible categories of holders, some of which may be subject to special tax rules.

**Material U.S. Federal Income Tax Considerations**

The following summary, subject to the limitations set forth below, describes the material U.S. federal income tax consequences to a U.S. Holder (as defined below) of the ownership and disposition of our ADSs and ordinary shares as of the date hereof. This summary is limited to U.S. Holders that hold our ADSs or ordinary shares as capital assets within the meaning of Section 1221 of the IRS Code.

This section does not discuss the tax consequences to any particular holder, nor any tax considerations that may apply to U.S. Holders subject to special tax rules, such as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• insurance companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• banks or other financial institutions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• individual retirement and other tax-deferred accounts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• regulated investment companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• real estate investment trusts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• individuals who are former U.S. citizens or former long-term U.S. residents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• brokers, dealers or traders in securities, commodities or currencies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• traders that elect to use a mark-to-market method of accounting;

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• persons holding our ADSs or ordinary shares through a partnership (including an entity or arrangement treated as a partnership for U.S. federal income tax purposes) or S corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• persons that received ADSs or ordinary shares as compensation for the performance of services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• grantor trusts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• tax-exempt entities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• persons that hold ADSs or ordinary shares as a position in a straddle or as part of a hedging, constructive sale, conversion or other integrated transaction for U.S. federal income tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• persons that have a functional currency other than the U.S. dollar;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• persons that own (directly, indirectly or constructively) 10% or more of our equity (by vote or value); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• persons that are not U.S. Holders.

In this section, a "U.S. Holder" means a beneficial owner of ADSs or ordinary shares that is, for U.S. federal income tax purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an individual who is a citizen or resident of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a corporation created or organized in or under the laws of the United States or any state thereof or the District of Columbia;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an estate the income of which is subject to U.S. federal income taxation regardless of its source; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a trust (i) the administration of which is subject to the primary supervision of a court in the United States and for which one or more U.S. persons have the authority to control all substantial decisions or (ii) that has an election in effect under applicable income tax regulations to be treated as a U.S. person for U.S. federal income tax purposes.

In addition, we have not received, nor do we expect to seek a ruling from the U.S. Internal Revenue Service, or the IRS, regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of those set forth below. Each U.S. Holder should consult its tax advisors with respect to the U.S. federal, state and local and non-U.S. tax consequences of owning and disposing of our ADSs and ordinary shares.

If an entity or arrangement treated as a partnership for U.S. federal income tax purposes acquires, owns or disposes of ADSs or ordinary shares, the U.S. federal income tax treatment of a partner in such partnership generally will depend on the status of the partner and the activities of the partnership. Such a partner or partnership should consult its own tax advisor as to the U.S. federal income tax consequences of owning and disposing of our ADSs or ordinary shares.

The discussion below is based upon the provisions of the IRS Code, and the U.S. Treasury regulations, rulings and judicial decisions thereunder as of the date hereof, and such authorities may be replaced, revoked or modified, possibly with retroactive effect, so as to result in U.S. federal income tax consequences different from those discussed below. In addition, this summary is based, in part, upon representations made by the depositary to us and assumes that the deposit agreement, and all other related agreements, will be performed in accordance with their terms.

***You are urged to consult your tax advisor with respect to the U.S. federal, as well as state, local and non-U.S., tax consequences to you of owning and disposing of ADSs or ordinary shares in light of your particular circumstances, including the possible effects of changes in U.S. federal and other tax laws.***

*Ownership of ADSs in General*

In general, for U.S. federal income tax purposes, U.S. Holders of ADSs will be treated as the beneficial owners of the ordinary shares represented by such ADSs. Accordingly, unless explicitly stated otherwise, the discussion below of the material U.S. federal income tax consequences with respect to owning ADSs also applies to owning ordinary shares.

*Passive Foreign Investment Company*

In general, a corporation organized outside the United States will be treated as a PFIC for any taxable year if (i) at least 75% of its gross income for the taxable year consists of certain types of passive income or (ii) at least 50% of its gross

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

assets during the taxable year, based on a quarterly average and generally determined by value, produce or are held for the production of passive income. Passive income for this purpose generally includes, among other things, dividends, interest, rents, royalties, gains from commodities and securities transactions and gains from the disposition of assets that produce or are held for the production of passive income. In determining whether a non-U.S. corporation is a PFIC, a pro-rata portion of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account. Under this rule, we should be deemed to own the assets and to receive the income of our wholly-owned subsidiaries for purposes of the PFIC determination. Additionally, if we are classified as a PFIC in any taxable year with respect to which you own ADSs, we generally will continue to be treated as a PFIC with respect to you in all succeeding taxable years, regardless of whether we continue to meet the tests described above, unless we cease to be a PFIC and you make the "deemed sale election" described below. Furthermore, if we are treated as a PFIC, then one or more of our subsidiaries may also be treated as PFICs.

Although we do not believe that we were a PFIC for the year ended June 30, 2025, our determination depends, in part, on the application of complex U.S. federal income tax rules, which are subject to differing interpretations. Accordingly, the IRS could challenge any determination made by us (or any of our subsidiaries) concerning PFIC status in any taxable year, and a court could sustain such challenge. Additionally, even if we are not a PFIC for a particular taxable year, we could become a PFIC for future years based on changes in our assets or the value thereof, including the value of our goodwill as indicated by our market capitalization, and based on changes in our activities and income. The determination of our PFIC status for any taxable year, however, will not be determinable until after the end of the taxable year, and will depend on, among other things, the composition of our income and assets (which could change significantly during the course of a taxable year) and the market value of our assets for such taxable year, which may be, in part, based on the market price of our ADSs (which may be especially volatile). However, the PFIC rules are complex and in some cases their application can be uncertain. In light of the foregoing, and because we must make a separate determination after the close of each taxable year as to whether we were a PFIC for that year, our PFIC status is subject to substantial uncertainty. Even if we determine that we are not a PFIC for a taxable year, there can be no assurance that the IRS will agree with our conclusion and that the IRS would not successfully challenge our position. Accordingly, we cannot assure you that we will not be a PFIC for our current or any future taxable year. In addition, our U.S. counsel expresses no opinion with respect to our PFIC status for our taxable year ended June 30, 2025, our current taxable year or future taxable years. Therefore, U.S. investors should invest in our ADSs only if they are willing to bear the U.S. federal income tax consequences (described below) of an investment in a PFIC. You should consult your own tax advisor regarding our PFIC status.

*U.S. Federal Income Tax Treatment of a Shareholder of a PFIC*

If we are determined to be a PFIC for any taxable year (or portion thereof) during which you hold ADSs, absent certain elections (including the mark-to-market election or qualified electing fund election described below), you generally will be subject to adverse rules (regardless of whether we continue to be classified as a PFIC) with respect to (1) any "excess distribution" (generally, any distributions you receive on your ADSs in a taxable year that are greater than 125% of the average annual distributions you receive in the three preceding taxable years or, if shorter, your holding period) and (2) any gain recognized from a sale. exchange or other taxable disposition of such ADSs. Under these special tax rules:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the excess distribution or gain will be allocated ratably over your holding period for the ADSs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were classified as a PFIC in your holding period, will be treated as ordinary income arising in the current taxable year (and would not be subject to the interest charge discussed below); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the amount allocated to each other taxable year during your holding period in which we were classified as a PFIC (i) will be subject to income tax at the highest rate in effect for that year and applicable to you and (ii) will be subject to an interest charge generally applicable to underpayments of tax with respect to the resulting tax attributable to each such year.

In addition, if you are a non-corporate U.S. Holder, you will not be eligible for reduced rates of taxation on any dividends that we pay if we are a PFIC for either the taxable year in which the dividend is paid or the preceding year.

If we are determined to be a PFIC for any taxable year during which you hold ADSs, the tax liability for amounts allocated to years prior to the year of disposition or excess distribution cannot be offset by any net operating loss, and gains (but not losses) recognized on the transfer of the ADSs cannot be treated as capital gains, even if the ADSs are held as capital assets. Furthermore, unless otherwise provided by the U.S. Treasury Department, if we are determined to be a PFIC for any taxable year during which you hold ADSs, you will be required to file an annual report (currently Form 8621) describing

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

your interest in us, making an election on how to report PFIC income, and providing other information about your share of our income.

Under certain attribution rules, if we are determined to be a PFIC, you generally will be deemed to own your proportionate share of our direct or indirect equity interest in any company that is also a PFIC (a "Subsidiary PFIC"), and generally will be subject to U.S. federal income tax on your proportionate share of (i) any "excess distributions," as described above, on the stock of a Subsidiary PFIC and (ii) a disposition or deemed disposition of the stock of a Subsidiary PFIC by us or another Subsidiary PFIC, both as if you directly held the shares of such Subsidiary PFIC. In addition, you may be subject to U.S. federal income tax on any indirect gain realized on the stock of a Subsidiary PFIC on the sale, exchange or other taxable disposition of our ADSs. Accordingly, U.S. Holders should be aware that they could be subject to tax under the PFIC rules even if no distributions are received on our ADSs and no redemptions or other dispositions are made. You should consult your tax advisor regarding the tax consequences if the PFIC rules apply to any of our subsidiaries.

If we are classified as a PFIC and then cease to be so classified, you may make an election (a "deemed sale election") to be treated for U.S. federal income tax purposes as having sold your ADSs on the last day of our taxable year during which we were a PFIC. A U.S. Holder that makes a deemed sale election would then cease to be treated as owning stock in a PFIC. However, gain recognized as a result of making the deemed sale election would be subject to the adverse rules described above, and loss would not be recognized.

*"Mark-to-Market" Election, QEF Election and Purging Election*

In certain circumstances, a holder of "marketable stock" of a PFIC can avoid certain of the adverse rules described above by making a mark-to-market election with respect to such stock. For purposes of these rules, "marketable stock" is stock which is "regularly traded" (traded in greater than de minimis quantities on at least 15 days during each calendar quarter) on a "qualified exchange" or other market within the meaning of applicable U.S. Treasury Regulations. A "qualified exchange" includes a national securities exchange that is registered with the SEC. A foreign securities exchange is a "qualified exchange" if (1) it is regulated or supervised by a governmental authority of the country in which the market is located, (2) it satisfies certain trading volume, listing, financial disclosure, surveillance, and other requirements, (3) the laws of the country ensure such requirements described in (2) are met, and (4) the rules of the exchange effectively promote active trading of listed stocks.

If a mark-to-market election is in effect, you generally would include in gross income, as ordinary income, for each taxable year that we are determined to be a PFIC an amount equal to the excess, if any, of the fair market value of your ADSs that are "marketable stock" at the close of the taxable year over your adjusted tax basis in such ADSs. If you make such election, you may also claim a deduction as an ordinary loss in each such year for the excess, if any, of your adjusted tax basis in such ADSs over their fair market value at the end of the year, but only to the extent of the net amount previously included in income as a result of the mark-to-market election. The adjusted tax basis of your ADSs with respect to which the mark-to-market election applies would be adjusted to reflect amounts included in gross income or allowed as a deduction because of such election. If you make an effective mark-to-market election, any gain you recognize upon the sale, exchange or other taxable disposition of your ADSs in a year that we are determined to be a PFIC will be treated as ordinary income and any loss will be treated as ordinary loss, but only to the extent of the net amount previously included in income as a result of the mark-to-market election.

Under current law, the mark-to-market election may be available to U.S. Holders of ADSs if the ADSs remain listed on the Nasdaq, which constitutes a qualified exchange, although there can be no assurance that the ADSs will be "regularly traded" for purposes of the mark-to-market election. While we would expect the Australian Securities Exchange, on which the ordinary shares are listed, to be considered a qualified exchange, no assurance can be given as to whether the Australian Securities Exchange is a qualified exchange, or that the ordinary shares would be traded in sufficient frequency to be considered regularly traded for these purposes. Additionally, because a mark-to-market election cannot be made for equity interests in any lower-tier PFIC that we may own, if we are determined to be a PFIC and you make a mark-to-mark election with respect to us, you may continue to be subject to the PFIC rules with respect to any indirect investments held by us that are treated as an equity interest in a PFIC for U.S. federal income tax purposes.

If a mark-to-market election is in effect, it will be effective for the taxable year for which the election is made and all subsequent taxable years unless the ADSs are no longer regularly traded on a qualified exchange or the IRS consents to the revocation of the election. A mark-to-market election will not apply to our ADSs for any taxable year during which we are not a PFIC, but will remain in effect with respect to any subsequent taxable year in which we become a PFIC. You are

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

urged to consult your tax advisors about the availability of the mark-to-market election, and whether making the election would be advisable in your particular circumstances.

The tax consequences that would apply if we are a PFIC would also be different from those described above if a U.S. Holder were able to obtain certain information from us and elect to treat us as a "qualified electing fund", or QEF, under Section 1295 of the IRS Code. Pursuant to the QEF election, you generally will be required to include in income your pro-rata share of our net capital gains (as long-term capital gain) and other earnings and profits (as ordinary income), on a current basis, in each case whether or not distributed, in the taxable year in which or with which our taxable year ends if we qualified as a PFIC in that taxable year.

A U.S. Holder that does not make a timely QEF election in the first taxable year (or portion thereof) in which we are a PFIC that is included in the holding period of such U.S. Holder may be able to mitigate the adverse PFIC tax consequences by making a QEF election in a subsequent taxable year and simultaneously making a purging election under the PFIC rules. Under one type of purging election, the U.S. Holder will be deemed to have sold its ADSs at their fair market value, and any gain recognized on such deemed sale will be treated in the same manner as an excess distribution, taxed as described above. As a result of this purging election, the U.S. Holder will have additional basis (to the extent of any gain recognized on the deemed sale). U.S. Holders are strongly urged to consult with and rely solely upon their tax advisors regarding the application of the rules governing purging elections to their particular circumstances.

U.S. Holders should be aware that there can be no assurances that we will satisfy the record keeping requirements that apply to a QEF, or that we will supply U.S. Holders with information that such U.S. Holders are required to report under the QEF rules, in the event that we are a PFIC. Thus, U.S. Holders may not be able to make a QEF Election, including a purging election, with respect to their ADSs.

*PFIC Reporting Requirements*

If we are a PFIC, each U.S. Holder would generally be required to file an annual information return on IRS Form 8621 containing such information as the U.S. Treasury Department may require. The failure to file IRS Form 8621 could result in the imposition of penalties and the extension of the statute of limitations with respect to U.S. federal income tax.

The U.S. federal income tax rules relating to PFICs, mark-to-market elections, and QEF elections are very complex and are affected by various factors in addition to those described above. You are strongly urged to consult your own tax advisor with respect to the impact of PFIC status on the purchase, ownership and disposition of our ADSs, the consequences to you of an investment in a PFIC, any elections available with respect to our ADSs and the IRS information reporting obligations with respect to the ownership and disposition of our ADSs.

*Distributions*

We do not currently anticipate paying any distributions on our ADSs or ordinary shares in the foreseeable future. However, to the extent there are any distributions made with respect to our ADSs or ordinary shares in the foreseeable future, and subject to the PFIC rules discussed above, the gross amount of any such distributions (without deduction for any withholding tax) made out of our current or accumulated earnings and profits (as determined for U.S. federal income tax purposes) generally will be taxable to you as ordinary dividend income on the date such distribution is actually or constructively received. Distributions in excess of our current and accumulated earnings and profits, as so determined, will be treated first as a tax-free return of capital to the extent of your adjusted tax basis in the ADSs or ordinary shares, as applicable, and thereafter as capital gain. Notwithstanding the foregoing, we do not intend to maintain calculations of earnings and profits, as determined for U.S. federal income tax purposes. Consequently, you should expect to treat any distributions paid with respect to our ADSs or ordinary shares as dividend income. (See "-*Backup Withholding Tax and Information Reporting Requirements" below).*

If you are a corporate U.S. Holder, dividends paid to you generally will not be eligible for the dividends-received deduction generally allowed under the IRS Code. If you are a non-corporate U.S. Holder, dividends paid to you by a "qualified foreign corporation" may be subject to taxation at a maximum rate of 20% if the dividends are "qualified dividends." Dividends will be treated as qualified dividends if (a) certain holding period requirements are satisfied, (b) we are eligible for benefits under the tax Treaty, or our ADSs or ordinary shares are readily tradable on an established U.S. securities market, and (c) we were not, in the taxable year prior to the year in which the dividend was paid, and are not, in the taxable year in which the dividend is paid, a PFIC (see the discussion above under "*-Passive Foreign Investment Company*"). You

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

are urged to consult your tax advisors regarding the availability of the reduced tax rate on dividends with regard to your particular circumstances.

The amount of any distributions paid in Australian dollars, including any Australian withholding taxes, will be included in your gross income in a U.S. dollar amount calculated by reference to the spot exchange rate in effect on the date of actual or constructive receipt, regardless of whether the Australian dollars are converted into U.S. dollars at that time. If Australian dollars are converted into U.S. dollars on the date of actual or constructive receipt, your tax basis in those Australian dollars generally will be equal to their U.S. dollar value on that date and, as a result, you generally should not be required to recognize any foreign exchange gain or loss.

If Australian dollars so received are not converted into U.S. dollars on the date of receipt, you will have a basis in the Australian dollars equal to their U.S. dollar value on the date of receipt. Any gain or loss on a subsequent conversion or other disposition of the Australian dollars generally will be treated as ordinary income or loss to you and generally will be income or loss from sources within the United States for foreign tax credit limitation purposes.

Dividends you receive with respect to ADSs generally will be treated as foreign source income, which may be relevant in calculating your foreign tax credit limitation. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. For these purposes, dividends generally will be categorized as "passive" income, or in the case of certain U.S. Holders, "general category" income. Subject to certain limitations, you generally will be entitled, at your option, to claim either a credit against your U.S. federal income tax liability or a deduction in computing its U.S. federal taxable income in respect of any Australian taxes withheld. If you elect to claim a deduction, rather than a foreign tax credit, for Australian taxes withheld for a particular taxable year, the election will apply to all foreign taxes paid or accrued by you or on your behalf in the particular taxable year.

The availability of the foreign tax credit and the limitations on its availability are fact-specific and are subject to complex rules. You are urged to consult your tax advisor as to the consequences of Australian withholding taxes and the availability of a foreign tax credit or deduction. See "*Australian Tax Considerations-Taxation of Dividends.*" You should also consult your tax advisor regarding the application of the foreign tax credit rules to the QEF and mark-to-market regimes described above in the event we are a PFIC.

*Sale, Exchange or Other Taxable Disposition of ADSs*

Subject to the discussion above under "-Passive Foreign Investment Company," you will, for U.S. federal income tax purposes, recognize gain or loss on a sale, exchange or other taxable disposition of ADSs in an amount equal to the difference between the amount realized on the sale, exchange or other taxable disposition (determined in the case of sales, exchange or other taxable dispositions in currencies other than U.S. dollars by reference to the spot exchange rate in effect on the date of the sale, exchange or, other taxable disposition or, in the case of a sale, exchange or other taxable disposition on an established securities market by a cash basis taxpayer or an electing accrual basis taxpayer, the spot exchange rate in effect on the settlement date) and your adjusted tax basis (as determined in U.S. dollars) in the ADSs. Your initial tax basis will be your U.S. dollar purchase price for such ADSs.

Such gain or loss generally will be capital gain or loss. Capital gains of a non-corporate U.S. Holder, including an individual, which has held the ADSs for more than one year are currently eligible for reduced tax rates. For foreign tax credit limitation purposes, gain or loss recognized upon a disposition generally will be treated as from sources within the United States. However, in limited circumstances, the Treaty can re-source U.S. source income as Australian source income. The deductibility of capital losses is subject to limitations for U.S. federal income tax purposes.

You should consult your own tax advisor regarding the availability of a foreign tax credit or deduction in respect of any Australian tax imposed on a sale, exchange or other taxable disposition of ADSs. See "*Australian Tax Considerations-Tax on Sales or other Dispositions of Shares.*"

*Backup Withholding Tax and Information Reporting Requirements*

Payments of dividends with respect to the ADSs and proceeds from the sale, exchange or other taxable disposition of the ADSs, by a U.S. paying agent or other U.S. intermediary, or made into the United States, will be reported to the IRS and to you as may be required under applicable Treasury regulations. Backup withholding may apply to these payments if you fail to provide an accurate taxpayer identification number or certification of exempt status or otherwise fail to comply with applicable certification requirements. Certain U.S. Holders (including, among others, corporations) are not subject to

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

backup withholding and information reporting. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to you will be refunded (or credited against your U.S. federal income tax liability, if any), provided the required information is timely furnished to the IRS. Prospective investors should consult their own tax advisors as to their qualification for exemption from backup withholding and the procedure for establishing an exemption.

Certain individual U.S. Holders (and under Treasury regulations, certain entities) may be required to report to the IRS (on Form 8938) information with respect to their investment in the ADSs not held through an account with a U.S. financial institution. You are urged to consult with your tax advisor regarding the reporting obligations that may arise from the ownership or disposition of our ADSs.

The discussion above is not intended to constitute a complete analysis of all tax considerations applicable to an investment in ADSs. You should consult with your tax advisor concerning the tax consequences to you in your particular situation.

**Australian Tax Considerations**

In this section, we discuss the material Australian income tax, stamp duty and goods and services tax considerations related to the ownership and disposal by the absolute beneficial owners of the ADSs.

It is based upon existing Australian tax law as of the date of this annual report, which is subject to change, possibly retrospectively. This discussion does not address all aspects of Australian tax law which may be important to particular investors in light of their individual investment circumstances, such as shares held by investors subject to special tax rules (for example, financial institutions, insurance companies or tax exempt organizations). In addition, this summary does not discuss any foreign or state tax considerations, other than stamp duty and goods and services tax.

Prospective investors are urged to consult their tax advisors regarding the Australian and foreign income and other tax considerations of the ownership and disposition of the shares. As used in this summary a "Non-Australian Shareholder" is a holder that is not an Australian tax resident and is not carrying on business in Australia through a permanent establishment.

*Taxation of Dividends*

Australia operates a dividend imputation system under which dividends may be declared to be "franked" to the extent of tax paid on company profits. Fully franked dividends are not subject to dividend withholding tax. An exemption for dividend withholding tax can also apply to unfranked dividends that are declared to be conduit foreign income, or CFI, and paid to Non-Australian Shareholders. Dividend withholding tax will be imposed at 30%, unless a shareholder is a resident of a country with which Australia has a double taxation agreement and qualifies for the benefits of the Treaty. Under the provisions of the current Treaty, the Australian tax withheld on unfranked dividends that are not declared to be CFI paid by us to a resident of the United States which is beneficially entitled to that dividend is limited to 15% where that resident is a qualified person for the purposes of the Treaty.

If a Non-Australian Shareholder is a company and owns a 10% or more interest, the Australian tax withheld on dividends paid by us to which a resident of the United States is beneficially entitled is limited to 5%. In limited circumstances the rate of withholding can be reduced to zero.

*Tax on Sales or other Dispositions of Shares-Capital gains tax*

Non-Australian Shareholders will not be subject to Australian capital gains tax on the gain made on a sale or other disposal of ADSs, unless they, together with associates, hold 10% or more of our issued capital, at the time of disposal or for 12 months of the last 2 years prior to disposal.

Non-Australian Shareholders who own a 10% or more interest would be subject to Australian capital gains tax if more than 50% of our direct or indirect assets, determined by reference to market value, consists of Australian land, leasehold interests or Australian extraction, quarrying or prospecting rights. The Treaty is unlikely to limit Australia's right to tax any gain in these circumstances. Net capital gains are calculated after reduction for capital losses, which may only be offset against capital gains.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*Tax on Sales or other Dispositions of Shares-Shareholders Holding Shares on Revenue Account*

Some Non-Australian Shareholders may hold shares on revenue rather than on capital account for example, share traders. These shareholders may have the gains made on the sale or other disposal of the shares included in their assessable income under the ordinary income taxing provisions of the income tax law, if the gains are sourced in Australia.

Non-Australian Shareholders assessable under these ordinary income provisions in respect of gains made on shares held on revenue account would be assessed for such gains at the Australian tax rates for non-Australian residents, which start at a marginal rate of 32.5%. This rate does not include the Temporary Budget Repair Levy of 2% that applies in certain circumstances. Some relief from Australian income tax may be available to Non-Australian Shareholders under the Treaty. Non-Australian Shareholders that are companies will be assessed at a rate of 30%.

To the extent an amount would be included in a Non-Australian Shareholder's assessable income under both the capital gains tax provisions and the ordinary income provisions, the capital gain amount would generally be reduced, so that the shareholder would not be subject to double tax on any part of the income gain or capital gain.

*Dual Residency*

If a shareholder is a resident of both Australia and the United States under those countries' domestic taxation laws, that shareholder may be subject to tax as an Australian resident. If, however, the shareholder is determined to be a U.S. resident for the purposes of the Treaty, the Australian tax would be subject to limitation by the Treaty. Shareholders should obtain specialist taxation advice in these circumstances.

*Stamp Duty*

No stamp duty is payable by Australian residents or non-Australian residents on the issue and trading of shares that are quoted on the ASX or Nasdaq at all relevant times and the shares do not represent 90% or more of all of our issued shares.

*Australian Death Duty*

Australia does not have estate or death duties. As a general rule, no capital gains tax liability is realized upon the inheritance of a deceased person's shares. The disposal of inherited shares by beneficiaries may, however, give rise to a capital gains tax liability if the gain falls within the scope of Australia's jurisdiction to tax.

*Goods and Services Tax*

The issue or transfer of shares to a non-Australian resident investor will not incur Australian goods and services tax.

**F.Dividends and Paying Agents**

Not applicable.

**G.Statement by Experts**

Not applicable.

**H.Documents on Display**

We are subject to the information reporting requirements of the Exchange Act applicable to foreign private issuers and under those requirements file reports with the SEC. You may read and copy the annual report on Form 20-F, including the related exhibits and schedules, and any document we file with the SEC without charge at the SEC's public reference room at 100 F Street, N.E., Room 1580, Washington, DC 20549. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Room 1580, Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. The SEC also maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings with the SEC will also be available to the public through the SEC's website at www.sec.gov.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act. However, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm, and may submit to the SEC, on a Form 6-K, unaudited quarterly financial information.

In addition, since our ordinary shares are traded on the ASX, we have filed annual and semi-annual reports with, and furnish information to, the ASX, as required under the ASX Listing Rules and the Corporations Act. Copies of our filings with the ASX can be retrieved electronically at www.asx.com.au under our symbol "IPX". We also maintain a web site at www.iperionx.com. The information contained on our website or available through our website is not incorporated by reference into and should not be considered a part of this annual report on Form 20-F, and the reference to our website in this annual report on Form 20-F is an inactive textual reference only.

**I.Subsidiary Information.**

Not applicable.

**J.Annual Report to Security Holders.**

Not applicable.

**ITEM 11.&nbsp;&nbsp;&nbsp;&nbsp;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Our principal financial instruments comprise cash, receivables, other financial assets, payables, loans and borrowings, and lease liabilities. The main risks arising from the Company's financial instruments are interest rate risk, foreign currency risk, credit risk and liquidity risk.

We manage our exposure to key financial risks in accordance with our financial risk management policy. Key risks are monitored and reviewed as circumstances change (e.g., acquisition of a new project) and policies are revised as required. The overall objective of our financial risk management policy is to support the delivery of our financial targets while protecting future financial security.

Given the nature and size of the business and uncertainty as to the timing and amount of cash inflows and outflows, we do not enter into derivative transactions to mitigate the financial risks. In addition, our policy is that no trading in financial instruments shall be undertaken for the purposes of making speculative gains. As our operations change going forward, we expect that our Board will review this policy periodically.

Our Board has overall responsibility for the establishment and oversight of the risk management framework. The Board reviews and agrees policies for managing our financial risks as summarized below. For additional information about our financial risk management objectives and policies, see Note 21 to our audited consolidated financial statements for fiscal 2025, included in this annual report.

**Interest Rate Risk**

Our exposure to the risk of changes in market interest rates relates primarily to the cash and short-term deposits with a floating interest rate. These financial assets with variable rates expose us to cash flow interest rate risk. All other financial assets and liabilities are either non-interest bearing (for example, receivables and payables) or have fixed interest rates (for example, lease liabilities, sub-lease receivables, and loans and borrowings).

Our cash at bank and on hand and short-term deposits had a weighted average floating interest rate at June 30, 2025 of 3.48% (2024: 4.16%).

We currently do not engage in any hedging or derivative transactions to manage interest rate risk.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**Foreign Currency Risk**

Foreign currency risk is the risk that the fair value of future cash outflows will fluctuate because of changes in foreign currency exchange rates.

Our exposure to the risk of changes in foreign exchange rate relates primarily to assets and liabilities that are denominated in currencies other than U.S. dollars. We also have transactional currency exposures relating to transactions denominated in currencies other than U.S. dollars. The currency in which these transactions primarily are denominated is Australian dollars.

It is our policy not to enter into any hedging or derivative transactions to manage foreign currency risk.

**Credit Risk**

Credit risk is the risk of financial loss to us if a customer or counterparty to a financial instrument fails to meet its contractual obligations. This arises principally from cash and cash equivalents, receivables, and other financial assets.

We did not have significant concentrations of credit risk as of June 30, 2025. With respect to credit risk arising from cash and cash equivalents, our exposure arises from default of the counter party, with a maximum exposure equal to the carrying amount of these instruments.

Trade and other receivables comprise primarily deposits, accrued interest and goods and services tax refunds due. Where possible we trade only with recognized, creditworthy third parties. It is our policy that all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivable balances are monitored on an ongoing basis with the result that our exposure to bad debts is not significant. There were no past due receivables at the date of this report.

**Liquidity Risk**

Liquidity risk is the risk that we will not be able to meet our financial obligations as they fall due. The Board's approach to managing liquidity is to ensure, as far as possible, that we will have sufficient liquidity to meet our liabilities when due. At June 30, 2025, we determined that we had sufficient liquid assets to meet our financial obligations.

**ITEM 12.&nbsp;&nbsp;&nbsp;&nbsp;DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES**

**A.Debt Securities.**

Not applicable.

**B.Warrants and rights.**

Not applicable.

**C.Other Securities.**

Not applicable.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**D.American Depositary Shares**

**Fees and Expenses**

---

| | |
|:---|:---|
| **Persons depositing or withdrawing ordinary shares or ADS holders must pay the depositary:** | **For:** |
| US$5.00 (or less) per 100 ADSs (or portion of 100 ADSs) | • Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property |
|  | • Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates |
| US$0.05 (or less) per ADS | • Any cash distribution to ADS holders |
| A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs | • Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders |
| US$0.05 (or less) per ADS per calendar year | • Depositary services |
| Registration or transfer fees | • Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares |
| Expenses of the depositary | • Cable (including SWIFT) and facsimile transmissions (when expressly provided in the deposit agreement) |
|  | • Converting foreign currency to U.S. dollars |
| Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes | • As necessary |
| Any charges incurred by the depositary or its agents for servicing the deposited securities | • As necessary |

---

The depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The depositary may collect any of its fees by deduction from any cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those services are paid.

From time to time, the depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance of the ADS program, waive fees and expenses for services provided to us by the depositary or share revenue from the fees collected from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers, dealers, foreign currency dealers or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads or commissions.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

The depositary may convert currency itself or through any of its affiliates, or the custodian or we may convert currency and pay U.S. dollars to the depositary. Where the depositary converts currency itself or through any of its affiliates, the depositary acts as principal for its own account and not as agent, advisor, broker or fiduciary on behalf of any other person and earns revenue, including, without limitation, transaction spreads, that it will retain for its own account. The revenue is based on, among other things, the difference between the exchange rate assigned to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying or selling foreign currency for its own account. The depositary makes no representation that the exchange rate used or obtained by it or its affiliate in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the time or that the method by which that rate will be determined will be the most favorable to ADS holders, subject to the depositary's obligation to act without negligence or bad faith. The methodology used to determine exchange rates used in currency conversions made by the depositary is available upon request. Where the custodian converts currency, the custodian has no obligation to obtain the most favorable rate that could be obtained at the time or to ensure that the method by which that rate will be determined will be the most favorable to ADS holders, and the depositary makes no representation that the rate is the most favorable rate and will not be liable for any direct or indirect losses associated with the rate. In certain instances, the depositary may receive dividends or other distributions from us in U.S. dollars that represent the proceeds of a conversion of foreign currency or translation from foreign currency at a rate that was obtained or determined by us and, in such cases, the depositary will not engage in, or be responsible for, any foreign currency transactions and neither it nor we make any representation that the rate obtained or determined by us is the most favorable rate and neither it nor we will be liable for any direct or indirect losses associated with the rate.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**PART II.**

**ITEM 13.&nbsp;&nbsp;&nbsp;&nbsp;DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES**

None.

**ITEM 14.&nbsp;&nbsp;&nbsp;&nbsp;MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS**

None.

**ITEM 15.&nbsp;&nbsp;&nbsp;&nbsp;CONTROLS AND PROCEDURES**

**Disclosure Controls and Procedures**

Our management, with the participation of our chief executive officer and our chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2025. "Disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to the company's management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based on evaluation of our disclosure controls and procedures, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of June 30, 2025, our disclosure controls and procedures were effective. Our Chief Executive Officer and Chief Financial Officer have concluded that the consolidated financial statements included elsewhere in this Annual Report fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented.

As disclosed in our previously filed annual reports on Form 20-F, the Company has in the past identified certain control deficiencies in the design and implementation of our internal control over financial reporting that constituted material weaknesses. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis. Our evaluation was based on the Committee of Sponsoring Organizations of the Treadway Commission Internal Control-Integrated Framework (2013).

The material weaknesses previously identified by management relate to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We have not sufficiently designed, implemented and documented internal controls at the entity level and across the key business and financial processes to allow us to achieve complete, accurate and timely financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We have not designed and implemented controls to maintain appropriate segregation of duties in our manual and IT based business processes.

To address the prior identified material weaknesses, in the fiscal year ended June 30, 2025, we implemented a remediation plan. The remediation plan included, but was not limited to the following measures:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• establishing effective monitoring and oversight controls for recurring, non-recurring and complex transactions to ensure the accuracy and completeness of our company's consolidated financial statements and related disclosures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• implementing formal processes and controls to identify, monitor and mitigate segregation of duties conflicts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• improving our IT systems and monitoring of the IT function; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expanded our accounting, reporting, and finance personnel resources and technical accounting and reporting expertise through both direct hires and outsource professionals to remediate material weaknesses in segregation of duties in manual and IT based processes and in internal control over financial reporting.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

As a result of these efforts, as of June 30, 2025, the material weaknesses related to ineffective IT general controls, and segregation of duties in our manual and IT based business processes, which were first identified in our Form 20-F for the year ended June 30, 2022 (2022 Form 20-F) have been remediated. The actions that were taken were subject to review by our executive management and are subject to the oversight of our Audit Committee.

**Management's Report on Internal Control over Financial Reporting**

Our management, including our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, as defined under Exchange Act Rules 13a-15(f) and 15d-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with IFRS as issued by the IASB. Internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS as issued by the IASB, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

Our Chief Executive Officer and Chief Financial Officer assessed the effectiveness of our internal control over financial reporting as of the end of the period covered by this Annual Report based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management's assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of our internal control over financial reporting. Based on that assessment, our Chief Executive Officer and Chief Financial Officer concluded that as of June 30, 2025, our internal control over financial reporting was effective.

**Attestation Report of the Registered Public Accounting Firm**

PricewaterhouseCoopers, our independent registered public accounting firm, has audited the consolidated financial statements of IperionX Limited as of and for the year ended June 30, 2025, included herein, and has issued an audit report on our internal control over financial reporting, which is included elsewhere in this Form 20-F.

**Changes in Internal Control over Financial Reporting**

During fiscal 2025, management updated procedures described in "Controls and Procedures" above. Following the implementation of these remedial actions, management has determined that the remedial actions implemented during the year were successful and, as of June 30, 2025, these material weaknesses have been remediated.

**ITEM 16.&nbsp;&nbsp;&nbsp;&nbsp;[RESERVED]**

**ITEM 16A.&nbsp;&nbsp;&nbsp;&nbsp;AUDIT COMMITTEE FINANCIAL EXPERT**

Our board of directors has determined that Mr. Tony Tripeny is an audit committee financial expert and is independent under the listing standards of the Nasdaq Capital Market for audit committee members and the heightened independence requirement for audit committee members required by Rule 10A-3 under the Exchange Act.

**ITEM 16B.&nbsp;&nbsp;&nbsp;&nbsp;CODE OF ETHICS**

We have adopted a code of conduct that applies to our directors, officers, employees and contractors (collectively called the employees) of the Company. The code of conduct is publicly available under the "Company Overview" section of our website at www.iperionx.com. Written copies are available upon request. If we make any substantive amendment to the code of conduct or grant any waivers, including any implicit waiver, from a provision of the codes of conduct, we will disclose the nature of such amendment or waiver on our website.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**ITEM 16C.&nbsp;&nbsp;&nbsp;&nbsp;PRINCIPAL ACCOUNTANT FEES AND SERVICES**

The following table sets forth, for each of the years indicated, the fees billed by PricewaterhouseCoopers, which has served as our independent registered public accounting firm for the last three completed fiscal years.

---

| | | | |
|:---|:---|:---|:---|
| **Services Rendered** | **Fiscal 2025<br>US$** | **Fiscal 2024<br>US$** | **Fiscal 2023<br>US$** |
| &nbsp;&nbsp;Audit or review of financial reports | 400000 | 270955 | 386587 |
| &nbsp;&nbsp;Other | - | - | - |
| Total | 400000 | 270955 | 386587 |

---

**Pre-Approval Policies and Procedures**

Our Audit Committee has adopted policies and procedures for the pre-approval of audit and non-audit services rendered by our independent registered public accounting firm. Pre-approval of an audit or non-audit service may be given as a general pre-approval, as part of the audit committee's approval of the scope of the engagement of our independent registered public accounting firm, or on an individual basis. Any proposed services exceeding general pre-approved levels also requires specific pre-approval by our audit committee. All of the fees described above were pre-approved by our board of directors prior to our listing on Nasdaq and by the Audit Committee after our listing on Nasdaq.

**ITEM 16D.&nbsp;&nbsp;&nbsp;&nbsp;EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES**

Not applicable.

**ITEM 16E.&nbsp;&nbsp;&nbsp;&nbsp;PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS**

Neither we, nor any affiliated purchaser of us, purchased any of our securities during the year ended June 30, 2025.

**ITEM 16F.&nbsp;&nbsp;&nbsp;&nbsp;CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT**

None.

**ITEM 16G.&nbsp;&nbsp;&nbsp;&nbsp;CORPORATE GOVERNANCE**

***Additional Corporate Governance Differences***

The Nasdaq Capital Market allows a foreign private issuer, such as IperionX, to follow its home country practices in lieu of certain of Nasdaq's corporate governance standards. In particular, we follow home country law instead of Nasdaq practice regarding:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that an issuer provide for a quorum as specified in its bylaws for any meeting of the holders of ordinary shares, which quorum may not be less than 33 1/3% of the outstanding shares of an issuer's voting ordinary shares. In compliance with Australian law, our Constitution provides that two shareholders present shall constitute a quorum for a general meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nasdaq's requirement that issuers obtain shareholder approval prior to the issuance of securities in connection with certain acquisitions, changes of control or private placements of securities, or the establishment or amendment of certain stock option, purchase or other compensation plans. Applicable Australian law and rules differ from Nasdaq requirements, with the ASX Listing Rules providing generally for prior shareholder approval in numerous circumstances, including (i) issuance of equity securities exceeding 15% (or an additional 10% capacity to issue equity securities for the proceeding 12-month period if shareholder approval by special resolution is sought at the Company's annual general meeting) of our issued share capital in any 12-month period (but, in determining the available issue limit, securities issued under an exception to the rule or with shareholder approval are not counted), (ii) issuance of equity securities to related parties (as defined in the ASX Listing Rules) and (iii) directors or their associates acquiring securities under an employee incentive plan.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Following our home country governance practices, as opposed to the requirements that would otherwise apply to a United States company listed on the Nasdaq Capital Market, may provide less protection than is accorded to investors in a U.S. issuer.

**ITEM 16H.&nbsp;&nbsp;&nbsp;&nbsp;MINE SAFETY DISCLOSURE**

Not applicable because we do not currently operate any mines subject to the U.S. Federal Mine Safety and Health Act of 1977.

**ITEM 16J.&nbsp;&nbsp;&nbsp;&nbsp;INSIDER TRADING POLICIES**

Our Securities Trading Policy governs purchases, sales and other dispositions of our securities by our directors, executive officers and employees. We believe our Securities Trading Policy is reasonably designed to promote compliance with applicable insider trading laws, rules and regulations. Our Securities Trading Policy prohibits purchases, sales and other dispositions of our securities while in possession of material nonpublic information about us and from disclosing such information to others. The foregoing summary does not purport to be complete and is qualified in its entirety by our Securities Trading Policy, a copy of which is filed as exhibit 11.1 to this annual report.

**ITEM16K.&nbsp;&nbsp;&nbsp;&nbsp;CYBERSECURITY**

As part of our risk management approach, our cyber security program includes monitoring and implementing various protective systems and incident reporting procedures. We engage managed service providers under strict oversight from our internal IT team to ensure alignment with organization standards and security protocols.

Within the last 12 months, we have not identified risks from known cybersecurity threats, including as a result of any previous cybersecurity incidents, that have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition.

Our audit committee is responsible for oversight of risks, including risks from cybersecurity threats. The Company's executive officers oversee the overall processes to safeguard data and comply with relevant regulations and will report material cybersecurity incidents to the audit committee. The Company possesses internal IT resources to manage and remediate cybersecurity risks, and the internal team will engage external advisors when deemed necessary.

**PART III.**

**ITEM 17.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL STATEMENTS**

We have elected to provide financial statements and related information pursuant to Item 18.

**ITEM 18.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL STATEMENTS**

The consolidated financial statements and the related notes required by this Item are included in this annual report on Form 20-F beginning on page <u>[F-1](#i760a975fe85d4d298949348d23ef9dde_250)</u>.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**ITEM 19.&nbsp;&nbsp;&nbsp;&nbsp;EXHIBITS.**

---

| | |
|:---|:---|
| **Exhibit<br>Number** | **Description** |
| <u>[1.1](https://www.sec.gov/Archives/edgar/data/1898601/000114036122011504/ny20002380x3_ex1-1.htm)</u> | Certificate of the Registration of IperionX Limited (formerly Hyperion Metals Limited) (incorporated by reference to Exhibit 1.1 to the Company's Registration Statement on Form 20-F, filed on March 29, 2023) |
| <u>[1.2](https://www.sec.gov/Archives/edgar/data/1898601/000114036122011504/ny20002380x3_ex1-2.htm)</u> | Constitution of IperionX Limited (formerly Hyperion Metals Limited) (incorporated by reference to Exhibit 1.2 to the Company's Registration Statement on Form 20-F, filed on March 29, 2023) |
| <u>[2.1](https://www.sec.gov/Archives/edgar/data/1898601/000114036122017611/ny20002380x5_ex2-1.htm)</u> | Deposit Agreement among IperionX Limited, The Bank of New York Mellon, and Owners and Holders of American Depositary Shares (incorporated by reference to Exhibit 2.1 to the Company's Amendment No. 1 to Registration Statement on Form 20-F, filed on May 4, 2022) |
| <u>[2.2](https://www.sec.gov/Archives/edgar/data/1898601/000114036122017611/ny20002380x5_ex2-1.htm)</u> | Form of American Depositary Receipt evidencing American Depositary Shares (included in Exhibit 2.1) |
| <u>[2.3](https://www.sec.gov/Archives/edgar/data/1898601/000114036122030925/brhc10040858_ex2-3.htm)</u> | Description of Share Capital (incorporated by reference to Exhibit 2.3 to the Company's Annual Report on Form 20-F, filed on August 26, 2022) |
| <u>[4.1](https://www.sec.gov/Archives/edgar/data/1898601/000114036122011504/ny20002380x3_ex4-4.htm)</u> | IperionX Limited (formerly Hyperion Metals Limited) Employee Incentive Plan (incorporated by reference to Exhibit 4.4 to the Company's Registration Statement on Form 20-F, filed on March 29, 2023) |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1898601/000114036122011504/ny20002380x3_ex4-5.htm)</u> | Form of Indemnity, Insurance and Access for Directors (incorporated by reference to Exhibit 4.5 to the Company's Registration Statement on Form 20-F, filed on March 29, 2022) |
| <u>[8.1\*](ex81-subsidiaries.htm)</u> | List of Subsidiaries of IperionX Limited |
| <u>[11.1](https://www.sec.gov/Archives/edgar/data/1898601/000114036124027216/ef20029858_ex99-1.htm)</u> | Securities Trading Policy (incorporated by reference to Exhibit 99.1 to the Company's Report on Form 6-K, filed on May 23, 2024) |
| <u>[12.1\*](ipx-20250630xex121.htm)</u> | Section 302 Certification of Chief Executive Officer |
| <u>[12.2\*](ipx-20250630xex122.htm)</u> | Section 302 Certification of Chief Financial Officer |
| <u>[13.1\*](ipx-20250630xex131.htm)</u> | Section 906 Certification of Chief Executive Officer |
| <u>[13.2\*](ipx-20250630xex132.htm)</u> | Section 906 Certification of Chief Financial Officer |
| <u>[15.1](https://www.sec.gov/Archives/edgar/data/1898601/000114036124044628/ef20031102_ex15-1.htm)</u> | Technical Report Summary on the Titan Project, dated June 30, 2024 (incorporated by reference to Exhibit 15.1 to the Company's Annual Report on Form 20-F, filed on October 30, 2024) |
| <u>[15.2\*](ex152-auditorconsent.htm)</u>  | Consent of PricewaterhouseCoopers |
| <u>[15.3\*](ex153-qpconsent.htm)</u> | Consent of Karst Geo Solutions, LLC as Qualified Person |
| <u>[97.1](https://www.sec.gov/Archives/edgar/data/1898601/000114036124044628/ef20031102_ex97-1.htm)</u> | Clawback Policy (incorporated by reference to Exhibit 97.1 to the Company's Annual Report on Form 20-F, filed on October 30, 2024) |
| 101.1 | The following financial statements from the Company's Annual Report on Form 20-F for the year ended June 30, 2025, formatted in Inline XBRL: (i) Consolidated Statements of Profit or Loss and Other Comprehensive Income, (ii) Consolidated Statement of Financial Position, (iii) Consolidated Statements of Changes in Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

\* Filed herewith.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**SIGNATURES**

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on Form 20-F filed on its behalf.

---

| | | |
|:---|:---|:---|
| | **IPERIONX LIMITED** | **IPERIONX LIMITED** |
| | By: | /s/ Marcela Castro |
| | | Marcela Castro |
| | | Chief Financial Officer |
| Date: October 14, 2025 |  |  |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**IperionX Limited**

**ANNUAL CONSOLIDATED FINANCIAL STATEMENTS**

**for the year ended June 30, 2025**

---

| | |
|:---|:---|
| | **PAGE** |
| <u>[REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM](#i760a975fe85d4d298949348d23ef9dde_253)</u> (PCAOB ID: 1379) | F-[2](#i760a975fe85d4d298949348d23ef9dde_253) |
| <u>[FINANCIAL STATEMENTS](#i760a975fe85d4d298949348d23ef9dde_256)</u> |  |
| &nbsp;&nbsp;<u>[CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME](#i760a975fe85d4d298949348d23ef9dde_259)</u> | F-[4](#i760a975fe85d4d298949348d23ef9dde_259) |
| &nbsp;&nbsp;<u>[CONSOLIDATED STATEMENT OF FINANCIAL POSITION](#i760a975fe85d4d298949348d23ef9dde_262)</u> | F-[5](#i760a975fe85d4d298949348d23ef9dde_262) |
| &nbsp;&nbsp;<u>[CONSOLIDATED STATEMENT OF CHANGES IN EQUITY](#i760a975fe85d4d298949348d23ef9dde_265)</u> | F-[6](#i760a975fe85d4d298949348d23ef9dde_265) |
| &nbsp;&nbsp;<u>[CONSOLIDATED STATEMENT OF CASH FLOWS](#i760a975fe85d4d298949348d23ef9dde_268)</u> | F-[7](#i760a975fe85d4d298949348d23ef9dde_268) |
| &nbsp;&nbsp;<u>[NOTES TO AND FORMING PART OF THE CONSOLIDATED FINANCIAL STATEMENTS](#i760a975fe85d4d298949348d23ef9dde_271)</u> | F-[8](#i760a975fe85d4d298949348d23ef9dde_271) |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**IperionX Limited**

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the Board of Directors and Shareholders of IperionX Limited

***Opinion on the Financial Statements***

We have audited the accompanying consolidated statement of financial position of IperionX Limited and its subsidiaries (the "Company") as of June 30, 2025 and 2024, and the related consolidated statements of profit or loss and other comprehensive income, of changes in equity and of cash flows for each of the three years in the period ended June 30, 2025, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of June 30, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2025 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board (IFRS). Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 30, 2025, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

***Basis for Opinion***

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under Item 15. Our responsibility is to express opinions on the Company's consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

***Definition and Limitations of Internal Control over Financial Reporting***

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

***Critical Audit Matters***

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

*Valuation of share-based payments*

As described in Notes 1(y) and 19 to the consolidated financial statements, the Company recognized share-based payment expenses of $9.6 million for the year ended June 30, 2025. The share-based payments are measured by management at fair value using valuation models that involved the use of significant assumptions including risk-free interest rate and share price volatility.

The principal considerations for our determination that performing procedures relating to the valuation of share-based payments is a critical audit matter are (i) the significant judgment by management, including the use of management's specialist, in determining the fair value of the share-based payments; (ii) a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating audit evidence related to management's (a) valuation models and (b) significant assumptions related to risk-free interest rate and share price volatility; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of share-based payments, including controls over the valuation models, significant assumptions, and underlying data. These procedures also included, among others (i) testing management's process for determining the fair value of the share-based payments; (ii) testing the completeness and accuracy of the underlying data used in the estimate; (iii) evaluating the work of management's specialist involved in the determination of significant judgments and assumptions; (iv) the involvement of professionals with specialized skill and knowledge to assist in evaluating the appropriateness of management's valuation models and reasonableness of certain significant assumptions; and (v) evaluating the disclosures made regarding the share-based payment expenses recognized in the consolidated financial statements against the requirements of IFRS.

<u>/s/</u> <u>PricewaterhouseCoopers</u>

Perth, Australia

October 14, 2025

We have served as the Company's auditor since 2021.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**IperionX Limited**

**CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME** 

FOR THE YEAR ENDED JUNE 30,

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| **Continuing operations** |  |  |  |  |
| &nbsp;&nbsp;Research and development costs | 2 | **(12748973)** | (8712610) | (5600653) |
| &nbsp;&nbsp;Exploration and evaluation expenses |  | **(2894369)** | (1950583) | (2826397) |
| &nbsp;&nbsp;Corporate and administrative expenses | 2 | **(10686376)** | (4516393) | (3990672) |
| &nbsp;&nbsp;Business development expenses |  | **(3373992)** | (3646141) | (2654420) |
| &nbsp;&nbsp;Share-based payment expenses | 19(a) | **(9568191)** | (3791541) | (2589413) |
| &nbsp;&nbsp;Finance income | 2 | **3550633** | 546029 | 494469 |
| &nbsp;&nbsp;Finance costs | 2 | **(306250)** | (187119) | (88138) |
| &nbsp;&nbsp;Other income and expenses | 2 | **678843** | 414712 | (189530) |
| **Loss before income tax** |  | **(35348675)** | (21843646) | (17444754) |
| &nbsp;&nbsp;Income tax expense | 3 | **-** | - | - |
| **Loss for the year** |  | **(35348675)** | (21843646) | (17444754) |
| **Loss attributable to shareholders of IperionX Limited** |  | **(35348675)** | (21843646) | (17444754) |
| **Other comprehensive income/(loss)** |  |  |  |  |
| *Items that may be reclassified subsequently to profit or loss:* | *Items that may be reclassified subsequently to profit or loss:* |  |  |  |
| &nbsp;&nbsp;Exchange differences arising on translation into presentation currency | 15(f) | **(1602139)** | (170014) | (411913) |
| **Other comprehensive loss for the year, net of tax** |  | **(1602139)** | (170014) | (411913) |
| **Total comprehensive loss for the year** |  | **(36950814)** | (22013660) | (17856667) |
| **Total comprehensive loss attributable to shareholders of IperionX Limited** |  | **(36950814)** | (22013660) | (17856667) |
| Basic loss per share (US$ per share) | 17 | **(0.12)** | (0.10) | (0.11) |
| Diluted loss per share (US$ per share) | 17 | **(0.12)** | (0.10) | (0.11) |

---

*The above Consolidated Statement of Profit or Loss and other Comprehensive Income should be read in conjunction with the accompanying notes.*

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**IperionX Limited**

**CONSOLIDATED STATEMENT OF FINANCIAL POSITION**

AS OF JUNE 30,

---

| | | | |
|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** |
| **ASSETS** |  |  |  |
| **Current Assets** |  |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | 5 | **54814125** | 33157356 |
| &nbsp;&nbsp;Trade and other receivables | 6 | **823268** | 2302010 |
| &nbsp;&nbsp;Prepayments | 7 | **3238894** | 6071735 |
| &nbsp;&nbsp;Inventories |  | - | 16920 |
| **Total Current Assets** |  | **58876287** | 41548021 |
| **Non-Current Assets** |  |  |  |
| &nbsp;&nbsp;Property, plant and equipment | 8 | **25197638** | 7773812 |
| &nbsp;&nbsp;Intangible assets | 9 | **13550993** | - |
| &nbsp;&nbsp;Exploration and evaluation assets | 10 | **6512326** | 6114061 |
| &nbsp;&nbsp;Prepayments | 7 | **897735** | - |
| Total Non-Current Assets |  | **46158692** | 13887873 |
| **TOTAL ASSETS** |  | **105034979** | 55435894 |
| **LIABILITIES** |  |  |  |
| **Current Liabilities** |  |  |  |
| &nbsp;&nbsp;Trade and other payables | 11 | **7489397** | 2317830 |
| &nbsp;&nbsp;Loans and borrowings | 12 | **472018** | 445755 |
| &nbsp;&nbsp;Provisions |  | **467001** | 287796 |
| Total Current Liabilities |  | **8428416** | 3051381 |
| **Non-Current Liabilities** |  |  |  |
| &nbsp;&nbsp;Other long term liability |  | **700000** | - |
| &nbsp;&nbsp;Loans and borrowings | 12 | **3462564** | 1044918 |
| Total Non-Current Liabilities |  | **4162564** | 1044918 |
| **TOTAL LIABILITIES** |  | **12590980** | 4096299 |
| **NET ASSETS** |  | **92443999** | 51339595 |
| **EQUITY** |  |  |  |
| &nbsp;&nbsp;Contributed equity | 14 | **197985920** | 112959638 |
| &nbsp;&nbsp;Reserves | 15 | **3688804** | 12262007 |
| &nbsp;&nbsp;Accumulated losses | 16 | **(109230725)** | (73882050) |
| **TOTAL EQUITY** |  | **92443999** | 51339595 |

---

*The above Consolidated Statement of Financial Position should be read in conjunction with the accompanying notes.*

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**IperionX Limited**

**CONSOLIDATED STATEMENT OF CHANGES IN EQUITY**

FOR THE YEAR ENDED JUNE 30, 2025

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Notes** | **Contributed<br> Equity**<br>**US$** | **Share-Based Payments Reserve**<br>**US$** | **Foreign Currency Translation<br>Reserve**<br>**US$** | **Accumulated Losses**<br>**US$** | **Total<br> Equity**<br>**US$** |
| **Balance at July 1, 2023** |  | **58764248** | **15004052** | **(1008244)** | **(52196828)** | **20563228** |
| &nbsp;&nbsp;Net loss for the year |  | - | - | - | (21843646) | (21843646) |
| &nbsp;&nbsp;Exchange differences arising on translation into presentation currency |  | - | - | (170014) | - | (170014) |
| **Total comprehensive loss for the year** |  | **-** | **-** | **(170014)** | **(21843646)** | **(22013660)** |
| &nbsp;&nbsp;Issue of shares – share placement |  | 45740157 | - | - | - | 45740157 |
| &nbsp;&nbsp;Issue of shares – exercise of options |  | 4335005 | (1743440) | - | - | 2591565 |
| &nbsp;&nbsp;Issue of shares – conversion of RSU's |  | 225734 | (225734) | - | - | - |
| &nbsp;&nbsp;Issue of shares – conversion of rights |  | 2757730 | (2757730) | - | - | - |
| &nbsp;&nbsp;Issue of shares to Blacksand |  | 2000000 | - | - | - | 2000000 |
| &nbsp;&nbsp;Issue of shares to consultants |  | 470000 | (470000) | - | - | - |
| &nbsp;&nbsp;Share issue costs |  | (1333236) | - | - | - | (1333236) |
| &nbsp;&nbsp;Expiry of employee rights |  | - | (158424) | - | 158424 | - |
| &nbsp;&nbsp;Share-based payment expense |  | - | 3791541 | - | - | 3791541 |
| **Balance at June 30, 2024** |  | **112959638** | **13440265** | **(1178258)** | **(73882050)** | **51339595** |
| &nbsp;&nbsp;Net loss for the year |  | - | - | - | (35348675) | (35348675) |
| &nbsp;&nbsp;Exchange differences arising on translation into presentation currency |  | - | - | (1602139) | - | (1602139) |
| **Total comprehensive loss for the year** |  | - | - | (1602139) | (35348675) | (36950814) |
| &nbsp;&nbsp;Issue of shares - share placement |  | 70919564 | - | - | - | 70919564 |
| &nbsp;&nbsp;Issue of shares - exercise of options |  | 205525 | - | - | - | 205525 |
| &nbsp;&nbsp;Issue of shares - conversion of RSUs |  | 2094041 | (2094041) | - | - | - |
| &nbsp;&nbsp;Issue of shares - conversion of rights |  | 13724952 | (13724952) | - | - | - |
| &nbsp;&nbsp;Issue of shares to consultants |  | 470262 | (470262) | - | - | - |
| &nbsp;&nbsp;Issue of shares to Director in lieu of bonus |  | 250000 | (250000) | - | - | - |
| &nbsp;&nbsp;Share issue costs |  | (2638062) | - | - | - | (2638062) |
| &nbsp;&nbsp;Share-based payment expense |  | - | 9568191 | - | - | 9568191 |
| **Balance at June 30, 2025** |  | **197985920** | **6469201** | **(2780397)** | **(109230725)** | **92443999** |

---

*The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.*

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**IperionX Limited**

**CONSOLIDATED STATEMENT OF CASH FLOWS**

FOR THE YEAR ENDED JUNE 30,

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Notes** | **2025**<br> **US$** | **2024**<br> **US$** | **2023**<br>**US$** |
| **Operating activities** |  |  |  |  |
| &nbsp;&nbsp;Payments to suppliers and employees |  | **(24240649)** | (19215938) | (15954550) |
| &nbsp;&nbsp;Receipts from third-parties |  | **569484** | 183159 | - |
| &nbsp;&nbsp;Interest paid |  | **(329740)** | (120313) | (49488) |
| &nbsp;&nbsp;Interest received |  | **2203220** | 546029 | 139644 |
| **Net cash flows used in operating activities** | 5 | **(21797685)** | (18607063) | (15864394) |
| **Investing activities** |  |  |  |  |
| &nbsp;&nbsp;Purchase of property, plant and equipment | 8 | **(16963016)** | (5018093) | (2077794) |
| &nbsp;&nbsp;Proceeds from sale of property, plant and equipment | 8 | **9417** | 2040083 | - |
| &nbsp;&nbsp;Purchases of intangible assets | 9 | **(6678750)** | - | - |
| &nbsp;&nbsp;Purchase of exploration and evaluation assets | 10 | **(644661)** | (3051559) | (627792) |
| &nbsp;&nbsp;Blacksand option prepayments | 7 | - | (500000) | (3000000) |
| **Net cash flows used in investing activities** |  | **(24277010)** | (6529569) | (5705586) |
| **Financing activities** |  |  |  |  |
| &nbsp;&nbsp;Proceeds from issue of shares |  | **71125089** | 48331724 | 29921945 |
| &nbsp;&nbsp;Share issue costs |  | **(2615882)** | (1315725) | (1511182) |
| &nbsp;&nbsp;Repayment of borrowings |  | **(5826)** | (5970) | (5594) |
| &nbsp;&nbsp;Payment of principal portion of lease liabilities |  | **(511749)** | (417866) | (512660) |
| **Net cash flows from financing activities** |  | **67991632** | 46592163 | 27892509 |
| &nbsp;&nbsp;Net increase in cash and cash equivalents |  | **21916937** | 21455531 | 6322529 |
| &nbsp;&nbsp;Net foreign exchange differences |  | **(260168)** | (236116) | (57139) |
| &nbsp;&nbsp;Cash and cash equivalents at beginning of the year |  | **33157356** | 11937941 | 5672551 |
| **Cash and cash equivalents at the end of the year** | 5 | **54814125** | 33157356 | 11937941 |
| **Supplemental cash flow information:** |  |  |  |  |
| Property, plant, equipment and intangible additions in accounts payable and other accrued liabilities |  | **2508971** | 734708 | - |

---

*The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.*

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**IperionX Limited** 

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

FOR THE YEAR ENDED JUNE 30, 2025

**1.&nbsp;&nbsp;&nbsp;&nbsp;STATEMENT OF MATERIAL ACCOUNTING POLICIES**

The material accounting policies adopted in preparing the consolidated financial statements of IperionX Limited ("IperionX" or "Company") and its consolidated entities ("Consolidated Entity" or "Group") for the years ended June 30, 2025, 2024 and 2023 are stated to assist in a general understanding of the consolidated financial statements.

IperionX is a for-profit company limited by shares, incorporated and domiciled in Australia. Our ordinary shares are listed on the Australian Securities Exchange, or ASX, under the symbol "IPX", and our American Depository Shares, or ADSs, each representing ten (10) of our ordinary shares, are listed on the Nasdaq Capital Market, or Nasdaq, under the symbol "IPX".

The principal activities of the Group during the year consisted of the development of its titanium metal technologies and the development of its mineral properties in the United States.

The Group is operating a U.S. based, integrated titanium business to support a range of advanced industries, including consumer electronics, aerospace, defense, medical, bicycles, additive manufacturing, and automotive. We expect to offer a range of titanium products and alloys for customers across these key industries.

Our portfolio of assets includes our operations at the Titanium Manufacturing Campus in Halifax County, Virginia; our Titan Project in Tennessee, which is in the exploration stage; and IPF R&D center in Salt Lake City, Utah, that together are re-shoring a sustainable titanium supply chain in the U.S.

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Basis of preparation**

The financial report is a general purpose financial report, which has been prepared in accordance with IFRS as issued by the IASB.

The consolidated financial report has also been prepared on a historical cost basis, except for other financial assets, which have been measured at fair value. The consolidated financial statements are presented in United States dollars (US$ or $).

*Going concern*

The financial statements have been prepared on the going concern basis, which contemplates the continuity of normal business activity and the realization of assets and the settlement of liabilities in the normal course of business.

The Group had net outflows from operating and investing activities of $46.1 million for fiscal 2025 (2024: $25.1 million) (2023: $21.6 million). At June 30, 2025, the Group has cash and cash equivalents of $54.8 million (2024: $33.2 million).

On July 29, 2025, the Company completed the placement of 14 million new fully paid ordinary shares at A$5.00 per share, to raise gross proceeds of $46 million (approximately A$70 million) before costs.

*Alleviation of Substantial Doubt About Going Concern*

During the prior fiscal year ended June 30, 2024, the Company disclosed in Note 1 to the consolidated financial statements that there were conditions and events that raised substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements were issued.

As of September 30, 2025, the Company concluded that the factors which led to the substantial doubt about the ability to continue as a going concern have been alleviated for at least twelve months from the issuance of these financial statements. The improvement in the Company's financial condition is attributable to the following events and actions taken by management:

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Continuous support from investors in the form of capital raise: During the year ended June 30, 2025, the Company successfully secured additional share placement cash inflows of $70.7 million. On July 29, 2025, the Company completed the placement of additional 14,000,000 new fully paid ordinary shares to raise proceeds of approximately $46 million (A$70 million) before costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Strong cash position: At June 30, 2025, the Group had cash reserves of $54.8 million. The subsequent capital raise in July 2025 mentioned above increased the cash position to approximately $100 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Continuous Government support: The U.S. government continues to support IperionX's efforts to re-shore a secure domestic titanium supply chain, building upon the initial $12.7 million contract awarded to IperionX in 2023. As of June 30, 2025, the Company has been awarded approximately $60 million in funding and grants through the U.S. DoW DPA Title III and IBAS programs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Subsequent inclusion in the ASX 200 index - attracting institutional investment and increasing liquidity, meaning improved access to capital.

These developments have led management to conclude that the substantial doubt about the Company's ability to continue as a going concern has been alleviated. The Company's current financial projections, which consider these positive developments, support the Company's ability to meet its obligations as they become due for at least one year from the issuance of these financial statements. No adjustments are required to the carrying amounts or classification of assets and liabilities in the financial statements.

**(b)&nbsp;&nbsp;&nbsp;&nbsp;New standards, interpretations and amendments**

In the current year, the Group has adopted all of the new and revised Accounting Standards and Interpretations effective from July 1, 2024 that are mandatory.

The adoption of the aforementioned standards has had no impact on the financial statements of the Company as at June 30, 2025. The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

**(c)&nbsp;&nbsp;&nbsp;&nbsp;Issued standards and interpretations not early adopted**

International Financial Reporting Standards and Interpretations that have recently been issued or amended but are not yet effective have not been adopted by the Group for the year ended June 30, 2025. Those which may be relevant to the Group are set out in the table below, but these are not expected to have any significant impact on the Group's financial statements:

---

| | | |
|:---|:---|:---|
| **Standard/Interpretation** | **Application Date<br> of Standard** | **Application Date <br>for the Group** |
| *Amendments to IFRS 10 and IAS 28 – Sale or Contribution of Assets between an Investor and its Associate or Joint Venture* | 1 January 2025 | 1 July 2025 |
| *IFRS 18 Presentation and Disclosure in Financial Statements* | 1 January 2027 | 1 July 2027 |

---

A discussion on the impact of the adoption of IFRS 18 *Presentation and Disclosure in Financial Statements* is included below. The adoption of the other aforementioned standard is not expected to have any significant impact on the Group's financial statements.

***IFRS 18 Presentation and Disclosure in Financial Statements***

IFRS 18 *Presentation and Disclosure in Financial Statements replaces IAS 1 Presentation of Financial Statements* and introduces new requirements for the presentation of financial statements. IFRS 18 will not change the recognition and measurement of items in the financial statements but will affect presentation and disclosure in the financial statements, including introducing new categories and subtotals in the statement of profit or loss, requiring the disclosure of management defined performance measures, and changing the grouping of information in the financial statements.

**(d)&nbsp;&nbsp;&nbsp;&nbsp;Principles of Consolidation**

The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of the Company.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Control is achieved when the Company has power over the investee, is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to use its power to affect its returns. The Company reassesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the three elements of control listed above. When the Company has less than a majority of the voting rights of an investee, it has power over the investee when the voting rights are sufficient to give it the practical ability to direct the relevant activities of the investee unilaterally. The Company considers all relevant facts and circumstances in assessing whether or not the Company's voting rights in an investee are sufficient to give it power.

Subsidiaries are all those entities (including special purpose entities) over which the Company has the power to govern the financial and operating policies, so as to obtain benefits from its activities, generally accompanying a shareholding of more than one-half of the voting rights. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Company controls another entity.

The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Company.

Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are de-consolidated from the date that control ceases.

Intercompany transactions and balances, income and expenses and profits and losses between Group companies, are eliminated.

**(e)&nbsp;&nbsp;&nbsp;&nbsp;Foreign Currencies**

*(i)Functional and presentation currency*

The functional currency of each of the Group's entities is measured using the currency of the primary economic environment in which that entity operates. The parent Company's functional currency is Australian dollars.

The Group's financial statements are presented in U.S. dollars which is the Group's presentation currency. U.S dollars has been chosen as the Group's presentation currency to better reflect the Groupʼs business activities in the U.S. and to enhance comparability with its industry peer group, the majority of which report in U.S. dollars.

*(ii)Transactions and balances*

Foreign currency transactions are translated into functional currency using the exchange rates prevailing at the date of the transaction. Foreign currency monetary items are translated at the year-end exchange rate. Non-monetary items measured at historical cost continue to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange rate at the date when fair values were determined.

Exchange differences arising on the translation of monetary items are recognized in the income statement, except where deferred in equity as a qualifying cash flow or net investment hedge.

Exchange differences arising on the translation of non-monetary items are recognized directly in equity to the extent that the gain or loss is directly recognized in equity, otherwise the exchange difference is recognized in the income statement.

*(iii)Group companies*

The financial results and position of operations whose functional currency is different from the Group's presentation currency are translated as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• assets and liabilities are translated at year-end exchange rates prevailing at that reporting date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• income and expenses are translated at average exchange rates for the year; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• retained earnings are translated at the exchange rates prevailing at the date of the transaction.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Exchange differences arising on translation into the presentation currency are transferred directly to the Group's foreign currency translation reserve in equity. These differences are recognized in profit or loss in the year in which the operation is disposed.

**(f)&nbsp;&nbsp;&nbsp;&nbsp;Cash and Cash Equivalents**

Cash and cash equivalents include cash on hand, deposits held at call with banks and other short-term highly liquid investments with original maturities of three months or less.

**(g)&nbsp;&nbsp;&nbsp;&nbsp;Trade and Other Receivables**

Trade receivables are recognized initially at fair value and subsequently measured at amortized cost using the effective interest method, less allowance for any expected credit loss applying the simplified approach. If collection of the amounts is expected in one year or less, they are classified as current assets. If not, they are presented as non-current assets. Trade receivables are generally due for settlement within 30 days and therefore are all classified as current.

As the majority of receivables are short term in nature, their carrying amount is assumed to be the same as their fair value.

An estimate for the expected credit loss is made based on the historical risk of default and expected loss rates at the inception of the transaction. Inputs are selected for the ECL impairment calculation based on the Group's past history, existing market conditions as well as forward looking estimates.

**(h)&nbsp;&nbsp;&nbsp;&nbsp;Prepayments**

Prepayments represent payments in advance of receipt of goods or services. The Group recognizes a prepayment as an asset within other current and non-current assets when payment for goods or services has been made in advance of the Group obtaining a right to access those goods or services. These prepayments are assessed for indicators of impairment each year. If future economic benefits are no longer expected to occur, and economic benefits cannot be derived from the prepayment in any other way, the prepayment will be unrecognized.

**(i)&nbsp;&nbsp;&nbsp;&nbsp;Property, Plant and Equipment**

All classes of property, plant and equipment are measured at cost. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets, except for land which is not depreciated. Currently the Group only has plant and equipment, buildings and leasehold improvements. Plant and equipment is depreciated over a period between 5 and 10 years. Buildings and leasehold improvements are depreciated over a period between 10 and 15 years.

**(j)&nbsp;&nbsp;&nbsp;&nbsp;Intangible Assets**

Intangible assets are stated at cost, net of accumulated amortization and accumulated impairment losses, if any. Cost in relation to patents includes registration, documentation and other legal fees associated with obtaining the patent. The costs of internally generated intangible assets are not capitalized and the expense is reflected as research and development costs in the statement of income as it is incurred.

The cost of intangible assets is amortized using the straight-line method over their estimated useful lives, and are reviewed at least annually. The expected changes in the useful life or in the pattern of consumption of the future economic benefits of the asset are accounted for when changing the period or amortization method, as appropriate, and they are treated as changes in the accounting estimates. Amortization expense is recognized in the statement of income as research and development costs.

The Group's primary patents each have a useful life between 8 and 20 years with a remaining weighted average useful life of 11.6 years. Further patents are granted in various jurisdictions to extend the territorial coverage of the primary patent. Intangible assets are tested for impairment when there is an indicator of impairment, as well as possible reversal of previous impairment losses.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**(k)&nbsp;&nbsp;&nbsp;&nbsp;Exploration and Evaluation Expenditure**

Exploration and evaluation expenditures are accounted for in accordance with the 'area of interest' method and with IFRS 6 *Exploration for and Evaluation of Mineral Resources.*

Exploration and evaluation expenditure encompasses expenditures incurred by the Group in connection with the exploration for and evaluation of mineral resources before the technical feasibility and commercial viability of extracting a mineral resource are demonstrable.

For each area of interest, expenditure incurred in the acquisition of rights to explore is capitalized and recognized as an exploration and evaluation asset. This includes option payments made to landowners under the Group's option agreements with local landowners which are considered part of the acquisition costs. Exploration and evaluation assets are measured at cost at recognition and are recorded as an asset if:

(i)the rights to tenure of the area of interest are current; and

(ii)at least one of the following conditions is also met:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the exploration and evaluation expenditures are expected to be recouped through successful development and exploitation of the area of interest, or alternatively, by its sale; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• exploration and evaluation activities in the area of interest have not at the reporting date reached a stage which permits a reasonable assessment of the existence or otherwise of economically recoverable reserves, and active and significant operations in, or in relation to, the area of interest are continuing.

All other exploration and evaluation expenditures are expensed as incurred. Once the technical feasibility and commercial viability of a program or project has been demonstrated with a bankable feasibility study, the carrying amount of the exploration and evaluation expenditure in respect of the area of interest is reclassified as a "mine development property".

Where a decision is made to proceed with development, accumulated expenditure is tested for impairment and transferred to development properties, and then amortized over the life of the reserves associated with the area of interest once mining operations have commenced. Recoverability of the carrying amount of the exploration and evaluation assets is dependent on successful development and commercial exploitation, or alternatively, sale of the respective areas of interest.

*Impairment*

Capitalized exploration costs are reviewed each reporting date to establish whether an indication of impairment exists. If any such indication exists, the recoverable amount of the capitalized exploration costs is estimated to determine the extent of the impairment loss (if any). Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but only to the extent that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset.

**(l)&nbsp;&nbsp;&nbsp;&nbsp;Research and Development Expenditure**

All costs associated with research and development are expensed as incurred. Research and development activities are directed toward the development of new products as well as improvements in existing titanium processing technologies. These costs primarily include salaries and related personnel expenses, subcontractor expenses, patent registration expenses, materials, depreciation and amortization, allocated overhead, and other development expenses associated with processing operations at our IPF in Utah and TPF in Virginia. This change from the Company's former policy of capitalizing internally developed intellectual property had no impact on the financials.

**(m)&nbsp;&nbsp;&nbsp;&nbsp;Trade and other payables**

These amounts represent liabilities for goods and services provided to the Group prior to the end of the financial year which are unpaid. The amounts are unsecured and are usually paid within 60 days of recognition. Trade and other payables are presented as current liabilities unless payment is not due within 12 months from the reporting date.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

They are recognized initially at their fair value and subsequently measured at amortized cost using the effective interest method. The carrying amounts of trade and other payables are considered to be the same as their fair values, due to their short-term nature.

**(n)&nbsp;&nbsp;&nbsp;&nbsp;Provisions**

Provisions are recognized when the Group has a legal or constructive obligation, as a result of past events, for which it is probable that an outflow of economic benefits will result and that outflow can be reliably measured.

**(o)&nbsp;&nbsp;&nbsp;&nbsp;Interest income**

Interest income is recognized on a time proportionate basis that takes into account the effective yield on the financial asset.

**(p)&nbsp;&nbsp;&nbsp;&nbsp;Income Tax**

The income tax expense for the year is the tax payable on the current year's taxable income based on the national income tax rate for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences between the tax bases of assets and liabilities and their carrying amounts in the financial statements, and to unused tax losses.

Deferred tax assets and liabilities are recognized for temporary differences at the tax rates expected to apply when the assets are recovered or liabilities are settled, based on those tax rates which are enacted or substantively enacted for each jurisdiction. The relevant tax rates are applied to the cumulative amounts of deductible and taxable temporary differences to measure the deferred tax asset or liability. An exception is made for certain temporary differences arising from the initial recognition of an asset or a liability. No deferred tax asset or liability is recognized in relation to these temporary differences if they arose on goodwill or in a transaction, other than a business combination, that at the time of the transaction did not affect either accounting profit or taxable profit or loss.

Deferred tax liabilities and assets are not recognized for temporary differences between the carrying amount and tax bases of investments in controlled entities where the Company is able to control the timing of the reversal of the temporary differences and it is probable that the differences will not reverse in the foreseeable future.

Deferred tax assets are recognized for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts will be available to utilize those temporary differences and losses.

The carrying amount of deferred income tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized.

Unrecognized deferred income tax assets are reassessed at each balance date and are recognized to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.

Current and deferred tax balances attributable to amounts recognized directly in equity are also recognized directly in equity.

Deferred tax assets and deferred tax liabilities are offset only if a legally enforceable right exists to set off current tax assets against tax liabilities and the deferred tax liabilities relate to the same taxable entity and the same taxation authority.

**(q)&nbsp;&nbsp;&nbsp;&nbsp;Employee Entitlements**

Provision is made for the Group's liability for employee benefits arising from services rendered by employees to balance date. Employee benefits that are expected to be settled wholly within 12 months have been measured at the amounts expected to be paid when the liability is settled, plus related on-costs.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**(r)&nbsp;&nbsp;&nbsp;&nbsp;Earnings per Share**

Basic EPS is calculated by dividing the net profit attributable to members of the Company for the reporting period, after excluding any costs of servicing equity, by the weighted average number of ordinary shares of the Company, adjusted for any bonus issue.

Diluted EPS is calculated by dividing the basic EPS earnings, adjusted by the after tax effect of financing costs associated with dilutive potential Ordinary Shares and the effect on revenues and expenses of conversion to Ordinary Shares associated with dilutive potential Ordinary Shares, by the weighted average number of Ordinary Shares and dilutive Ordinary Shares adjusted for any bonus issue. Diluted earnings per share excludes all dilutive potential shares if their effect is anti-dilutive.

**(s)&nbsp;&nbsp;&nbsp;&nbsp;Use and Revision of Accounting Estimates, Judgments and Assumptions**

The preparation of the financial report requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised if the revision affects only that year, or in the year of the revision and future years if the revision affects both current and future years.

In particular, information about significant areas of estimation uncertainty and critical judgments in applying accounting policies that have the most significant effect on the amount recognized in the financial statements are described in the following notes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Functional currency (Note 1(e));

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Impairment of property plant and equipment (Note 8), intangibles (Note 9), and exploration and evaluation assets (Note 10);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Lease accounting (Note 13); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Share-based payments (Note 19).

**(t)&nbsp;&nbsp;&nbsp;&nbsp;Operating Segments**

An operating segment is a component of an entity that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity), whose operating results are regularly reviewed by the entity's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance and for which discrete financial information is available. This includes start up operations which are yet to earn revenues. Management will also consider other factors in determining operating segments such as the existence of a line manager and the level of segment information presented reviewed by the chief operating decision maker.

Operating segments have been identified based on the information provided to the chief operating decision makers.

The Group aggregates two or more operating segments when they have similar economic characteristics, and the segments are similar in each of the following respects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nature of the products and services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nature of the production processes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Type or class of customer for the products and services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Methods used to distribute the products or provide the services; and if applicable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nature of the regulatory environment.

Operating segments that meet the quantitative criteria as prescribed by IFRS 8 Operating Segments are reported separately. However, an operating segment that does not meet the quantitative criteria is still reported separately where information about the segment would be useful to users of the financial statements.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

Information about other business activities and operating segments that are below the quantitative criteria are combined and disclosed in a separate category for "all other segments".

Currently, the Group has only one operating segment.

**(u)&nbsp;&nbsp;&nbsp;&nbsp;Impairment of Non-Financial Assets**

The Group assesses at each reporting date whether there is an indication that an asset may be impaired. If any such indication exists, or when annual impairment testing for an asset is required, the Group makes an estimate of the asset's recoverable amount. An asset's recoverable amount is the higher of its fair value less costs of disposal and its value in use and is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets and the asset's value in use cannot be estimated to be close to its fair value. In such cases the asset is tested for impairment as part of the cash-generating unit to which it belongs. When the carrying amount of an asset or cash-generating unit exceeds its recoverable amount, the asset or cash-generating unit is considered impaired and is written down to its recoverable amount.

In assessing the value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

An assessment is also made at each reporting date as to whether there is any indication that previously recognized impairment losses may no longer exist or may have decreased. If such indication exists, the recoverable amount is estimated. A previously recognized impairment loss is reversed only if there has been a change in the estimates used to determine the asset's recoverable amount since the last impairment loss was recognized. If that is the case the carrying amount of the asset is increased to its recoverable amount. That increased amount cannot exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. After such a reversal the depreciation charge is adjusted in future years to allocate the asset's revised carrying amount, less any residual value, on a systematic basis over its remaining useful life.

**(v)&nbsp;&nbsp;&nbsp;&nbsp;Fair Value Estimation**

The fair value of financial assets and financial liabilities must be estimated for recognition and measurement or for disclosure purposes.

The fair value of financial instruments traded in active markets (such as publicly traded derivatives, and equity securities classified as fair value through other comprehensive income) is based on quoted market prices at the reporting date. The quoted market price used for financial assets held by the Group is the current bid price; the appropriate quoted market price for financial liabilities is the current ask price.

The nominal value less estimated credit adjustments of trade receivables and payables are assumed to approximate their fair values. The fair value of financial liabilities for disclosure purposes is estimated by discounting the future contractual cash flows at the current market interest rate that is available to the Group for similar financial instruments.

**(w)&nbsp;&nbsp;&nbsp;&nbsp;Issued and Unissued Capital**

Ordinary Shares and Performance Shares are classified as equity. Issued and paid up capital is recognized at the fair value of the consideration received by the Company. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.

**(x)&nbsp;&nbsp;&nbsp;&nbsp;Dividends**

Provision is made for the amount of any dividend declared on or before the end of the year but not distributed at balance date.

**(y)&nbsp;&nbsp;&nbsp;&nbsp;Share-Based Payments**

Equity-settled share-based payments are provided to officers, employees, consultants and other advisors. These share-based payments are measured at the fair value of the equity instrument at the grant date. The fair value of options is estimated

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

using the Black Scholes option valuation model. The fair value of performance rights that have market-based vesting conditions is estimated using a trinomial valuation model. The fair value of restricted stock units and performance rights that do not have market-based vesting conditions are estimated based on the underlying share price. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the Company's estimate of equity instruments that will eventually vest. At each reporting date, the Company revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognized in profit or loss over the remaining vesting period, with a corresponding adjustment to the share-based payments reserve.

Equity-settled share-based payments may also be provided as consideration for the acquisition of assets. Where ordinary shares are issued, the transaction is recorded at fair value based on the quoted price of the ordinary shares at the date of issue. The acquisition is then recorded as an asset or expensed in accordance with accounting standards.

**(z)&nbsp;&nbsp;&nbsp;&nbsp;Leases**

The Group assesses at contract inception whether a contract is, or contains, a lease. That is, if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.

*Right-of-use assets*

The Group recognizes right-of-use assets at the commencement date of the lease (i.e. the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets. If ownership of the leased asset transfers to the Group at the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset. The right-of-use assets are also subject to impairment.

*Lease liabilities*

At the commencement date of the lease, the Group recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating the lease, if the lease term reflects the Group exercising the option to terminate.

In calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments (e.g. changes to future payments resulting from a change in an index or rate used to determine such lease payments) or a change in the assessment of an option to purchase the underlying asset.

*Short-term leases and leases of low-value assets*

The Group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e. those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption to leases of office equipment that are considered to be low value. Lease payments on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**aa) Accounting for Government Funding Arrangements**

The U.S. government has invested significant resources to re-shore to the U.S. a secure domestic titanium supply chain. As of June 30, 2025, the Company has received awards under the U.S. DoW DPA and IBAS funding programs in the amount of approximately $60 million, with $17.7 million obligated as of June 30, 2025 under contract as described below. These contracts are accounted for under IAS 20, *Accounting for Government Grants and Disclosure of Government Assistance.*

*Funding under DPA* $12.7 million

In October 2023, IperionX executed a $12.7 million contract in funding under the U.S. DoW DPA Title III authorities to address the U.S. titanium supply chain vulnerabilities. The government share will be matched with $13.4 million in funding from IperionX, for a total funding amount of $26 million. This funding is being applied towards the Group's Titanium Production Facility in Virginia. The agreement has an initial term of 39 months, scheduled to terminate on January 30, 2027, and provides that it may be extended by mutual agreement. Under the agreement, the Company and the U.S. government have agreed to use best efforts to achieve the goals of the agreement, which include the Company conducting a research and development program with respect to titanium technology.

For accounting purposes, the Company's role with respect to the equipment is to acquire it on behalf of the government in an agency capacity. Upon procurement of the asset for the government, only a receivable is recognized reflecting the reimbursement due from the government. No amounts are capitalized or expensed by the Company.

As of June 30, 2025, the Company has procured assets on behalf of the government that cost approximately $10.3 million. (2025: $4.0 million), (2024: $6.3 million). We received cash reimbursements from the U.S. DoW of $5.6 million during the twelve months ended June 30, 2025 (2024: $4.7 million). We expect to utilize the full $12.7 million of available funding by the end of fiscal year 2026.

Title to all assets purchased by the Group with funds from the U.S. government vest with the U.S. government during the term of the technology investment agreement. The U.S. government can elect to, but is not obliged to, transfer such title to all (or some) of the assets to the Company at the end of the agreement, which is scheduled to terminate on January 30, 2027, if the Group's performance is satisfactory. Accordingly, the Company does not have an enforceable right to the assets acquired with federal funds, even where the conditions of the agreement are complied with, and so there is no current grant to be recognized. Instead, for accounting purposes, the Company's role with respect to the equipment is to acquire it on behalf of the U.S. government in an agency capacity. Upon procurement of the asset for the U.S. government, only a receivable is recognized reflecting the reimbursement due from the U.S. government. If, per the agreement, the government subsequently decides to transfer title of the assets to the Company at the end of the program, this is the point at which a grant would crystallize and the Company would record a non-monetary government grant.

*Funding under IBAS* $47.1 million

In February 2025, the Company was awarded up to $47.1 million by the U.S. DoW to strengthen the U.S. Defense Industrial Base by accelerating the scale-up of a resilient, low-cost, and fully-integrated U.S. mineral-to-metal titanium supply chain. The grant will be matched with $23.6 million in funding by IperionX, for a total funding amount of $70.7 million. This funding aims to bolster the U.S. defense Industrial base by developing a fully integrated, low-cost titanium supply chain sourced domestically. The project scope under the IBAS program had been revised to prioritize accelerated expansion of IperionX's titanium metal and manufacturing production capacity at IperionX's Virginia Titanium Manufacturing Campus.

As part of the initial phase, the DoW has obligated $5.0 million, and IperionX will contribute $1.0 million, to expedite the Titan Critical Minerals Project in Tennessee to 'shovel-ready' status, an important milestone in securing a new domestic source of titanium, rare earths and zircon critical minerals. Subsequent to year end, the DoW obligated an additional $12.5 million in August of 2025, and another $25.0 million in September of 2025, through the IBAS program to purchase orders for long-lead, major capital equipment required for the next stage of capacity scale-up to over 1,400 metric tons per year at the Virginia Titanium Manufacturing Campus. Total obligations now stand at $42.5 million, with the remaining $4.6 million expected to be obligated by the DoW over the contract term. The matching funding by IperionX increased to $48.1 million for a total funding amount of $95.2 million as of the date of this filing. Government reimbursements provided as grants are subject to conditional funding provisions. Grants for the initial phase are recognized as *"Other income and* 

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

*expenses"* in the consolidated statements of profit and loss and other comprehensive income, once all conditions for reimbursement are met.

As of June 30, 2025, the Company has incurred costs of $0.9 million toward the Titan Project definitive feasibility study and has requested reimbursements from U.S. DoW in the amount of $0.9 million which is recognized as "Other income and expenses" in the consolidated statements of profit and loss during fiscal year 2025. We have received cash reimbursements from the U.S. DoW of $0.1 million during the twelve months ended June 30, 2025. (2024: nil).

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**2.&nbsp;&nbsp;&nbsp;&nbsp;INCOME AND EXPENSES**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| **Research & development costs** |  |  |  |  |
| &nbsp;&nbsp;Wages and benefits |  | **(5519763)** | (3232758) | (1726207) |
| &nbsp;&nbsp;Payroll taxes on stock compensation benefits | 8 | **(183373)** | (49118) | - |
| &nbsp;&nbsp;Depreciation of property, plant and equipment | 8 | **(683678)** | (113224) | (147069) |
| &nbsp;&nbsp;Amortization of patents | 9 | **(768128)** | - | - |
| &nbsp;&nbsp;Amortization of right-of-use assets |  | **(710678)** | (427666) | (156204) |
| &nbsp;&nbsp;Other operating expenses<sup>(1)</sup> |  | **(4883353)** | (4889844) | (3571173) |
|  |  | **(12748973)** | (8712610) | (5600653) |
| **Corporate and administrative expenses** |  |  |  |  |
| &nbsp;&nbsp;Wages and benefits |  | **(4956272)** | (2047386) | (1637848) |
| &nbsp;&nbsp;Payroll taxes on stock compensation benefits |  | **(994640)** | (160058) | - |
| &nbsp;&nbsp;Other operating expenses<sup>(2)</sup> |  | **(4735464)** | (2308949) | (2352824) |
|  |  | **(10686376)** | (4516393) | (3990672) |
| **Employee benefits expense** |  |  |  |  |
| &nbsp;&nbsp;Salaries, wages and benefits |  | **(14830183)** | (8831195) | (5657464) |
| &nbsp;&nbsp;Share-based payment expenses | 19 | **(9568191)** | (3791541) | (2589413) |
|  |  | **(24398374)** | (12622736) | (8246877) |
| **Finance income** |  |  |  |  |
| &nbsp;&nbsp;Interest income |  | **2203220** | 546029 | 139697 |
| &nbsp;&nbsp;Net foreign exchange gain |  | **1347413** | - | 354772 |
|  |  | **3550633** | 546029 | 494469 |
| **Finance costs** |  |  |  |  |
| &nbsp;&nbsp;Interest expense |  | **(279541)** | (122736) | (88138) |
| &nbsp;&nbsp;Net foreign exchange loss |  | **-** | (48588) | - |
| &nbsp;&nbsp;Other finance costs |  | **(26709)** | (15795) | - |
|  |  | **(306250)** | (187119) | (88138) |
| **Other income and expenses** |  |  |  |  |
| &nbsp;&nbsp;Other income<sup>(3)</sup> |  | **939412** | 629815 | 60470 |
| &nbsp;&nbsp;Impairment of property, plant and equipment |  | **-** | (198750) | - |
| &nbsp;&nbsp;Loss on disposal of property, plant and equipment |  | **(260569)** | (16353) | - |
| &nbsp;&nbsp;Loss on derecognition of financial asset |  | **-** | - | (250000) |
|  |  | **678843** | 414712 | (189530) |

---

**Notes:**

<sup>(1)</sup> Research and development other operating expenses primarily includes expenses for the R&D facilities, materials, consumables, and consulting fees for continuous technology research.

<sup>(2)</sup> Corporate and administrative other operating expenses primarily includes insurance, legal and other professional fees, ERP system implementation costs and other corporate fees related to operating a public company.

<sup>(3)</sup> Other income includes $869,928 for government grant income billed to the U.S. DoW under the IBAS program. See Note 1(aa) for additional details.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**3.&nbsp;&nbsp;&nbsp;&nbsp;INCOME TAX**

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br> **US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| **Recognized in profit or loss** |  |  |  |
| Current income tax: |  |  |  |
| &nbsp;&nbsp;&nbsp;Current income tax benefit in respect of the current year | **-** | - | - |
| Deferred income tax: |  |  |  |
| &nbsp;&nbsp;&nbsp;Origination and reversal of temporary differences | **-** | - | - |
| Income tax expense reported in profit or loss | **-** | - | - |
| **Reconciliation between tax expense and accounting loss before income tax** | **Reconciliation between tax expense and accounting loss before income tax** |  |  |
| Accounting loss before income tax | **(35348675)** | (21843646) | (17444754) |
| Tax benefit at the Australian income tax rate of 30% | **(10604603)** | (6553094) | (5233426) |
| &nbsp;&nbsp;&nbsp;Effect of lower income tax rate in the United States | **1032615** | 631007 | 488952 |
| &nbsp;&nbsp;&nbsp;Expenditure not allowable for income tax purposes | **2885033** | 1427582 | 870584 |
| &nbsp;&nbsp;&nbsp;Income not assessable for income tax purposes | **(404224)** | - | - |
| &nbsp;&nbsp;&nbsp;Exchange differences | **(639)** | (2369) | 5329 |
| &nbsp;&nbsp;&nbsp;Adjustments in respect of deferred tax of previous years | **(738316)** | 583422 | (182314) |
| &nbsp;&nbsp;&nbsp;Effect of deferred tax assets not brought to account | **7830134** | 3913452 | 4050875 |
| Income tax expense reported in profit or loss | **-** | - | - |
| **Deferred tax assets and liabilities** |  |  |  |
| Deferred tax liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Right-of-use assets | **980747** | 414270 | 305000 |
| &nbsp;&nbsp;&nbsp;Deferred tax assets used to offset deferred tax liabilities | **(980747)** | (414270) | (305000) |
| Net deferred tax liabilities | **-** | - | - |
| Deferred tax assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;Accrued expenditures | **117578** | 70662 | 139113 |
| &nbsp;&nbsp;&nbsp;Provisions | **122051** | 75215 | 21956 |
| &nbsp;&nbsp;&nbsp;Lease liabilities | **1023320** | 383082 | 246832 |
| &nbsp;&nbsp;&nbsp;Capital allowances | **10394779** | 10896126 | 3241541 |
| &nbsp;&nbsp;&nbsp;Tax losses available to offset against future taxable income | **9668204** | 1556178 | 5361043 |
| &nbsp;&nbsp;&nbsp;Deferred tax assets used to offset deferred tax liabilities | **(980747)** | (414270) | (305000) |
| &nbsp;&nbsp;&nbsp;Other deferred tax assets not brought to account<sup>(1)</sup> | **(20345185)** | (12566993) | (8705485) |
| Net deferred tax assets | **-** | - | - |

---

**Notes:**

<sup>(1)</sup> The benefit of deferred tax assets not brought to account will only be subsequently recognized if: (a) future assessable income is derived of a nature and of an amount sufficient to enable the benefit to be realized; (b) the conditions for deductibility imposed by tax legislation continue to be complied with; and (c) no changes in tax legislation adversely affect the Group in realizing the benefit.

**4.&nbsp;&nbsp;&nbsp;&nbsp;DIVIDENDS PAID OR PROVIDED FOR ON ORDINARY SHARES**

No dividends have been paid or proposed for the year ended June 30, 2025 (2024: nil) (2023: nil).

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**5.&nbsp;&nbsp;&nbsp;&nbsp;CASH AND CASH EQUIVALENTS**

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| Cash at bank and on hand | **54814125** | 33157356 | 11937941 |
| **Reconciliation of loss before income tax to net cash flows from operations** | **Reconciliation of loss before income tax to net cash flows from operations** |  |  |
| Loss for the year | **(35348675)** | (21843646) | (17444754) |
| **Adjustment for non-cash income and expense items** |  |  |  |
| &nbsp;&nbsp;&nbsp;Share-based payments expense | **9568191** | 3791541 | 2589413 |
| &nbsp;&nbsp;&nbsp;Amortization of right-of-use assets | **793981** | 521099 | 249387 |
| &nbsp;&nbsp;&nbsp;Amortization of intangibles | **768128** | - | - |
| &nbsp;&nbsp;&nbsp;Depreciation of property, plant and equipment | **716147** | 124752 | 177147 |
| &nbsp;&nbsp;&nbsp;Net foreign exchange (gain)/loss | **(1347413)** | 48588 | (354772) |
| &nbsp;&nbsp;&nbsp;Loss on derecognition of financial asset | **-** | - | 250000 |
| &nbsp;&nbsp;&nbsp;Loss on disposal of property, plant and equipment | **260569** | 16353 | - |
| &nbsp;&nbsp;&nbsp;Impairment loss | **-** | 198750 | - |
| **Changes in assets and liabilities** |  |  |  |
| &nbsp;&nbsp;&nbsp;Receivables and prepayments | **1121984** | (2073615) | (650067) |
| &nbsp;&nbsp;&nbsp;Payables and provisions | **1669403** | 609115 | (680748) |
| Net cash outflow from operating activities | **(21797685)** | (18607063) | (15864394) |

---

**6.&nbsp;&nbsp;&nbsp;&nbsp;TRADE AND OTHER RECEIVABLES**

---

| | | |
|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** |
| **Current** |  |  |
| &nbsp;&nbsp;Receivables from U.S. Government<sup>(1)</sup> | **774248** | 1655435 |
| &nbsp;&nbsp;Receivables from other third-parties | **49020** | 646575 |
| Total trade and other receivables | **823268** | 2302010 |

---

**Notes:**

<sup>(1)</sup> See Note 1(aa) for additional details.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**7.&nbsp;&nbsp;&nbsp;&nbsp;PREPAYMENTS**

---

| | | |
|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** |
| **Current** |  |  |
| &nbsp;&nbsp;Blacksand option prepayments<sup>(1)</sup> | **-** | 5500000 |
| &nbsp;&nbsp;Construction prepayments | **2741220** | - |
| &nbsp;&nbsp;Other prepayments | **497674** | 571735 |
| Total current prepayments | **3238894** | 6071735 |
| **Non-current** |  |  |
| &nbsp;&nbsp;Security deposits | **438704** | - |
| &nbsp;&nbsp;Other non-current prepayments | **459031** | - |
| Total non-current prepayments | **897735** | - |

---

**Notes:**

<sup>(1)</sup> As of June 30, 2024, the Group had an exclusive option to purchase certain assets (including all intellectual property rights) of Blacksand. As consideration for the option, IperionX made option payments to Blacksand totaling $5,500,000 during the Option Period which represents the prepayments above. During the year ended June 30, 2025, the Group exercised its exclusive option to purchase intellectual property rights. See Note 9 for additional details.

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**8.&nbsp;&nbsp;&nbsp;&nbsp;PROPERTY, PLANT AND EQUIPMENT**

---

| | | | |
|:---|:---|:---|:---|
| | **Plant and<br> equipment**<br>**US$** | **Right-of-use assets**<br>**US$** | **Total**<br>**US$** |
| **2025** |  |  |  |
| &nbsp;&nbsp;Carrying amount at June 30, 2024 | **6188697** | **1585115** | **7773812** |
| &nbsp;&nbsp;Additions | **15996078** | **2961466** | **18957544** |
| &nbsp;&nbsp;Disposals | **(23590)** | **-** | **(23590)** |
| &nbsp;&nbsp;Depreciation | **(716147)** | **(793981)** | **(1510128)** |
| Carrying amount at June 30, 2025 | **21445038** | **3752600** | **25197638** |
| - at cost | **22350584** | **5444538** | **27795122** |
| - accumulated depreciation and impairment | **(905546)** | **(1691938)** | **(2597484)** |
| **2024** |  |  |  |
| &nbsp;&nbsp;Carrying amount at June 30, 2023 | 2822765 | 1167018 | 3989783 |
| &nbsp;&nbsp;Additions | 5745871 | 939196 | 6685067 |
| &nbsp;&nbsp;Disposals | (2056437) | - | (2056437) |
| &nbsp;&nbsp;Impairment | (198750) | - | (198750) |
| &nbsp;&nbsp;Depreciation | (124752) | (521099) | (645851) |
| Carrying amount at June 30, 2024 | **6188697** | **1585115** | **7773812** |
| - at cost | 6508437 | 2483072 | 8991509 |
| - accumulated depreciation and impairment | (319740) | (897957) | (1217697) |
| **2023** |  |  |  |
| &nbsp;&nbsp;Carrying amount at July 1, 2022 | 922118 | 465868 | 1387986 |
| &nbsp;&nbsp;Additions | 2077794 | 950537 | 3028331 |
| &nbsp;&nbsp;Depreciation | (177147) | (249387) | (426534) |
| Carrying amount at June 30, 2023 | **2822765** | **1167018** | **3989783** |
| - at cost | 3034599 | 1543876 | 4578475 |
| - accumulated depreciation and impairment | (211834) | (376858) | (588692) |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**9.&nbsp;&nbsp;&nbsp;&nbsp;INTANGIBLES**

---

| | |
|:---|:---|
| | **Intellectual property rights**<br>**US$** |
| **2025** |  |
| &nbsp;&nbsp;Carrying amount at June 30, 2024 | **-** |
| &nbsp;&nbsp;Transfers from prepayments<sup>(1)</sup> | **5500000** |
| &nbsp;&nbsp;Additions | **8819121** |
| &nbsp;&nbsp;Amortization | **(768128)** |
| Carrying amount at June 30, 2025 | **13550993** |
| - at cost | **14319121** |
| - accumulated amortization | **(768128)** |
| **2024** |  |
| Carrying amount at June 30, 2024 | **-** |

---

**Notes:**

<sup>(1)</sup> During the period, the Group exercised its exclusive option to purchase intellectual property rights of Blacksand Technology, LLC. The group now holds the exclusive commercial licensing rights for more than 40 global patents through a license agreement with the University of Utah including the global patents for patented technologies that can produce low-cost and low-carbon titanium metal. As consideration for the option, IperionX has made or will make payments totaling $14,270,495 (of which $5,500,000 was paid in prior periods, $6,616,251 was paid during the twelve months ended June 30, 2025, and $2,154,244 was payable at June 30, 2025, of which $1,454,244 was included in trade and other payables and $700,000 was included in other long term liabilities).

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**10.&nbsp;&nbsp;&nbsp;&nbsp;EXPLORATION AND EVALUATION ASSETS**

---

| | |
|:---|:---|
| | **Titan Project** <sup>(1)</sup><br>**US$** |
| **2025** |  |
| &nbsp;&nbsp;Carrying amount at July 1, 2024 | **6114061** |
| &nbsp;&nbsp;Additions | **644661** |
| &nbsp;&nbsp;Write-offs | **(246396)** |
| Carrying amount at June 30, 2025<sup>(1) (2)</sup> | **6512326** |
| **2024** |  |
| &nbsp;&nbsp;Carrying amount at July 1, 2023 | 3059021 |
| &nbsp;&nbsp;Additions | 3055040 |
| Carrying amount at June 30, 2024 | **6114061** |
| **2023** |  |
| &nbsp;&nbsp;Carrying amount at July 1, 2022 | 2431229 |
| &nbsp;&nbsp;Additions | 627792 |
| Carrying amount at June 30, 2023  | **3059021** |

---

**Notes:**

<sup>(1)</sup> At June 30, 2025, the Titan Project comprised of approximately 10,083 acres of surface and associated mineral rights in Tennessee prospective for heavy mineral sands, including titanium, rare earth minerals, high grade silica sand, and zircon, of which approximately 1,488 acres are owned by IperionX, approximately 417 acres are subject to long-term lease by IperionX, and approximately 8,178 acres are subject to exclusive option agreements with IperionX. These exclusive option agreements, upon exercise, allow the Group to lease, or in some cases purchase, the surface property and associated mineral rights.

<sup>(2)</sup> The ultimate recoupment of costs carried forward for exploration and evaluation is dependent on the successful development and commercial exploitation or sale of the respective areas of interest.

**11.&nbsp;&nbsp;&nbsp;&nbsp;TRADE AND OTHER PAYABLES**

---

| | | |
|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** |
| **Current** |  |  |
| &nbsp;&nbsp;Trade payables | **6004071** | 1309067 |
| &nbsp;&nbsp;Accruals | **1307087** | 259325 |
| &nbsp;&nbsp;Other payables | **178239** | 749438 |
| Total trade and other payables | **7489397** | 2317830 |

---

------

*<u>[Table of](#i760a975fe85d4d298949348d23ef9dde_7)[Content](#i760a975fe85d4d298949348d23ef9dde_7)[s](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**12.&nbsp;&nbsp;&nbsp;&nbsp;LOANS AND BORROWINGS**

---

| | | | |
|:---|:---|:---|:---|
| | **Other Loans and Borrowings**<br>**US$** | **Lease Liabilities**<br>**US$** | **Total Loans and Borrowings**<br>**US$** |
| **2025** |  |  |  |
| &nbsp;&nbsp;Carrying amount at July 1, 2024 | **24893** | **1465780** | **1490673** |
| &nbsp;&nbsp;Additions | **-** | **2961565** | **2961565** |
| &nbsp;&nbsp;Repayments | **(5826)** | **(511830)** | **(517656)** |
| Carrying amount at June 30, 2025 | **19067** | **3915515** | **3934582** |
| Current | **6764** | **465254** | **472018** |
| Non-Current | **12303** | **3450261** | **3462564** |
| **2024** |  |  |  |
| &nbsp;&nbsp;Carrying amount at July 1, 2023 | 30863 | 944451 | 975314 |
| &nbsp;&nbsp;Additions | - | 939195 | 939195 |
| &nbsp;&nbsp;Repayments | (5970) | (417866) | (423836) |
| Carrying amount at June 30, 2024 | **24893** | **1465780** | **1490673** |
| Current | 6373 | 439382 | 445755 |
| Non-Current | 18520 | 1026398 | 1044918 |

---

**13.&nbsp;&nbsp;&nbsp;&nbsp;LEASES**

The Group leases office premises, vehicles, and plant and equipment in the United States. No restrictions or covenants are imposed by the leases.

The carrying amounts of right-of-use assets (included under property, plant and equipment) and the movements during the year are in Note 8.

The carrying amounts of lease liabilities (included under financial liabilities) and the movements during the year are set out in Note 12.

The following are the amounts recognized in profit or loss in respect of leases:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| &nbsp;&nbsp;Amortization of right-of-use assets | 8 | **(793981)** | (521099) | (249387) |
| &nbsp;&nbsp;Interest expense on lease liabilities |  | **(278186)** | (106474) | (78040) |
| &nbsp;&nbsp;Expense relating to short-term leases and leases of low-value assets |  | **(143789)** | (72542) | (85100) |
| Net amount recognized in profit or loss |  | **(1215956)** | (700115) | (412527) |

---

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**14.&nbsp;&nbsp;&nbsp;&nbsp;CONTRIBUTED EQUITY**

---

| | | | |
|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** |
| **Issued capital** |  |  |  |
| 319,927,854 (2024: 257,244,759) fully paid ordinary shares | 14(a) | **197985920** | 112959638 |

---

We do not have a limit on our authorized share capital and the concept of par value is not recognized under Australian law.

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Movements in issued capital**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Number of<br> Ordinary <br>Shares** | **Number of<br> Class A<br> Performance <br>Shares** | **Number of<br> Class B<br> Performance <br>Shares** | **US$** |
| Opening balance at July 1, 2022 | **140288491** | **19800000** | **19800000** | **29782268** |
| &nbsp;&nbsp;Issue of shares – share placements | 50000000 | - | - | 29637300 |
| &nbsp;&nbsp;Issue of shares – exercise of options | 2102363 | - | - | 477156 |
| &nbsp;&nbsp;Issue of shares – conversion of RSUs | 200001 | - | - | 167487 |
| &nbsp;&nbsp;Issue of shares – conversion of performance rights | 215495 | - | - | 216007 |
| &nbsp;&nbsp;Issue of shares to consultants | 687623 | - | - | 350000 |
| &nbsp;&nbsp;Share issue costs | - | - | - | (1865970) |
| Closing balance at June 30, 2023 | **193493973** | **19800000** | **19800000** | **58764248** |
| &nbsp;&nbsp;Issue of shares – share placements | 43476381 | - | - | 45740157 |
| &nbsp;&nbsp;Issue of shares – exercise of options | 11231823 | - | - | 4335005 |
| &nbsp;&nbsp;Issue of shares – conversion of RSUs | 341461 | - | - | 225734 |
| &nbsp;&nbsp;Issue of shares – conversion of rights | 5140420 | - | - | 2757730 |
| &nbsp;&nbsp;Issue of shares to consultants | 554538 | - | - | 470000 |
| &nbsp;&nbsp;Issue of shares to Blacksand in lieu of cash | 3006163 | - | - | 2000000 |
| &nbsp;&nbsp;Share issue costs | - | - | - | (1333236) |
| Closing balance at June 30, 2024 | **257244759** | **19800000** | **19800000** | **112959638** |
| &nbsp;&nbsp;Issue of shares – share placements | **34951630** | **-** | **-** | **70919564** |
| &nbsp;&nbsp;Issue of shares – exercise of options | **1525000** | **-** | **-** | **205525** |
| &nbsp;&nbsp;Issue of shares – conversion of RSUs | **1639496** | **-** | **-** | **2094041** |
| &nbsp;&nbsp;Issue of shares – conversion of rights | **24273335** | **-** | **-** | **13724952** |
| &nbsp;&nbsp;Issue of shares to consultants | **151760** | **-** | **-** | **470262** |
| &nbsp;&nbsp;Issue of shares to Director in lieu of cash bonus | **141844** | **-** | **-** | **250000** |
| &nbsp;&nbsp;Conversion of performance shares | **30** | **(19800000)** | **-** | **-** |
| &nbsp;&nbsp;Share issue costs | **-** | **-** | **-** | **(2638062)** |
| Closing balance at June 30, 2025 | **319927854** | **-** | **19800000** | **197985920** |

---

**(b)&nbsp;&nbsp;&nbsp;&nbsp;Rights attaching to Ordinary Shares**

The rights attaching to fully paid Ordinary Shares arise from a combination of the Company's Constitution, statute and general law:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Shares* - The issue of shares in the capital of the Company and options over unissued shares by the Company is under the control of the directors, subject to the *Corporations Act 2001*, ASX Listing Rules and any rights attached to any special class of shares.

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**14. CONTRIBUTED EQUITY (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Meetings of Members* - Directors may call a meeting of members whenever they think fit. Members may call a meeting as provided by the *Corporations Act 2001*. The Constitution contains provisions prescribing the content requirements of notices of meetings of members and all members are entitled to a notice of meeting. A meeting may be held in two or more places linked together by audio-visual communication devices. A quorum for a meeting of members is two shareholders. The Company holds annual general meetings in accordance with the *Corporations Act 2001* and the Listing Rules.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Voting* - Subject to any rights or restrictions at the time being attached to any shares or class of shares of the Company, each member of the Company is entitled to receive notice of, attend and vote at a general meeting. Resolutions of members will be decided by a show of hands unless a poll is demanded. On a show of hands each eligible voter present has one vote. However, where a person present at a general meeting represents personally or by proxy, attorney or representative more than one member, on a show of hands the person is entitled to one vote only despite the number of members the person represents. On a poll each eligible member has one vote for each fully paid share held and a fraction of a vote for each partly paid share determined by the amount paid up on that share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Changes to the Constitution* - The Company's Constitution can only be amended by a special resolution passed by at least three quarters of the members present and voting at a general meeting of the Company. At least 28 days' written notice specifying the intention to propose the resolution as a special resolution must be given.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Listing Rules* - Provided the Company remains admitted to the Official List, then despite anything in its Constitution, no act may be done that is prohibited by the Listing Rules, and authority is given for acts required to be done by the Listing Rules. The Company's Constitution will be deemed to comply with the Listing Rules as amended from time to time.

**(c)&nbsp;&nbsp;&nbsp;&nbsp;Rights attaching to Performance Shares**

Performance Shares comprise of 19,800,000 Class A and 19,800,000 Class B Performance Shares issued in relation to the acquisition of HMAPL and are issued based upon the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Performance Shareholders are not entitled to a dividend;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Performance Shares are not transferable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Performance Shareholders shall have no right to vote, subject to the Corporations Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Performance Shares convert into Ordinary Shares as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Each Class A Performance Share convert into one (1) Ordinary Share upon completion of a positive pre-feasibility study (prepared in accordance with the JORC Code and independently verified by a Competent Person) for heavy mineral sands mining and processing on any of the Titan Project area which demonstrates a net present value of at least A$200,000,000 before September 17, 2024 (the "**Pre-Feasibility Study Milestone**"). The Pre-Feasibility Study Milestone was not met by September 17, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Each Class B Performance Share convert into one (1) Ordinary Share upon the commencement of commercial production from the Titan Project area before September 17, 2025 (the "**First Production Milestone**"). The First Production Milestone was not met by September 17, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ All Performance Shares shall automatically convert into Ordinary Shares upon the occurrence of certain change of control events before the applicable expiry date (being December 1, 2024 for the Class A Performance Shares and December 1, 2025 for the Class B Performance Shares);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ To the extent that any Performance Shares have not converted into Ordinary Shares by the applicable expiry date, (being December 1, 2024 for the Class A Performance Shares and December 1, 2025 for the Class B Performance Shares), all such Performance Shares for each holder will automatically lapse and be combined into one single Performance Share that will then convert into one single Ordinary Share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ The 19,800,000 Class A Performance Shares had not converted into Ordinary Shares by the applicable expiry date of December 1, 2024, so the 19,800,000 Class A Performance Shares converted into 30 Ordinary Shares during fiscal 2025; and

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**14. CONTRIBUTED EQUITY (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ If the 19,800,000 Class B Performance Shares have not converted into Ordinary Shares by the applicable expiry date of December 1, 2025, then the 19,800,000 Class B Performance Shares will convert into 30 Ordinary Shares during fiscal 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Ordinary Shares issued on conversion of any Performance Share will rank equally with and confer rights identical with all other Ordinary Shares then on issue and application will be made by the Company to ASX for official quotation of the Ordinary Shares upon the date of conversion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company shall allot and issue Ordinary Shares immediately upon conversion of the Performance Shares for no consideration and shall record the allotment and issue in the manner required by the Corporations Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Performance Shares are unquoted. No application for quotation of the Performance Shares will be made by the Company.

**15.&nbsp;&nbsp;&nbsp;&nbsp;RESERVES**

---

| | | | |
|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** |
| Share-based payments reserve | 15(b) | **6469201** | 13440265 |
| Foreign currency translation reserve | 15(f) | **(2780397)** | (1178258) |
|  |  | **3688804** | 12262007 |

---

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Nature and purpose of reserves**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(i)Share-based payments reserve*

The share-based payments reserve is used to record the fair value of Unlisted Options, RSUs and Performance Rights issued by the Group.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(ii)Foreign currency translation reserve*

Exchange differences arising on translation of entities whose functional currency is different to the Group's presentation currency are taken to the foreign currency translation reserve, as described in Note 1(e).

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**15. RESERVES (continued)**

**(b)&nbsp;&nbsp;&nbsp;&nbsp;Movements in share-based payments reserve during the year**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Number of** <br>**Unlisted**<br>**Options**<br> (Note 15(c)) | **Number of** <br>**Performance** <br>**Rights**<br>(Note 15(d)) | **No. of** <br>**Restricted Stock** <br>**Units**<br> (Note 15(e)) | **US$** |
| **2025** |  |  |  |  |
| &nbsp;&nbsp;Opening balance at July 1, 2024 | **11749372** | **27469335** | **4377034** | **13440265** |
| &nbsp;&nbsp;Grant of employee options, rights and RSUs | **2679746** | **5288409** | **2220020** | **-** |
| &nbsp;&nbsp;Exercise of options, rights and RSUs | **(1525000)** | **(24273335)** | **(1639496)** | **(15818993)** |
| &nbsp;&nbsp;Issue of shares to consultants | **-** | **-** | **-** | **(470262)** |
| &nbsp;&nbsp;Issue of shares to Director in lieu of bonus | **-** | **-** | **-** | **(250000)** |
| &nbsp;&nbsp;Lapse/forfeiture of employee rights and RSUs | **-** | **(980000)** | **(159333)** | **-** |
| &nbsp;&nbsp;Share-based payment expense | **-** | **-** | **-** | **9568191** |
| Closing balance at June 30, 2025 | **12904118** | **7504409** | **4798225** | **6469201** |
| **2024** |  |  |  |  |
| &nbsp;&nbsp;Opening balance at July 1, 2023 | 23011372 | 29146000 | 824371 | 15004052 |
| &nbsp;&nbsp;Grant of employee rights and RSUs | - | 4021000 | 3894124 | - |
| &nbsp;&nbsp;Exercise of options, rights and RSUs | (11262000) | (5147665) | (341461) | (4726904) |
| &nbsp;&nbsp;Issue of shares to consultants | - | - | - | (470000) |
| &nbsp;&nbsp;Expiry of employee rights | - | (550000) | - | (158424) |
| &nbsp;&nbsp;Share-based payment expense | - | - | - | 3791541 |
| Closing balance at June 30, 2024 | **11749372** | **27469335** | **4377034** | **13440265** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **2023** |  |  |  |  |
| &nbsp;&nbsp;Opening balance at July 1, 2022 | 23824000 | 27620000 | 600000 | 12985856 |
| &nbsp;&nbsp;Grant of employee incentive securities | 424372 | 1935000 | 424372 | - |
| &nbsp;&nbsp;Grant of options to financial advisor | 1000000 | - | - | 354788 |
| &nbsp;&nbsp;Exercise of options  | (2237000) | - | - | (192511) |
| &nbsp;&nbsp;Conversion of RSUs | - | (329000) | - | (167487) |
| &nbsp;&nbsp;Conversion of performance rights | - | - | (200001) | (216007) |
| &nbsp;&nbsp;Issue of shares to a consultant | - | - | - | (350000) |
| &nbsp;&nbsp;Lapse of employee incentive securities | - | (80000) | - | - |
| &nbsp;&nbsp;Share-based payment expense | - | - | - | 2589413 |
| Closing balance at June 30, 2023 | **23011372** | **29146000** | **824371** | **15004052** |

---

**Notes:**

<sup>(1)</sup> For details on the valuation of Unlisted Options, Performance Rights and RSUs, including models and assumptions used, refer to Note 19 of the financial statements.

**(c)&nbsp;&nbsp;&nbsp;&nbsp;Terms and conditions of Unlisted Options**

Unlisted Options granted as share-based payments have the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Each Unlisted Option entitles the holder to the right to subscribe for one share upon the exercise of each Unlisted Option;

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**15. RESERVES (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Unlisted Options outstanding at the end of the financial year have the following exercise prices and expiry dates:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,200,000 vendor unlisted options exercisable at A$0.20 each on or before December 1, 2025 (issued to the original vendors of HMAPL as consideration for the Company's acquisition of HMAPL in fiscal 2021);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 4,000,000 vendor Class A performance options exercisable at A$0.20 each on or before December 1, 2025 (issued to the original vendors of HMAPL as consideration for the Company's acquisition of HMAPL in fiscal 2021);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 4,000,000 vendor Class B performance options exercisable at A$0.20 each on or before December 1, 2025 (issued to the original vendors of HMAPL as consideration for the Company's acquisition of HMAPL in fiscal 2021);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 424,372 director options exercisable at A$0.87 each on or before December 5, 2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 600,000 director options exercisable at A$1.33 each on or before September 9, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,305,000 director options exercisable at A$8.00 each on or before June 30, 2027; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,374,746 director options exercisable at A$5.00 each on or before April 10, 2029.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Unlisted Options are exercisable at any time prior to the Expiry Date, subject to vesting conditions being satisfied (if applicable);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Shares issued on exercise of the Unlisted Options rank equally with the then Shares of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Application will be made by the Company to ASX for official quotation of the Shares issued upon the exercise of the Unlisted Options;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If there is any reconstruction of the issued share capital of the Company, the rights of the Unlisted Option holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the time of the reconstruction; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No application for quotation of the Unlisted Options will be made by the Company.

**(d)&nbsp;&nbsp;&nbsp;&nbsp;Terms and conditions of Performance Rights**

Performance Rights granted as share-based payments have the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Each Performance Right automatically converts into one Share upon vesting of the Performance Right;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Each Performance Right is subject to performance conditions (as determined by the Board from time to time) which must be satisfied in order for the Performance Right to vest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Performance Rights outstanding at the end of the financial year have the following performance conditions and expiry dates:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 2,885,000 employee performance rights that vest upon achieving a 30-day VWAP of A$4.00 per share (2,440,000 expiring December 21, 2028 and 445,000 expiring December 31, 2027);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,157,803 employee performance rights that vest upon achieving a 30-day VWAP of A$6.00 expiring April 10, 2031;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,157,803 employee performance rights that vest upon achieving a 30-day VWAP of A$7.00 per share expiring April 10, 2031;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,157,803 employee performance rights that vest upon achieving a 30-day VWAP of A$8.00 per share expiring April 10, 2031; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,146,000 employee performance rights that vest upon achieving various (non-market based) performance conditions (271,000 expiring December 22, 2025, 175,000 expiring December 31, 2025, 400,000 expiring April 23, 2026, 275,000 expiring December 22, 2026, and 25,000 expiring December 31, 2026).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Application will be made by the Company to ASX for official quotation of the Shares issued upon conversion of the Performance Rights;

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**15. RESERVES (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If there is any reconstruction of the issued share capital of the Company, the rights of the Performance Right holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the time of the reconstruction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No application for quotation of the Performance Rights will be made by the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Without approval of the Board, Performance Rights may not be transferred, assigned or novated, except, upon death, a participant's legal personal representative may elect to be registered as the new holder of such Performance Rights and exercise any rights in respect of them.

**(e)&nbsp;&nbsp;&nbsp;&nbsp;Terms and conditions of Restricted Stock Units**

RSUs granted as share-based payments have the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Each RSU automatically converts into one Share upon vesting of the RSU;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Each RSU is subject to service based performance conditions (as determined by the Board from time to time) which must be satisfied in order for the RSU to vest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The RSUs outstanding at the end of the financial year have the following conditions and expiry dates:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 141,456 director RSUs that vest upon achieving various service-based conditions, expiring December 5, 2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 270,084 director RSUs that vest upon achieving various service-based conditions, expiring December 5, 2027;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,083,355 director and employee RSUs that vest upon achieving various service-based conditions, expiring December 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,083,330 director and employee RSUs that vest upon achieving various service-based conditions, expiring 12/31/2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 25,132 director RSUs that vest upon achieving various service-based conditions, expiring 12/31/2027;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 212,430 director RSUs that vest upon achieving various service-based conditions, expiring December 16, 2028;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 344,483 employee RSUs that vest upon achieving various service-based conditions, expiring December 31, 2028;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ 1,637,975 director and employee RSUs that vest upon achieving various service-based conditions, expiring April 10, 2029.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Application will be made by the Company to ASX for official quotation of the Shares issued upon conversion of the RSUs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If there is any reconstruction of the issued share capital of the Company, the rights of the RSU holders may be varied to comply with the ASX Listing Rules which apply to the reconstruction at the time of the reconstruction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No application for quotation of the RSUs will be made by the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Without approval of the Board, RSUs may not be transferred, assigned or novated, except, upon death, a participant's legal personal representative may elect to be registered as the new holder of such RSUs and exercise any rights in respect of them.

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**15. RESERVES (continued)**

**(f)&nbsp;&nbsp;&nbsp;&nbsp;Movements in foreign currency translation reserve during the year**

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| Balance at start of year | **(1178258)** | (1008244) | (596331) |
| Exchange differences arising on translation into presentation currency | **(1602139)** | (170014) | (411913) |
| Balance at June 30 | **(2780397)** | (1178258) | (1008244) |

---

**16.&nbsp;&nbsp;&nbsp;&nbsp;ACCUMULATED LOSSES**

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| Balance at start of year | **(73882050)** | (52196828) | (34752074) |
| Net loss for the year | **(35348675)** | (21843646) | (17444754) |
| Adjustment for expiry of employee rights | **-** | 158424 | - |
| Balance at June 30 | **(109230725)** | (73882050) | (52196828) |

---

**17.&nbsp;&nbsp;&nbsp;&nbsp;LOSS PER SHARE**

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| Basic loss per share | **(0.12)** | (0.10) | (0.11) |
| Diluted loss per share | **(0.12)** | (0.10) | (0.11) |

---

The following reflects the income and share data used in the calculations of basic earnings per share:

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| Net loss | **(35348675)** | (21843646) | (17444754) |
| Net loss used in calculating basic and dilutive earnings per share | **(35348675)** | (21843646) | (17444754) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**Share #** | **2024**<br>**Share #** | **2023**<br>**Share #** |
| Weighted average number of Ordinary Shares used in calculating basic and dilutive earnings per share | **296887872** | 217842947 | 168029357 |

---

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Anti-Dilutive Securities**

As at June 30, 2025, 12,904,118 Unlisted Options, 7,504,409 Performance Rights, 4,798,225 RSUs and 19,800,000 Performance Shares, which together represent 45,006,752 potential Ordinary Shares (2024: 83,195,741), (2023: 92,581,743), were not included in the calculation of diluted loss per share because they are considered anti-dilutive as they would decrease the loss per share for the years presented.

**(b)&nbsp;&nbsp;&nbsp;&nbsp;Conversions, Calls, Subscriptions or Issues after June 30, 2025**

Subsequent to June 30, 2025, the Company has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• issued 13,566,770 ordinary shares pursuant to a placement of ordinary shares; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• issued 1,716,396 ordinary shares pursuant to the exercise of unlisted options.

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• issued 165,000 unlisted performance rights to employees and contractors.

Other than as above, there have been no other conversions to, calls of, or subscriptions for Ordinary Shares or issues of potential Ordinary Shares since the reporting date and before the completion of this financial report.

**18.&nbsp;&nbsp;&nbsp;&nbsp;RELATED PARTIES**

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Subsidiaries**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Equity Interest** | **Equity Interest** | **Equity Interest** |
| | | **2025** | **2024** | **2023** |
| |<br>**Country of**<br>**Incorporation** | **%** | **%** | **%** |
| Hyperion Metals (Australia) Pty Ltd | Australia | 100 | 100 | 100 |
| IperionX Critical Minerals LLC | United States | 100 | 100 | 100 |
| IperionX Technology LLC | United States | 100 | 100 | 100 |
| IperionX Inc. | United States | 100 | 100 | 100 |

---

**(b)&nbsp;&nbsp;&nbsp;&nbsp;Ultimate Parent**

IperionX Limited is the ultimate parent of the Group.

**(c)&nbsp;&nbsp;&nbsp;&nbsp;Key Management Personnel**

The aggregate compensation made to KMP of the Group is set out below:

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| Short-term employee benefits | **4012976** | 3100958 | 2109813 |
| Post-employment benefits | **62632** | 68300 | 47502 |
| Share-based payments | **5496070** | 2749346 | 1650382 |
| Total compensation | **9571678** | 5918604 | 3807697 |

---

No loans were provided to or received from KMP during the year ended June 30, 2025 (2024: nil) (2023: nil).

Mr Swan provides services as the Company Secretary through a services agreement with the Apollo Group and was listed as a KMP during fiscal year 2024 and 2023. During the 2024 financial year, Apollo Group was paid or is payable $270,763 (A$413,000) (2023:$212,519; A$318,000) for the provision of serviced office facilities and administrative, accounting and company secretarial services to the Group. Mr. Swan ceased to be CFO and KMP effective December 21, 2023.

**(d)&nbsp;&nbsp;&nbsp;&nbsp;Other transactions with Related Parties**

Performance Industries, Inc., a company associated with Mr. Scott Sparks, COO of the Company, was paid $53,138 during the 2024 (2025: nil) financial year for the provision of engineering and construction services to the Group. The Company considers that the services provided by Performance Industries, Inc. were provided on an arm's length or better basis.

Balances and transactions between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not disclosed in this note.

**19.&nbsp;&nbsp;&nbsp;&nbsp;SHARE-BASED PAYMENTS**

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Recognized share-based payment expense**

From time to time, the Group grants ordinary shares, unlisted options, performance rights, and RSUs to officers, employees, consultants and other key advisors as part of remuneration and incentive arrangements. The number of Shares,

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**19. SHARE-BASED PAYMENTS (continued)**

Options, Rights, and RSUs granted, and the terms of the Shares, Options, Rights, and RSUs granted are determined by the Board. Shareholder approval is sought where required.

During fiscal 2025, fiscal 2024, and fiscal 2023 the following equity-settled share-based payments have been recognized in profit or loss:

---

| | | | |
|:---|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** | **2023**<br>**US$** |
| Expense arising from staff remuneration arrangements | **(9568191)** | (3791541) | (2589413) |
| Total expense arising from equity-settled share-based payment transactions | **(9568191)** | (3791541) | (2589413) |

---

In addition to share-based payment expenses recognized through profit or loss, a share-based payment of $2 million was recognized as an asset (prepayments) during the 2024 financial year, relating to the issue of 3,006,163 new fully paid ordinary shares to nominees of Blacksand in lieu of future cash option payments totalling $2 million owed to Blacksand under the option agreement between the Company and Blacksand.

**(b)&nbsp;&nbsp;&nbsp;&nbsp;Summary of securities granted as share-based payments**

The following table illustrates the number and weighted-average exercise price of Options, and weighted-average grant date fair value for Rights and RSUs granted as share-based payments during fiscal 2025, fiscal 2024, and fiscal 2023:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Stock Option Awards** | **WA - Exercise Price A$** | **Restricted Stock Units** | **WA - Grant Date Fair Value A$** | **Performance Rights Awards (market-based conditions)** | **WA - Grant Date Fair Value A$** | **Performance Rights Awards (performance conditions)** | **WA - Grant Date Fair Value A$** |
| **July 1, 2022** | **23824000** | **0.27** | **600000** | **1.17** | **25655000** | **0.95** | **1965000** | **1.10** |
| Granted | 1424372 | 1.03 | 424372 | 0.74 | 1305000 | 0.32 | 630000 | 0.81 |
| Exercised/Converted | (2237000) | (0.25) | (200001) | (1.17) | - | - | (329000) | (0.95) |
| Forfeited | - | **-** | - | **-** | (50000) | (0.67) | (30000) | (0.99) |
| **June 30, 2023** | **23011372** | **0.32** | **824371** | **0.95** | **26910000** | **0.69** | **2236000** | **1.04** |
| Granted | - | **-** | 3894124 | 2.18 | 3980000 | 0.99 | 41000 | **1.10** |
| Exercised/Converted | (11262000) | (0.35) | (341461) | (0.99) | (4726665) | (0.71) | (421000) | (0.89) |
| Forfeited | - | **-** | - | **-** | (550000) | (0.66) | - | **-** |
| **June 30, 2024** | **11749372** | **0.28** | **4377034** | **2.04** | **25613335** | **0.74** | **1856000** | **1.08** |
| **Granted** | **2679746** | **6.46** | **2220020** | **3.99** | **4938409** | **3.49** | **350000** | **3.81** |
| **Exercised/Converted** | **(1525000)** | **(0.20)** | **(1639496)** | **(1.93)** | **(23273335)** | **(0.79)** | **(1000000)** | **(1.24)** |
| **Forfeited** | **-** | **-** | **(159333)** | **(2.27)** | **(920000)** | **(0.98)** | **(60000)** | **(0.91)** |
| **June 30, 2025** | **12904118** | **1.57** | **4798225** | **2.97** | **6358409** | **2.66** | **1146000** | **1.78** |

---

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**19. SHARE-BASED PAYMENTS (continued)**

**(b)&nbsp;&nbsp;&nbsp;&nbsp;Summary of securities granted as share-based payments (continued)**

The following Options, Rights and RSUs were granted as share-based payments during fiscal 2025, fiscal 2024, and fiscal 2023:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **2025** | **Security<br> Type** | **Number** | **Grant Date** | **Expiry<br>Date** | **Exercise<br>Price<br>A$** | **Vesting Hurdle<br>(30-day VWAP)<br>A$** | **Fair<br>Value<br> A$** |
| Series 1 | Rights | 445000 | 1-Nov-24 | 31-Dec-27 | - | 4.00 | 2.980 |
| Series 2 | Rights | 435000 | 1-Nov-24 | 23-Apr-26 | - | 3.00 | 3.120 |
| Series 3 | Rights | 585000 | 1-Nov-24 | 23-Apr-26 | - | 4.00 | 2.530 |
| Series 4 | Rights | 30000 | 1-Nov-24 | 31-Dec-25 | - | - | 3.400 |
| Series 5 | Rights | 200000 | 1-Nov-24 | 23-Apr-26 | - | - | 3.400 |
| Series 6 | RSUs | 25132 | 1-Nov-24 | 31-Dec-27 | - | - | 3.400 |
| Series 7 | RSUs | 169944 | 22-Nov-24 | 16-Dec-28 | - | - | 4.400 |
| Series 8 | Rights | 120000 | 20-Dec-24 | 31-Dec-25 | - | - | 4.600 |
| Series 9 | RSUs | 42486 | 9-Mar-25 | 16-Dec-28 | - | - | 3.370 |
| Series 10 | RSUs | 40000 | 6-May-25 | 31-Dec-28 | - | - | 3.490 |
| Series 11 | RSUs | 113475 | 8-May-25 | 31-Dec-28 | - | - | 3.400 |
| Series 12 | RSUs | 56738 | 9-May-25 | 31-Dec-28 | - | - | 3.550 |
| Series 13 | RSUs | 82335 | 10-May-25 | 10-Apr-29 | - | - | 3.550 |
| Series 14 | Options | 216672 | 10-May-25 | 10-Apr-29 | 5.00 | - | 1.870 |
| Series 15 | RSUs | 13617 | 12-May-25 | 31-Dec-28 | - | - | 3.410 |
| Series 16 | RSUs | 8511 | 13-May-25 | 31-Dec-28 | - | - | 3.170 |
| Series 17 | RSUs | 400533 | 15-May-25 | 10-Apr-29 | - | - | 3.110 |
| Series 18 | Rights | 415695 | 15-May-25 | 10-Apr-31 | - | 6.00 | 2.760 |
| Series 19 | Rights | 415695 | 15-May-25 | 10-Apr-31 | - | 7.00 | 2.680 |
| Series 20 | Rights | 415695 | 15-May-25 | 10-Apr-31 | - | 8.00 | 2.600 |
| Series 21 | RSUs | 48227 | 16-May-25 | 31-Dec-28 | - | - | 3.200 |
| Series 22 | RSUs | 82335 | 23-May-25 | 10-Apr-29 | - | - | 3.550 |
| Series 23 | Options | 216672 | 23-May-25 | 10-Apr-29 | 5.00 | - | 1.860 |
| Series 24 | RSUs | 24823 | 29-May-25 | 31-Dec-28 | - | - | 3.580 |
| Series 25 | RSUs | 9362 | 30-May-25 | 31-Dec-28 | - | - | 3.690 |
| Series 26 | RSUs | 26326 | 31-May-25 | 31-Dec-28 | - | - | 3.690 |
| Series 27 | RSUs | 357732 | 12-Jun-25 | 10-Apr-29 | - | - | 4.100 |
| Series 28 | Options | 941402 | 12-Jun-25 | 10-Apr-29 | 5.00 | - | 2.260 |
| Series 29 | RSUs | 3404 | 12-Jun-25 | 31-Dec-28 | - | - | 4.100 |
| Series 30 | Options | 1305000 | 26-Jun-25 | 30-Jun-27 | 8.00 | - | 1.090 |
| Series 31 | RSUs | 715040 | 27-Jun-25 | 10-Apr-29 | - | - | 4.750 |
| Series 32 | Rights | 742108 | 27-Jun-25 | 10-Apr-31 | - | 6.00 | 4.480 |
| Series 33 | Rights | 742108 | 27-Jun-25 | 10-Apr-31 | - | 7.00 | 4.380 |
| Series 34 | Rights | 742108 | 27-Jun-25 | 10-Apr-31 | - | 8.00 | 4.290 |

---

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**19. SHARE-BASED PAYMENTS (continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **2024** | **Security<br>Type** | **Number** | **Grant Date** | **Expiry<br> Date** | **Exercise<br>Price<br>A$** | **Vesting Hurdle<br>(30-day VWAP)<br>A$** | **Fair<br>Value<br>A$** |
| Series 1 | Shares | 116538 | 15-Aug-23 | - | - | - | 0.983 |
| Series 2 | Rights | 21000 | 15-Aug-23 | 22-Dec-24 | - | - | 1.095 |
| Series 3 | Rights | 10000 | 15-Aug-23 | 22-Dec-25 | - | - | 1.095 |
| Series 4 | Rights | 10000 | 15-Aug-23 | 22-Dec-26 | - | - | 1.095 |
| Series 5 | Rights | 200000 | 18-Dec-23 | 23-Apr-26 | - | 3.00 | 0.788 |
| Series 6 | Rights | 300000 | 18-Dec-23 | 23-Apr-26 | - | 4.00 | 0.630 |
| Series 7 | Rights | 3330000 | 18-Dec-23 | 21-Dec-28 | - | 4.00 | 1.008 |
| Series 8 | Shares | 388000 | 30-Jan-24 | - | - | - | 1.365 |
| Series 9 | Shares | 50000 | 30-Jan-24 | - | - | - | 1.365 |
| Series 10 | RSUs | 1434000 | 26-Mar-24 | 31-Dec-27 | - | - | 2.270 |
| Series 11 | RSUs | 2055000 | 9-Apr-24 | 31-Dec-27 | - | - | 2.270 |
| Series 12 | RSUs | 405124 | 22-Nov-23 | 5-Dec-27 | - | - | 1.415 |
| Series 13 | Rights | 75000 | 21-May-24 | 23-Apr-26 | - | 3.00 | 1.612 |
| Series 14 | Rights | 75000 | 21-May-24 | 23-Apr-26 | - | 4.00 | 1.322 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **2023** | **Security<br>Type** | **Number** | **Grant Date** | **Expiry<br>Date** | **Exercise<br>Price<br>A$** | **Vesting Hurdle<br>(30-day VWAP)<br>A$** | **Fair<br>Value<br>A$** |
| Series 1 | Options | 1000000 | 14-Sep-22 | 14-Sep-25 | 1.10 | - | 0.519 |
| Series 2 | Options | 424372 | 25-Nov-22 | 05-Dec-26 | 0.87 | - | 0.424 |
| Series 3 | RSUs | 424372 | 25-Nov-22 | 05-Dec-26 | - | - | 0.740 |
| Series 4 | Rights | 400000 | 8-Aug-22 | 23-Apr-26 | - | 3.00 | 0.354 |
| Series 5 | Rights | 400000 | 8-Aug-22 | 23-Apr-26 | - | 4.00 | 0.293 |
| Series 6 | Rights | 200000 | 8-Aug-22 | 23-Apr-26 | - | - | 0.675 |
| Series 7 | Rights | 10000 | 6-Sep-22 | 23-Apr-26 | - | 2.00 | 0.617 |
| Series 8 | Rights | 15000 | 6-Sep-22 | 23-Apr-26 | - | 3.00 | 0.496 |
| Series 9 | Rights | 35000 | 6-Sep-22 | 23-Apr-26 | - | 4.00 | 0.428 |
| Series 10 | Rights | 10000 | 6-Jun-22 | 23-Apr-26 | - | 2.00 | 0.556 |
| Series 11 | Rights | 15000 | 6-Jun-22 | 23-Apr-26 | - | 3.00 | 0.460 |
| Series 12 | Rights | 20000 | 6-Jun-22 | 23-Apr-26 | - | 4.00 | 0.390 |
| Series 13 | Rights | 10000 | 8-Jun-22 | 31-Dec-24 | - | - | 0.780 |
| Series 14 | Rights | 10000 | 8-Jun-22 | 31-Dec-25 | - | - | 0.780 |
| Series 15 | Rights | 10000 | 8-Jun-22 | 31-Dec-26 | - | - | 0.780 |
| Series 16 | Shares | 687623 | 20-Dec-22 | - | - | - | 0.775 |
| Series 17 | Rights | 400000 | 1-Feb-23 | 31-Jan-27 | - | - | 0.880 |
| Series 18 | Rights | 25000 | 16-Mar-23 | 23-Apr-26 | - | 3.00 | 0.286 |
| Series 19 | Rights | 25000 | 16-Mar-23 | 23-Apr-26 | - | 4.00 | 0.219 |
| Series 20 | Rights | 175000 | 1-Apr-23 | 23-Apr-26 | - | 3.00 | 0.321 |
| Series 21 | Rights | 175000 | 1-Apr-23 | 23-Apr-26 | - | 4.00 | 0.247 |

---

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**19. SHARE-BASED PAYMENTS (continued)**

**(c)&nbsp;&nbsp;&nbsp;&nbsp;Weighted Average Remaining Contractual Life** 

At June 30, 2025, the weighted average remaining contractual life of Unlisted Options was 0.96 years. (2024: 1.45 years) (2023: 2.90 years).

**(d)&nbsp;&nbsp;&nbsp;&nbsp;Option, Right and RSU Pricing Models**

The fair value of granted RSUs and Rights that do not have market-based vesting conditions are estimated as at the date of grant based on the underlying share price.

The fair value of granted Options is estimated as at the date of grant using the Black Scholes option valuation model taking into account the terms and conditions upon which the Unlisted Options were granted. The table below list the inputs to the valuation models used for Options granted by the Group during fiscal 2025, fiscal 2024 and fiscal 2023:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Expected life (weighted average)  | **2.96 years** | - | 3.31 years |
| Risk-free interest rate (weighted average) | **3.28%** | - | 3.31% |
| Expected volatility (weighted average)  | **80%** | - | 87.00% |
| Expected dividend yield  | **-%** | - | -% |

---

The fair value of granted Rights that have market-based vesting conditions is estimated as at the date of grant using a trinomial valuation model taking into account the market-based vesting criteria upon which the Rights were granted. The table below list the inputs to the valuation models used for the Rights that have market-based vesting conditions granted by the Group during fiscal 2025, fiscal 2024 and fiscal 2023:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Expected life (weighted average) | **4.69 years** | 4.56 years | 3.51 years |
| Risk-free interest rate (weighted average) | **3.73%** | 3.75% | 2.97% |
| Expected volatility (weighted average) | **77%** | 80% | 78% |
| Fair value at grant date (weighted average) | **A$3.49** | A$0.99 | A$0.32 |
| Share price at grant date (weighted average) | **A$3.94** | A$1.36 | A$0.71 |
| Vesting hurdle (30-day VWAP) (weighted average) | **A$6.02** | A$3.93 | A$3.49 |

---

**20.&nbsp;&nbsp;&nbsp;&nbsp;SEGMENT INFORMATION**

IFRS 8 requires operating segments to be identified on the basis of internal reports about components of the Consolidated Entity that are regularly reviewed by the chief operating decision maker in order to allocate resources to the segment and to assess its performance. The Consolidated Entity operates in one segment, being exploration and evaluation of mineral properties in the U.S. and research and development of associated metals technologies to support an integrated titanium processing operation.

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Reconciliation of non-current assets by geographical location**

---

| | | |
|:---|:---|:---|
| | **2025**<br>**US$** | **2024**<br>**US$** |
| United States of America | **45719988** | 13887873 |
|  | **45719988** | 13887873 |

---

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**21.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES**

**(a)&nbsp;&nbsp;&nbsp;&nbsp;Overview**

The Group's principal financial instruments comprise cash, receivables, other financial assets, payables, loans and borrowings and lease liabilities. The main risks arising from the Group's financial instruments are interest rate risk, foreign currency risk, credit risk and liquidity risk.

The Group manages its exposure to key financial risks in accordance with the Group's financial risk management policy. Key risks are monitored and reviewed as circumstances change and policies are revised as required. The overall objective of the Group's financial risk management policy is to support the delivery of the Group's financial targets whilst protecting future financial security.

Given the nature and size of the business and uncertainty as to the timing and amount of cash inflows and outflows, the Group does not enter into derivative transactions to mitigate the financial risks. In addition, the Group's policy is that no trading in financial instruments shall be undertaken for the purposes of making speculative gains. As the Group's operations change, the Directors will review this policy periodically going forward.

The Board of Directors has overall responsibility for the establishment and oversight of the risk management framework. The Board reviews and agrees policies for managing the Group's financial risks as summarised below.

**(b)&nbsp;&nbsp;&nbsp;&nbsp;Credit Risk**

Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument fails to meet its contractual obligations. This arises principally from cash and cash equivalents, receivables, and other financial assets.

There are no significant concentrations of credit risk within the Group. The carrying amount of the Group's financial assets represents the maximum credit risk exposure, as represented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** |
| Cash and cash equivalents | 5 | **54814125** | 33157356 |
| Trade and other receivables | 6 | **823268** | 2302010 |
|  |  | **55637393** | 35459366 |

---

With respect to credit risk arising from cash and cash equivalents, the Group's exposure arises from default of the counter party, with a maximum exposure equal to the carrying amount of these instruments. The credit risk for cash and cash equivalents is considered negligible, since the counterparties are reputable banks with high quality external credit ratings.

Trade and other receivables comprise primarily deposits, accrued interest and GST refunds due. Where possible the Group trades only with recognized, creditworthy third parties. It is the Group's policy that all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivable balances are monitored on an ongoing basis with the result that the Group's exposure to bad debts is not significant. There were no past due receivables at the date of this report.

**(c)&nbsp;&nbsp;&nbsp;&nbsp;Liquidity Risk**

Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due. The Board's approach to managing liquidity is to ensure, as far as possible, that the Group will always have sufficient liquidity to meet its liabilities when due. At June 30, 2025, the Group had sufficient liquid assets to meet its financial obligations.

The Group had no financial covenants during the 2025 and 2024 financial periods, as the Group's lease liabilities and other loans and borrowings do not impose any financial covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes.

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**21. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES (continued)**

The contractual maturities of financial liabilities, are provided below. There are no netting arrangements in respect of financial liabilities.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **≤1 year**<br>**US$** | **1-5 years**<br>**US$** | **≥5 years**<br>**US$** | **Total <br>contractual <br>cash flows**<br>**US$** | **Carrying <br>amount of <br>liabilities**<br>**US$** |
| **2025** |  |  |  |  |  |
| **Financial liabilities** |  |  |  |  |  |
| Trade and other payables | **7489397** | **-** | **-** | **7489397** | **7489397** |
| Lease liabilities | **465254** | **1425380** | **2024881** | **3915515** | **3915515** |
| Other loans and borrowings | **6764** | **12303** | **-** | **19067** | **19067** |
|  | **7961415** | **1437683** | **2024881** | **11423979** | **11423979** |
| **2024** |  |  |  |  |  |
| **Financial liabilities** |  |  |  |  |  |
| Trade and other payables | 2317830 | - | - | 2317830 | 2317830 |
| Lease liabilities | 439382 | 1336962 | - | 1776344 | 1465780 |
| Other loans and borrowings | 6373 | 20117 | - | 26490 | 24893 |
|  | 2763585 | 1357079 | - | 4120664 | 3808503 |

---

**(d)&nbsp;&nbsp;&nbsp;&nbsp;Interest Rate Risk**

The Group's exposure to the risk of changes in market interest rates relates primarily to the cash and short-term deposits with a floating interest rate. These financial assets with variable rates expose the Group to cash flow interest rate risk. All other financial assets and liabilities are either non-interest bearing (for example, receivables and payables) or have fixed interest rates (for example, lease liabilities, sub-lease receivables, and loans and borrowings).

At the reporting date, the interest rate profile of the Group's financial instruments was:

---

| | | | |
|:---|:---|:---|:---|
| | **Notes** | **2025**<br>**US$** | **2024**<br>**US$** |
| Cash at bank and on hand | 5 | **54814125** | 33157356 |
|  |  | **54814125** | 33157356 |

---

The Group's cash at bank and on hand and short-term deposits had a weighted average floating interest rate at year end of 3.48% (2024: 4.16%).

The Group currently does not engage in any hedging or derivative transactions to manage interest rate risk.

**Interest rate sensitivity**

A sensitivity of 0.5% (50 basis points) has been selected as this is considered reasonable given the current level of both short term and long-term interest rates. A 0.5% (50 basis points) movement in interest rates at the reporting date would

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**21. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES (continued)**

have increased (decreased) equity and profit or loss by the amounts shown below. This analysis assumes that all other variables, in particular foreign currency rates, remain constant.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Profit or loss** | **Profit or loss** | **Equity** | **Equity** |
| | **+0.5%**<br>**US$** | **-0.5%**<br>**US$** | **+0.5%**<br>**US$** | **-0.5%**<br>**US$** |
| **2025** |  |  |  |  |
| Cash and cash equivalents | **274071** | **(274071)** | **274071** | **(274071)** |
| **2024** |  |  |  |  |
| Cash and cash equivalents | 165787 | (165787) | 165787 | (165787) |
| **2023** |  |  |  |  |
| Cash and cash equivalents | 59690 | (59690) | 59690 | (59690) |

---

**(e)&nbsp;&nbsp;&nbsp;&nbsp;Foreign Currency Risk**

Foreign currency risk is the risk that the fair value of future cash outflows will fluctuate because of changes in foreign currency exchange rates.

The Group's exposure to the risk of changes in foreign exchange rate relates primarily to assets and liabilities that are denominated in currencies other than the functional currency of the group entity.

The Company's functional currency is Australian dollars. The financial statements are presented in United States dollars which is the Group's presentation currency.

The Group also has transactional currency exposures relating to transactions denominated in currencies other than the functional currency of the entity.

It is the Group's policy not to enter into any hedging or derivative transactions to manage foreign currency risk.

At the reporting date, the Group's exposure to financial instruments denominated in currencies other than the functional currency of the group entity:

---

| | | |
|:---|:---|:---|
| **Assets and liabilities denominated in currencies other than the functional currency of the group entity** | **2025 <br>US$ Equivalent** | **2024 <br>US$ Equivalent** |
| **Financial assets** | | |
| &nbsp;&nbsp;Cash and cash equivalents | **29417896** | 25268133 |
| **Financial liabilities** |  |  |
| &nbsp;&nbsp;Trade and other payables | **(1130814)** | (256267) |
| Net exposure | **28287082** | 25011866 |

---

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**21. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES (continued)**

**Foreign exchange rate sensitivity**

At the reporting date, had the US$ appreciated or depreciated against the A$, as illustrated in the table below, profit or loss and equity would have been affected by the amounts shown below. This analysis assumes that all other variables remain constant.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Profit or loss** | **Profit or loss** | **Equity** | **Equity** |
| | **+10%**<br>**US$** | **-10%**<br>**US$** | **+10%**<br>**US$** | **-10%**<br>**US$** |
| **2025** |  |  |  |  |
| Group | **2828708** | **(2828708)** | **2828708** | **(2828708)** |
| **2024** |  |  |  |  |
| Group | 2501186 | (2501186) | 2501186 | (2501186) |

---

**(f)&nbsp;&nbsp;&nbsp;&nbsp;Commodity Price Risk**

The Group's major commodity price exposure is to the price of titanium and titanium products. The price of titanium is affected by numerous factors beyond the control of the Group. The Group is currently researching, developing and commercializing its titanium metal technologies and exploring its mineral properties in the United States. To date, the Group has not had significant sales of titanium and titanium products, but anticipates product sales now that the Group's Titanium Manufacturing Campus in Virginia has been fully commissioned and started operations. We currently do not enter into hedging or derivative transactions to manage commodity price risk.

**(g)&nbsp;&nbsp;&nbsp;&nbsp;Capital Management**

The Board's policy is to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business. Given the stage of development of the Group, the Board's objective is to minimize debt and to raise funds as required through the issue of new shares. The Group is not subject to externally imposed capital requirements.

There were no changes in the Group's approach to capital management during the year.

**(h)&nbsp;&nbsp;&nbsp;&nbsp;Fair Value**

The fair value of financial assets and financial liabilities approximates their carrying value. The methods for estimating fair value are outlined in the relevant notes to the consolidated financial statements.

**22.&nbsp;&nbsp;&nbsp;&nbsp;CONTINGENT ASSETS AND LIABILITIES**

***Titan Project***

The Titan Project is prospective for critical mineral sands including titanium minerals, rare earth minerals, high grade silica sand and zircon minerals. At June 30, 2025, the Group had entered into exclusive option agreements with local landowners in Tennessee, in relation to its Titan Project, which upon exercise, allows the Group to lease or, in some cases purchase, the acres of surface property and the associated mineral rights from the local landowners. As of June 30, 2025, the Titan Project comprised approximately 10,083 acres of surface and associated mineral rights in Tennessee, of which approximately 1,488 acres are owned by IperionX, approximately 417 acres are subject to long-term lease by IperionX, and approximately 8,178 acres are subject to exclusive option agreements with IperionX. During the option period, our option agreements provide us with exclusive right to access, enter, occupy and use the surface property for all purposes related to exploring for and evaluating all minerals in return for making annual option payments and bonus payments during periods when we conduct drilling. Upon exercise, in the case of an option to lease, the Company will pay a production royalty to the landowners, subject to a minimum royalty. Upon exercise, in the case of a purchase, the Company will pay cash consideration approximating the fair market value of the property, excluding the value of any minerals, plus a premium.

------

*<u>[**Table of Contents**](#i760a975fe85d4d298949348d23ef9dde_7)</u>*

**23.&nbsp;&nbsp;&nbsp;&nbsp;EVENTS SUBSEQUENT TO BALANCE DATE**

(a)On July 29, 2025, the Company completed the first tranche of a placement of 14,000,000 new fully paid ordinary shares at A$5.00 per share, to raise gross proceeds of US$46 million (approximately A$70 million) before costs. The first tranche consisted of 13.6 million shares to institutional and sophisticated investors to raise gross proceeds of $44.3 million (~A$67.8 million) before costs. The second and final tranche consists of 0.4 million shares to Directors of the Company, subject to shareholder approval, to raise gross proceeds of $1.4 million (~ A$2.2 million) before costs. The placement positioned the company to capitalize on the United States' demand for a reliable source of titanium metal – particularly for defense, aerospace and advanced manufacturing applications. Ordering long-lead capital items at that time was expected to shorten the construction schedule for planned scale-up in titanium production capacity and underpinned ongoing engagement with the U.S. DoW.

(b) On August 26, 2025, the Company announced that the U.S. DoW had obligated $12.5 million under IperionX's previously announced $47 million award to strengthen the U.S. Defense Industrial Base by accelerating the scale-up of a resilient, low-cost, and fully-integrated U.S. mineral-to-metal titanium supply chain. The $12.5 million was applied to purchase orders for long-lead, major capital equipment required for the next stage of capacity scale-up to over 1,400 metric tons per year at the Virginia Titanium Manufacturing Campus; and

(c)On September 26, 2025, the Company announced that the DoW obligated an additional $25.0 million under IperionX's previously announced $47.1 million award bringing the total obligated award to $42.5 million, with the remaining $4.6 million to be obligated through the end of the contract term.

Other than the above, as at the date of this report there are no other matters or circumstances which have arisen since June 30, 2025 that have significantly affected or may significantly affect:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the operations, in financial years subsequent to June 30, 2025, of the Group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the results of those operations, in financial years subsequent to June 30, 2025, of the Group; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the state of affairs, in financial years subsequent to June 30, 2025, of the Group.

## Exhibit 8.1

**Exhibit 8.1**

**<u>List of Subsidiaries</u>**

---

| | | |
|:---|:---|:---|
| **<u>Name</u>** | **<u>Jurisdiction of Organization</u>** | **<u>Ownership Percentage</u>** |
| Hyperion Metals (Australia) Pty Ltd | Australia | 100% |
| IperionX Critical Minerals LLC | United States | 100% |
| IperionX Technology LLC | United States | 100% |
| IperionX Inc. | United States | 100% |

---

## Exhibit 12.1

**Exhibit 12.1**

**CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Anastasios Arima, certify that:

1. I have reviewed this annual report on Form 20-F of IperionX Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and

5. The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | October 14, 2025 |
| By: | /s/ Anastasios Arima |
|  | **Anastasios Arima** |
|  | Chief Executive Officer and Managing Director |
|  | (principal executive officer) |

---

## Exhibit 12.2

**Exhibit 12.2**

**CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Marcela Castro, certify that:

1. I have reviewed this annual report on Form 20-F of IperionX Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and

5. The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | October 14, 2025 |
| By: | /s/ Marcela Castro |
|  | **Marcela Castro** |
|  | Chief Financial Officer |
|  | (principal financial officer) |

---

## Exhibit 13.1

**Exhibit 13.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of IperionX Limited (the "Company") on Form 20-F for the fiscal year ended June 30, 2025 (the "Annual Report") as filed with the Securities and Exchange Commission on the date hereof, I, Anastasios Arima, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. the Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, as amended; and

2. the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of IperionX Limited.

---

| | |
|:---|:---|
| Date: | October 14, 2025 |
| By: | /s/ Anastasios Arima |
|  | **Anastasios Arima** |
|  | Chief Executive Officer and Managing Director |
|  | (principal executive officer) |

---

## Exhibit 13.2

**Exhibit 13.2**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of IperionX Limited (the "Company") on Form 20-F for the fiscal year ended June 30, 2025 (the "Annual Report") as filed with the Securities and Exchange Commission on the date hereof, I, Marcela Castro, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. the Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, as amended; and

2. the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of IperionX Limited.

---

| | |
|:---|:---|
| Date: | October 14, 2025 |
| By: | /s/ Marcela Castro |
|  | **Marcela Castro** |
|  | Chief Financial Officer |
|  | (principal financial officer) |

---

## Exhibit 15.2

**Exhibit 15.2**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-273519) and Form S-8 (No. 333-267088) of IperionX Limited our report dated October 14, 2025 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting of IperionX Limited, which appears in this Form 20-F.

<u>/s/</u> <u>PricewaterhouseCoopers</u>

Perth, Australia

October 14, 2025

## Exhibit 15.3

**Exhibit 15.3**

**Consent of Qualified Person**

Karst Geo Solutions, LLC ("Karst"), in connection with the annual report on Form 20-F of IperionX Limited for the year ended June 30, 2025 and any further amendments or supplements and/or exhibits thereto (collectively, the "Form 20-F"), consents to:

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the incorporation by reference and use of the technical report summary titled "Technical Report Summary for Titan Project" (as amended, the "Technical Report Summary"), as an exhibit to the Form 20-F;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the use of and references to Karst's name, including Karst's status as an expert or "qualified person" (as defined in Subpart 1300 of Regulation S-K promulgated by the Securities and Exchange Commission), in connection with the Form 20-F and the Technical Report Summary;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any extracts from, or summaries of, the Technical Report Summary in the Form 20-F and the use of information derived, summarized, quoted or referenced from the Technical Report Summary, or portions thereof, that was prepared by Karst, that Karst supervised the preparation of and/or that was reviewed and approved by Karst, that is included or incorporated by reference in the Form 20-F; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-267088) and Form F-3 (File No. 333-273519) of the above items as included in the Form 20-F.

Karst is responsible for authoring, and this consent pertains to, the Technical Report Summary. Karst certifies that it has read the Form 20-F and that it fairly and accurately represents the information in the Technical Report Summary for which it is responsible.

Date: October 14, 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

By: <u>/s/ Adam Karst</u>

Name: Adam Karst

Title: President & Principal Geologist of Karst Geo Solutions, LLC

<br>